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Prefácio 
 
 
 
O objecto de estudo desta tese foi o mecanismo de acção de um péptido vector, 
pep-1, capaz de introduzir proteínas dentro de células. Para a realização do trabalho 
usaram-se essencialmente técnicas espectroscópicas e de microscopia. Do trabalho 
realizado resultaram os seguintes artigos já publicados: 
 
1) Henriques S.T., Castanho M.A.R.B. (2004) Consequences of nonlytic membrane 
perturbation to the translocation of the cell penetrating peptide pep-1 in lipidic 
vesicles, Biochemistry, 43, 9716-9724. 
 
2) Henriques S.T., Castanho M.A.R.B. (2005) Environmental factors that enhance 
the action of the cell penetrating peptide pep-1. A spectroscopic study using 
lipidic vesicles, Biochim. Biophys. Acta, 1669, 75-86. 
 
3) Henriques S.T., Costa J., Castanho M.A.R.B. (2005) Translocation of β-
Galactosidase mediated by the cell-penetrating peptide pep-1 into lipid vesicles 
and human HeLa cells is driven by membrane electrostatic potential, 
Biochemistry, 44, 10189-98.  
 
4) Henriques S.T., Costa J., Castanho M.A.R.B. (2005) Re-evaluating the role of 
strongly charged sequences in amphipathic cell-penetrating peptides. A 
fluorescence study using Pep-1, FEBS Lett., 579, 4498-502. 
 
5) Henriques S.T., Melo M.N, Castanho M.A.R.B. (2006) Cell-Penetrating 
Peptides and Antimicrobial Peptides: how different are they?, Biochem J, 399, 
1-7. 
 
6) Henriques S.T., Melo M.N, Castanho M.A.R.B. (2007) How to address CPP and 
AMP translocation? Methods to detect and quantify peptide internalization in 
vitro and in vivo, Mol Memb Biol, 24, 173-184. 
 
7) Henriques S.T., Quintas A., Bagatolli L.A., Homblé F., Castanho M.A.R.B. 
(2007) Energy-independent translocation of cell-penetrating peptides occurs 
without formation of pores. A biophysical study with pep-1, Mol Memb Biol, 24, 
282-293. 
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8) Henriques S.T., Castanho M.A.R.B. (2007) Translocation or membrane 
disintegration? Implication of peptide-membrane interactions in pep-1 activity, J 
Pep Science, no prelo.  
 
 Como a maior parte do trabalho experimental relativo ao estudo do pep-1 já foi 
publicado em revistas internacionais, optou-se pela sua apresentação com recurso aos 
artigos científicos e pela redacção da tese em língua inglesa. 
 O manuscrito está dividido em oito capítulos. O primeiro capítulo apresenta uma 
introdução geral ao tema da internalização de macromoléculas dentro das células, com 
particular destaque para os péptidos vectores, vulgarmente designados por cell 
penetrating peptides (CPPs) e ao pep-1 como objecto de estudo. No segundo capítulo 
estão descritos estudos de interacção péptido-membrana realizados com modelos de 
membrana, os quais foram publicados em dois artigos (artigos 1 e 2, ver lista acima). A 
totalidade destes estudos foi realizada no laboratório de biofísica da FCUL sob 
orientação do Prof. Dr. Miguel Castanho onde foram empregues metodologias 
biofísicas. No terceiro capítulo é apresentado um artigo (artigo 7) onde se explorou a 
possibilidade de formação de poro induzida pelo pep-1. A parte experimental foi 
realizada essencialmente em laboratórios estrangeiros sob a orientação do Dr. Fabrice 
Homblé (Université Libre de Bruxelles, Bruxelas, Bélgica) e do Dr. Luís Bagatolli 
(Southern Denmark University, Odense, Dinamarca) onde se aplicaram técnicas não 
disponíveis no laboratório de biofísica da FCUL tais como: espectroscopia de 
infravermelho; equipamento para a realização de medidas de electrofisiologia; 
equipamento para preparar vesículas unilamelares grandes por aplicação do método de 
electroformação e microscopia confocal. No capítulo quatro estão apresentados os 
estudos realizados com linhas celulares de Humano, os quais foram publicados em dois 
artigos (artigos 3 e 4). Os estudos in vitro foram realizados no laboratório de biofísica 
na FCUL e os estudos em linhas celulares foram realizadas em colaboração com a Dr. 
Júlia Costa (ITQB, Oeiras). No capítulo cinco são integrados os resultados e 
apresentadas as conclusões. Uma comparação do mecanismo de acção do pep-1 com o 
mecanismo de outros péptidos vectores é apresentada. No capítulo seis estão os anexos 
onde se encontram três artigos de revisão que foram publicados no decurso do trabalho 
doutoral e relacionados com o pep-1 e os CPPs em geral (artigos 5, 6 e 8).  
Durante o doutoramento foi ainda objecto de estudo um outro péptido, o 
PrP(106-126), correspondente a um fragmento da proteína de prião que é considerado 
como o responsável pela toxicidade na doença do prião. Não se sabe se a toxicidade 
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deste péptido ocorre ao nível da membrana ou se dentro da célula. Como o PrP(106-126) 
possui uma estrutura anfipática semelhante à do pep-1, a possibilidade do PrP(106-126) 
atravessar a membrana por um mecanismo semelhante ao do pep-1 foi testada. Os 
resultados obtidos serão apresentados em dois artigos, ainda em preparação. No capítulo 
sete está um dos artigos ainda não publicado onde se incluem os resultados obtidos nos 
estudos com o péptido PrP(106-126). Por último, o capítulo oito compreende a 
bibliografia. 
 
Gostaria de agradecer a todos aqueles que de alguma forma contribuíram para a 
realização dos trabalhos aqui apresentados. 
Agradeço em primeiro lugar ao Professor Miguel Castanho pela oportunidade 
para a realização do doutoramento no seu laboratório, pela sua dedicação e empenho, 
pelos ensinamentos, pela sua formação pessoal e profissional, e sobretudo pela amizade. 
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Bioquímica da Faculdade de Ciências da Universidade de Lisboa pelas facilidades 
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Tecnologia pelo apoio financeiro concedido (bolsa SFRH/BD14337/2003).  
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Resumo 
 
 
 
 
A introdução de genes e de proteínas dentro de células é vista como uma 
possível ferramenta no estudo de processos celulares, bem como no tratamento de 
doenças genéticas. Esta possibilidade é no entanto limitada pela membrana celular, a 
qual constitui uma barreira para a entrada de moléculas hidrófilas. Para a possível 
entrada de moléculas com interesse farmacológico, ou com qualquer outra finalidade, é 
necessário utilizar um meio de transporte capaz de introduzir moléculas activas dentro 
de células. Nos últimos anos, têm sido desenvolvidas diferentes estratégias no sentido 
de contornar a barreira da célula. Como por exemplo: o uso de vectores virais; uso de 
lipossomas; electroporação ou microinjecção. Os primeiros, apesar de muito eficientes, 
devem ser evitados devido a reacções imunogénicas. Os restantes apresentam menos 
imunogenicidade mas são menos eficientes, apresentam uma baixa especificidade com 
dificuldades em atingir o alvo celular, elevados níveis de toxicidade e de consumo de 
tempo. Isto traduz-se numa incapacidade para atingir os efeitos bioquímicos desejados. 
Algumas proteínas citoplasmáticas, quando adicionadas extracelularmente, são 
capazes de entrar na célula por um mecanismo não tóxico. A capacidade de 
internalização destas proteínas deve-se à existência de sequências peptídicas ricas em 
aminoácidos básicos na proteína. Estas sequências catiónicas, frequentemente 
designadas por cell-penetrating peptides (CPPs), quando acopladas a outras proteínas, 
funcionam como vectores para a introdução de macromoléculas dentro das células. O 
mecanismo usado por estes péptidos revelou-se não tóxico e não invasivo. A introdução 
da proteína ao invés do gene tem ainda a vantagem de conseguir modificar o fenótipo de 
uma forma rápida e eficiente e com um maior impacto para futuras aplicações. Na 
maioria dos CPPs o complexo CPP/macromolécula é obtido pela ligação covalente entre 
CPP e a macromolécula.   
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Os CPPs mais estudados são a penetratina (16 resíduos de aminoácidos) e o TAT 
(13 resíduos de aminoácidos), os quais são provenientes da proteína pAntp (proteína de 
transcrição da Drosophila) e da proteína Tat (proteína de transcrição do HIV-1), 
respectivamente. Estes péptidos foram os primeiros identificados com propriedades de 
vector. Depois da descoberta do possível potencial destes péptidos, um grande número 
de outros péptidos têm sido relatados com propriedades semelhantes. Actualmente esta 
família inclui péptidos provenientes de diferentes fontes: uns derivados de proteínas ou 
de toxinas, outros são sintéticos e há ainda péptidos que resultam da quimera de duas ou 
mais sequências provenientes de diferentes fontes. De um modo geral os CPPs podem 
ser descritos como: pequenos péptidos (não mais do que 35 aminoácidos), solúveis em 
água, não tóxicos, capazes de translocar através da membrana celular por um 
mecanismo independente de receptores e de transportar consigo moléculas hidrófilas.   
Apesar das muitas possíveis aplicações destes péptidos o mecanismo usado 
pelos mesmos é tema de debate na literatura. A elucidação da estratégia usada por estes 
vectores é importante para uma futura distribuição de macromoléculas com interesse 
biológico em organismos vivos. 
Inicialmente foi proposto um mecanismo independente de receptores 
(sequências L e D foram internalizadas com a mesma eficiência, o que exclui a 
intervenção de um receptor para mediar a entrada dentro da célula) e independente de 
endocitose. A possível contribuição da endocitose foi avaliada pela eficiência de 
internalização a 37ºC e a 4ºC por meio de observações microscópicas. Eficiências 
semelhantes para as duas temperaturas sugerem que a entrada dos CPPs é independente 
das vias endossomais (a baixas temperaturas a produção de ATP é inibida e os 
processos celulares dependentes de energia, tal como a endocitose, são inibidos). Estes 
resultados sugerem que a translocação dos CPPs envolve a interacção directa do péptido 
com a membrana, onde as interacções péptido-lípido apresentam um papel central no 
processo. A observação da translocação directa de CPPs em modelos de membrana, 
compostos apenas por lípidos, veio apoiar esta hipótese de translocação. 
Contudo, observações recentes sugerem que a localização dos CPPs dentro das 
células a 4ºC é artificial e resulta de procedimentos de fixação das células para poderem 
ser visualizadas ao microscópio. A possível explicação para esta localização artificial 
prende-se com a grande afinidade dos CPPs para a membrana, devida à carga positiva 
dos péptidos e à carga negativa da membrana celular, o que faz com que permaneçam 
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adsorvidos à superfície da membrana mesmo que não sejam internalizados. Após a 
fixação, um processo agressivo para as células, o péptido aparece no citoplasma ou no 
núcleo. Depois desta observação foi realizada uma reavaliação do processo de 
internalização e houve uma tendência geral para aceitar que o mecanismo fisiológico 
mais relevante para a internalização dos CPPs é a endocitose. Todavia, resultados 
contraditórios têm sido publicados e diferentes grupos apoiam uma ou a outra hipótese. 
 
O péptido anfipático pep-1 (Ac-KETWWETWWTEWSQPKKKRKV-
cisteamina) inclui-se na família dos CPPs. Este péptido apresenta uma grande eficiência 
para a introdução de proteínas, péptidos e anticorpos dentro células de uma forma não 
tóxica e não imunogénica. O pep-1 oferece vantagens relativamente a outros CPPs pois 
em vez de ligações covalentes entre o péptido e a macromolécula, a formação do 
complexo CPP/macromolécula é mediada por interacções electrostáticas e hidrófobas.  
À semelhança do que acontece com os outros CPPs no início deste projecto 
havia incerteza no possível mecanismo de translocação usado por este péptido. Para 
uma aplicação mais generalizada deste transportador, e de outros pertencentes à mesma 
classe, a elucidação do mecanismo de acção é determinante. Os principais objectivos 
deste projecto são: a elucidação do mecanismo de translocação do pep-1; avaliar a sua 
qualidade como vector e comparar a seu modo de acção com os demais do grupo. 
A estrutura primária do pep-1 pode ser dividida em três domínios: um domínio 
hidrófobo rico em resíduos de Trp (Ac-KETWWETWWTEW); um domínio hidrófilo 
rico em aminoácidos básicos (KKKRKV-cisteamina) e um espaçador entre os dois 
anteriores (SQP) aumentando a flexibilidade e a integridade dos outros dois domínios. 
Em condições oxidantes há uma ligação persulfureto entre duas moléculas de péptido 
devido ao grupo cisteamina na extremidade C. Tendo em conta a anfipaticidade do pep-
1 é de esperar que apresente uma elevada afinidade para a membrana celular que poderá 
ser relevante para a sua actividade biológica. Este foi o ponto de partida para a 
realização dos nossos estudos.  
O trabalho experimental foi desenhado no sentido de crescente complexidade. 
Numa fase inicial avaliou-se a interacção do pep-1 com modelos de membranas simples 
compostos apenas por fosfolípidos. Estes modelos lipídicos são simples mas permitem 
modular as propriedades da membrana, como a fluidez e a carga da membrana, a força 
iónica e o pH. Em seguida foram realizados estudos em cultura de células humanas 
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onde se testou a capacidade vector do pep-1 quando complexado com uma proteína. 
Pela utilização de diferentes metodologias aplicando essencialmente técnicas biofísicas 
(e.g. espectroscopia de fluorescência e espectroscopia de UV-vis, dicroísmo circular, 
espectroscopia de infravermelho e electrofisiologia) e técnicas microscópicas 
(epifluorescência e microscopia confocal) foi possível obter resultados que integrados 
indicam que o pep-1 é capaz de translocar através da membrana celular por um 
mecanismo não mediado por endocitose.  
Resumidamente, foi possível verificar que a o mecanismo de translocação do 
péptido é iniciado pela partição do pep-1 na membrana celular. As interacções péptido-
lípido são inicialmente governadas por interacções electrostáticas entre o domínio 
hidrófilo e os grupos polares dos fosfolípidos que compõem a membrana celular. 
Subsequentemente, dada a proximidade com a membrana, o domínio hidrófobo insere-
se na bicamada, adquirindo uma conformação em hélice α. Aquando da inserção, o 
domínio hidrófobo induz destabilizações locais na membrana mas sem indícios para a 
formação de poro. A distribuição assimétrica das cargas na membrana celular 
(relativamente à composição lipídica e a gradiente electroquímico) é responsável pela 
existência de um potencial transmembranar (negativo dentro da célula) o qual promove 
a translocação do pep-1 da camada externa para a camada interna da membrana. Este 
processo é facilitado pelos distúrbios locais promovidos pela inserção do péptido na 
membrana e pelas interacções electrostáticas entre a molécula de péptido carregada 
positivamente e o interior da membrana carregada negativamente. Em contacto com o 
meio intracelular, ambiente redutor em contraste com as condições oxidantes fora da 
célula, o péptido perde afinidade para a membrana tornando-se mais estável dentro da 
célula. O processo torna-se praticamente irreversível e o equilíbrio é sempre deslocado 
no sentido extracelular → intracelular o que facilita a internalização do péptido bem 
como das macromoléculas associadas.  
A translocação ocorre por um processo mediado pela afinidade do pep-1 para a 
membrana onde as interacções de natureza electrostáticas e hidrófoba são determinantes 
no processo. Pelos estudos in vivo foi possível confirmar que este é o único mecanismo 
com relevância fisiológica, não se tendo identificado indícios para a endocitose como 
possível via alternativa. 
A entrada do pep-1 por um mecanismo independente de endocitose, em 
desacordo com o verificado para outros CPPs, sugere que o mecanismo de entrada não é 
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igual para todos os elementos desta família de péptidos e cada caso deverá ser analisado 
independentemente.  
No decurso do nosso trabalho experimental usou-se o pep-1 não derivatizado, 
fazendo-se uso das suas propriedades fluorescentes intrínsecas. No entanto, um pep-1 
derivatizado com uma sonda fluorescente foi também estudado e comparado com o 
péptido original. O péptido modificado apresentou uma menor afinidade para a 
membrana bem como uma menor eficiência de penetração nas células. Verificou-se 
ainda que, a pequena percentagem de péptido que entra na célula fá-lo por endocitose, 
ao contrário do pep-1 original. Estes resultados sugerem que o mecanismo de 
internalização utilizado depende especificamente do péptido, das condições 
experimentais e da sua afinidade para a membrana a qual modula a concentração de 
péptido particionado na membrana celular. Para baixas concentrações a endocitose é o 
mecanismo mais provável, ao passo que concentrações elevadas de péptido na 
membrana activam o processo físico, mais rápido que a endocitose.   
Esta hipótese baseia-se na observação de que alguns péptidos, dependendo das 
condições e em especial da concentração em solução, apresentam uma internalização 
mediada maioritariamente ou por endocitose (para baixas concentrações) ou pela 
penetração directa através da membrana (para altas concentrações). A suportar esta 
hipótese está também a relação entre afinidade e partição observada em vários estudos.  
É de referir que, quando os CPPs são internalizados por um mecanismo mediado 
por endocitose, a macromolécula acoplada ao vector só atingirá o seu alvo final se o 
CPP conseguir escapar dos endossomas. Para que isto ocorra o CPP terá de atravessar a 
membrana dos endosomas o que pressupõe um processo físico. O gradiente de pH, que 
existe entre os endosomas (pH =5) e o citoplasma (pH=7.4), é um possível potenciador 
da passagem de CPPs através da membrana, em semelhança ao que acontece quando a 
translocação é mediada pelo potencial transmembranar. CPPs cuja internalização ocorra 
maioritariamente por um mecanismo mediado por endocitose revelaram-se menos 
eficientes.  
O trabalho aqui apresentado revela os princípios que modulam a translocação do 
pep-1. A internalização deste vector ocorre por um processo físico, rápido e com 
elevada eficiência. A aplicação do pep-1 como vector é mais vantajosa que o uso de 
vectores virais porque não induz imunogeneicidade e é mais eficiente que outros 
métodos não virais como a electroporação, a microinjecção ou mesmo outros CPPs. 
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Com este projecto é possível uma orientação mais focada para a utilização de um meio 
eficaz que consiga ultrapassar a barreira da membrana celular e introduzir fármacos 
dentro de organismos vivos. 
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Abstract 
 
 
 
The introduction of genetic material or proteins to originate a defined 
biochemical effect inside the cell has a remarkable potential for the treatment of Human 
diseases, however this is hampered by the cell membrane barrier for the entry of 
hydrophilic macromolecules. A possible strategy to overcome the membrane barrier 
was proposed after the discovery of basic peptidic sequences with ability to pass trough 
the membrane in a non-toxic and non-immunogenic manner. These peptides are 
commonly designated as cell-penetrating peptides (CPPs). Pep-1 is a CPP and has been 
successfully used to introduce several macromolecules biologically active inside 
cultured cells. The main goal of this thesis is to clarify the mechanism used by this 
peptide to pass through the membrane and to confirm if its efficiency as a carrier to 
introduce proteins inside cells. The interaction with membranes was followed in vitro 
with model membranes: large unilamellar vesicles; planar lipid membranes, giant 
unilamellar vesicles and supported bilayers. HeLa cells were used to follow the 
translocation of pep-1 associated with a protein. Fluorescence and UV-Vis spectroscopy 
methodologies, CD and ATR-FTIR spectroscopy, electrophysiological measurements 
and fluorescence microscopy were used to carry on the experimental work. It was 
shown that pep-1 is able to interact with and to destabilize the lipidic bilayers without 
evidence for pore formation at variance with other CPPs that use an endosomal pathway. 
Although all the evidences show that pep-1 translocates by a physically-mediated 
mechanism promoted by transmembrane potential with no evidences for the use of 
endosomal routes as an alternative pathway. Differences between this particular pep-1 
and other CPPs can be related with the affinity for membrane. Peptides with higher 
affinity for membrane have more propensities to be internalized by a non-endocytic 
mechanism. Lower affinity for membranes favours endocytic uptake. 
 
  xviii 
 
 
 
 
  Keywords 
 
 
  xix
 
 
 
 
Keywords 
 
 
 
 
Drug delivery  
Cell-penetrating peptides  
Translocation  
Membrane 
Permeability 
Transmembrane potential 
 
  xx 
 
 
 
 
 
  Abbreviations and Symbols 
 
 
  xxi
 
 
 
 
Abbreviations and Symbols 
 
 
 
 
AMPs   Antimicrobial peptides  
ATR-FTIR Attenuated total reflection Fourier transform infrared 
BLMs   Black lipid membranes  
CD  Circular dichroism  
CF   Carboxyfluorescein  
Chol  Cholesterol 
CLIC  Clathrin and dynamin-independent carriers  
CPPs   Cell-Penetrating Peptides  
CTxB   Cholera toxin B  
DPPC  Dipalmitoyl-sn-glycero-3-phosphocholine 
DPPS   1,2-Dipalmitoyl-sn-glycero-3-phosphoserine  
EK   Potassium Nernst potential 
FITC   Fluorescein isothiocyanate  
FRET   Fluorescence resonance energy transfer  
GEEC  Early endosomal compartment  
GUVs  Giant unilamellar vesicle 
IW   Fluorescence intensities in the absence of lipid 
IL   Fluorescence intensities in presence of lipid  
IR   Infrared 
IRE   Internal reflection plate  
K0    Extracellular potassium concentration 
Ki   Intracellular potassium concentrations 
KP   Partition coefficient  
[L]   Lipid concentration 
Lα   Liquid crystalline phase 
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Lβ  Lamellar gel phase  
Lo   Liquid ordered phase 
LDL   Low density lipoprotein 
LUVs  Large unilamellar vesicles 
MAPs   Model amphipathic peptides 
MLVs  Multilamellar vesicles  
MUG   4-methylumbelliferone-β-D-galacto-pyranoside  
NBD   7-nitro-2-1,3-benzoxadiazol-4-il  
NLS   Nuclear localization signal  
NMR  Nuclear magnetic resonance 
ONPG  o-nitrophenyl-β-galactopyranoside  
pAntp   Drosophila antennapedia transcription protein 
PC   Phosphatidylcholine  
PE   Phosphatildylethanolamine  
Penetratin CPP from pAntp 
PLMs  Planar lipid membranes 
POPC  1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine  
POPG   1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol  
PS  Phosphatidylserine  
Rh   Rhodamine  
SM   Sphingomyelin  
SUVs   Small unilamellar vesicles  
Tat   HIV-1 transcriptional activator protein 
TAT   CPP from Tat  
TB  Trypan blue  
TRITC Tetramethylrhodamine  
 
4-MU   4-Methylumbelliferone  
5-NS   5-Doxyl-stearic acid   
16-NS  16-Doxyl-stearic acid  
 
β-Gal  β-Galactosidase 
γL   Molar volume of lipid   
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1.1. Strategies to introduce macromolecules inside cells  
 
The introduction of genetic material or proteins to originate a defined 
biochemical effect inside cells has shown tremendous potential as a biological tool for 
studying cellular processes and is challenging for the treatment of human diseases (see 
reference [1] and references therein). 
Hydrophilic macromolecules that lack specific membrane receptors are not able 
to cross plasma membranes due to hydrophobic nature of the core of lipid bilayers. An 
efficient cellular delivery system is of first importance for an insertion of 
macromolecules of pharmacological interest or other biological potential. Over the last 
years, several strategies have been developed to introduce material inside the cells for a 
variety of purposes such as: protein structure/function studies; DNA insertion to 
modulate expression of proteins; and drug delivery with therapeutic purposes. Some 
examples of approaches that have been used are: viral vectors; liposomes-based delivery; 
electroporation and microinjection [2]. 
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Viruses are really efficient infecting a host cell and introducing their DNA or 
RNA genomes, this observation led to the use of viral particles as vectors to introduce 
exogenous genetic material to cells. The development of viral vectors for long-term 
gene delivery to mammalian cells has been the main goal of viral vectorology since 
early 1980s. Adenoviruses and retroviruses have been used in a broad host range and for 
multiple applications (see references [3-5] and references therein). These viral 
associated vectors are efficient, although the possible pathogenic effects against the host 
organism, the high costs of production, the limit size of the genetic material that can be 
packaged for viral gene therapy and a lack of desired tissue selectivity has hampered a 
more extensive and global therapeutic application. So non-viral alternatives have 
gathered much attention [2, 6]. 
 
Non-viral strategies which are potentially less immunogenic have been 
developed to overcome viral vectors limitations. Microinjection is an example; this 
approach involves the transfer of macromolecules into a living cell using micropipettes 
(Figure 1.1).  
 
 
 
Figure 1.1. Microinjection approach to introduce 
material inside cells. Macromolecules are injected 
inside cells by the use of micropipettes; this procedure 
has to be performed cell by cell. Source: 
http://transgenese.crchul.ulaval.ca/transgeniques.htm 
 
This technique has no cell-type restriction and there is no apparent limitation on 
the size or type of macromolecule that can be injected [7]. However, because this 
technique can only be performed one cell at a time with individual glass micropipettes, 
it is time consuming, requires specific technical skills and is practical only when 
treating a small number of cells [8]. There is also a limitation to the cell types that can 
be readily used for microinjection [8]. An efficient method for transforming a larger 
number of cells at once should be improved for a more generalized application.  
 
Another non-viral strategy is the use of electric pulses (electroporation), which 
was first demonstrated with the introduction of DNA in 1982 [9]. When transmembrane 
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potential is above a threshold, transient pores are formed which allow cellular uptake of 
hydrophilic molecules (see Figure 1.2) (see reference [10] and references therein for 
possible applications). This technique can be applied to many cells at once, however it 
is a non-specific strategy and can become toxic, since molecules can enter or exit the 
cell without control during transient membrane destabilizations [2]. A large cell death 
percentage may occur [8].     
 
 
Figure 1.2. Electroporation 
approach to introduce material 
inside cells. An electric field 
induces transient pore formation 
which enables the entry of material. 
A) Electron micrographs of cells 
before and after brief electric pulses; 
opening pores and resealing of 
membrane is observed. B) 
Illustration of material entrance 
during electropermeabilization. 
Source:  
http://www.inovio.com/technology/
electroporation.htm     
 
 
In 1987 Felgner et al. reported the use of cationic liposomes as an efficient and 
effective system to deliver DNA [11]. Upon mixing DNA with cationic liposomes, 
DNA is condensed into small particles called lipoplexes, the process involving an initial 
rapid association of polycationic liposomes and polyanionic DNA through electrostatic 
interaction (see reference [2] and references therein). This gene therapy strategy is not 
immunogenic, does not have size restriction and different types of nucleic acids can be 
delivered ([6]). It is inexpensive and is relatively easy to use in large-scale [6]. 
Liposomal carriers have been successfully used to deliver genetic material into cells and 
can be internalized by endosomal vesicles through endocytosis or by direct fusion with 
the cell membrane. In endosomal route genetic material may stay enclosed within 
endosomes and fail to access the cytoplasm and nucleus, leading to inefficient low gene 
expression (see Figure 1.3). Cell transfection by direct fusion produces increased levels 
A 
Before electric pulse During electric pulse After electric pulse 
B 
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of gene expression [6]. The uncertainty in the pathway for cell entry, the low efficiency 
of delivery [6], a possible toxicity related to gene transfer by lipoplexes [2] and 
potential interference with lipid metabolism [8] hamper a more general application of 
cationic liposomes as a vehicle to introduce material in vivo. Different strategies have 
been developed in order to improve transfection efficiency of liposomal carriers, some 
of them involving direct injection [6, 12]. 
 
 
Figure 1.3. Cationic liposomes can 
be used to introduce genetic 
material inside the cell. Due to 
electrostatic interactions between 
negatively-charged DNA and 
cationic liposomes, a good delivery 
system can be obtained. Cationic 
liposomes are internalized by 
endocytosis. The escape from 
endosomes can hamper an efficient 
delivery. 
 
A non-invasive administration with a better efficiency for a good transfection 
and application in vivo is of particular interest to the future development of gene 
therapy [6]. 
Nucleous 
Cell 
Endocytosis 
?
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1.2. New strategy to introduce macromolecules inside the cells 
using peptides as vectors 
 
All the non-viral strategies above mentioned are more focussed and improved 
for genetic material delivery and all of them have serious drawbacks which result in a 
transient and varied gene expression with a consequent incapacity to reach the final 
desired effect [1]. 
The fact that some intracellular proteins when added to extracellular medium are 
able to pass through the membrane inspired a new approach. This phenomenon was first 
observed with Tat (HIV-1 transcriptional activator protein) [13] and pAntp (Drosophila 
antennapedia transcription protein) [14]. The ability of these proteins to cross the 
membranes is due to basic amino acid sequences and the minimal peptidic sequences 
necessary for the translocation to occur within Tat [15] and pAntp [16] were elucidated.  
Conjugated molecules such as peptides [17] or proteins [18] coupled to these 
basic peptides can be delivered into cells; this observation made these basic sequences 
very attractive and a new class of vectors, initially denoted as Protein Transduction 
Domains (PTDs) [19] and more recently re-baptized as Cell-Penetrating Peptides (CPPs) 
[20], emerged.  
The CPP derived from pAntp has 16 amino acid residues [16] and is commonly 
known as penetratin. The Tat (48-60) fragment which include the whole basic regions of 
the protein and its Nuclear Localization Signal (NLS) is the most efficient in 
internalization [15]. 
This strategy prospects a substantial improvement in cellular delivery. The 
greater advantage of this strategy when compared with the above referred is the 
possibility to introduce proteins in a non-toxic and non-invasive way. Internalization of 
proteins instead of genes can modify the phenotype in less than 2 hours in an efficient 
manner envisaging a fast and effective strategy for drug delivery with a major impact on 
future treatments [21, 22]. This new approach opens new possibilities for the 
development of vaccines and protein therapies for cancer and infectious diseases [23].  
After the discovery of the potential of Tat peptide (TAT) and penetratin as 
vectors a larger number of peptides (Table 1.1), including peptides from protein 
sequences (pVEC [24] and VP22 [25]), synthetic peptides (such as model amphipathic 
peptides (MAPs) [26], and oligoarginines [27]) or chimera peptides (obtained by the 
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fusion of sequences from different sources, as transportan [28] and MPG [29]) have 
been shown to translocate across cellular membrane.  
 
Table 1.1. Source and amino acid sequence of some CPPs. Positively-charged amino acids are 
highlighted. 
Peptide Source Sequence 
Penetratin  pAntp homeodomain [16] RQIKIWFQNRRMKWKK 
TAT HIV-1 Transcriptional activator [15] GRKKRRQRRRPPQ 
VP22 Viral protein (HSV-1) [25] DAATATRGRSAASRPTERPRAPARSASRPRRPVE 
pVEC Murin VE-Cadherin [24] LLIILRRRIRKQAHAHSK 
MAP Synthetic [30] KLALKLALKALKAALKLA 
Oligoarginine Synthetic [31] RRRRRRRR 
Transportan Chimeric (galanin-mastoparan) [28] GWTLNSAGYLLGKINLKALAALAKKIL 
S413-PV Chimeric (dermaseptin S4-SV40) [32] ALWKTLLKKVLKAPKKKRKV-cysteamine 
MPG Chimeric (gp41-SV40) [33] GALFLGFLGAAGSTMGAWSQPKKKRKV 
 
 
This ability is part of the biological function of many of these peptides, although 
this does not automatically mean that they can be used as a carrier. In order to 
distinguish between translocating peptides able to deliver cargoes and others unable to 
do it, a CPP can be defined as a short (no more that 35 residues) water soluble, non-
toxic, peptide able to efficiently translocate through cellular membrane by a mechanism 
independent from a chiral receptor, able to deliver hydrophilic macromolecules into 
cells and eventually originating a defined biochemical effect inside the cell [34]. 
 
Besides proteins [18, 19, 35-37], several other hydrophilic macromolecules have 
been efficiently coupled to these CPPs and delivered inside the cells, such as: peptides 
[17, 38-40]; antisense oligonucleotides [29, 41-44]; SiRNA [45, 46] and plasmid DNA 
[47, 48]. Nanoparticles [49] and liposomes [50] have also been internalized by means of 
CPP. Introduction of cargo macromolecules into primary and transformed cultured cells 
with efficiency close to 100% can be obtained. 
 
The application of CPPs to deliver macromolecules inducing a specific 
biochemical effect has been efficiently used in vivo in rats with a construct of penetratin 
associated to a peptide nucleic acid [44]. A caveolin-1 scaffolding domain peptide 
attached to penetratin was also successfully taken up by mouse aorta rings and its 
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biological effects were detected [51]. The capacity to pass blood brain barrier mediated 
by a CPP strategy was also shown by a CPP-dexorubicin construct [52] and also with a 
construct of TAT-β-Galactosidade [23]. This last CPP-cargo construct can also reach 
mice organs via systemic circulation and transduces in a variety of murine tissues, 
including liver, kidney, heart, muscle, lung, spleen and brain [23]. This unspecificity 
can limit the application of these CPP constructs when a single organ or tissue is the 
target.  
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1.3. How do CPPs translocate across cell membrane? 
 
The exact mechanism underlying the translocation used by CPPs to pass through 
cellular membrane still awaits complete understanding; the information available in the 
literature is scarce and controversial. A mechanism independent on receptors was 
proposed based on studies with reverse and D-enantiomer sequences, which have 
similar translocation efficiency as the original peptide [27, 31, 53]. A mechanism 
independent of endosomal pathway was also purposed supported by the observation that 
internalization of such peptides is similar at 4ºC and 37ºC [15, 16, 27, 53, 54] (at low 
temperatures ATP production is inhibited and energy-dependent cellular processes, like 
endocytosis, are inhibited or greatly diminished).  
 
Recent observations suggesting that the cell localization observed for CPPs is 
artifactual and occurs during cell fixation for immunochemistry and cell imaging [55], 
raised the questioned if the translocation of such peptides is really dependent on 
endocytosis. An artificial cell localization was first reported in 2001 with the structural 
protein VP22 [55], which also possesses vector properties and can be used to transport 
other proteins [25]. VP22 binds to surface which allow the protein to remain attached to 
cells during washing. In the cell fixation process the protein is released and co-localized 
with nucleus due to affinity of VP22 to DNA [55]. The artifactual cell localization by 
fixation was confirmed by comparison of the localization of the Histone H1, which does 
not have cell-penetrating properties, before and after cellular fixation [56]. Biased 
localization of soluble proteins, during preparation of cells for immunofluorescence, 
was formerly reported in 1992 [57]. The possibility of an artifactual cell localization 
was further confirmed in 2003 by Thorén et al [58] and a re-evaluation of the 
translocation mechanism of several CPPs has been done is the last 4 years.  
 
By the re-evaluation of the translocation mechanism it is clear that penetratin [58, 
59], TAT [60-64] and oligoarginine [60, 65-67] among other CPPs, can cross the 
plasmatic membrane by endocytosis. A tendency to accept this pathway as the main 
mechanism for internalization of all the CPPs has been generalized in the literature; 
however, there is no consensus in the specific endocytic pathway used for the uptake of 
these peptides. The involvement of different pathways has been identified, for instance 
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raft-dependent pathway involving macropinocytosis [68], clathrin-mediated endocytosis 
[69, 70] or caveolae-dependent endocytosis [62, 71]. Controversial results are published 
the dissimilarities being due to different experimental conditions in particular with 
different cellular lines, labelled-peptides and protein-conjugated peptides, which can 
inhibit some pathways while favouring other.  
The involvement of the basic residues in peptide translocation was tested and it 
was found that the deletion or substitutions of a single basic amino acid residue 
dramatically reduced TAT uptake [72]. The importance of the overall charge of the 
peptide was further confirmed by Wender et al., and it was identified that nonaarginine 
(R9) is more efficiently internalized than Tat fragment [73]. 
These results suggest that the first interaction with membrane, prior to 
endocytosis event, appears to be governed by electrostatic interactions between the 
basic amino acids within CPPs sequence and biological membranes. The heparan 
sulfate (HS) proteoglycans at the cell membrane were proposed to act as receptors for 
penetratin [63, 74-76], Tat peptide [63, 70] and also for oligoarginine [66].  
The biological activity exhibited by CPPs is consistent with the cargoes 
macromolecules reaching the cytosol. In a picture where the endosomal pathway 
emerges as the physiological uptake of CPPs, the escape from endosomes is mandatory 
for the potential use of CPPs as a strategy to deliver macromolecules with biological 
relevance inside the cell; this raises the question by which mechanism the internalized 
CPPs reach the final target?  
An escape from endosomes due to acidification was proposed for penetratin, 
TAT and oligoarginine [61, 65]. This hypothesis is supported by Granslund and co-
workers results, where penetratin was encapsulated in liposomes. In the absence of pH 
gradient no penetratin escape takes place, while when a pH gradient exist (5.5 inside, 
7.4 outside), there is a fraction escaping from the liposomes and this occurs without 
membrane lysis neither pore formation [77]. In opposite to this it was verified that a 
higher membrane disturbance induced by poliarginines occurs with pH in the average 
7.5-9.5 and an escape of endosomes prior to their acidification was suggested [66].  
 
If a mechanism able to permeate membrane for endosomal escape exists, this 
can also suggest a similar mechanism to pass cell membranes. Direct observation of 
some CPPs translocation in model membranes systems [78, 79] support the existence of 
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a possible energy-independent mechanism, governed by peptide-membrane interactions, 
to cross the membrane. Furthermore, higher amounts of oligoarginine peptide were 
located in cytosol at 4ºC than at 37ºC. A possible explanation for this phenomenon is 
that when incubation is held at 37ºC, oligoarginine release in the cytoplasm can be 
difficult due to endosome entrapment [67], at 4ºC the existence of an alternative 
pathway which operates when endosomal pathways are inhibited can more easily locate 
oligoarginine in cytosol. A possibility of an alternative pathway to endocytosis was 
proposed [80] shortly after the discovery of Tat protein capacity to internalize inside 
cell. 
A translocation dependence on a negative transmembrane potential was 
observed in vitro with liposomes [78] and in vivo into HeLa cells [81] for some CPPs. 
Terrone et al. suggested that a part of the peptide can transverse through the membrane 
by a mechanism dependent on transmembrane potential (negative inside) and other part 
is internalized by endosomal pathway. When in endosomes the membrane potential may 
facilitate translocation of CPPs from endosomal lumen to the cytoplasm, considering 
that the endocytic compartment exhibit a significant transmembrane potential (lumenal 
side positive) [78].  
 
Even with direct observation of CPP internalization in membrane model systems, 
a broadly acceptance that the main cellular internalization mechanism of CPPs involves 
endocytosis, compromise the usage of these peptides for drug delivery. When entering 
in the cell via endocytosis the molecules can become entrapped in the endosome and 
ultimately end in the lysosome, where degradation processes take place. Thus even if 
efficient cellular uptake via endocytosis is observed, the delivery of intact 
peptide/protein or other macromolecule is compromised by insufficient endosomal 
escape and subsequent lysosomal degradation. An inefficient escape from endosomes 
was verified by the observation that after TAT-Cre peptide uptake the majority of the 
complex remained entrapped in endosomes even after 24h [68]. One possible solution is 
to complement CPP with a membrane destabilizing agent (e.g. viral fusogenic peptide 
or membrane-destabilizing peptide) to improve CPP-mediated protein transfection as 
has been proposed by Wadia et al. [68]. A markedly enhanced CPP-cargo construct 
escape from endosomes was verified when a fusogenic peptide was associated with the 
TAT. In a more recent report, Lebleu and co-workers found that a modified penetratin 
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in which six Arg residues where added to N-terminus make the CPP more efficient to 
internalize and to target a PNA with a high efficiency [82]. 
 
For a generalized application of these peptides as a vehicle with pharmaceutical 
relevance or other biological/scientific applications, the elucidation of the translocation 
mechanism is of first importance. The experiments to study CPP internalization are 
frequently carried on with TAT and Penetratin. In the last years, peptides from diverse 
sources have been identified with CPP properties, beside the ability to enter cells and 
the presence of basic amino acid residues, these peptides can vary in size, nature, 
biological function, secondary structure, hydrophobicity and amphipathicity (see 
reference [34] and references therein). The mechanism by which CPPs pass through the 
membrane is far from being completely understood. Taking into account all the 
information available in the literature regarding the translocation mechanism and the 
varied nature of the different peptides belonging to the CPP family, a careful and special 
attention to this topic should be taken and a simplistic comparison with other CPPs 
should be carefully done. 
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1.4. Pep-1 a new peptide carrier 
 
In most CPPs so far referred, the CPP-macromolecule complex is obtained due 
to covalent link between the CPP and the cargo molecule. The strategy to couple 
cargoes to CPPs can be obtained by production of a CPP-cargo by chemical peptide 
synthesis, which is generally restricted to short cargoes (e.g. 10-20 amino acids); larger 
protein cargoes can be produced by recombinant DNA technologies with expression in 
bacteria and their purification prior to use [83]. Another approach is to synthesize the 
CPP and the cargo molecule independently and posterior linkage by a reactive residue 
included in either CPP and cargo molecules (e.g. activated cysteine at CPP N-Terminal 
with a free cysteine included in the cargo molecule). This approach enables coupling of 
large proteins (see reference [83] and references therein). After cellular uptake, the 
reducing environment in the cytosol cleaves the disulfide linkage and frees the cargo 
molecule from the CPP [26], avoiding interferences with cargo biological function or its 
cellular localization. All these strategies to couple a cargo have limitations, are time 
consuming and require specific technical skills; moreover a CPP-cargo may induce 
desnaturation of the protein due to covalent link to the CPP.  
 
A new approach based on an amphipathic peptide named pep-1 (Chatiot®) has 
been proposed for protein delivery. Pep-1 delivers a broad range of protein directly into 
mammalian cells maintaining their biological activity in different cellular lines with 
lack of toxicity and lack of sensitivity to serum [84]. The advantage of this peptide in 
comparison with CPPs above referred is that this peptide forms a non-covalent complex 
with the macromolecule to be delivered, avoiding complicate procedures with covalent 
links above referred. This complex is easily obtained by mixing the peptide with the 
macromolecule during about 30 minutes and a complex, stable in physiological buffer, 
is obtained and ready to use onto cells. The size and the nature of the cargo protein to be 
delivered can influence the number of pep-1 molecules required to obtain an efficient 
complex. After cellular uptake the complex dissociates in the cytosol leaving the 
macromolecule biologically active and free to proceed to its target organelles, while 
pep-1 localizes in the nucleus and does not affect the final cargo location [84]. The 
efficiency of translocation can vary in the range 60-95%, depending on the cell type and 
the cargo molecule [84]. 
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Pep-1 has been efficiently used to introduce several peptides [84-87], proteins 
[88-93] and biologically active antibodies [85, 94-99] inside cultured cells from 
different sources. It is noteworthy the capacity to deliver macromolecules in neuronal 
cells [88, 93, 95, 96], and also plant cells converted into protoplasts [92] producing the 
expected biochemical effect in the correct localization inside the cell. The biological 
activity is generally maintained after translocation of the delivered macromolecule, for 
instance: 1) enzymatic activity was detected after enzyme internalization [84, 90, 91]; 2) 
pep-1 was efficiently employed to deliver an antibody to clarify the intracellular 
trafficking of a membrane-anchored enzyme [98], which indicates that after 
internalization, the antibody diffuses throughout the cells and interacts with the target 
protein and thus, allows the identification of the subcellular compartment that harbours 
the target protein. The use of pep-1 in animals has also been reported [100, 101], where 
pep-1/cargo complexes were intratracheally instilled, for instance Aoshiba et al. have 
used pep-1 to deliver Caspase-3 to the lungs of mice; alveolar wall apoptosis and 
emphysematous changes were detected as a result of actively internalized Caspase-3 
[100].     
Altogether these published reports strengthen the use of pep-1 as a vehicle for 
intracellular deliver of macromolecules with biological interest such as pharmaceutical 
agents.  
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1.5. Main goals of the project 
 
Pep-1 (acetyl-KETWWETWWTEWSQPKKKRKV-cysteamine) is an 
amphipathic peptide with three domains: (i) a Trp-rich “hydrophobic” domain (Ac-
KETWWETWWTEW), responsible for “hydrophobic interaction” with proteins and 
cell membranes; (ii) a hydrophilic domain (KKKRKV-Cys) derived from a nuclear 
localization signal (NLS) of Simian Virus 40 (SV-40) large T antigen, required to 
improve solubility; and (iii) a spacer domain (SQP) which improves the flexibility and 
the integrity of the other two domains [84]. A cysteamine group is present in the C-
terminal and an acetyl group caps the N-terminus. In oxidizing conditions a disulfide 
link is formed between two peptide molecules by the cysteamine group (Figure 1.4). 
 
The term amphipathicity refers to molecules with both hydrophilic and 
hydrophobic parts [102] and is dependent on the relative abundance of hydrophobic and 
hydrophilic domains within a peptide. One possible quantitative measure of 
amphipathicity is the hydrophobic moment [103]. It is possible to distinguish between 
primary amphipathicity and secondary amphipathicity in peptides. Peptides with 
primary amphipathicity are made of a hydrophobic and a hydrophilic domain. A peptide 
with secondary amphipathicity has hydrophobic and only hydrophilic residues however 
a separation of hydrophilic and hydrophobic parts is only achieved with the peptide 
secondary structure [102]. The simplest and most common secondary structure in 
peptides is the amphipathic α-helix [102].   
 
Cell membranes are composed of amphipathic bilayers, therefore an increasing 
hydrophobic moment of model peptide results in a significant increase in the 
permeability and haemolytic activities of these peptides in target membranes, which 
implies a better peptide-membrane affinity (see reference [103] and references therein). 
Antimicrobial peptides (AMPs) activity is known to be dependent on peptide-membrane 
interaction and on the capacity to induce membrane leakage. For AMPs the capacity to 
interact with membranes and the degree of amphipathicity are correlated. For these 
peptides amphipathic α-helix formation occurs upon membrane interaction, which 
seems to favour peptide insertion and cellular toxicity [103].  
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Figure 1.4. Schematic representation of pep-1 molecule. Primary amphipathicity is evident: 
“hydrophobic” domain (Ac-KETWWETWWTEW) is represented by five Trp residues and hydrophilic 
domain (KKKRKV-Cys) is represented by five positive charges. In between a spacer domain (SQP) with 
a Pro residue is responsible by the flexibility and integrity of the other two domains. In oxidizing 
conditions a disulfide link between two cysteamine groups is expected, reducing environment cleavages 
this disulfide link.  
 
 
The use of an amphipathic transporter to deliver cargoes molecules inside cells 
where the cell membrane is the first barrier seems feasible; in this regard, peptide 
interacts first with hydrophilic region and then penetrates the hydrophobic interior of 
the cell membrane [102]. A clear dependence of peptide incorporation upon 
amphipathicity was demonstrated with MAPs [104]. Reports from Divita and Heitz 
group demonstrate that peptides with primary amphipathicity are also efficient to 
interact with lipidic membranes and to translocate across cell membrane [33, 105].  
 
+    +     +     +     +   Trp     Trp     Trp     Trp     Trp -SH 
               Oxidation       Reduction  
+    +     +     +     +   Trp     Trp     Trp     Trp     Trp -S 
+    +     +     +     +   Trp     Trp     Trp     Trp     Trp -S 
Hydrophobic domain Hydrophilic domain 
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Pep-1 is a promising vehicle to deliver macromolecules with biological 
relevance into cells. However, for a more generalized and optimized use of this carrier 
the elucidation of the mechanism of action is mandatory. When I started my PhD, there 
was not much information regarding the possible mechanisms used by this peptide to 
translocate across cellular membranes. Morris et al. suggested that this peptide 
translocates by an endocytosis-independent pathway, although, these results were 
obtained in fixation conditions and with a labelled peptide [84], which can compromise 
the results, as stated above.  
The main objective of this project was to unravel how pep-1 interacts with cells 
at membrane level. Pep-1 is a peptide with primary amphipathicity, which suggests 
direct interaction with lipids in biological membranes and this can be the key-feature to 
explain pep-1 ability to pass through the cell membrane. In order to evaluate this 
hypothesis, the experimental work was first performed with model membranes to 
evaluate the possible effect of membrane charge, viscosity and ionic strength. Different 
model membranes were used depending on the methodology: Large unilamellar vesicles 
were used with fluorescence methodologies; Giant unilamellar vesicles were used in 
confocal microscopy and planar lipid membranes for electrophysiological 
measurements. In order to evaluate the possible effect of a cargo on the translocation 
mechanism studies with a complex pep-1/protein were also performed. The protein 
chosen for these experiments was β-Galactosidade (β-Gal) from E. Coli. After 
characterization of pep-1 interaction with model membranes, cultured mammalian cells 
were used. Results obtained in vitro and in vivo were compared.  
 
In the following chapters published results are presented in the paper format. An 
introduction with the specific objectives, model membranes and the methodologies used 
was included for detailed information.  
 
     
 
 
 
 
 
 
 
Chapter 2 
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Chapter 2.   
 
 
Pep-1 and model membranes  
 
 
2.1. Introduction  
 
2.1.1. General membrane remarks  
The plasma membrane defines the boundary of the cell and is the surface of 
contact with its environment [106]. Biological membranes play a central role in both the 
structure and function of cells and are complex structures where lipid and proteins are 
the principal components and its relative contribution is dependent on cell type and 
function. Phospholipids are the most commonly found membrane lipids (essentially 
glycerophospholipids, Figure 2.1.A) [107] and due to it amphipathic nature and 
cylindrical shape, the most favourable structure in aqueous environment is the lipidic 
bilayer, which forms spontaneously by self-assembly of lipid molecules with a 
hydrocarbon interior and polar groups on either side (Figure 2.1.B). With this bilayer 
shape, lipids minimize the contact with water and this phenomenon is known as 
entrotopic effect, also named “hydrophobic effect” designated by hydrophobic force 
[108].  
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The hydrophobic core of the lipidic bilayer is the most important structural 
feature in the role of membranes as a barrier [107]. Proteins for instance are embedded 
with their hydrophobic surfaces buried in the lipid. Besides its highly dynamic structure 
where lipids and proteins can rotate or diffuse laterally [106], lipid bilayers are 
impermeable to several molecules and are responsible for a restrict regulation of 
molecules passage inward and outward, which is responsible for maintaining the 
gradient levels essential for vital cellular functions.  
 
 
 
 
 
 
 
 
 
Figure 2.1. A) Schematic representation of 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphocholine (POPC), 
a glycerophospholipid. B) Schematic representation of a lamellar arrangement of a lipidic bilayer. Polar 
headgroups interface the aqueous environment and shield the hydrophobic core.  
 
Cell membranes are complex structures with an enormous diversity with 
multiple lipids that appear to play several roles within membranes (see reference [107] 
for further information). In a simplistic point of view, lipidic mixture can be regard as a 
stable matrix and cell barrier in which the proteins can function. The amount and nature 
of membrane proteins vary and are considered the biochemically active components of 
the membrane, which comprise a diversity of activities such as enzymatic, transporters, 
receptors, pores, depending on the nature of each particular membrane [107].     
 
2.1.2. Membrane phase behaviour 
Depending on the temperature, pressure, hydration and phospholipid nature 
(hydrocarbon tails and the composition of headgroups) a pure lipidic bilayer can present 
different thermodynamic phases. In the most common phospholipids the low-
temperature phase is designated by a lamellar gel phase (Lβ) (Figure 2.2.A). The 
A 
Polar headgroup 
Hydrophobic tails 
B
 
Water-lipid interface
Hydrophobic core 
 
Water-lipid interface
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molecules are packed more tightly together and the acyl chains are more highly ordered 
and are maximally extended [107, 109]. At higher temperature, the gel phase undergoes 
a transition to the Lα phase, which is designated as liquid crystalline or fluid phase 
(Figure 2.2.B). This form has a considerable disorder in the acyl chains and is usually 
assumed to be physiologically the most important phase [107, 109]; in the fluid phase 
the bilayer thickness is shorter than in the gel phase (Figure 2.2).  
The major thermodynamic driving force stabilizing hydrated lipid aggregates is 
the entropic effect, however van der Waals forces (short, weak and attractive forces 
between adjacent hydrocarbon chains) and hydrogen bonding (between polar 
headgroups of some lipid molecules) are also stabilizing factors of the bilayer structure. 
At phase transition van der Waals forces between fatty acyl chains have an important 
role; these forces are responsible for the relative stability of the gel and liquid crystalline 
phases. The stability of the phase increases with the tail length because of the increased 
van der Waals interactions in longer chains [109]. In the presence of a double bond 
(trans or cis) the ability of the chains to interact orderly is decreased and so the ability 
to form a gel phase [107]. 
 
 
 
 
 
 
 
Figure 2.2. Schematic representation of lipidic bilayers in: A) Lamellar gel phase (Lβ) where the 
molecules are packed tightly and orderly together; and B) Lamellar liquid crystalline phase (Lα) with a 
considerable disorder in the acyl chains conformation. These structural features were elucidated by X-ray 
diffraction data. Figures adapted from [107, 109]. 
 
Cholesterol is the most common found sterol in animal cell membranes and it 
constitutes about 30% of the mass of the membrane lipids of many cell plasma 
membranes [107]. Cholesterol modulates membrane fluidity. When cholesterol is added 
to a liquid-crystalline phase a more ordered phase, liquid ordered (Lo) phase (less fluid 
than liquid crystalline phase but more fluid than gel phase), occurs on the membrane 
[110]. Depending on the cholesterol-phospholipid proportion the membrane has fluid 
B
Lβ Lα
A 
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phase or liquid ordered properties. At low cholesterol concentration lipidic membranes 
have fluid phase properties, while at high cholesterol concentration membrane is more 
ordered and Lo phase properties are dominant. For intermediate concentrations the two 
phases coexist [110].    
 
The fluid mosaic model of biological membranes proposed by Singer and 
Nicolson [111] emphasizes membrane fluidity and free lateral diffusion of membrane 
components the fluid phase is considered to be the bulk phase in biological membranes, 
but the observation of patches of lipids with composition and physical state different 
from the rest of the membrane suggests the coexistence of phases. This model is 
referred as “lipid-raft” model and is based on dynamic clustering of sphingolipids and 
cholesterol to form platforms that move in the fluid bilayer. A role on protein 
attachment during signal transduction has been proposed by Simons and Ikari [112]. 
The physical state of these domains is assumed to be similar to a Lo phase [112-114].     
 
Figure 2.3. Schematic drawing of a 
liquid ordered domain (Lo) in a fluid 
phase bilayer (Lα). Hexagon 
represents cholesterol molecules 
which modulate membrane viscosity. 
Figure adapted from [114]. 
 
 
2.1.3. Membrane asymmetry 
The membrane is a twofold asymmetric structure. The two leaflets of the 
membrane bilayer have their specific lipid and protein composition. The asymmetric 
arrangement of membrane proteins was the first to be discovered [115] which accounts 
for the differences in the function of the outer and inner surface. The interior of the 
membrane contains proteins involved in intracellular events while outside may contain 
proteins involved in the defence mechanism of the cell [115], for instance. The 
transverse asymmetry of phospholipids has became apparent due to asymmetrical 
localization of the enzymes involved in phospholipid synthesis [116] and due to the fact 
that the chemical environment of both bilayers is different [115]. Now is known that the 
compositional asymmetry of the plasma membrane does not correspond to the 
  
 
 
 
 
 
 
Lo domain 
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asymmetry of lipid synthesis or hydrolysis. The transbilayer lipid distribution results 
from a continuous inward and outward movement of lipids between two monolayers 
(for further information see reference [117]). Hence, lipid asymmetry is formed and 
afterwards maintained by specific mechanisms that control lipid movement across the 
bilayer [117].   
The asymmetric arrangement of phospholipids in plasma membrane was first 
established for natural lipids in erythrocytes and confirmed with different techniques 
[118-120]. Asymmetry in different animal eukaryotic membranes have also been 
elucidated and in general is possible to assume that the choline-containing lipids, 
phosphatidylcholine (PC) and sphingomyelin (SM), are primarily on the external leaflet 
of the plasma membrane, while amino-containing glycerophospholipids, 
phosphatildylethanolamine (PE) and phosphatidylserine (PS) are located preferentially 
on the cytoplasmic leaflet [115, 121-123]. The relative molar fraction of each lipid 
depends on the membrane organelle and species. Noteworthy are the neutral 
composition of external layer and the negative charge of inner layer of plasma 
membrane in Human cells. The erythrocyte plasma membrane for instance has about 
20% molar of PS in the inner layer [107]).  
 
Besides lipidic and protein transbilayer asymmetry there are also membrane 
potentials contributing for transmembrane asymmetry. There are three types of electric 
potential related to membranes [124]: 1) the transmembrane potential, which is 
associated with gradients of electric charge across the phospholipid membrane (negative 
inside) and is important in different biological processes; 2) the electrostatic surface 
potential, which results from the net charge found on the membrane surface; the 3) 
membrane dipole potential, which results from the net contribution of molecular 
polarizations arising from the water molecules that adopt an organized structure in the 
membrane surface and electrical dipoles associated with the carbonyl group of the lipids 
(see [124] and references therein). The various electrical potentials associated with 
membranes are involved in a large number of cellular processes [125, 126] and they 
may also be implicated in protein- and peptide-membrane interaction, structure and 
function [127-131]; moreover membrane potentials can be modulated when peptides 
insert in the membrane [128, 132].    
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2.1.4. Model membranes used in spectroscopy studies 
Due to the complexity of biological membrane peptide-membrane interaction 
studies are usually initiated with simple model membranes so that different properties 
such as lipid charge, membrane viscosity and the presence of sterols can be modulated. 
Each of the several model membranes that have been used to study membrane-active 
peptides has advantages and disadvantages, depending on the techniques to be 
employed. To start our studies, peptide/membrane interactions were followed using 
spectroscopic methodologies and liposomes.  
 
Figure 2.4. Preparation of LUVs and 
SUVs. A) Lipids are dissolved in 
chloroform and the solvent is 
removed to yield a lipid film. After 
addition of water/buffer, hydrated 
lipid sheets detach spontaneously. B) 
Upon agitation and freeze-thaw 
cycles, a MLVs suspension is 
obtained. C) Sonication may be used 
to produce SUVs while D) extrusion 
can be used to obtain LUVs. Image 
adapted from:  
http://www.avantilipids.com. 
 
. 
When phospholipids are suspended in an excess of aqueous solution they 
spontaneously form multilamellar vesicles (MLVs). These aqueous dispersions 
produced by mechanical agitation of an aqueous medium in the presence of a dry lipid 
film were designated as liposome by Bangham et al. [133] (Figure 2.4). Generically the 
term liposome is applied for hydrated lipid dispersions which can be characterized 
based on size and number of lamellas [134]. MLVs are large vesicles with two or more 
lamellas; vesicles with one lamella can be: small unilamellar vesicles (SUVs) with a 
∼30nm diameter; large unilamellar vesicles (LUVs) with a ∼100nm diameter; and giant 
unilamellar vesicles (GUVs) with a diameter higher than 10μm. The type of liposome 
obtained is dependent on the preparation procedure, where three phases can be 
distinguished: lipidic film preparation, lipid hydration and final processing to obtain a 
Dry lipid film Water Hydration of lipid  
Agitation 
MLVs 
Sonication homogenization 
SUVs 
LUVs 
Extrusion 
A 
B 
C
D 
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specific liposome (e.g. sonication to obtain SUVs with a diameter of about 30nm [135] 
and extrusion of MLVs to obtain LUVs with a diameter of about 100nm [134], see 
Figure 2.4). 
 
SUVs or LUVs are the preferred vesicles used for the application of 
spectroscopic methodologies; they both have particular advantages and drawbacks. 
SUVs have smaller size and therefore reduced light scattering, but due to high 
membrane curvature these liposomes are characterized by a non-ideal lipid packing 
(less dense packing of phospholipids), which may produces anomalous peptide binding 
(see reference [136] and references therein). LUVs have a lipid packing close to planar 
membrane due to their larger radii of curvature relative to molecular dimensions and are 
more stable than SUVs [136]. Moreover the binding enthalpies and entropies were 
distinctly different for the two membrane systems; the binding to SUVs is enthalpy-
driven whereas the binding to LUVs is entropy-driven [137]. Even with higher 
scattering artefacts associated (which can be easily corrected) LUVs are more suitable 
models of biological membranes [136] and they were chosen for the first 
characterization of the pep-1/membrane interactions.   
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2.2. Interaction of Pep-1 with model membranes followed by 
spectroscopy methodologies 
 
Characterization of pep-1 interaction with model membranes carried in this 
project is published in two articles with the following titles: 1) Environmental factors 
that enhance the action of the cell penetrating peptide pep-1. A spectroscopic study 
using lipidic vesicles and 2) Consequences of nonlytic membrane perturbation to the 
translocation of the cell penetrating peptide pep-1 in lipidic vesicles, which are 
presented afterwards. Experiments presented in these two reports were mainly obtained 
by fluorescence methodologies and using LUVs as model membranes.  
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2.2.1. Environmental factors that enhance the action of the cell 
penetrating peptide pep-1. A spectroscopic study using lipidic vesicles  
 
2.2.1.1. Motivation and methodologies 
In the paper Environmental factors that enhance the action of the cell 
penetrating peptide pep-1. A spectroscopic study using lipidic vesicles a 
characterization of pep-1 interaction with model membranes was performed, where 
peptide affinity for different model membranes and in-depth location in the lipidic 
bilayer was determined.  
Fluorescence spectroscopy is a powerful technique for peptide/membrane 
interactions analysis; peptides containing aromatic amino acids enable the use of 
fluorescence spectroscopy with no need for chemical derivatization with fluorescent 
probes. Pep-1 is intrinsically fluorescent due to its five Trp residues. Trp fluorescence 
emission is environmental-sensitive: when Trp residues are totally exposed to aqueous 
environment its fluorescence emission has a spectral maximum at ~350nm; at variance, 
in a more hydrophobic environment there is a blue shift in fluorescence emission 
spectrum with a concomitant increase in quantum yield and a decrease in emission band 
width at half-height (see references [138, 139] and references therein).  
 
To carry on these studies a photophysical characterization of pep-1 was 
performed in the absence and in the presence of lipid membranes: i.e., quantum yields, 
excited states, red-edge excitation shifts and anisotropies were quantified (for a detailed 
information on these photophysical parameters see reference [138]). Altogether pep-1 
photophysical parameters gave information about peptide organization in aqueous 
solution and affinity for model membranes. The influence of environmental factors such 
as: pH, ionic strength, and reducing environment were addressed.  
 
In the study of the interaction of a peptide with model membranes systems, the 
determination of peptide extension of insertion in lipidic bilayers is of first importance 
to obtain information on the peptide affinity to membranes [140]. The extension of 
interaction of pep-1 with lipid membranes was quantified by means of the molar ratio 
partition coefficient, KP  
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The increase in the fluorescence intensity (I) with lipid concentration was used 
to determine KP by means of eq.2.2:  
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where IW and IL are the fluorescence intensities in the absence of lipid and limit value 
for increasing lipid concentrations, respectively, γL is the molar volume of lipid and [L] 
is the lipid concentration – for more details see reference [140]). 
 
In-depth location when pep-1 inserts in lipidic membrane was studied by 
acrylamide quenching and by differential quenching of 5-Doxyl-stearic acid (5-NS) and 
16-Doxyl-stearic acid (16-NS) using Fernandes et al. formalism [141]. Fluorescence 
quenching refers to the phenomena of fluorescence quantum yield decrease due to direct 
interaction between the fluorophore and a quencher molecule; this can result from a 
static and/or a dynamic mechanism – for more details see reference [139].  
Acrylamide is a quencher of Trp fluorescence emission, soluble in aqueous 
solution [138]. At variance, it is unable to efficiently quench the fluorescence of Trp 
residues deeply buried in the bilayer [142]. With this quencher one has information 
about the sub-population of fluorophores that is accessible to the aqueous environment 
[142] (Figure 2.5). The population of fluorophores that inserts in the lipidic membrane 
can be assessed by 5-NS and 16-NS, which are derivatized fatty acids, able to partition 
in lipidic bilayers, with a doxyl group (NO•) in position 5 and 16, respectively. This 
group is able to quench Trp residues and its in depth location in the membrane is near 
the interface for 5-NS or deeply buried in hydrophobic core for 16-NS (Figure 2.5). 
Stern-Volmer formalism was used to determine KSV  (more details in references [138, 
139, 141]), which provides information about the quenching efficiency and ultimately 
about the in-depth location of fluorophores [142] (see Figure 2.5).  
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Figure 2.5. Peptide in depth location determined by 
quenching of acrylamide, 5-NS and 16-NS. A) 
Quenchers location in the presence of lipidic 
membranes: acrylamide is soluble in aqueous 
medium and is unable to insert extensively in the 
membrane; the doxyl group (NO•) in 5-NS fatty 
acid locates close to the water-lipid interface but 
the doxyl group in 16-NS molecule has deeper 
location, in the hydrophobic core. B) Fraction of 
fluorophores not inserted in the membrane or that 
adsorbs at membrane surface are quenched by 
acrylamide. C) When peptide inserts in the 
membrane close to the water-lipid interface 5-NS is 
a more efficient quencher than 16-NS; if the 
fluorophore inserts more deeply in hydrophobic 
phase 16-NS is a more efficient quencher.   
 
 
Phospholipids with a phosphatidylcholine (PC) headgroup are the major 
component in animal cell membranes. The most common acyl chains are C16, C18 and 
C20; the degree of unsaturation varies widely [107]. Our studies were started with 
liposomes composed by 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (16:0-18:1; 
POPC). This lipid forms bilayers in fluid phase at room temperature and can be used to 
represent the bulk phase in cell membrane. Inner leaflet of plasma membrane is 
considered to have 20% of negatively-charged phospholipids [107]; in order to evaluate 
the charge effect in pep-1 affinity and to mimic the inner leaflet, liposomes with POPC 
and different percentages of a negatively-charged phospholipid with similar acyl chains, 
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (POPG), were used. The more 
abundant negatively-charged phospholipid in mammalian cells is PS, the use of PG 
instead of PS does not compromise the objective to evaluate electrostatic interaction 
effect, since previous reports demonstrate that interactions mediated by electrostatic 
forces are independent on the lipid headgroup (PG vs. PS) and the basic amino acids 
(Arg vs. Lys) within the peptide [143, 144]. 
A 
           B 
      
      
C 
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A possible effect of viscosity and the interaction of pep-1 with more rigid 
domains within plasma membrane were tested with vesicles composed by POPC/Chol 
(2:1 molar ratio). With this lipidic composition homogeneous membranes with a liquid 
ordered-like phase are obtained [145, 146].  
More rigid membranes were obtained with liposomes composed by 1,2-
dipalmitoyl-sn-glycero-3-phosphocholine (16:0-16:0; DPPC). This lipid forms a gel 
phase at room temperature due to saturated acyl chains which favour van der Waals 
forces between molecules and a more highly ordered bilayer. Charge effect in gel-like 
phase was evaluated with 1,2-Dipalmitoyl-sn-glycero-3-phosphoserine (DPPS); 
different DPPC/DPPS mixtures were compared.  
These lipidic systems were used and compared through the studies presented in 
the following manuscripts. 
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Abstract
Pep-1 is a cell penetrating peptide (CPP) derived from the nuclear localization sequence of Simian Virus 40 large antigen T and from
reverse transcriptase of Human Immunodeficiency Virus. Although it has been successfully used to transport proteins into cells, its action at
the molecular level is not yet clear, mainly the local environmental factors that condition partition and translocation. Characterization in
aqueous medium and quantification of partition into bilayers were carried out. Dynamic light scattering studies show that pep-1 self-
associates in aqueous medium. The role of the bilayer phase, anionic lipids, ionic strength of the medium, reducing agents and pep-1
concentration on the extent and kinetics of partition were studied. Unlike others cationic CPP (e.g. penetratin) pep-1 has a high affinity to
neutral vesicles (Kp=2.8103), which is enhanced by anionic lipids. In a reduction environment partition is strongly inhibited
(Kp=2.2102), which might be a key-feature in the biological action of pep-1. Peptide incorporation takes place in the millisecond time-
range to the lipidic interfaces. These environmental factors are systematized to enlighten how they help cellular uptake.
D 2005 Elsevier B.V. All rights reserved.
Keywords: Translocation; Vector; Peptide carrier; Fluorescence; Vesicle
1. Introduction
The observation that some intracellular proteins trans-
locate naturally across the plasmatic membrane and the
identification of basic peptidic sequences responsible for
this ability, lead to novel techniques of protein transduction
[1–6]. These peptidic sequences, also known as protein
transduction domains (PTDs), have been used and opti-
mized as carriers. The three most investigated PTDs are
derived from the Human Immunodeficiency Virus 1 (HIV-1)
transcriptional activator (tat), the Drosophila homeotic
transcription factor Antennapedia (Antp), and the Herpes
Simplex Virus (HSV) protein VP22 [1,2,5,7]. These PTDs
require covalent coupling with the target protein [3,7].
However, this kind of interaction induces alterations in the
native form of protein, which can limit the technology [7].
Pep-1 is a synthetic peptide carrier forming non-
covalent hydrophobic interactions with the cargo, capable
of introducing a great variety of proteins in different
cellular lines, without the need to denature proteins [7–
10]. This kind of interaction stabilizes the protein,
avoiding degradation and preserving its natural character-
istics [7,9]. Pep-1 delivers proteins into mammalian cells
[7,8,10–12], or in plant cells converted in protoplasts [13],
and maintains at least 80% of the viability of different
cellular cultures in concentrations up to 1 mM [7] at an
average efficiency of 60–95%, depending on the cell type
and the protein being transduced [8]. Since it is a non-
toxic and non-invasive method with results in less than 2
h, pep-1 is an attractive vehicle to introduce functional
proteins in cells [7,8]. This method can potentially: 1)
correct genetic diseases by altering the phenotype; 2)
function like a vaccine by the introduction of antibodies
and 3) be used for research on the study of the function/
structure of proteins.
0005-2736/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2004.11.017
T Corresponding author. Tel.: +351 217500931; fax: +351 217500088.
E-mail address: castanho@fc.ul.pt (M.A.R.B. Castanho).
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Pep-1 has 21 amino acids residues (KETWWETWW-
TEWSQPKKKRKV) with three different domains: the so-
called hydrophobic, rich in Trp residues (KETWWETWW-
TEW), the hydrophilic one rich in basic amino acids
(KKKRKV) and a spacer sequence with a Pro (SQP),
between the other two [7]. The peptide is acetylated in the N
terminal and has a cysteamine group on the C terminal [7]
and has a tendency to form disulfide bonds in aqueous
solution. The hydrophobic domain is from HIV-1 reverse
transcriptase [14] and is responsible for both forming
hydrophobic interactions with proteins and for an efficient
targeting to the cell membrane [7]. The hydrophilic
sequence is a nuclear localization signal (NLS) from the
large antigen T of Simian Virus 40 (SV40) [7] and has been
used in other peptide carriers [9,15]. This domain improves
solubility and intracellular distribution of the peptide [7].
The presence of the Pro residue in spacer sequence
promotes a large flexibility and the integrity of other two
domains [7].
The understanding of the mechanism of Pep-1 action and
the local environmental factors that affect such a mechanism
is of first importance for a generalized application and
optimization of the process. The amphipaticity of the carrier
suggests a strong interaction with the lipidic biomembranes.
Despite some molecular-level details, biochemical and
biophysical actions of pep-1 are still unknown; Silvius
and co-workers recently demonstrated that translocation of
cell penetrating peptides is intimately related to the trans-
membrane potential across lipidic membranes [16]. For pep-
1, dependence on membrane potential for translocation
occurrence was also verified [17]. Deshayes et al. [18]
addressed several specific points relative to pep-1 trans-
location. Our aim in this paper is to give insight on
additional environmental processes that furthermore favour
translocation. The presence of five residues of Trp enables
the application of fluorescence spectroscopy techniques
with no need for derivatization with a fluorescent probe.
2. Material and methods
2.1. Materials
Chariotk, the commercial name of pep-1, was obtained
from Active Motif (Rixensart, Belgium) with purity higher
than 95%, carboxyfluorescein-labelled pep-1 (pep-1-CF;
linked by a Lys in C terminal and blocked with a Ser) was
obtained from GenScript Corporation (Piscataway, New
Jersey) with purity higher than 95%; 2-(4-(2-Hydroxyethul)-
1-piperazinyl) ethanesulfonic acid (HEPES), sodium chlor-
ide, l-Tryptophan, acrylamide, ethanol and chloroform
spectroscopic were from Merk (Darmstadt, Germany); 1-
Palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphocholine (POPC),
1-Palmitoyl-2-Oleoyl-sn-Glycero-3-(Phospho-rac-(1-glyc-
erol)) (POPG), 1,2-Dipalmitoyl-sn-Glycero-3-phosphocho-
line (DPPC) and 1,2-Dipalmitoyl-sn-Glycero-3-(phospho-l-
serine) (DPPS), from Avanti Polar-Lipids (Alabaster,
Alabama); 5-Doxyl-stearic acid (5DS) and 16-Doxyl-stearic
acid (16DS) from Aldrich Chem Co. (Milwaukee, Wiscon-
sin); Cholesterol (chol) and DL-Dithiothreitol (DTT) from
sigma (St. Louis, Missouri), tris-(2-cyanoethyl)phosphine
(phosphine) from molecular probes (Eugene, Oregon), and
Oxidized glutathione (GSSG) from Boehringer Manheim
(Germany).
Pep-1 solutions were prepared in HEPES buffer (10 mM
HEPES, pH 7.4 containing 10 mM (low ionic strength) or
150 mM NaCl (the so-called physiologic ionic strength)).
The assays were performed at room temperature in a UV-Vis
spectrophotometer Jasco V-530 and in a spectrofluorometer
SLM Aminco 8100, equipped with 450 W Xe lamp, Glan-
Thompson polarizers, and double monochromators. Fluo-
rescence intensity values were corrected for inner filter
effect [19].
2.2. Characterization of pep-1 in aqueous solution
Spectral characterization was performed and fluores-
cence steady-state anisotropy was used to study red-edge
effects (details have been published elsewhere, see Ref.
[20]). Quantum yield-dependence on peptide concentration,
ionic strength and reduction effects in the presence of
phosphine (1 mM) were also evaluated.
A light scattering apparatus equipped with a He–Ne laser
(632.8 nm; 35 mW) model 127 from Spectra-Physics and a
72 channels UNICOR autocorrelator was used to study the
aggregation of pep-1 in aqueous solution. Peptide solutions
were filtered through a sterile 0.22 AM pore Millipore filter.
Data was fitted with a tri-exponential function; the average
diffusion coefficient, D, was determined (k=632.8 nm;
right angle geometry) and hydrodynamic radius, Rh, was
calculated by means of the Stokes–Einstein equation (details
have been published elsewhere, see Ref. [21]).
Pep-1-CF solutions (0.023, 0.058, 0.12, 0.17, 0.23 and
0.58 AM) at low ionic strength, were titrated with small
volumes of a pep-1 stock solution (688 AM). Pep-1-CF
fluorescence was followed with kexc=490 nm.
2.3. Reduction effect and fluorescence quenching in
aqueous solution
Quenching assays were followed by fluorescence inten-
sity with excitation at 280 nm and emission at 350 nm unless
stated otherwise. Fluorescence quenching by acrylamide was
carried out using kexc=290 nm to minimize the relative
quencher/fluorophore light absorption ratio. Nevertheless,
the quenching data were corrected for the simultaneous light
absorption of fluorophore and quencher [22]. Quenching
assays data with negative deviation from the Stern–Volmer
representation Eq. (1) were analysed using Eq. (2),
I0
I
¼ 1þ KSV Q½  ð1Þ
S.T. Henriques, M.A.R.B. Castanho / Biochimica et Biophysica Acta 1669 (2005) 75–8676
35
(I and I0 are the fluorescence intensity of the sample in the
presence and absence of quencher, respectively, KSV is the
Stern–Volmer constant and [Q] the concentration of
quencher) [20,23],
I0
I
¼ 1þ KSV Q½ 
1þ KSV Q½ ð Þ 1 fBð Þ þ fB ð2Þ
(fB ¼ I0;BI0 is the fraction of light accessible to the quencher
and I0,B is the fluorescence intensity of the accessible
population to the quencher, when [Q]=0 [20,23]).
2.4. Preparation of lipid vesicles
Large unilamellar vesicles (LUVs), with typical 100 nm
diameter [24] were prepared by the extrusion method
described elsewhere [25] and used as models of biological
membranes.
2.5. Extent and kinetics of partition in LUV
The extent and kinetics of partition assays of pep-1 (6.88
AM) in the absence or presence of phosphine (1 mM), were
carried out with LUVs of POPC and POPG (liquid-crystal
phase), DPPC and DPPS (gel phase) or POPC and chol (2:1)
(liquid-ordered phase). Titrations of pep-1 with lipidic
suspensions (final concentrations ranges from 0 to 3.75
mM), both in low and physiologic ionic strength, were used
to evaluate the extent of the partition. Samples were left to
incubate for 10 min after each addition of lipid suspension.
The partition coefficient, Kp, is calculated from the fit of
experimental data with Eq. (3) as described elsewhere [26]
I
IW
¼
1þ KpcL ILIW L½ 
1þ KpcL L½ 
ð3Þ
where IW and IL are the fluorescence intensities in aqueous
solution and in lipid solution, respectively, cL is the molar
volume of lipid and [L] is the lipidic concentration) [26] cL
used was 7.6310 1 dm3 mol 1 for vesicles containing
POPC [27] and 6.8910 1 dm3 mol 1 for vesicles
containing DPPC [28]. Pep-1 is restricted to the outer leaflet
of bilayers in the absence of a transbilayer potential [17], so
data analysis was carried out considering the effective lipid
concentration as half of the total lipid concentration [26].
Kinetic assays were followed by fluorescence emission
intensity (kex=280 nm and kem=340 nm; pep-1 in lipidic
vesicles has a 10 nm blue-shifted emission spectrum, by
application of Eq. (AI.8), see Appendix B). Lipidic
suspensions (final concentration of 3.75 mM; this concen-
tration ensures that the molar fraction of partitioned peptide
in lipidic phase, XL, is z0.8, calculated using Eq. (4) [29])
were added to the peptide solutions (6.88 AM) with
physiologic ionic strength.
XL ¼ KpcL L½ 
1þ KpcL L½ 
ð4Þ
The Eq. (AIII.11) deduced in Appendix C was used to fit the
kinetics data.
2.6. Location in lipidic membranes
The membrane in-depth location of the pep-1 Trp
residues was studied by differential quenching method-
ologies. 5DS and 16DS are quenchers of Trp fluorescence,
which have different locations in the lipidic bilayer. 5DS is
located near the interface while 16DS buries more deeply
into the bilayer core [30]. Titration of peptide samples (6.88
and 1.45 AM), in the presence of LUVs composed of
different lipid mixtures (3.5 mM lipid in buffer with low or
physiologic ionic strength), was carried out with ethanolic
solution of 5DS and 16DS (final ethanol concentration was
kept below 2%). The assays were followed by fluorescence
emission intensity (kex=280 nm, kem=340 nm). Data were
corrected for simultaneous absorption of fluorophore and
quencher [22]. Effective concentration of quencher in the
lipidic bilayer matrix, [Q]L,
Q½ Lc
Kp;Q Q½ T
1þ Kp;qcL L½ 
cL L½ bb1 ð5Þ
was used in the Stern–Volmer plots; [Q]T is the quencher
concentration in total solution volume and Kp,Q is the
quencher partition coefficient [29]. For gel phase vesicles
Kp,Q equals 12,570 and 3340 for 5 DS and 16 DS,
respectively. In crystal-liquid-like phase the values used for
5 DS and 16 DS were 89,000 and 9730, respectively [31].
Acrylamide is unable to efficiently quench the fluores-
cence of Trp residues deeply buried in the bilayer; titration
of peptide in the presence of LUVs with this quencher also
gives insight on peptide in-depth location [19]. Fluorescence
emission quenching (kexc=290 nm, kem=340 nm) with
acrylamide was carried out with different lipidic mixtures
(3.5 mM lipid concentration) in the absence and presence of
phosphine (1 mM).
3. Results and discussion
3.1. Aqueous solution
The organization of pep-1 may be potentially influenced
by the ionic strength (pep-1 is a charged peptide at pH 7.4)
and reduction agents (via inter-molecular disulfide bonds at
the cysteamine terminal). Pep-1 has five Trp residues
located in its so-called hydrophobic region, which enable
structural characterization by fluorescence spectroscopy.
The fluorescence spectra of peptide and free Trp in aqueous
media present equal vibrational progression (Fig. 1A), this
is true both in low and physiologic ionic strength.
At low ionic strength the peptide quantum yield is slightly
concentration-dependent (Fig. 1B). Dynamic light scattering
correlograms (data not shown) show evidence for the
presence of aggregates with mean (weight-averaged) hydro-
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dynamic radius of bRhNc60 nm in both 1.45 AM and 6.88
AM pep-1 solutions (i.e. below and above the apparent
critical concentrations of 3.4F1.7 AM (Fig. 1B)). However
these averaged values do not exclude the presence of smaller
aggregates in suspension (light scattering techniques have
very low sensitivity for smaller aggregates in polydispersed
systems) [32]. It is not possible to conclude from Fig. 1B
alone if the bcritical concentrationQ is a monomer/micelle
transition or reflects the clustering of previously formed n-
mers (similarly to what was concluded for polyene anti-
biotics [33]). Fig. 1C shows that, when pep-1-CF is titrated
with unlabelled peptide, fluorescence emission intensity of
the carboxy-fluorescein moiety increases when low concen-
trations of labelled peptide are used. This may be explained
on the basis of fluorescence re-absorption (btrivial effectQ
energy transfer) caused by self-aggregation and closely
packed chromophores. Trapping photons in the oligomers
increase the probability of non-radiative decay of the
fluorophores to the ground state. Therefore, oligomeric
forms of the amphipathic peptide occur in solution.
Non-linear Stern–Volmer plots for the fluorescence
quenching of the aggregates by the hydrophilic molecule
Fig. 1. Characterization of Pep-1 in aqueous solution. Pep-1 (or free Trp) in 10 mM HEPES buffer pH 7.4 containing 10 mM NaCl. (A) Fluorescence emission
spectra (kexc=280 nm) of free Trp (solid line) and pep-1 (dashes) in aqueous solution. (B) Fluorescence intensity (kexc=280 nm and kem=350 nm) dependence
on pep-1 concentration. There are two linear zones with different slopes, that intersect at an apparent critical concentration (3.4F1.7 AM); below (circles) and
above (squares) it, the peptide has different quantum yields. (C) Titration of 0.023 (solid circle), 0.058 (open circles), 0.12 (solid square), 0.17 (open square),
0.23 (open triangle) and 0.58 AM (solid triangle) pep-1-CF with non-labelled pep-1 followed by fluorescence emission at kexc=490 nm kem=520 nm. (D) Red-
edge excitation shift of 6.88 AM pep-1: variation of maximum emission wavelength (circles) and variation of anisotropy for pep-1 (black solid line), free Trp in
buffer (control 1; grey solid line) and free Trp in glycerol (control 2; dashes) with the excitation wavelength. (E) Quenching of fluorescence emission of free
Trp by GSSG (circles) and by GSH (squares), notice that hydrolysis of one GSSG molecule forms two GSH molecules. (F) Effect of reducing agent phosphine
on free Trp (control; circles), 6.88 AM pep-1 (squares) and 1.45 AM pep-1 (triangles).
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acrylamide ( fB =0.59 and 0.61 for 1.45 and 6.88 AM,
respectively) are evidence that Trp residues sense heteroge-
neous local micro-environments [26]. Moreover, there is a
fraction of the fluorophores not in contact with the aqueous
solvent (hydrophobic bpocketsQ in the aggregates). This result
is further confirmed by the occurrence of red-edge excitation
shift in the fluorescence spectra of 6.88 AM pep-1 (Fig. 1D),
which supports the hypothesis of a reduced mobility on the
Trp side chain [34]. A complete depolarization of clustered
pep-1 at kexcitationb280 nm at variance to what is observed
with immobilized Trp residues in glycerol (Fig. 1D) is a
consequence of Trp–Trp energy migration (homotransfer),
which is favoured by adjacent Trp residues in the peptide
sequence. Energy migration is known to play a role in red-
edge phenomena since red-shifting of Trp emission leads to a
decrease in the absorption/emission spectral overlap [23].
Depolarization by migration is not efficient and anisotropy
raises at the red-edge. The large ratio of anisotropies taken at
310 /270 nm is a consequence of energy migration. Largely
shifted emission spectra of Trp (Fig. 1D) are not common but
other cases have been reported before [26,35].
It should be stressed that -SH group is a quencher of Trp
fluorescence (Fig. 1E). Moreover disulfide bonds are also
efficient quenchers (Fig. 1E). The differential effect of the
reducing agent phosphine on the fluorescence quantum
yield of the aggregates below and above the apparent critical
concentration (Fig. 1F) is an evidence of an alteration of the
internal molecular structure of the aggregate. Reduction of
the -S-S- bonds implies a more pronounced effect at lower
concentration (quenching is enhanced with the addition of
phosphine; reduction of -S-S- induces a larger diffusional
freedom of pep-1, resulting in improved quenching of Trp
residues by -SH groups). At higher concentrations, the
addition of phosphine does not induce a pronounced
alteration in the contact of -S-S- or -SH groups with Trp
residues. The fraction of fluorophores accessible to acryl-
amide in the presence of reducing agent phosphine is bigger
for 1.45 AM pep-1 ( fB=0.80) than for 6.88 AM ( fB=0.71).
The red-edge excitation shift for 6.88 AM pep-1 is not
significantly influenced by the reducing agent phosphine.
At physiologic ionic strength the pep-1 quantum yield is
independent of concentration and is not altered in the
presence of reducing agent (data not shown). These results
suggest that the organization of pep-1 is similar in the range
of concentrations evaluated. A non-linear Stern–Volmer
( fB=0.73 for 1.45 AM and 0.63 for 6.88 AM pep-1) and a
red-edge excitation shift was also observed for physiologic
ionic strength, indicating that peptide aggregates in aqueous
solution, but organization of these aggregates is not
dependent on concentration.
3.2. Extent of partition into liquid-crystal bilayers
Titration of aqueous suspensions of the peptide (1.45 or
6.88 AM) with lipidic vesicles leads to blue-shifted emission
spectra (Fig. 2A) and an increase in the fluorophore
quantum yield (Fig. 2B). The fluorescence intensity is
related to Kp by Eq. (3). When POPC large unilamellar
vesicles are used ([pep-1]=6.88 AM), Kp= (2.8F0.6)103
for low ionic strength, which leads to DG =1.9104 J
mol 1. The calculated molar fraction of the peptides
Fig. 2. Partition of pep-1 in LUVs. 6.88 AM pep-1 in 10 mM HEPES
buffer pH 7.4 containing 10 mM NaCl. (A) Fluorescence emission spectra
of pep-1 in aqueous solution (long and short dashes), in the presence of
0.5 mM POPC LUVs (solid line) and when is completely inserted in
lipidic phase (short dashes; spectra calculated using Eq. (AI.8), Appendix
A); fluorescence emission spectra were recorded for other lipidic concen-
trations but only one is represented for the sake of simplicity. (B)
Fluorescence emission intensity of pep-1 normalized to [L]=0 (I / IW)
upon titration with LUVs of POPC (circles) or DPPC (squares)—Eq. (3)
and Eq. (AII.10) (see Appendix B), respectively, were fitted to data. (C) Kp
(logarithmic scale) of pep-1 in vesicles with different molar ratios of
POPC:POPG.
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inserted in the lipidic matrix at 3.5 mM POPC (close to the
reference value in biological systems [36]) is XL=0.80 (Eq.
(4)). This value is not sensitive to the ionic strength of the
medium (Kp= (3.4F0.6)103 for physiologic strength),
because POPC is globally a neutral lipid. Kp increases
exponentially with the molar fraction content of the
negatively charged lipid POPG in the POPC bilayer (Fig.
2C). Such exponential behaviour is predicted under the
framework of simple theories [37]. For 20% negative lipids
(the expected natural occurrence in most cells [38]) and
[L] =3.5 mM, XL is very close to 100% (Kp=2.8F
0.4)104), i.e. virtually all the peptide is inserted in
biological membranes. Naturally, at higher ionic strengths,
partition coefficient values are decreased (Kp =2.2F
0.4)104), but the difference is not significant and for
[L]=3.5 mM XL is also close to 100%. When phosphine is
added to the POPC suspension, Kp is remarkably reduced to
(4.8F1.2)102, showing that the aggregate formed by
monomeric peptides in aqueous solution is more stable than
the aggregates formed by the dimers. In other words, the
reducing environment stabilizes the peptide in aqueous
solution. A similar phenomenon was reported for a
magainin analogue [39]. When POPG (20%) is present,
Kp is also decreased in reducing conditions ((7.2F
2.4)102 for physiologic ionic strength), which means that
peptide organization effects superimpose to electrostatic
ones in partition.
3.3. Extent of partition into gel phase bilayers
The importance of biomembranes lateral heterogeneity
(membrane domains) in the occurrence and control of
several biochemical phenomena [40] prompted us to study
gel-phase membranes in addition to fluid liquid-crystal
ones. DPPC, a neutral lipid at pH 7.4, forms gel bilayers in
aqueous environment at room temperature. In the presence
of DPPC, the fluorescence spectrum of the peptide is blue-
shifted relative to aqueous solution (data not shown).
Nevertheless, the fluorescence quantum yield decreases at
low lipid concentrations, increasing afterwards (Fig. 2B).
We explored the hypothesis that this could be due to self-
quenching because at low lipidic concentrations the
peptide/lipid molar ratio is high. Eq. (AII.10) was derived
(see Appendix B) assuming self-quenching occurrence in
partition plots and it fits the experimental data (Fig. 2B).
There is no significant difference in partition coefficients of
[pep-1]=6.88 AM, for low and physiologic ionic strength
(Kp= (1.3F0.4)104 and (0.6F0.2)104, respectively).
As partition to gel phase bilayers occurs as surface
adsorption and/or insertion in line defects in the lipidic
palisades, a direct and quantitative comparison with Kp
obtained in POPC is prevented. Yet, it should be stressed
that Kp is also quite big in rigid lipidic areas of heteroge-
neous membranes. As before, in the presence of phosphine
Kp decreases at both ionic strength ((8.0F1.6)103 for low
ionic strength and (8.0F2.3)103 for physiologic ionic
strength). DPPS, a negatively charged lipid which keeps gel
phase properties in the DPPC matrix, causes an increase in
Kp up to 10% molar (Kp= (1.4F0.6)105 for low ionic
strength). In the 10–50% range Kp is broadly constant (data
not shown). This saturation is probably related to a
saturation of the line defects in the gel. Likewise, increas-
ingly blue-shifted emission fluorescence spectra are
observed up to 5% DPPS, the wavelength of the emission
maximum remaining constant after that.
3.4. Extent of partition into cholesterol-containing bilayers
POPC bilayers having 33% molar cholesterol are
homogeneous [41] and can be regarded as model compo-
sitions to study liquid-ordered-like patches in biological
membranes [42]. Both blue-shifted emission spectra and
increased fluorescence quantum yield are detected when
pep-1 is in the presence of POPC/cholesterol vesicles.
Evidence for self-quenching at high peptide/lipid ratios is
obtained (data not shown), as before with DPPC. Never-
theless, the apparent extent of partition is close to the one
measured when only POPC was used, (Kp = (3.4F
0.4)103 for low ionic strength and (2.2F0.6)103 for
physiologic ionic strength). Cholesterol affects the partition
patterns but not significantly its extent i.e. it favours sulfur/
indole interactions, whether by modulation of its organ-
Fig. 3. Partition kinetics of 6.88 AM pep-1 (10 mM HEPES buffer pH 7.4
containing 150 mM NaCl) in 3.75 mM DPPC:DPPS (4 :1) LUVs. Fit was
realized with Eq. (A.III.11) (see Appendix C).
Table 1
Parameters of 6.88 AM pep-1 kinetic incorporation in LUVs, determined by
non-linear regression fitting of Eq. (AIII.11) (see Appendix C)
Lipida t1/2 (102 ms) Kp (104)
POPC 6.9F5.2 1.2F0.7
POPC:POPG (4 :1) 0.5F0.3 3.4F1.8
POPC:col (2 :1) 1.9F0.3 1.5F0.5
DPPC 2.4F0.8 1.4F0.4
DPPC:DPPS (4 :1) 1.2F0.3 2.6F0.6
a The final lipidic concentration in each case is 3.75 mM (10 mM HEPES
buffer pH 7.4 containing 150 mM NaCl).
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ization, or by forcing peptide location in a narrower space
of the membrane. The second hypothesis seems more
reasonable, on the account of the results obtained with
DPPC.
3.5. Kinetics
Partition of pep-1 into lipid bilayers occurs in the
second time range, presenting an hyperbolic-like depend-
ence of fluorescence intensity with time (Fig. 3).This
dependence was rationalized in terms of a simple
partition model (Appendix C) and t1/2= ln 2 /kin, as well
as Kp, were calculated by fitting Eq. (AIII.11) to the
experimental data (Table 1). Partition is faster for gel-phase
and liquid-ordered membranes relative to liquid-crystal
ones. Anionic lipids decrease t1/2. There is a correlation
between partition extent and velocity. In spite of differences
in methodologies to determine the Kp’s, the ones obtained
from kinetic data are in fair agreement with those obtained
in steady-state experiments (the effect of negative lipids is
well pronounced).
3.6. Pep-1 location in the lipid palisade
In-depth location on the pep-1 Trp residues was carried
out by means of fluorescence quenching with doxyl
derivatized stearic acid. The closer the Trp residues are
to the quencher group, the more efficient is the quench-
ing. Thus 5DS probes the bilayer interface while 16DS
probes its core. More refined methods [30] are difficult to
apply because the Trp residues span a 9-amino acids
sequence in the peptide. Stern–Volmer plots show down-
ward deviation from linearity (Fig. 4). This can be due to
the existence of fluorescence sub-populations with differ-
ential accessibility to the quencher [23]. In the limit, a
fraction of the fluorophores may be completely segregated
from the quenchers [43]. For instance incomplete partition
into membranes (XLb1) renders a fraction of fluorophores
completely inaccessible to lipophilic quenchers. Thus, Eq.
(2) was used for data analysis. fB should be equal to the
fraction of light emitted from the incorporated peptide, fL,
which can be calculated from Kp [29]
fL ¼ IL=IWð ÞKpcL L½ 
1þ IL=IWð ÞKpcL L½ 
ð6Þ
The results are presented in Table 2. Regardless of the
lipidic systems or peptide concentrations, 5DS is a more
efficient quencher than 16DS. This is evidence of a
shallow position of the so-called hydrophobic region of
Fig. 4. Pep-1 location in POPC LUVs. Stern–Volmer plot of the
fluorescence quenching of 6.88 AM Pep-1 by 5DS (circles) and 16DS
(squares) concentration. Effective quencher concentration in lipidic phase
was determined using Eq. (5). Eq. (2) was fitted to data by means of non-
linear regression. Lipidic concentration is 3.5 mM in a 10 mM HEPES
buffer pH 7.4 containing 10 mM NaCl.
Table 2
Emission fluorescence quenching of pep-1, incorporated in LUVs, by 5DS and 16DSa
[pep-1] (AM) Lipid Ionic strength fL fB ,5DS KSV,5DS (M 1) fB ,16DS KSV,16DS (M 1)
6.88 POPC low 0.90 0.95F0.43 22.1F2.6 0.92F0.45 9.7F1.1
physiologic 0.94 1 12.3F0.5 1 3.6F0.1
POPC:POPG (4 :1) physiologic 0.99 0.96F0.24 29.4F1.9 1 6.3F0.1
DPPC low 0.94 0.95F0.22 70.4F6.3 1 15.7F0.4
physiologic 0.98* 0.97F0.30 207F28 1 16.5F0.7
DPPC:DPPS (4 :1) physiologic 0.99* 0.92F0.33 374F61 1 8.8F0.4
1.45 POPC physiologic 0.95* 0.74F0.24 27.2F3.8 1 3.0F0.1
POPC:POPG (4 :1) physiologic 0.98* 0.78F0.33 29.9F5.2 1 6.3F0. 4
DPPC:DPPS (4 :1) physiologic 0.99* 0.81F0.45 262F67.9 0.77F0.20 22.4F2.4
a Total lipidic concentration was 3.5 mM. Assays were performed in 10 mM HEPES buffer containing 10 mM (low ionic strength) or 150 mM (the so-called
physiologic ionic strength) NaCl. fB and KSV were determined by fitting Eq. (2) or Eq. (1) ( fB=1) to experimental data. fL was determined by application of Eq.
(6) using Kp values obtained by the steady-state or kinetic methodologies (marked with *).
Table 3
Emission fluorescence quenching of 6.88 AM pep-1, incorporated in LUVs,
by acrylamidea
Lipid [phosphine] (mM) KSV (M
 1)
POPC 0 3.1F0.5
1 17F4.5
POPC:POPG (4 :1) 0 2.7F0.4
1 30.9F9.9
DPPC 0 3.1F0.2
1 69.4F16.2
DPPC:DPPS (4 :1) 0 3.8F0.2
1 19.3F3.5
a Total lipidic concentration was 3.5 mM. Assays were performed in 150
mM (the so-called physiologic ionic strength) NaCl. fB and KSV were
determined by fitting Eq. (2) to experimental data.
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pep-1 at the membrane interface. fL is in agreement with
fB,5DS and fB,16DS, given the intrinsic experimental error. It
is interesting to notice that the quenching efficiency using
lipophilic doxyl probes is bigger in gel-phase membranes.
This may be due to segregation of both fluorophore and
quenchers to defect lines in the gel matrix, favouring static
quenching mechanisms at high local concentrations in a
molecular scale.
To further search the membrane insertion extent of pep-1,
fluorescence quenching experiments using the hydrophilic
quencher acrylamide were carried out at 6.88 AM pep-1 and
150 mM NaCl. Results presented in Table 3 demonstrate
that fluorescence emission of pep-1 in the presence of LUVs
is not efficiently quenched by acrylamide. Although Trp
residues are located near the water–lipid interface, they are
protected from aqueous environment. In the presence of a
reducing agent the quenching efficiency was markedly
improved, which suggests that pep-1 is not so extensively
incorporated in lipidic vesicles. These results are in agree-
ment with partition data.
4. Conclusions
In a recently published work [17] the capacity of pep-1
to translocate across a lipidic bilayer was demonstrated.
Translocation in vesicles only occurs in the presence of a
transmembrane potential. The nature of cell membrane
(negatively charged inside and neutral outside) prompted
us to evaluate the pep-1 affinity for lipidic bilayers in
different conditions. The information gathered in the
present study highlights some important features of
environmental factors that may be crucial to pep-1
molecular action at the biological membrane level. Fig. 5
gathers the information into a mechanistic model. Most
biomembranes are asymmetrically charged (neutral at the
outer surface and negative inside [38]). The present study
shows that Pep-1 in the outer aqueous environment inserts
extensively into membranes, whether at high or low
concentration, even when no transbilayer potential is
present. After anchorage at the bilayer surface, electrostatic
attraction combined with lipid bilayer perturbation prob-
ably causes translocation into the inner leaflet of the
membrane [17]. Being an anionic interface, the release into
the cellular environment could be problematic if it was not
for the pep-1 reduction (Fig. 5), which turns the peptide
aggregates into stable structures with low Kp. This makes
the process irreversible in practice inside cells and pep-1 is
then available for uptake by cellular compartments.
Results obtained with DPPC suggest that the liquid hete-
rogeneity boundaries in biological membranes may serve as
gateways for pep-1 crossing. Membrane fusion may
also facilitate translocation, as addressed by Terrone et al.
(2003) [16].
Fig. 5. Mechanistic model for the environmental factors that lead to cellular uptake of pep-1. Pep-1 in the outer aqueous environment incorporates extensively
in lipidic bilayers (see text) and translocation occurs, mainly due to membrane perturbation and electrostatic interaction [17]. This sketch depicts the influence
of a reducing environment at the cell interior, which is responsible for membrane detachment of pep-1 (thus, it is a crucial factor in pep-1 functionality).
Although partition equilibrium of the dimerized peptide to the negatively charged inner leaflet of the mammals’ model membranes (A) greatly favours lipidic
phase (see text), reduction of pep-1 in the cell interior combined with a partition equilibrium (B) which favours aqueous phase for the monomeric peptide (see
text) results in availability of free pep-1 inside the cell. Light blue fragments represent the Lys-rich hydrophilic domain. In dark blue are the Trp-rich domains.
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Appendix A. Theoretical calculation of the peptide
fluorescence emission spectrum when it is completely
inserted in lipid bilayers
The Trp emission fluorescence is very sensitive to the
polarity of the surrounding solvent. The total emission
spectrum of pep-1, It(k), is dependent both on the spectrum
of pep-1 sub-population incorporated in lipid, IL(k), and the
spectrum of the sub-population of the fluorophore present in
aqueous solution, IW(k),
It kð Þ ¼ nLiL kð Þ þ nWiW kð Þ ¼ IL kð Þ þ IW kð Þ ðAI:1Þ
where ii(k) is the spectrum of one molecule and ni the
number of molecules in lipid, L, or in water, W. Eq. (AI.1)
can be rewritten,
It kð Þ ¼ nLULIL;N kð Þ þ nWUWIW;N kð Þ ðAI:2Þ
where Ii,N(k) is the normalized emission spectrum; UL and
UW are the quantum yield in lipid and water, respectively.
Eq. (AI.2) can be rewritten in terms of the molar fraction of
peptide in lipid, XL, and in water, XW,
It kð Þ
nL þ nW ¼ XLULIL;N kð Þ þ XWUWIW;N kð Þ ðAI:3Þ
It(k), can be expressed in terms of the average quantum
yield of peptide, hUiL,W,
It kð Þ ¼ nL þ nWð ÞhUiL;WIt;N kð Þ ðAI:4Þ
hUiL;W ¼ XLUL þ XWUW ¼ 1 XWð ÞUL þ XWUW
ðAI:5Þ
Combining Eqs. (AI.3), (AI.4) and (AI.5):
IL;N kð Þ¼ 1þ XW
1 XW
UW
UL
 
It;N kð Þ  XW
1 XW
UW
UL
IW;N kð Þ
ðAI:6Þ
Considering the Eq. (4) (see text),
XW
1 XW c
1
KpcL L½ 
ðAI:7Þ
Therefore, the peptide emission spectrum when totally
inserted in lipid membranes, is obtained,
IL;N kð Þ¼ 1þ 1
KpcL L½ 
UW
UL
 
It;N kð Þ  1
KpcL L½ 
UW
UL
IW;N kð Þ
ðAI:8Þ
Appendix B. Partition formalism accounting for
self-quenching in membranes
The quantum yield of a fluorophore population is a linear
combination of its components,
U ¼ XLUL þ XWUW ðAII:1Þ
Eq. (4) (see text) can be applied to most experimental con-
ditions (lipidic volume very small relative to the total sam-
ple volume, cL[L]bb1). Combining Eqs. (AII.1) and (4):
U ¼ cLKp L½ 
1þ cLKp L½ 
UL þ 1
1þ cLKp L½ 
UW ðAII:2Þ
Considering that there is no significant spectral shift
influence on the measured fluorescence intensity, I:
I ¼ cLKp L½ 
1þ cLKp L½ 
IL þ 1
1þ cLKp L½ 
IW ðAII:3Þ
where IL is the emission intensity of the fluorophore
molecules incorporated in lipid, in the case of self-
quenching absence. IL is constant if the fluorophore
concentration is maintained throughout the experiment. In
the case of existing self-quenching, IL is dependent on
lipidic concentration. When lipid concentration is low, the
fluorophore concentration in the membrane is high, and the
self-quenching notable. In the case of self-quenching, IL is
the intensity that would be recorded in case all fluorophores
had the quantum yield of molecules incorporated in lipid at
infinite dilution.
In homogeneous solution, self-quenching can be
described by, [1]
1
I
¼ kf þ knr
Iexcelkf F½  þ
kq
Iexcelkf
ðAII:4Þ
where Iexc is the excitation light intensity, kq is the kinetic
constant of the quenching process, kf is the radiative
fluorescence constant, and [F] is the fluorophore concentra-
tion. Considering k1=IexcUel and k2 ¼ kqkf 1el , the fluorescence
intensity of flurophore can be described by Eq. (AII.5),
I ¼ k1 F½ 
1þ k2k1 F½  ðAII:5Þ
In a partition experiment, self-quenching is a conse-
quence of fluorophore compartmentalization inside the
lipidic matrix. Imagining that all illuminated volume is
occupied by lipidic matrix (limit condition for IL) and that
the lipidic concentration is constant, the fluorescence
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intensity dependence on fluorophore concentration, IL([F])
is dictated by Eq. (AII.5), where [F] stands for the
fluorophore concentration in the lipidic matrix ([F]L).
In this limit situation, [F]L=nt/vt, where nt is the total
number of solute moles and vt is the total illuminated
volume. However, in attainable experimental conditions,
only a fraction of the lipid is being illuminated. This
fraction equals the fraction of fluorophores being illumi-
nated (ni /nt, where ni and nt are the illuminated and total
moles of fluorophore, respectively). Thus,
I L½ ð Þ ¼ k1 F½ L
1þ k2k1 F½ L
ni
nt
¼ k1 F½ t
1þ k2k1 F½ L
ðAII:6Þ
([F]t is the fluorophore concentration over the whole
volume). Taking Eq. (3) (see text), [F]L is related with
[F]t,
F½ L ¼
Kp
1þ KpcL L½ 
F½ t ðAII:7Þ
So, fluorescence intensity dependence on lipid concen-
tration is:
I L½ ð Þ¼ k1 F½ t
1þ k2k1 Kp F½ t
1þ kpcL L½ 
¼k1 F½ t
1þ KpcL L½ 
1þ KpcL L½  þ k2Kpk1 F½ t
ðAII:8Þ
k1[F]t= IL is the fluorescence emission intensity recorded
in the absence of self-quenching, so,
I L½ ð Þ ¼ IL 1þ KpcL L½ 
1þ KpcL L½  þ k2KpIL
ðAII:9Þ
Combining Eqs. (AII.3) and (AII.9),
I ¼ cLKp L½ IL
1þ KpcL L½  þ k2KpIL
þ IW
1þ cLKp L½ 
ðAII:10Þ
Appendix C. Kinetic of partition formalism
If the limit conditions are,
nW t ¼ 0ð Þ ¼ nt; nL t ¼ 0ð Þ ¼ 0
nL t ¼lð ÞccL L½ KpnW
0btbl nW tð Þ ¼ nt  nL tð Þ
the fluorescence intensity dependence on time can be
described by:
I tð Þ~ULnL þ UWnW
I t ¼ 0ð Þ~UWnt
0btbl
therefore,
I tð Þ
I t ¼ 0ð Þ ¼
UL
UW
nL tð Þ
nt
þ nW tð Þ
nt
ðAIII:1Þ
The relative intensity, IR(t) = I(t) p I(t = 0), can be rewritten:
IR tð Þ ¼ ULUW  1
 
nL tð Þ
nt
þ 1 ðAIII:2Þ
At t =l,
nL t ¼lð Þ
nW t ¼lð Þ ¼ cL L½ Kp ðAIII:3Þ
nL t ¼lð Þ
nt  nL t ¼lð Þ ¼ cL L½ Kp ðAIII:4Þ
nL t ¼lð Þ
nt
¼ cL L½ Kp
1þ cL L½ Kp
ðAIII:5Þ
Kp can be expressed in terms of kinetic constants,
Kp ¼ kin
kout
ðAIII:6Þ
where kin and kout are the first-order velocity constants of the
fluorophore entering and leaving the lipidic matrix, respec-
tively. Under the framework of our kinetic model, [2]
kint ¼ nL t ¼lð Þ
nt
ln
nL t ¼lð Þ
nt t ¼lð Þ  nL tð Þ
 
ðAIII:7Þ
Therefore,
exp kint
nt
nL t ¼lð Þ
 
¼ nL t ¼lð Þ
nt t ¼lð Þ  nL tð Þ ðAIII:8Þ
But
nL tð Þ
nL t ¼lð Þ ¼ 1 exp 
nt
nL t ¼lð Þ kint
 
ðAIII:9Þ
combining Eq. (AIII.5) with Eq. (AIII.9),
nL tð Þ
nt
¼ cL L½ Kp
1þ cL L½ Kp
1 exp  nt
nL t ¼lð Þ kint
  
ðAIII:10Þ
when this term is applied in Eq. (AIII.2),
IR tð Þ ¼ ULUW  1
 
cL L½ Kp
1þ cL L½ Kp
 ð1 exp  1þ Kp L½ cL
cL L½ Kp
 
kintÞ þ 1 ðAIII:11Þ
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2.2.2. Consequences of nonlytic membrane perturbation to the 
translocation of the cell penetrating peptide pep-1 in lipidic vesicles. 
 
2.2.2.1. Motivation and methodologies used 
After characterization of environmental factors that improve pep-1 affinity for 
lipidic membranes and the possible location of this peptide in the membrane, functional 
abilities of pep-1 and the effects on membrane integrity were aimed. The possibility of 
vesicle aggregation and fusion of lipids; induction of phospholipid flip-flop; segregation 
of anionic phospholipids; ability to induce pore formation and to translocate across cell 
membrane were evaluated. The results and conclusions were published in the article 
titled: Consequences of nonlytic membrane perturbation to the translocation of the cell 
penetrating peptide pep-1 in lipidic vesicles. 
 
The stability of liposomes dispersion is mainly governed by three types of forces: 
electrostatic repulsion, van der Waals attraction and hydration forces [147]. The 
electrostatic force is affected by charge density of the vesicles and the electrolyte 
concentration, while van der Waals interactions can be modulated by modification of 
the vesicle size. The magnitude of hydration force is related to the energy required to 
remove water from the surface. The presence of polyvalent cations is able not only to 
charge surface density upon adsorption to the membrane but also to dehydrated the lipid 
headgroup and thereby induce aggregation of phospholipid vesicles. Pep-1 has 7 
positive charges and a positive global charge (+3) at physiological conditions. 
Regarding this positive global charge and peptide affinity for lipidic membranes it 
would be expected that this peptide could work as a destabilising agent, as observed for 
penetratin [147]. Optical density was employed to monitor vesicle aggregation induced 
by pep-1. Turbidity is directly proportional to the R2 (R, particle size) [148], 
consequently, small increases in the size of the liposomes due to aggregation originate a 
high increase in turbidity which can be followed by optical density. The possibility of 
vesicle aggregation was further confirmed with fluorescence microscopy with vesicles 
doped with a Rhodamine B-labelled phospholipid.  
 
Vesicle fusion may result from a variety of stimuli able to destabilize lipidic 
membranes [149]. Some examples of propitious conditions for fusion events occurrence 
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are discussed in the reference [150]. Pep-1 is amphipathic, which is a common 
characteristic among fusiogenic peptides [151]; the possibility of vesicle fusion induced 
by this peptide was evaluated by the use of Förster Resonance Energy Transfer (FRET) 
methodology. FRET is referred to the process in which the energy associated with 
electronic excitation in a molecule (donor) is “shared” with a nearby molecule (acceptor) 
trough dipole-dipole coupling. The energy shared is dependent on distance between 
dipoles [152] and is strongly dependent on the overlap of emission spectrum of donor 
molecule and excitation spectrum of acceptor molecule.  
To follow vesicle fusion induced by pep-1 FRET between 7-nitro-2-1,3-
benzoxadiazol-4-il (NBD; acceptor) and Rhodamine (Rh; donor) was followed. NBD is 
a fluorophore with an emission at about 463nm and Rh is excited around 470nm. 
Vesicles doped with NBD-PE and with Rh-PE were mixed with non-labelled vesicles. 
In the case of fusion of vesicles induced by pep-1, NBD and Rh molecules become 
more separated on average and a decrease in FRET efficiency is monitored (Figure 2.6). 
 
Figure 2.6. Fusion of vesicles can be 
followed by FRET between NBD 
(yellow, donor) and Rh (red, acceptor). 
A decrease in FRET efficiency is 
expected upon fusion of labelled 
vesicles (doped with Rh and NBD) with 
non-labelled vesicles. A decrease in 
FRET efficiency results from an 
increase in the distance between donor 
and acceptor. Image adapted from 
http://probes.invitrogen.com/handbook/. 
 
 
Pep-1 affinity to lipidic membranes increases in the presence of anionic 
phospholipids [153] (see section 2.2.1); results obtained with other CPPs suggest that 
the internalization mechanism is dependent on the interaction with anionic lipids or 
other negatively-charged molecules at cell surface [63, 66, 70, 154]. A specific 
interaction with anionic phospholipids and the possibility of pep-1-induced anionic lipid 
segregation were tested. This was also followed by FRET between NBD and Rh by the 
use of vesicles labelled with C6-NBD-PG (anionic phospholipid) and Rh-PE 
+ 
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(zwitterionic phospholipid). In the case of segregation of anionic phospholipids due to 
peptide-inducing clustering, the average distance between Rh and NBD would increase 
and a decrease in FRET efficiency upon peptide addition should be notorious.  
 
Some basic peptides are able to induce membrane perturbation that provokes 
membrane leakage and ultimately membrane lyses. This is a common feature among 
AMPs such as Melitin [155, 156], Magainin 2 [157] and Buforin 2 [158]. The 
possibility of pore formation induced by pep-1 was tested by means of NBD 
fluorescence emission quenching in the presence of Co2+ ions [159]. This quencher can 
not access the inner core of membranes but is able to quench NBD molecules attached 
to phospholipid headgroups in the water-lipid interface [159]. When vesicles are doped 
with NBD-labelled phospholipid (N-NBD-PE), NBD molecules are homogenously 
distributed in the two layers. Upon Co2+ addition, fluorescence emission of NBD 
molecules in the outer layer is quenched, while NBD molecules in the inner layer are 
inaccessible to the quencher because Co2+ ions are notable to transverse the lipid bilayer. 
In the case of pore formation upon peptide addition, the membrane becomes permeable 
to Co2+ ions, which will result in quenching of the fluorescence emission of NBD 
molecules in the inner layer (Figure 2.7).     
 
 
Figure 2.7. Pore formation 
followed by quenching of NBD 
with Co2+ ions. NBD fluorophores 
are homogeneously distributed 
trough inner and outer layers. 
Upon Co2+ addition A) 
fluorescence emission of NBD 
fluorophores in the outer layer will 
be quenched; B) in the case of 
pore formation, the membrane 
becomes impermeable to Co2+ 
ions, which in addition will 
quench NBD molecules in the 
inner layer.  
 
+ CO2+ 
A 
B 
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The pore formation was also evaluated by means of Rh fluorescence, which is 
quenched by pep-1 molecules. Vesicles were prepared with Rh B-containing buffer in 
the absence or in presence of pep-1. Then, non-encapsulated Rh B was removed by 
exclusion chromatography. For this particular study MLVs instead of LUVs were used 
to enable a gradual effect in the case of pore formation due translocation through the 
various lamellae. In the sample prepared with peptide, pep-1 is accessible to 
encapsulated Rh B molecules, serving as control; in the samples prepared without 
peptide, pep-1 was added later than and the quenching efficiency was compared to the 
control. If pep-1 does not form pores, it does not quench the Rh B molecules 
encapsulated in the vesicles. In the case of pore formation, pep-1 quenches the Rh B 
fluorophores inside the liposomes and the Rh fluorescence intensity is similar to the one 
obtained when pep-1 was added prior to vesicle formation. 
 
Peptide incorporation in lipidic vesicles can promote flip-flop (transbilayer 
movement) of phospholipids due to lipidic bilayer perturbation [160-162]. Peptide 
mediated “flop” is primarily the results of local disturbances of the bilayer structure in 
the vicinity of the peptide [161].   
If pore formation is not observed, flip-flop can be evaluated with a methodology similar 
to the one used to evaluate pore formation (see Figure 2.7) but with C6-NBD-PG 
instead of N-NBD-PE (in the former molecule NBD fluorophore is in the acyl chain 
while in N-NBD-PE the fluorophore is attached to the headgroup). C6-NBD-PG can 
undergo flip-flop [161, 163, 164], whereas NBD-PE cannot (NBD fluorophores 
derivatized in the polar group of the phospholipids inhibit flip-flop due to hydrophilic 
nature of the probe and its location [165]). In the case of flip flop an increase in NBD 
fluorescence emission quenching induced by Co2+ ions is expected after peptide 
addition.   
 
The biological activity of Pep-1 is dependent on its capacity to translocate across 
cell membrane. The possibility of pep-1 to translocate through model membranes was 
tested. The methodology used took advantage from the pep-1 quencher properties 
relative to Rh fluorescence. For these studies the fluorophore was placed in the lipidic 
bilayers attached to a phospholipid (Rh-PE) and two approaches were used. In the first 
one MLVs doped with Rh-PE were prepared with buffer in the presence or absence of 
Pep-1 and model membranes  Chapter 2. 
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pep-1. In this later sample, pep-1 was added afterwards and the Rh fluorescence 
quenching induced by the pep-1 was compared with the value obtained with the sample 
where the pep-1 was added prior to vesicle formation. In the second approach LUVs 
doped with Rh-PE were used, where the fluorophore is distributed homogeneously in 
the two layers. Upon peptide addition Rh fluorophores outside the membrane will be 
quenched; in the case of translocation pep-1 will became accessible to Rh molecules in 
the inner layer and a more efficient quenching will be notice (similar to what is 
represented in Figure 2.7). 
Terrone et al. [78] verified that penetratin and related CPPs are able to 
translocate across model membranes by a physical mechanism dependent on 
transmembrane potential. The transmembrane potential similar to the one presented in 
cellular membranes (negative inside) can be mimetized with liposomes loaded with K+-
containing buffer and dispersed in a Na+-containing buffer after valinomycin addition. 
Valinomycin forms highly specific pores for potassium ions (at variance with sodium 
ions, for instance) in the cell membrane. It works as a potassium-specific carrier 
facilitating the passage of potassium ions across membranes and modifying the 
electrochemical potential gradient [166, 167], creating a net charge with an excess of 
positive charges in of the bilayer sides. 
 
The methodologies above referred were used to evaluate the functional features 
of pep-1 with model membranes; the manuscript with the results obtained is presented 
afterwards.    
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Consequences of Nonlytic Membrane Perturbation to the Translocation of the Cell
Penetrating Peptide Pep-1 in Lipidic Vesicles†
So´nia Troeira Henriques and Miguel Augusto Rico Botas Castanho*
Centro de Quı´mica e Bioquı´mica, Faculdade de Cieˆncias da UniVersidade de Lisboa, Ed. C8, Campo Grande,
1749-016 Lisboa, Portugal
ReceiVed December 29, 2003; ReVised Manuscript ReceiVed April 27, 2004
ABSTRACT: The action of the cell penetrating pep-1 at the molecular level is not clearly understood. The
ability of the peptide to induce (1) vesicle aggregation, (2) lipidic fusion, (3) anionic lipid segregation,
(4) pore or other lytic structure formation, (5) asymmetric lipidic flip-flop, and (6) peptide translocation
across the bilayers in large unilamellar vesicles was studied using photophysical methodologies mainly
related to fluorescence spectroscopy. Neflometry and turbidimetry techniques show that clustering of
vesicles occurs in the presence of the peptide in a concentration- and anionic lipid content-dependent
manner. Results from Forste¨r resonance energy transfer-based methodologies prove lipidic fusion and
anionic lipid segregation, but no evidence for pores or other lytic structures was found. Asymmetric lipid
flip-flop was not detected either. A specific method related to the quenching of the rhodamine-labeled
lipids by pep-1 was developed to study the eventual translocation of the peptide. Translocation does not
occur in symmetrical neutral and negatively charged vesicles, except when a valinomycin-induced
transmembrane potential exists. Our work strongly suggests that the main driving force for peptide
translocation is charge asymmetry between the outer and inner leaflet of biological membranes and reveals
that pep-1 is able to perturb membranes without being cytotoxic. This nonlytic perturbation is probably
mandatory for translocation to occur.
The molecular ability to cross the biomembrane barrier
and introduce material into cells is a recent matter of interest
in research. So far, gene delivery technologies are most used,
but these kinds of delivery systems have some drawbacks,
such as low efficiency, poor specificity, poor bioavailability,
and toxicity (1). Introduction of proteins directly into a cell
is a better alternative because the posttranslation modification
is critical for the biological function of the protein (2).
Nevertheless traditional methods to introduce proteins have
low efficiency; the transduced protein often enters the
endocytic pathway and traffics to the lysosome where it will
be degraded and inactivated (2). New strategies for protein
transduction have been developed that use peptide carriers
designated as protein transduction domains (PTDs)1 (1-7).
These “vectors” are basic sequences capable of translocating
across the plasmatic membranes in a manner independent
of receptors or the endosomal pathway, carrying proteins
covalently linked (1-7).
Pep-1, a synthetic peptide carrier capable of introducing
active proteins into cells, has advantages over “genetic
therapy” because phenotype can be altered in less than 2 h
(3, 8, 9), as well as over other PTDs since the interaction
with proteins is independent of covalent links; the complex
pep-1/protein is promoted by hydrophobic forces (3, 8, 10).
The pep-1 has 21 amino acid residues (KETWWETWW-
TEWSQPKKKRKV), which can be divided into three
different domains: a “so-called” hydrophobic one, rich in
tryptophans (KETWWETWWTEW), a hydrophilic domain
with basic residues (KKKRKV), and a spacer between them
(SQP) (3, 8). The hydrophobic sequence is responsible for
the hydrophobic interactions with proteins (3, 8) and for the
intrinsic fluorescence of the peptide. The hydrophilic domain
improves intracellular distribution and the solubility of
peptide (3, 8). The spacer sequence is a link between the
other two domains (3, 8). Peptide is acetylated on the N
terminus and has a cysteamine group on the C terminus (8);
at physiological pH (7.4), the peptide has a global charge of
+3.
Like others PTDs, pep-1 translocates along biological
membranes in a manner independent of the endosomal
pathway (8), which suggests a physical process dictated by
the lipid bilayer. Pep-1 has high affinity for lipid bilayers,
and the presence of negative charges in the vesicles enhances
the partition to lipid bilayers, showing a strong electrostatic
interaction (11).
In the present paper, our aim is to present functional
abilities of the peptide (vesicle aggregation, dissociation, and
† This work was supported by Fundacü a˜o para a Cieˆncia e Tecnologia
(Portugal).
* To whom correspondence should be addressed. Tel.:
+351217500931. Fax: +351217500088. E-mail: castanho@fc.ul.pt.
1 Abbreviations: PTDs, protein transduction domains; HEPES, 2-(4-
(2-hydroxyethyl)-1-piperazinyl)ethanesulfonic acid; POPC, 1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphocholine; POPG, 1-palmitoyl-2-oleoyl-sn-
glycero-3-(phospho-rac-(1-glycerol)); DPPC, 1,2-dipalmitoyl-sn-glycero-
3-phosphocholine; DPPS, 1,2-dipalmitoyl-sn-glycero-3-(phospho-L-
serine); C6-NBD-PC, 1-myristoyl-2-[6-[(7-nitro-2-1,3-benzoxadiazol-
4-yl)amino]caproil]-sn-glycero-3-phosphocholine; C6-NBD-PG, 1-myrist-
oyl-2-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]caproil]-sn-glycero-3-
phosphoglycerol; N-NBD-PE, 1,2-dipalmitoyl-sn-glycero-3-phospho-
ethalonamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl); N-Rh-PE, 1,2-di-
palmitoyl-sn-glycero-3-phosphoethalonamine-N-(lissamine rhodamine
B sulfonyl); Rh B, rhodamine B; TX-100, Triton X-100; LUVs, large
unilamellar vesicles; MLVs, multilamellar vesicles; FRET, Forste¨r
resonance energy transfer; OD, optical density.
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fusion, pore formation in the lipidic bilayer, induction of
phospholipid flip-flop, segregation of anionic phospholipid,
and the ability to translocate) and to propose a molecular
model of action.
EXPERIMENTAL PROCEDURES
Reagents and Apparatus. Chariot, the commercial name
of pep-1, was obtained from Active Motif (Rixensart,
Belgium) with purity >95%; 2-(4-(2-Hydroxyethyl)-1-pip-
erazinyl)ethanesulfonic acid (HEPES), sodium chloride, and
chloroform (spectroscopic grade) were from Merk (Darm-
stadt, Germany); 1-palmitoyl-2-oleoyl-sn-glycero-3-phos-
phocholine (POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-
(phospho-rac-(1-glycerol)) (POPG), 1,2-dipalmitoyl-sn-
glycero-3-phosphocholine (DPPC), 1,2-dipalmitoyl-sn-glycero-
3-(phospho-L-serine) (DPPS), 1-myristoyl-2-[6-[(7-nitro-2-
1,3-benzoxadiazol-4-yl)amino]caproil]-sn-glycero-3-phos-
phocholine (C6-NBD-PC), 1-myristoyl-2-[6-[(7-nitrro-2-1,3-
benzoxadiazol-4-yl)amino]caproil]-sn-glycero-3-phospho-
glycerol (C6-NBD-PG), 1,2-dipalmitoyl-sn-glycero-3-phos-
phoethalonamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (N-
NBD-PE), and 1,2-dipalmitoyl-sn-glycero-3-phosphoethalon-
amine-N-(lissamine rhodamine B sulfonyl) (N-Rh-PE) were
from Avanti Polar-Lipids (Alabaster, Alabama); Triton X-100
(TX-100), rhodamine B (Rh B), and valinomycin were from
Sigma (St. Louis, Missouri); cobalt(II) chloride hexahydrate
(CoCl2â6H2O) was from Acro´s organics (Geel, Belgium), and
tris-(2-cyanoethyl)phosphine (phosphine) was from molecular
probes (Eugene, Oregon).
The assays were performed at room temperature in a UV-
vis spectrophometer, Jasco V-530, in a spectrofluorometer,
SLM Aminco 8100 (equipped with a 450 W Xe lamp, Glan-
Thompson polarizers, and double monochromators), and in
a fluorescence microscope, Olympus BX41 (using band-pass
filters). The microscopy results were recorded in a digital
camera, Olympus camedia 4040 zoom. Solutions were
prepared in 10 mM HEPES buffer, pH 7.4, containing 150
mM NaCl (the so-called physiologic ionic strength). Osmo-
lalities were measured in a freezing-point depression os-
mometer (Osmometer Automatic; Knauer, Berlin, Germany).
Preparation of Lipid Vesicles. Large unilamellar vesicles
(LUVs) are a good model of biological membranes having
no significant curvature effects (typical 100 nm diameter)
(12). LUVs were prepared by the extrusion method described
elsewhere (13). To obtain multilamellar vesicles (MLVs),
the extrusion step was not performed. To study the effect of
transmembrane potential in translocation, LUVs were pre-
pared in HEPES buffer with 150 mM KCl or with 150 mM
NaCl and passed through a 10 mL Econo-Pac 10DG column
(Bio-Gel P-6DG gel with 6 kDa molecular weight exclusion)
packed in buffer containing 150 mM NaCl or 150 mM KCl,
respectively (determined dilution factor of vesicles is 1.2).
Addition of valinomycin immediately induces a negative
potential in K+-loaded vesicles in Na+-buffer and a positive
one in Na+-loaded vesicles in K+-buffer (14).
Vesicle Aggregation Induced by Pep-1. Vesicle aggrega-
tion was monitored by optical density (OD) at 436 nm as
described elsewhere (15). Briefly 6.88 íM pep-1 was added
to a LUV suspension; additional lipid suspension aliquots
were added after signal stabilization. LUVs of POPC or of
different molar ratios of POPC and POPG (4:1 and 1:1) were
prepared. Initial and final lipidic concentrations used in the
assays were 25 and 106 or 106 and 222 íM, respectively.
The pep-1 concentration effect was tested with POPC/POPG
(1:1) vesicles; 0.54, 1.45, 3.40, and 6.88 íM pep-1 concen-
trations were used. Fluorescence microscopy studies were
carried out with POPC vesicles doped with 1% of N-Rh-
PE, a 510-550 nm excitation filter, and a 590 nm band-
pass filter. The final lipidic and pep-1 concentrations used
were 0.1 and 1.45 or 6.88 íM, respectively.
LUV Fusion and Anionic Lipid Segregation Induced by
Pep-1. Fusion was tracked using the Forste¨r resonance energy
transfer (FRET)-based methodology described before by
others (16-18). Briefly, vesicles doped with both 1%
N-NBD-PE (donor) and 1% N-Rh-PE (acceptor) and unla-
beled vesicles were mixed; after that, 0.54, 1.45, or 6.88 íM
pep-1 was added. If fusion between unlabeled vesicles and
donor/acceptor-labeled vesicles occurs, the average distance
between donors and acceptors increases, that is, FRET
efficiency decreases. POPC, POPC/POPG (4:1), and POPC/
POPG (1:1) were used (final lipid concentrations of 50 and
100 íM). Fluorescence intensity was followed with ìexc )
463 nm (NBD absorption) and ìem ) 590 nm (Rh emission).
Control experiments were carried out in all cases. Fluores-
cence quenching of Rh by pep-1 was evaluated by adding
pep-1 (0-6.88 íM) to 1% N-Rh-PE doped vesicles to
establish the minimal fluorescence intensity decrease ex-
pected (i.e., corresponding to fusion absence). The other end
of the fusion scale (100%) was calculated by adding excess
TX-100 surfactant (0.2% v/v) to the vesicle suspension.
Fusion extent was calculated by linear interpolation between
these limits.
Pep-1-induced anionic lipid segregation was also followed
by FRET between NBD and Rh. Fluorescence emission
intensity of Rh B dependence on pep-1 concentration (0-
6.88 íM) was monitored in LUVs of POPC and POPC/
POPG (4:1) containing 1% C6-NBD-PG and 1% N-Rh-PE.
Final lipidic concentrations of 0.05, 0.1, and 1 mM were
used. Control assays were carried out with C6-NBD-PC
(zwiterionic) instead of C6-NBD-PG.
Pore Formation and Phospholipid Flip-Flop. Co2+ is an
aqueous quencher of NBD fluorescence (19, 20) and is
accessible to N-NBD-PE and C6-NBD-PC inserted in
vesicles (20). Pore formation was tested as described
previously by others (20). Briefly vesicle suspensions of
POPC, POPC/POPG (4:1), DPPC, and DPPC/DPPS (4:1)
containing 1% N-NBD-PE were prepared in the absence and
presence of 20 mM CoCl2. In vesicles prepared without Co2+,
the quencher was added after LUV formation to guarantee
that Co2+ is accessible only to NBD present in the external
layer. No significant shrinkage was detected by turbidimetry
in agreement with the small effect expected for vesicles upon
osmolality variation due to 20 mM Co2+ (in/out osmolality
ratio ) 0.83; see Figure 1 in ref 21). NBD fluorophores
derivatized in the polar group of phospholipids inhibit flip-
flop (17, 22) given the hydrophilic nature of the probe and
its localization (17). The same methodology was used to
study flip-flop, but LUVs were doped with 1% C6-NBD-
PC or 1% C6-NBD-PG. Phospholipids derivatized in short
acyl chains can undergo flip-flop (23-25). Flip-flop was
studied in POPC and DPPC LUVs. Fluorescence emission
intensity (ìexc ) 460 nm and ìem ) 531 nm; excitation
wavelength is optimized for best NBD/Co2+ absorbance
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ratios) was recorded before and after 1.45 and 6.88 íM (final
concentrations) pep-1 addition. Control assays without Co2+
were performed. The lipid concentration used was 100 íM.
The data values were corrected for the inner filter effect (19).
Pore formation was also evaluated in LUVs loaded with
30 íM rhodamine B. Buffer containing the desired Rh B
concentration was added to the lipidic film prior to MLV
formation; after the extrusion step, the vesicle suspension
FIGURE 1: Vesicle aggregation induced by pep-1. Panel A shows the time course of the optical density (OD) at 436 nm showing aggregation
of POPC/POPG (4:1) LUVs. After signal stabilization, 6.88 íM pep-1 was added to the 25 íM lipidic suspension in 10 mM HEPES buffer,
pH 7.4, containing 150 mM NaCl. Peptide addition induced vesicle aggregation. Further addition of vesicle suspension to a 106 íM lipidic
concentration induces more vesicle aggregation. Panel B shows the dependence of the normalized OD at 436 nm of a 25 íM lipidic
suspension of POPC, POPC/POPG (4:1), and POPC/POPG (1:1) LUVs on pep-1 effective concentration in the membrane (eq 10 in ref 26)
below (9) and above (b) critical concentration for aggregate organization (3.4 ( 1.7 íM; ref 11) (see Table 1). Panel C shows micrographs
of POPC LUVs doped with 1% N-Rh-PE obtained by fluorescence microscopy with a 510-550 nm excitation filter and a 1000 amplification
(1) in the absence and in the presence of (2) 1.45 and (3) 6.88 íM pep-1. In micrograph 3, less and larger bright units (aggregated vesicles)
are presented. Fusion of subunits occurs as seen in amplifications 4 and 5 (6.88 íM pep-1). It is possible to identify different LUV subunits
that constitute the aggregates. Panel D shows the percentage of bright units in preparations of POPC LUVs doped with 1% N-Rh-PE
observed by fluorescence microscopy with a 510-550 nm excitation filter (filled columns refer to control, hatched to 1.45 íM pep-1
addition, and unfilled to 6.88 íM pep-1): (a) bright units where only one LUV could be noticed, (b) aggregates where fusion already
occurred, and (c,d) aggregates formed by 2-3 and 4 or more units, respectively.
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was eluted through a 10 mL Econo-Pac 10DG column (Bio-
Gel P-6DG gel with 6 kDa molecular weight exclusion)
packed with buffer (without Rh B) to remove nonencapsu-
lated Rh B. Encapsulated Rh B fluorescence intensity was
recorded (ìexc ) 554 nm and ìem ) 576 nm) prior to and
after addition of 1.45 and 6.88 íM peptide.
Translocation Assays. Vesicles doped with 1% N-Rh-PE
(100 íM total lipid concentration) were used to evaluate
fluorescence emission quenching of Rh by pep-1. The Rh
emission fluorescence intensity was monitored at ìexc ) 570
nm and ìem ) 590 nm.
To study translocation in absence of transmembrane
potential, POPC and POPC/POPG (4:1) MLVs were prepared
in the absence and presence of 1.45 or 6.88 íM peptide.
Vesicles prepared directly in pep-1 suspensions are controls
because in this case pep-1 is accessible to Rh fluorophores
present in all lamellae. In the other experiments, pep-1 was
added to MLVs prepared in absence of pep-1 to a final
concentration of 1.45 or 6.88 íM. The assays were repeated
in the presence of 1 mM phosphine. Usage of MLVs enables
a gradual effect in case translocation occurs.
Transbilayer potentials were created in POPC, POPC/
POPG (4:1), and POPC/POPG (1:1) vesicles (see Preparation
of Lipid Vesicles). Pep-1 was added to vesicles to a final
concentration of 6.88 íM. After the fluorescence signal was
constant, valinomycin was added to vesicles at a 1:104 molar
ratio (mol/mol lipid; 14; from ethanolic solution; final ethanol
concentration 0.2%). Controls without valinomicin (i.e., in
the absence of a transmembrane potential) were also
prepared. Pore formation (in POPC/POPG (4:1) LUVs) and
flip-flop (of C6-NBD-PC and C6-NBD-PG in POPC LUVs)
were also evaluated (see methodology in previous section)
in the presence of negative transmembrane potential. Vali-
nomycin was added after addition of 6.88 íM pep-1.
RESULTS AND DISCUSSION
Pep-1 Induced Vesicle Aggregation. Vesicle aggregation
is dependent on three main forces (15): electrostatic repul-
sion, van der Waals attraction, and hydration. Multivalent
cations may alter the charge density at the vesicles surfaces,
as well as dehydrate the lipid polar groups, and therefore
eventually lead to aggregation of vesicles. Pep-1 is a
multivalent cation that anchors at the lipidic membrane
interface (11): this prompted us to study the effect of pep-1
on aggregation of vesicles. When the peptide is added to
LUVs of POPC/POPG 4:1 (molar), the optical density of
the solution slowly increases (Figure 1A) until a plateau is
reached 100 min later. Further addition of lipids results in
a second increase in optical density (Figure 1A), that is, lipid
addition does not revert the vesicle aggregation, at variance
to penetratin-induced aggregation (15). Table 1 presents data
that account for the effect of anionic lipids, total lipidic
concentration, and peptide concentration on vesicle aggrega-
tion ability. Effective concentration of the peptide at the
lipidic environment was calculated in all cases to enable
direct comparisons (see ref 11 and eq 10 in ref 26). The
main experimental evidences from Table 1 are as follows:
(1) Anionic lipids favor aggregation, although the effect is
relatively weak (Figure 1B). (2) Addition of lipids to increase
the total lipid concentration also leads to further aggregation
(Figure 1A); when penetratin is used, the opposite effect is
observed (15), suggesting that pep-1 and penetratin do not
coincide in their mode of action at molecular level. (3) The
optical density obtained upon peptide addition when the
initial lipidic concentration is 106 íM is different from the
one obtained when initial lipidic concentration is 25 íM and
is increased to 106 íM after peptide addition. The final
dimension of vesicle aggregates does not depend on the
lipidic concentration, only. Stepwise addition of lipid results
in bigger aggregates (in terms of light scattering intensity,
the effect of volume change superimposes to the simulta-
neous process of scattering particle concentration decrease).
One possible explanation is the ability of pep-1 to add
isolated vesicles to previously formed aggregates but inability
to cluster large previously formed aggregates. Stepwise
addition of vesicles enlarges previously formed aggregates
rather than create new small aggregates. (4) Pep-1 organiza-
tion in the aqueous environment (i.e., 1.45 vs 6.88 íM in
Table 1) influences vesicle aggregation (Figure 1B).
Fluorescence microscopy studies using POPC vesicles
doped with N-Rh-PE confirm aggregation (Figure 1C). Pep-1
addition results in less and bigger bright units relative to the
control in the micrographs. At higher pep-1 concentration,
aggregation of smaller units is noticeable with a magnifica-
tion of 1000 (Figure 1C,D). Because turbidity is propor-
tional to the squared volume of scattering entities, a small
fraction of big aggregates may lead to high optical density
values.
Peptide-induced vesicle aggregation implies a severe
reduction in vesicle stability due to a decrease in electrostatic
repulsion and interference with the hydration layer. This
second factor seems dominant since POPC vesicle aggrega-
tion is quite significant and similar to the one obtained with
POPC/POPG (i.e., anionic vesicles).
Pep-1 Induced Vesicle Fusion. Vesicle fusion implies that
(1) the inner content of two or more vesicles is mixed and
(2) lipids from previously separated bilayers coexist in the
same bilayer after fusion (27). Fusion may result from a
variety of stimuli (27). Pep-1 induced lipidic vesicle fusion
seems plausible because vesicle aggregation (see previous
section) creates propitious conditions (28). Moreover, pep-1
is amphipathic, which is a common characteristic among
fusiogenic peptides (18).
Table 1: Vesicle Aggregation Induced by Pep-1
lipid
[lipid]
(íM)a
initial/final
XLb
initial/final
[pep-1]T
(íM)
[pep-1]memb
(mM)c
initial/final
ODd
peptide/lı´pid
POPC 25/106 0.03/0.12 6.88 11.3/10.3 4.1/7.9
0.12/0.23 6.88 10.3/9.08 4.8/8.2
POPC/POPG 25/106 0.17/0.47 6.88 74.1/69.5 4.6/9.5
(4:1) 106/222 0.47/0.65 6.88 69.5/63.8 4.4/6.9
POPC/POPG 25/106 0.49/0.80 0.54 13.8/5.35 1.1/1.2
(1:1) 1.45 37.1/14.7 1.5/1.9
0.65/0.89 3.44 117/37.7 4.2/6.0
6.88 233/75.4 5.8/8.8
a Before peptide addition, lipid concentration was 25 or 106 íM;
after more lipid was added, the final concentration became 106 or 222
íM, respectively. b The molar fraction of peptide inserted in lipid (XL)
was determined by eq 3 in ref 34 using partition coefficients for pep-1
(11). c Pep-1 concentration in lipidic bilayer by application of eq 10 in
ref 26. d Optical density (OD) at 436 nm (normalized to [pep-1] ) 0)
of POPC and POPC/POPG vesicles (prepared in 10 mM HEPES, pH
7.4, buffer containing 150 mM NaCl) after peptide, first number, and
more lipid addition, second number (see Figure 1B).
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The FRET-based methodology described elsewhere (16-
18) to study vesicle fusion was adapted to account for the
N-Rh-PE fluorescence quenching by pep-1 (Figure 2A). The
Rh fluorescence intensity depends on the exact effective
pep-1 concentration in the membrane environment, [pep-
1]memb (see eq 10 in ref 26, reported as [Q]L), even in the
absence of fusion because N-Rh-PE fluorescence is quenched
by pep-1. This fluorescence emission intensity corresponding
to 0% fusion is calculated from the Stern-Volmer formalism
(Figure 2A,B). In excess TX-100, donor/acceptor mean
interdistance becomes much bigger than the Fo¨rster radius,
R0, minimizing the fluorescence intensity (100% of the fusion
scale). Figure 2B illustrates the data analysis procedure. NBD
quenching by TX-100 (18) is not relevant for our purpose.
The results obtained using different lipid concentrations,
lipidic charge densities, and pep-1 concentration are pre-
sented in Table 2. Fusion is only significant when [pep-1]
) 6.88 íM, which is also true for aggregation. Anionic lipids
may not have a direct role in fusion. POPG interference with
fusion may result from enhanced partition into the membrane
(11). When fusion percentage is plotted as a function of [pep-
1]memb for systems having different anionic charge densities
and lipid concentrations (Figure 2C), one single homoge-
neous data set is obtained. Thus, [pep-1]memb seems to be
FIGURE 2: Vesicle fusion induced by pep-1. Fusion assays were monitored by FRET between NBD (donor) and rhodamine B (acceptor)
(ìex ) 463 nm; ìem ) 590 nm; sensitized emission of acceptor). Vesicle suspensions doped with 1% N-NBD-PE and 1% N-Rh-PE were
prepared in 10 mM HEPES, pH 7.4, buffer containing 150 mM NaCl. Panel A shows a Stern-Volmer plot of the fluorescence emission
quenching of 100 íM POPC LUVs doped with 1% N-Rh-PE (ìem ) 570 nm; ìex ) 590 nm) by pep-1 (the effective pep-1 concentration
in membrane is considered; eq 10 in ref 26). The Lehrer equation (see eq 11 in ref 26) was fitted to the data (solid line). Panel B shows
the relative fusion scale of 50 íM POPC/POPG (4:1) LUVs; 0% fusion (full line) is obtained by the Stern-Volmer plot of the Rh B
quenching by pep-1 (Figure 2A), and 100% fusion (dashed line) is the fluorescence emission of vesicle suspensions in excess TX-100.
Effective peptide membrane concentration in the membrane is used for the sake of comparison with other LUV compositions since the
extent of peptide partition is dependent on the anionic lipid composition. The filled circle refers to the fluorescence intensity obtained by
addition of 6.88 íM total concentration of pep-1. Fusion percentage (22.1%) was calculated from linear interpolation. Panel C shows the
fusion percentage in POPC and POPC/POPG LUVs. All data were obtained in the presence of 6.88 íM pep-1 total concentration; however,
effective concentration in membranes vary (see Table 2). Fusion extension and effective concentration in membranes are linearly correlated.
Table 2: Vesicle Fusion Induced by Addition of Pep-1
lipid
[lipid]
(mM)
[pep-1]Ta
(íM)
[pep-1]membb
(mM)
I0/Ic
(0% fusion)
I0/Id
(100% fusion)
I0/I
(assay) fusion (%)e
POPC 0.05 6.88 11.3 ( 3.9 1.30 ( 0.61 4.35 ( 0.07 1.45 ( 0.02 4.9 ( 0.07
POPC/POPG (4:1) 0.05 6.88 49.8 ( 39.8 1.38 ( 1.27 3.87 ( 0.09 1.93 ( 0.004 22.1 ( 0.05
0.1 6.88 39.0 ( 31.2 1.37 ( 1.27 3.15 ( 0.05 1.64 ( 0.02 15.2 ( 0.18
POPC/POPG (1:1) 0.05 0.54 9.3 ( 6.7 1.28 ( 1.08 3.98 ( 0.09 1.21 ( 0.02 0
1.45 24.9 ( 17.9 1.35 ( 1.13 3.98 ( 0.09 1.38 ( 0.02 1.1 ( 0.02
6.88 141.7 ( 85.6 1.40 ( 1.02 3.98 ( 0.09 3.18 ( 0.07 69.0 ( 1.5
0.1 6.88 79.3 ( 47.9 1.38 ( 1.00 3.28 ( 0.05 1.90 ( 0.03 27.4 ( 0.43
a Refers to total pep-1 concentration in bulk solution. b Refers to effective peptide in lipidic matrix. c Refers to pep-1 quenching fluorescence of
rhodamine B. d Refers to the addition of Triton X-100. e The vesicle fusion percentage of different lipidic mixtures (POPC, POPC/POPG (4:1) and
POPC/POPG (1:1)) in 10 mM HEPES, pH 7.4, buffer containing 150 mM NaCl was determined as illustrated in Figure 2B. Results are presented
along with standard errors.
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the key regulator issue in vesicle fusion. Pep-1 organization
in the aqueous environment is another important factor (no
fusion detected in 1.45 íM pep-1 solution). Fusiogenic
activity is usually associated with R-helix conformation in
membranes (18). This suggests that pep-1 may adopt R-helix
conformation at 6.88 íM in the presence of lipidic bilayers.
However, direct evidence from CD spectroscopy, for in-
stance, is prevented due to the typical low sensitivity of these
techniques.
Pep-1 Induced Anionic Lipid Segregation. Some cell-
penetrating peptides such as penetratin are believed to have
their biochemical mode of action dependent on the interaction
with anionic lipids (29). Electrostatic interaction is essential
for lipidic bilayer structure perturbation afterward. To test
the hypothesis that perturbation results from peptide-induced
anionic lipid lateral redistribution in the membranes, we used
NBD-labeled PG (anionic) and Rh-labeled PE (zwitterionic)
in POPC vesicles and carried out FRET experiments. Anionic
lipid segregation results in a decrease in FRET efficiency in
the presence of peptide. Control experiments were carried
out using NBD-labeled PC instead of PG (the quenching of
Rh B by the peptide is accounted for in the control). Figure
3 shows that pep-1-induced anionic lipid segregation occurs
to an extent that depends both on the lipidic and on the
peptide concentrations. Variations in FRET efficiency are
not detected when 20% (molar) POPG is present in the
vesicles (results not shown), as expected due to the “dilution”
of anionic lipidic probes in excess anionic lipids.
Pore Formation in the Absence of Transmembrane Po-
tential. Some membrane-interacting peptides, such as mel-
litin, possess unspecific lytic ability (30, 31). Mellitin
resembles pep-1 for the presence of a proline residue in its
sequence (27) among other reasons. These similarities
prompted us to test pep-1-induced pore formation across
lipidic membranes. Co2+ is an aqueous quencher of NBD
fluorophores (19, 20) and was used to quench N-NBD-PE
inserted in LUVs in the presence and absence of pep-1 (a
method based on previously published ones (19)). In the
absence of pep-1, Co2+ is expected to leave 50% of the
N-NBD-PE fluorophores accessible if added to a LUV
suspension after vesicles are formed and all the fluorophores
if it is added before vesicles are formed. In the case that
pores or other lytic perturbations are formed by the peptide,
Co2+ first present only outside lipidic vesicles is able to
penetrate vesicles and reach all the fluorophores, that is, the
quenching extent is dependent on lytic perturbations of the
membrane induced by pep-1 (Figure 4A). Results presented
in Figure 4B show that no lytic action occurs in POPC
vesicles because peptide presence does not change NBD
quenching by Co2+. Similar results were obtained with
POPC/POPG (4:1) vesicles (results not shown). These results
were confirmed in LUVs with encapsulated Rh B (dissolved
in buffer). The addition of pep-1 does not induce a significant
quenching of Rh B fluorescence emission (data not shown),
revealing that peptide is inaccessible to vesicle lumen and
that there is no ion leakage.
Asymmetric Lipidic Flip-Flop in the Absence of Trans-
membrane Potential. Flip-flop refers to the lipidic exchange
between outer and inner layers (23) and may be promoted
by peptide insertion in membranes (23, 24). Peptides perturb
FIGURE 3: Anionic lipid segregation induced by pep-1. The assays
were followed by FRET between NBD (donor) and rhodamine
(acceptor) (ìex ) 463 nm; ìem ) 590 nm; sensitized emission of
acceptor). The POPC vesicle suspension was prepared with 1%
N-Rh-PE and 1% C6-NBD-PG (or C6-NBD-PC in the control
assay, 9) in 10 mM HEPES, pH 7.4, buffer containing 150 mM
NaCl. The total lipidic concentrations used were 50 (2) and 100
íM (b). A more pronounced decrease of Rh B fluorescence
intensity relative to the control assay means a greater distance
between donor and acceptor, that is, segregation of anionic lipids
near the partition local of pep-1 in vesicles.
FIGURE 4: Vesicle pore formation induced by pep-1. Co2+
quenching of fluorescence emission of LUVs doped with 1%
N-NBD-PE (ìem ) 460 nm; ìex )531 nm) was performed to test
for pep-1-induced pore formation in vesicles. Vesicles with 20 mM
Co2+ accessible to both layers and vesicles with 20 mM quencher
accessible just to external layer have been produced in a 10 mM
HEPES, pH 7.4, buffer containing 150 mM NaCl. In panel A, the
hyperbole-like curve (full line) simulated with the Lehrer equation
with fB ) 50% (see eq 11 in ref 26) indicates the NBD fluorescence
quenching of the latter vesicles in the case of no pore formation. If
the addition of pep-1 leads to a more pronounced quenching (dashed
line), near linearity (the limit where the quencher is accessible to
all NBD fluorophores) pores are formed. At a given quencher
concentration, I0/I, can be used to account for pore formation. Panel
B shows the ratio of NBD intensity of 100 íM POPC LUVs in the
absence of quencher and in the presence of 20 mM Co2+ for the
vesicles with Co2+ accessible to both layer (white columns) and
accessible only to the outer layer (black columns). Comparing the
results with control, it is possible to conclude that there is no pore
formation in the presence of 1.45 or 6.88 íM pep-1.
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membranes causing defects at the interfacial packing that
allow passage of the polar lipidic heads through the aliphatic
region of membranes (24). The same methodology used
before for pore formation assays was used to test for
asymmetric lipidic flip-flop, except that C6-NBD-PC and
C6-NBD-PG were used instead of N-NBD-PE. The latter
probe does not translocate across membranes due to the bulky
NBD residue at its polar head (17). Results (not shown) do
not present evidence of asymmetric flip-flop of lipids in any
of the lipidic systems tested (POPC and DPPC with and
without anionic lipids). In case that flip-flop occurs at all, it
is bidirectional and occurs at the same rate in the inner/outer
and opposite direction.
Peptide Translocation across Lipidic Bilayers. The bio-
chemical activity of pep-1 is related to its ability to
translocate across lipidic membranes. Translocation assay
methodologies were based on the peptide quencher properties
relative to Rh B (Figure 2A). We prepared MLVs with
peptide solutions from the start (samples A) or buffer without
peptide. In the latter samples, peptide was added after vesicle
formation (samples B) to the final peptide concentration used
in samples A. In the case that translocation occurs, fluores-
cence intensity in samples B decreases with time until the
fluorescence intensity of samples A is reached. No translo-
cation was detected in POPC and POPC/POPG (4:1) vesicles
both in the absence (Figure 5A) and presence of phosphine
(results not shown).
Previous studies have shown that translocation of peptidic
sequences across a synthetic bilayer is largely stimulated in
the presence of a transmembrane potential (14, 32, 33). In a
recently published work, Terrone et al. (32) showed that
penetratin translocation in LUVs is mediated by transbilayer
potential in a manner dependent on vesicle composition. The
effect of transbilayer potential in pep-1 translocation was
evaluated in POPC, POPC/POPG (4:1), and POPC/POPG
(1:1) doped with N-Rh-PE. After peptide addition to LUVs,
a significant fluorescence quenching of Rh B emission
fluorescence was recorded in studied lipidic systems (I0/I 
2, which is an expected value because in these conditions
pep-1 is accessible only to Rh B in the external layer). If
translocation occurs in the presence of a transbilayer
potential, an increase of Rh emission fluorescence quenching
is expected (pep-1 is accessible to Rh in the internal layer).
The presence of valinomycin-induced negative transbilayer
potential (maximum transbilayer potential about 120 mV (32,
33), stable for 10 min (14)) in K+-loaded vesicles in Na+-
buffer causes a significant translocation of pep-1 in POPC/
POPG (4:1) and POPC/POPG (1:1) (Figure 5B) on the
second time scale. In POPC, the translocation occurs to a
minor extent. The rapid translocation is in agreement with
in vivo studies (8) that show translocation of the peptide
across cell membranes on the minute time scale. The effect
of a positive transbilayer potential was tested in POPC/POPG
(4:1) vesicles. The addition of valinomycin to Na+-loaded
vesicles in K+-buffer does not alter the fluorescence emission
quenching of Rh B by pep-1. This result shows that a positive
transbilayer potential does not lead to translocation. Similar
results were obtained with vesicles dispersed in buffer
containing 150 mM KCl (K+ in and out) and with vesicles
prepared in buffer with 150 mM NaCl (Na+ in and out).
Figure 5C, which represents a Stern-Volmer-like plot,
shows that translocation is dependent on the effective
FIGURE 5: Pep-1 translocation across lipidic bilayer. Translocation
assays were followed by fluorescence quenching of rhodamine B
(ìex ) 570 nm; ìem ) 590 nm) by pep-1 in 100 íM vesicles doped
with 1% N-Rh-PE. In panel A, POPC and POPC/POPG (4:1) MLVs
(10 mM HEPES, pH 7.4, buffer containing 150 mM NaCl) were
used. The results are presented in terms of intensity ratio without
and with 6.88 íM pep-1 added at the moment of the vesicle
preparation (white columns) and after the vesicle preparation (black
columns). In case translocation exists, the same fluorescence
intensity is expected for both columns. No peptide translocation
was detected. Panel B shows translocation of pep-1 in the presence
of transmembrane potential in POPC, POPC/POPG (4:1), and
POPC/POPG (1:1) LUVs (loaded with 10 mM HEPES pH 7.4
buffer containing 150 mM KCl and dispersed in buffer containing
150 mM NaCl). Rhodamine B fluorescence emission was recorded,
and a decrease to approximately half of the initial value was detected
after 6.88 íM pep-1 addition (pep-1 accessible to N-Rh-PE in
external layer). The Rh B fluorescence intensity ratio after (Ival)
and before (I0) addition of valinomycin (1:104 mol/mol lipid) is
represented for the three lipidic systems in the presence (white
columns) and absence (black columns) of 6.88 íM pep-1. A
decrease in Ival/I0 upon valinomycin addition (negative transmem-
brane potential) indicates that pep-1 is accessible to N-Rh-PE in
the inner layer and translocation across bilayer occurs. An enhanced
effect is visible with an increase in anionic lipid. Panel C shows a
Stern-Volmer-like plot, which represents I0/Ival (see panel B)
dependence on effective pep-1 concentration in membrane (see eq
10 in ref 26). Translocation extension is dependent on effective
pep-1 concentration in membrane (increases with peptide concen-
tration in membrane).
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concentration of peptide in membrane ([pep-1]memb). The
results show that the translocation driving force is the
negative membrane potential across bilayer and affinity of
peptide to membrane determines the extent of translocation.
In the presence of negative transmembrane potential, no
significant drop in NBD fluorescence was detected, when
valinomycin was added (after 6.88 íM pep-1 addition) to
POPC/POPG (4:1) LUVs doped with N-NBD-PE or to
POPC vesicles doped with C6-NBD-PC or C6-NBD-PG
(Co2+ accessible to the external layer of the vesicles in both
cases). Fluorescence intensities with the quencher accessible
to internal and external layers were used as a positive control.
No pore formation or significant phospholipid flip-flop
occurs during peptide translocation (data not shown).
CONCLUSION
Pep-1 is effective in inducing vesicle aggregation and
lipidic fusion. Aggregation takes place by vesicle clustering,
but lipidic exchange among vesicles is possible. The process
is dependent both on anionic lipid content and on peptide
concentration. Segregation of anionic lipids in the presence
of peptide is detected. Despite all these effects, no evidence
was found for lytic action or ion leakage. Translocation
occurs only in vesicles with a negative membrane potential
and is enhanced by the presence of anionic lipids, probably
by electrostatic attraction of the peptide to anionic bilayers.
Taking our work as a whole, one concludes that the main
driving force for peptide translocation is a charge gradient
across membrane (negative inside). In biological membranes,
the transmembrane potential caused by charge asymmetry
between outer and inner leaflets created by anionic lipids in
the inner layer is probably responsible for translocation.
Moreover, pep-1 is a strong perturber of lipid membrane
organization (Figure 6), which is probably a key role of its
action because the energetic cost of solvation layer removal
(mandatory for crossing an unperturbed membrane) would
be prohibitive. Bilayer perturbation renders electrostatic
attraction dominant over solvation effects. As proposed
schematically in Figure 6, fusion is probably the main cause
of close range electrostatic attraction between positively
charged peptide and negatively charged lipids in the cell
membrane inner leaflets. Transient inverted micelle-like
structures may be formed, leading to translocation. An active
role of membrane aggregation in translocation was very
recently proposed for the cell-penetrating peptide penetratin
(32).
ACKNOWLEDGMENT
We thank Dr. Fernando Antunes and Nuno M. V. Pedroso
for helping with fluorescence microscopy and Dr. M. Prieto
and Dr. Cla´udio Soares for valuable critical discussions.
REFERENCES
1. Wadia, J. S., Becker-Hapak, M., and Dowdy, S. F. (2002) Protein
transport, in Cell-penetrating peptides, processes and applications
(Langel, U‹ ., ed) pp 365-375, CRC Press Pharmacology &
Toxicology Series, CRC Press, New York.
2. Bogoyevitch, M. A., Kendrick, T. S., Dominic, C. H., and Barr,
R. K. (2002) Taking the cell by stealth or storm? Protein
transduction domain (PTDs) as versatile vectors for delivey, DNA
Cell Biol. 21, 879-894.
3. Bonetta, P. (2002) Getting protein into cells, Scientist 17, 38-40.
4. Eguchi, A., Akuta, T., Okuyama, H., Senda, T., Yokoi, H.,
Inokuchi, H., Fujita, S., Hayakama, T., Takeda, K., Hasegawa,
M., and Nakanisshi, M. (2001) Protein transduction domain of
HIV-1 Tat protein promotes efficient delivery of DNA into
mammalian cells, J. Biol. Chem. 247, 27205-27210.
5. Richard, J. P., Melikov, K., Vives, E., Ramos, C., Verbeure, B.,
Gait, M. J., Chernomordik, L. V., and Lebleu, B. (2003) Cell-
penetrating peptides, a reevaluation of the mechanism of cellular
uptake, J. Biol. Chem. 278, 585-590.
6. Schwarze, S. R., Hruska, K. A., and Dowdy, S. F. (2000) Protein
transduction: unrestricted delivery into all cells? Trends Cell Biol.
10, 290-295.
7. Chaloin, L., Mau, N. V., Divita, G., and Heitz, F. (2002)
Interactions of cell-penetrating peptides with membranes, in Cell-
penetrating peptides, processes and applications (Langel, U‹ ., ed)
FIGURE 6: Putative pep-1 translocation mechanism across lipidic
bilayer. This scheme outlines a possible mechanism for pep-1
translocation. The peptide has the ability of inserting in the bilayer
outer interface and causes local and transient fusion of membranes
(experimental results show clustering of vesicles without collapse
and no lytic lesions). Transiently fused biological membranes
(negatively charged inner face) bring the cationic sequences of the
peptide closer to the anionic inner leaflet of the membranes. In
this situation, electrostatic attraction is strong enough to move pep-1
to one of the inner leaflets of the membranes and segregate anionic
lipids. The inverted micelle-like structure originated from fusion
is then reverted. The partition equilibrium in the cell inner lipidic
hemilayer is shifted toward the nonlipidic environment due to the
reduction of pep-1 dimers (11) and cellular uptake. The role of
partition equilibria in the regulation of pep-1 action across lipidic
bilayers is addressed in ref 11.
Translocation of Pep-1 Biochemistry, Vol. 43, No. 30, 2004 9723
59
pp 23-51, CRC Press Pharmacology & Toxicology Series, CRC
Press, New York.
8. Morris, M. C., Depollier, J., Mery, J., Heitz, F., and Divita, G.
(2001) A peptide carrier for the delivery of bilogically active
proteins into mammalian cells, Nat. Biotechnol. 19, 1143-1147.
9. Chariot, simple efficient protein delivery system. http://www.
activemotif.com/products/cell/chariot (accessed July 2003).
10. Morris, C. M., Chalion, L., Heitz, F., and Divita, G. (2002) Signal
sequence-based cell-penetrating peptides and their application for
gene delivery, in Cell-penetrating peptides, processes and ap-
plications (Langel, U‹ ., ed) pp 93-113, CRC Press Pharmacology
& Toxicology Series, CRC Press, New York.
11. Henriques, S., and Castanho, M. (2004) Environmental factors that
affect the cell penetrating peptide pep-1 action across lipidic
membranes, Chem.Phys.Chem. submitted for publication.
12. Wieprecht, T., Beyermann, M., and Seeling, J. (2002) Thermo-
dynamics of the coil-R-helix transition of amphipathic peptides
in membrane in a membrane environment; the role of vesicle
curvature, Biophys. Chem. 96, 191-201.
13. Mayer, L. D., Hope, M. J., and Cullis, P. R. (1986) Vesicles of
variable sizes produced by a rapid extrusion procedure, Biochim.
Biophys. Acta 858, 161-168.
14. van Dalen, A., Killian, A., and de Kruijff, B. (1999) ¢ª stimulates
membrane translocation of the C-terminal part of a signal
sequence, J. Biol. Chem. 274, 19913-19918.
15. Persson, D., Thore´n, P. E. G., and Norde´n, B. (2001) Penetratin-
induced aggregation and subsequent dissociation of negatively
charged phospholipid vesicles, FEBS Lett. 505, 307-312.
16. Haugland, R. P. (2002) Handbook of Fluorescent Probes and
Research Products, 9th ed., Molecular Probes, New York.
17. Maier, O., Oberle, V., and Hoekstra, D. (2002) Fluorescent lipid
probes: some properties and applications (a review), Chem. Phys.
Lipids 116, 3-18.
18. Pe´cheur, E.-I., Martin, I., Ruysschaert, J.-M., Bienvenu¨e, A., and
Hoekstra, D. (1998) Membrane fusion induced by 11-mer anionic
and cationic peptides: a structure-function study, Biochemistry
37, 2361-2371.
19. Caputo, G. A., and London, E. (2003) Using a novel dual
fluorescence quenching assay for measurement of tryptophan depth
within lipid bilayes to determine hydrophobic R-helx location
within membranes, Biochemistry 42, 3265-3274.
20. Chattopadhyay, A., and London, E. (1988) Spectroscopic and
ionization of N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-labeled lipid
in model membranes, Biochim. Biophys. Acta 938, 24-34.
21. Pencer, J., White, G. F., and Hallet, F. R. (2001) Osmotically
induced shape changes of large unilamellar vesicles measured by
dynamic light scattering, Biophys. J. 81, 2716-2728.
22. Wimley, W. C., and White, S. H. (2000) Determining the
membrane topology of peptides by fluorescence quenching,
Biochemistry 39, 161-170.
23. Kol, M. A., Laak A. N. C. van, Rijkers, D. T. S., Killian, J. A.,
Kroon, A. I. P. M. de, and Kruijff, B. de (2003) Phospholipid
flop induced by transmembrane peptides in model membranes is
modulated by lipid composition, Biochemistry 42, 231-237.
24. John, K., Schreiber, S., Kubelt, J., Herrmann, A., and Mu¨ller, P.
(2002) Transbilayer movement of phospholipids at the main phase
transition of lipid membranes: implications for rapid flip-flop in
biological membranes, Biophys. J. 83, 3315-3323.
25. Marx, U., Lassmann, G., Holzhu¨tter, H.-G., Wu¨stner, D., Mu¨ller,
P., Ho¨hlig, A., Kubelt J., and Herrmann A. (2000) Rapid flip-
flop of phospholipids in endoplasmic reticulum membranes studied
by a stopped-flow approach, Biophys. J. 78, 2628-2640.
26. Santos, N. C., Prieto, M., and Castanho, M. A R. B. (1998)
Interaction of the major epitope region of HIV protein gp41 with
membrane model systems. A fluorescence study, Biochemistry 37,
8674-8682.
27. Basan˜ez, G. (2002) Membrane fusion: the process and its energy
suppliers, Cell. Mol. Life Sci. 59, 1478-1490.
28. Nieva, J. L., and Nir, S. (2000) Interactions of peptides with
liposomes: pore formation and fusion, Prog. Lipid Res. 39, 181-
206.
29. Dupont, E., Joliot, A., and Prochiantz, A., (2002) Penetratins, in
Cell-penetrating peptides, processes and applications, (Langel,
U‹ ., ed) pp 23-51, CRC Press Pharmacology & Toxicology Series,
CRC Press, New York.
30. Matsuzaki, K., Yoneyama, S., and Miyajima, K. (1997) Pore
formation and translocation of melitin, Biophys. J. 73, 831-838.
31. Papo, N., and Shai, Y. (2003) Exploring peptide membrane
interaction using surface plasmon resonance: differentiation
between pore formation versus membrane disruption by lytic
peptides, Biochemistry 42, 458-466.
32. Terrone, D., Sang, S. L. W., Roudaia, L., and Silvius, J. R. (2003)
Penetratin and related cell-penetrating cationic peptides can
translocate across lipid bilayers in the presence of a transbilayer
potential, Biochemistry 42, 13787-13799.
33. Maduke, M., and Roise, D. (1993) Import of a mitochondrial
presenquence into protein-free phospholipid vesicles, Science 260,
364-367.
34. Santos, N. C., Prieto, M., and Castanho, M. A R. B. (2003)
Quantifying molecular partition into model systems of biomem-
branes: an emphasis on optical spectroscopic methods, Biochim.
Biophys. Acta 1612, 123-135.
BI036325K
9724 Biochemistry, Vol. 43, No. 30, 2004 Henriques and Castanho
60
      
 
 
 
 
 
 
 
Chapter 3 
 
 
Does pep-1 form 
pores? 
 
 
 
  
 
 
 
 
Chapter 3.  Does pep-1 form pores? 
 
 
    63
 
 
Chapter 3.   
 
 
Does pep-1 form pores? 
 
 
3.1. Introduction  
 
A translocation mechanism for peptides involving direct interaction with 
membrane lipids was proposed shortly after the identification of these basic sequences 
with capacity to pass through the membrane [15, 16]. This was further supported by the 
strong correlation of uptake with lipid-binding affinity [168]. A passive diffusion by 
charged molecules is not likely to occur due to the membrane properties including the 
low dielectricity in the core of the bilayer. Nevertheless, different mechanisms have 
been proposed to explain a possible internalization mechanism independent on 
endocytosis (Figure 3.1). 
 
One of the earliest energy-independent mechanism proposed for transmembrane 
translocation is the “inverted micelle” model [53]. The proposed mechanism was based 
on Nuclear Magnetic Resonance (NMR) studies in which the penetratin and an analogue 
were compared. The first peptide was demonstrated to induce formation of hexagonal 
phase/inverted micelles and to have the capacity to translocate, whereas the analogue 
does not form these structures, or translocates across the lipidic membranes. In this 
model the interaction of the peptide with membrane in promoted by electrostatic 
interactions between the cationic peptide and the negative charges in the lipidic 
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membranes. A recruitment of negatively-charged phospholipids and induction of 
formation of an inverted micelle occurs upon interaction of the peptide with the lipidic 
membrane. The hydrophilic cavity of the micelle would accommodate putatively the 
cargo (Figure 3.1.A) [53]. However, this mechanism cannot account for the uptake of 
highly basic peptides such as oligoarginines (which do not contain hydrophobic amino 
acids required to induce hexagonal phase formation) [34], either for the uptake of high 
cargoes.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. Schematic representation of permeation mechanisms independent on endocytosis. These 
models are dependent on the mode of peptide interaction with phospholipid bilayers: A) peptide passes 
through the membrane enclosed in “inverted micelle”, which originates from membrane bilayer 
disruption upon peptide insertion; B) barrel-stave pore formed by a cluster of peptide molecules which 
span across the lipidic membrane; in this model hydrophobic interactions are relevant for pore formation 
and stability; C) toroidal pore across lipidic membrane, in which the phospholipids headgroups are 
always in contact with the peptidic chain to screen the net positives charge of peptide molecules; and D) 
Carpet model, peptide molecules bind to the membrane surface “carpeting” the membrane surface; above 
a threshold concentration the peptide disrupt the lipid packing leading to the peptide internalization. 
Image adapted from reference [169]. 
 
 
A mechanism involving pore formation has been suggested for MPG, an 
amphiphatic peptide that can be an efficient carrier for nucleic acids [170]. This is a 
typical feature of several toxins and antimicrobial peptides that have an action at 
B
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membrane level. In this mechanism the interaction of the peptide with the membrane is 
followed by alteration of membrane structure and in some cases entry of peptide into the 
interior of the target cell [171]. It is clear that peptide-lipid interactions govern the 
function of most membrane-lytic peptides, rather than a receptor-mediated process 
[172]. Three alternative mechanisms were proposed to account for the membrane 
permeability of amphipathic lytic peptides: “barrel-stave” pore (Figure 3.1.B), 
“toroidal” pore (Figure 3.1.C) and “carpet” model (Figure 3.1.D). In all models there is 
an initial adsorption of the peptide with the membrane surface. Adsorption in the lipid 
headgroup surface leads to a lateral expansion of the membrane and a thinning of the 
hydrophobic core [173, 174]. The lipidic membrane can respond in different ways to 
reduce the strain imposed on the lipidic bilayers by the adsorption of peptide, depending 
on different physicochemical characteristics of the peptide and membrane [175].  
 
The “barrel-stave”-type pore (Figure 3.1.B) was first proposed for alamethicin, 
an amphipathic peptide with helical conformation [176]. This model is dominated by 
hydrophobic interactions between peptide and membrane, with the peptide chain 
inserted perpendicular to the lipidic bilayer surfaces and recruiting more peptide 
molecules to form a transmembrane pore that resembles a “barrel-stave” [177, 178]. In 
this arrangement hydrophobic amino acid residues interact with the lipid membrane 
while the hydrophilic residues face inwards to the lumen of the pore [177, 178]. Such 
organization requires peptides that span the lipid bilayer with an amphipathic α-helix 
conformation [172], forming contacts with other peptide molecules. Therefore, their 
length should match the bilayer thickness [175]. Weakly-charged peptides are 
compatible with this model to avoid intermolecular electrostatic repulsion within the 
pore [179]. Noteworthy, in this model peptide-membrane interactions are predominantly 
driven by hydrophobic interactions and they should bind to phospholipid membranes 
irrespective of their charge [172].  
 
In the toroidal model (Figure 3.1.C), which has been proposed for magainins, 
melittin and protegrins [180], pores are also formed, but headgroups are always in 
contact with inserted peptides, even when they adopt a transmembrane orientation. In 
this model, to relieve the curvature strain caused by peptide binding, phospholipids 
bend continuously from the top to the bottom. Peptide pack together with lipid 
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headgroups to form a pore [34, 175, 180]. This model is usually associated with highly-
charged peptides that do not self-associate at low peptide concentration [179]. The lipid 
headgroups play an important role in screening the peptide charges, whereas in the 
barrel-stave such screening is absent [180]. A cooperative assembly of pores only 
occurs when the concentration of peptides on the membrane surface exceeds a certain 
limiting value [179]. 
 
Another translocation mechanism involving membrane permeation is based on 
the “carpet” model (Figure 3.1.D) which was proposed for the first time to describe the 
mode of action of dermaseptin S [181]. In this model, reorientation of peptide chains 
can be hampered by strong electrostatic interactions between positively-charged 
residues and lipid headgroups [175], as a result peptides bind onto the surface of 
membrane and cover it in a carpet-like manner [172]. Membrane permeation occurs 
only if there is a high local concentration of membrane-bound peptide, where peptide 
molecules accumulation on the membrane surface causes tension between the two 
leaflets of the bilayer, which above a threshold concentration leads to disintegration of 
the membrane [175] due to disruption of the bilayer curvature [172]. In this mechanism 
the peptide does not necessarily adopt a specific structure upon its binding to the 
membrane, neither span across lipidic bilayer or assemble with their hydrophilic 
surfaces facing each other [172]. The carpet model seems to be a more general 
permeabilization mechanism than barrel-stave pore [175].  
The formation of transient holes can occur as an intermediate step before the 
collapse of the membrane [172, 175], enabling the passage of low molecular weight 
molecules prior to membrane disruption [172]. In this transient pores peptide molecules 
remains in contact with the lipid headgroups during all the process and a peptide match 
with the bilayer thickness is not required; such features are similar to the toroidal pore 
model [175]. The similarities between carpet model and toroidal model suggest that 
torus-type pores may be part of a transient step before the membrane collapse [182].  
 
In all models described an initial association of the peptide with the surface of 
the bilayer constitutes the first step, which is generally assumed to be governed by 
electrostatic interaction with negatively charged membrane lipids. However entropy-
driven events in partition can also take part on the next steps [169]. Electrostatic 
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interaction are long range [183], so the structure of the peptide is less important in 
interactions governed by electrostatic interaction than when hydrophobic interactions 
are dominating. Actually many peptides are unstructured in solution but acquire a 
secondary structure upon interaction with lipidic membranes [184]. However it is worth 
mentioning that the nature of membrane perturbation depends on the orientation of the 
peptides. Interfacially-adsorbed peptides with an horizontal orientation with respect to 
the membrane plane perturb the lipid bilayer significantly more severely than 
transmembrane peptides that form barrel-stave pores [179]. It is suggested by Zemel et 
al. that the membrane perturbations induced by peptide can provides unspecific driving 
force that facilitates the pore formation, depending on the peptide orientation [179].  
The above referred models that involve pore formation mechanisms may be 
relevant to CPPs with pronounced toxic effects, or ultimately can explain its toxic effect 
for high peptide/lipid ratios. This is relevant because peptide translocation resulting in 
membrane permeabilization conferring cytotoxic effects hampers it use in drug delivery 
applications [169].   
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3.2. Energy-independent translocation of cell-penetrating peptides 
occurs without formation of pores. A biophysical study with pep-1  
 
3.2.1. Motivation and methodologies 
 It has been previously suggested by Deshayes et al. [185] that pep-1 is able to 
pass trough the membrane by a mechanism mediated by pore formation. In this 
hypothesis the pore is formed with the hydrophobic domain, which upon interaction 
with membrane becomes helical and inserts in the membrane with a perpendicular 
orientation to the membrane surface [185]. The pore model proposed is not clear and the 
possible perpendicular orientation is putative. No experimental evidences are presented.  
 Our previous results on permeability of LUVs to Co2+ in the presence of pep-1 
suggests that this peptide in unable to form pores or induce leakage [186], however the 
hypothesis of pore suggested by Deshayes et al. [185] prompt us to make a more 
detailed study and to consider more carefully this possibility. In that way several 
questions regarding the differences between different permeation models need to be 
addressed, for instance: Is the binding of the peptide to the lipidic membranes 
electrostaticaly driven only or is dependent on hydrophobic interactions? Does pep-1 lie 
on the membrane surface or inserts in the hydrophobic core? Are there alterations in 
peptide conformation upon interaction with membrane? 
 
Different methodologies were used to answer these questions. A characterization 
of the secondary structure of pep-1 and the study of the effect of membranes on peptide 
conformations were carried out by circular dichroism (CD) spectroscopy and also by 
Attenuated total reflection Fourier transform infrared (ATR-FTIR) spectroscopy 
techniques. The possible orientation of peptide when in the presence of lipidic bilayers 
was also studied by ATR-FTIR. The prospect of pore formation was tested with 
electrophysiological measurements by the use of planar lipid membranes (PLM) and 
also by confocal fluorescence microscopy using GUVs. 
 
CD is a technique that has been widely used for determination of the secondary 
structure of proteins/peptides. CD refers to differential absorption of the left and right-
handed circularly polarized light that occurs when a chromophore is chiral (optically 
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active) [187]. In practice, when two circularly polarized light components are absorbed 
by the sample in different extension, the resultant radiation would trace out an ellipse. 
The CD instrument detects the two components independently and then displays the 
dichroism at a given wavelength of radiation, which can be expresses as the ellipticity in 
degrees.  
CD ellipticity is highly sensitive to the different secondary structures which have 
ellipticity bands with characteristic wavelengths and magnitudes [188], mainly in the 
far-UV (in the wavelength range 170-250nm). There are three major secondary 
structures identifiable by CD: a random coil structure that is coincident with the well 
defined poli(Pro)II (P2) CD spectral form with a strong negative band around 195nm; a 
α-helix conformation with minima bands at 208 and 222nm and a positive band at 
192nm; and β-sheet with a positive band below 200nm but with a single negative band 
at ∼ 220nm [187, 189-191]. (Figure 3.2). The CD signal of β-sheet conformation is 
weaker that the others.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2. CD spectra of α-helix, β-sheet and poliproline II deconvoluted from a reference protein set. 
MRE is the mean residue ellipticity. Figure adapted from [192]. 
 
Protein/peptide structure is determined by comparison of the obtained spectra 
with CD data in literature. A number of algorithms can be used to provide an estimation 
of the secondary structure composition of proteins/peptides. Most procedures use data 
bases which comprise sets of CD spectra of different proteins whose structures have 
been solved by x-ray crystallography [191]. For a CD analysis is necessary to know 
precisely the peptide concentration to calculate the mean residue ellipticity (MRE) for 
α
β 
  P2 
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comparison with the data base spectra. Generally all the methods assume that the 
spectrum of a protein/peptide can be represented by a linear combination of the spectra 
of the secondary structure elements [188].  
 
ATR-FTIR is a powerful tool to study the structure of peptides and their 
interaction with lipids without introducing a perturbing probe and requires small 
quantities of sample [193]. Because of the long IR wavelength, light scattering does not 
affect such measurements, in contrast to most other spectroscopic techniques. In ATR-
FTIR experimental setup a drop of the sample (liposomes containing the peptides) is 
spread on the internal reflection plate (IRE) (e.g. trapezoidal Ge plate, see Figure 3.3) 
by slowly evaporation of the solvent, which results in several thousands 
macroscopically aligned multibilayers [194].  
 
Figure 3.3. Total internal reflection at the 
interface of an internal reflection element 
(trapezoidal plate design). The components 
of electric field along the X, Y and Z axis are 
shown. The incident light can be polarized 
with a parallel orientation with the respect to 
plane of incidence (E//) or perpendicular to 
plane of incidence (E⊥). The angle θ is the 
light beam incident angle with respect to the 
IRE surface. Figure adapted from the 
reference [194]. 
 
The light travels inside the plate by means of a series of internal reflections from 
one surface of the plate to the other (see Figure 3.3), creating an exponentially decaying 
evanescent radiation outside the plate. Absorption of the energy of the evanescent field 
by the supported membranes and the peptide, provides ATR-FTIR spectra which 
contain information about the structure of the sample [195]. The spectra of peptide-lipid 
systems possess well-resolved absorbance bands not only on the lipidic membranes but 
also on the different structural groups within peptides. The amide I mode, among 
various “amid vibrational modes”, is the most sensitive to the protein secondary 
structure and is found between 1700 and 1600cm-1 [193, 195, 196]. Amide I frequencies 
are essentially determined by the properties of the peptide backbone structure and so 
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practically independent on the amino acid sequence, its hydrophilic or hydrophobic 
character, its size, and its charge [196]. Determination of the peptide/protein secondary 
structure relies on the fact that the amide I vibrations of different conformations occurs 
at different frequencies as specified in the Table 3.1. 
 
Table 3.1. Amide I frequencies of typical secondary structures elements in 
proteins in non-deutered (H2O) and deutered (D2O) environments. Table 
adapted from [195]. (↑↓ antiparallel) 
 Frequency (cm-1) 
Secondary structure H2O D2O 
αI - helix  1658-1650 1655-1646 
αII - helix 1666-1658 1658-1652 
310 - helix 1670-1660 1670-1660 
↑↓β- sheet 1638-1632 1636-1630 
↑↓β- sheet 1695-1675 1680-1670 
Intermolecular β- sheet 1625-1615 1625-1615 
β- turns  1685-1655 1675-1640 
γ- turns 1690-1650 1690-1650 
irregular 1660-1652 1648-1640 
amide or aromatic side chains 1618-1605 1615-1600 
 
For secondary structure determination, the spectra of deutered and non-deutered 
samples can be intercompared to gain insight. This procedure relies on the possible 
interference of the solvent due to the strong HOH bending mode around 1643cm-1 [197] 
and also on the fact that in non-deutered form the random coil and α-helix conformation 
absorb IR radiation at the same frequency range (see Table 3.1). In the deutered form 
the random coil is shifted to lower wavenumbers, which facilitate the distinction and 
quantification of these two types of structure. Moreover, non-deutered amino acid 
chains can also contribute to the spectra in the amide I vibration range (see Table 3.1) 
[196].  
For determination of the secondary structure of a peptide a curve-fitting of the 
amide I band that includes the decomposition of the amid I band into its constituent 
bands and their assignment (see Table 3.1), is necessary (for further information on 
curve-fitting and band assignment see references [193, 196, 197]). The component 
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bands are calculated and assigned to secondary structures comparing the results with 
previous reports, for instance [195-199].  
 
For secondary structure determination is broadly accepted that CD 
measurements provide more accurate estimations of α-helix content whereas IR is more 
sensitive to the presence of β-sheets [200], so both techniques complement each other. 
 
With polarized light in ATR-FTIR measurements is possible to have information 
about the orientation of the peptide with respect to lipidic membranes [195]. The 
method is based on the fact that the IR light absorption is maximal if the dipole 
transition moment is parallel to the electric field component of the incident light. In an 
ordered membrane deposited on the IRE surface all the lipid molecules have the same 
orientation with respect to a normal to the IRE surface. By measuring the spectral 
intensity with polarized light is therefore possible to detect changes in the orientation of 
dipoles of both peptides and phospholipids [194]. In practice, spectra with parallel and 
perpendicular polarization of the infrared light (relative to the incident plane) are 
collected, which enable the calculation of the dichroic spectrum (i.e. the difference 
between the spectra recorded with parallel and perpendicular polarization) and of the 
ATR dichroic ratio (RATR; which is the ratio between the integrated absorbance of a 
band measured with a parallel polarization of the incident light (A//) and the absorbance 
measured with a perpendicular polarization of the incident light (A⊥) [194]: 
⊥
=
A
AR ATR //           (eq. 3.1) 
This parameter provides information on the orientation of the peptide inserted in the 
lipidic bilayer. A larger absorbance for the parallel polarization (upward deviation on 
the dichroism spectrum) indicates a dipole oriented preferentially closer to the normal of 
the ATR plate, whereas a larger absorbance for the perpendicular polarization 
(downward deviation in the dichroism spectrum) indicates a dipole oriented 
approximately parallel to the ATR plate [201].  
To determine the orientation of a specific peptide with respect to the membrane 
is necessary to first assign the contribution of each band in the IR spectrum and then to 
quantify the possible contribution of α-helix conformation within the peptide (this is the 
secondary structure that is commonly associated with linear peptides inserted in lipidic 
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membranes [172, 184]). By determination of RATR relative to the α-helical band is 
possible to calculate the orientation of the α-helix long axis with respect to the IRE 
surface normal and therefore the orientation of the peptide within the membrane [194]. 
Briefly, the RATR is related to an orientational order parameter S by the equation: 
⎟⎠
⎞⎜⎝
⎛
−++= S
S
E
E
E
ER
y
z
y
xATR
1
312
2
2
2
        (eq. 3.2) 
where 2xE , 
2
yE and 
2
zE are the time averaged square electric field amplitudes of the 
evanescent wave in the lipidic film at the IRE/film interface. The Sexperimental is related 
with the helix axis by the relation: 
dipolehelixmembraneerimental SSSS ××=exp        (eq. 3.3) 
where Smembrane describes the distribution function of the lipid membrane with respect to 
the IRE, Shelix describes the orientation of the helix with respect to the membrane plane, 
and Sdipole describes the dipole orientation of amide I with respect to the helix axis (see 
Figure 3.4 for a better understanding). Sdipole is correlated with the angle α (angle 
between the amide I transition dipole moment and the helix angle; see Figure 3.4) by 
the equation: 
2
1cos3 2 −= αdipoleS          (eq. 3.4) 
It is normally assumed that Smembrane = 1 and Sdipole is a characteristic of the secondary 
structure (for helix conformation the angle α is considered to be 33.3º [201]; this value 
permits the calculation of the Sdipole by the eq. 3.4). With the Sexperimental and Sdipole, Shelix 
can be determined and therefore the tilt β (see Figure 3.4) of the helix axis with respect 
to the membrane normal by the following equation [194]: 
3
12arccos += helixSβ          (eq. 3.5) 
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Figure 3.4. Axially symmetric distributions for the 
calculation of the angle of a dipole in relation with 
the IRE normal. The angle between the plate normal 
and the lipidic membrane is angle γ (assumed to be 
0), the angle between the molecular axis (helix axis) 
and the membrane normal is angle β and the 
transition dipole moment in relation with the helix 
angle is α (assumed to be ∼33.3º). By experimental 
determination of the order parameter S (see text) it is 
possible to determine the peptide tilt (angle β) in 
respect with the membrane normal. Figure adapted 
from the reference [194].  
 
 
Previous reports on pep-1 secondary structure suggest that the hydrophobic 
domain of pep-1 has tendency to adopt an α-helical conformation when in contact with 
the membrane environment [185]. Taking into account the possible helical 
conformation of the peptides, ATR-FTIR can be used to determine the orientation of the 
hydrophobic domain when the pep-1 is interacting with lipidic membranes. 
  
Different strategies can be used to detect pore formation in lipidic bilayers. The 
most important evidence for the possibility of barrel-stave model is the single-channel 
conductance induced by peptides when in lipidic bilayers, can be detected by ion 
conductance and are characterized by reproducible multiple discrete states [180]. Ion 
conductance can be studied with electrophysiological measurements using planar lipid 
membranes (PLMs) [202], also known as black lipid membranes (BLMs). With 
macroscopically assembled PLMs is possible to have access to both sides of the lipidic 
bilayers; the measurement of current flow across the lipidic bilayer gives information on 
the possible pore formation or membrane perturbation induced by the presence of 
peptides. 
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Figure 3.5. Experimental setup for planar lipid bilayers electrophysiology. Two chambers (cis and trans) 
are separated by a Teflon film which contains a small hole, ~50 to 200 μm in diameter. The chamber is 
filled with electrolyte-containing buffer and a lipid bilayer is formed across the hole. Electrodes are 
connected to each chamber (via salt bridges). The membrane potential is controlled (clamped) and the 
current is amplified using a voltage-clamp amplifier. Channel formation is monitored by step-wise 
increases in the current due to channels into the membrane. Figure adapted from [203]. 
 
PLMs can be prepared by the method originally developed by Montal and 
Mueller [202], where the experimental setup is prepared with the two chambers, cis and 
trans, separated by a thin Teflon film (25μm) containing a hole where lipidic membrane 
is formed (Figure 3.5). The chambers should be filled with an electrolyte-containing 
solution where the level of solution should be initially below the aperture. Lipid 
solution should be spread over the surface on two chambers to form a lipid monolayer at 
water-air interface. To form a planar lipid bilayer the two monolayers are folded 
together by raising the solution level of each compartment above the hole [202]. Both 
compartments have an electrode and are connected through a salt bridge. The formation 
and stability of bilayer membrane can be checked by continuously following membrane 
capacitance [204, 205]. This method has the possibility to form asymmetric bilayers by 
spreading lipid solutions with different lipid compositions in cis and trans chamber 
[202].  
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A planar lipid bilayer can be regarded as an insulator, therefore the presence of a 
conducting channel will lead to an electric field perturbation [203] which can be 
recorded with time. A pattern with reproducible multiple discrete states upon voltage 
potential application is indicative of pore formation by a barrel-stave mechanism 
(Figure 3.6) 
 
Figure 3.6. Current fluctuations with 
discrete conducting states, (step-wise 
increase) typical for proteins/peptides 
able to induce a channel formation 
across lipidic bilayers. 
 
  
GUVs vesicles are suitable membrane models systems due to their size 
(diameter >10μm), which is similar to the size of the plasma membrane of the cells and 
can be directly visualized using microscopy techniques [206]. GUVs can be obtained by 
electroformation based on the protocol originally developed by Angelova and Dimitrov 
[207] among other techniques. In this protocol GUVs are formed by lipid swelling on 
platinum electrodes, under an electrical field. In a chamber (Figure 3.7), containing two 
parallel platinum wire electrodes, connected to an alternating current field generator, the 
lipid solution is spread onto each of the two wires and dried. An aqueous solution is 
added until wires cover. Upon attenuate electric field application osmotic forces and 
electrostatic forces drive the formation of liposomes [207]. 
 
To gain more information on the lytic action of peptides a strategy developed by 
Ambroggio et al. was used [208]. In this methodology, GUVs filled with fluorescent 
dyes with different sizes are followed by confocal microscopy. With this approach, 
visual information is obtained and related to the possible leakage mechanism. The 
capacity of this peptide to induce leakage is imaged and, in the case of pore formation, 
the pore size can be estimated [208, 209] (Figure 3.8). Briefly, to evaluate whether 
pores are formed, GUVs were prepared in a sucrose solution containing three dyes 
emitting at different wavelengths and with different sizes (Alexa Fluor633 C5-maleimide 
(Mr ∼1330), Alexa Fluor488-Dextran (Mr∼10000) and Alex Fluor488 Dextran Mr ∼3000). 
To remove the fluorescence dye from outside the vesicles GUVs solution was passed 
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through a sephadex G-100 column equilibrated with a glucose iso-osmolar solution. 
Vesicles loaded with sucrose and dispersed in a glucose solution led the GUVs to 
precipitate, making imaging in the inverted confocal fluorescence microscope easier.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7. Array of individual chambers (12) to prepare GUVs by the electroformation method. The 
array is prepared with Teflon and Pt wires (with a diameter of 0.5mm) and the water flux from the 
circulating bath in a plastic tube surrounding the module. Lipid is dried on the pt wires and GUVs are 
formed upon Alternating current application. Figure adapted from [206] and [210].  
 
In the case of pore formation, after peptide addition, a sequential escape of the 
three dyes (from the smaller to the large one), or the leak of just one or two dyes will 
give information about pore size (see Figure 3.8). Membrane integrity can be evaluated 
by a membrane dye [208, 209]. 
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Figure 3.8. Approach for direct visualization of the lytic activity of peptides. By the use of GUVs loaded 
with fluorescent dyes with different size and by screening these fluorescent markers with confocal 
microscopy is possible to evaluate the leakage caused by the peptide. If the membrane becomes leaky to 
one, two or the three dyes one has information on the pore size. In this schematic representation the dyes 
with different sizes are represented by blue, green and red.  
 
   
The methodologies above referred were used to evaluate pore formation induced 
by the pep-1. The following manuscript presents the most relevant results achieved with 
these studies. 
   
   
  
    Peptide
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Energy-independent translocation of cell-penetrating peptides occurs
without formation of pores. A biophysical study with pep-1
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Abstract
Pep-1 is a cell-penetrating peptide (CPP) with the ability to translocate across biological membranes and introduce active
proteins inside cells. The uptake mechanism used by this CPP is, as yet, unknown in detail. Previous results show that such
a mechanism is endocytosis-independent and suggests that physical-chemical interactions between the peptide and lipid
bilayers govern the translocation mechanism. Formation of a transmembrane pore has been proposed but this issue has
always remained controversial. In this work the secondary structure of pep-1 in the absence/presence of lipidic bilayers was
determined by CD and ATR-FTIR spectroscopies and the occurrence of pore formation was evaluated through
electrophysiological measurements with planar lipid membranes and by confocal microscopy using giant unilamellar
vesicles. Despite pep-1 hydrophobic domain tendency for amphipathic a-helix conformation in the presence of lipidic
bilayers, there was no evidence for membrane pores in the presence of pep-1. Furthermore, alterations in membrane
permeability only occurred for high peptide/lipid ratios, which induced the complete membrane disintegration. Such
observations indicate that electrostatic interactions are of first importance in the pep-1-membrane interactions and show
that pores are not formed. A peptide-lipid structure is probably formed during peptide partition, which favours peptide
translocation.
Keywords: Peptide carrier, peptide-membrane interaction, translocation mechanism, membrane pore, peptide secondary
structure, model membranes
Introduction
Whilst the introduction of hydrophilic molecules
into mammalian cells is controlled by the lipid
membrane barrier, the use of cell-penetrating-pep-
tides (CPPs) has become a good strategy to over-
come the membrane impermeability. A CPP is a
short, basic and water-soluble, peptide able to
translocate through cell membranes, with high
efficiency and low toxicity, in a way independent
on receptors [1,2].
Despite their potential for drug delivery, the
mechanism used by CPPs to translocate across the
cell membrane, without damaging it, is still a
mystery. A single general mechanism for all does
not seem reasonable and more than one mechanism
for each individual peptide is a possibility [24].
Nonetheless, the existence of the basic amino acid
residues in all the peptides suggests that the electro-
static interaction with phospholipid bilayers is a
common step in the mechanism of action of CPPs.
Many CPPs including penetratin, TAT and
oligoarginines are internalized by an endocytotic
pathway (so-called ‘energy-dependent’ mechanism)
[24]. However, the strong correlation of uptake
with lipid-binding affinity, the direct observation of
translocation in model membranes, and the impor-
tance of electrostatic interactions, suggests that a
translocation mechanism involving only direct phy-
sical interactions with lipids can operate for some
peptides [1].
Pep-1 (Ac-KETWWETWWTEWSQPKKKRKV
-cysteamine) is a chimeric CPP with a primary
amphipathicity, which can be divided into three
domains: (i) a so-called hydrophobic domain
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(KETWWETWWTEW), responsible for hydropho-
bic interactions with proteins and for an interaction
with the cell membrane; (ii) a hydrophilic Lys-rich
domain derived from the nuclear localization signal
(NLS) of simian virus 40 (SV-40) large T antigen
(KKKRKV), required to improve solubility and
intracellular distribution of the peptide, and (iii) a
spacer domain (SQP) which improves the flexibility
and the integrity of the other two domains. This
CPP has advantages relative to the others because it
does not need covalent link with the cargo [5];
physical assemblies between peptide and macromo-
lecules, stabilized by hydrophobic and electrostatic
interactions, are formed [6].
Our previous works demonstrated that pep-1 is
able to translocate in vitro or in vivo by a physical-
mediated mechanism promoted by transmembrane
potential [6,7], with no evidences for any alternative
‘energy-dependent’ process [6]. The high efficiency
of the peptide to be translocated by an ‘energy-
independent’ process seems to be related to its
primary amphipathicity, which is responsible for
the high affinity for lipidic membranes [8]. Further-
more, it has been shown that the C-terminal
cysteamine group is relevant for membrane affinity
and translocation efficiency [810].
A variety of models have been suggested to
describe an ‘energy-independent’ pathway for the
translocation of CPPs (recently reviewed in refer-
ences [1,11]) and a possible mechanism is pore
formation. In our previous studies, with model
membranes, no evidence for pore formation was
detected in the presence of pep-1 [7] and this result
was confirmed by Weller et al. [10]. However, this
issue remains very controversial as electrophysiolo-
gical studies using oocyte membrane [12] suggest
that a transmembrane pore-like structure could be
formed, mediated by pep-1 conformational changes.
The main aim of the present work is to find out if
pore formation occurs and is a relevant mechanism
for pep-1 translocation. Attenuated total reflection-
Fourier transform infrared (ATR-FTIR) spectro-
scopy was performed in order to identify the peptide
conformation and its orientation when inserted in
the membrane [13]. The pore formation hypothesis
was tested by electrophysiological measurement in
Planar Lipid Membranes (PLMs) [14] and by
confocal microscopy using Giant Unilamellar Vesi-
cles GUVs [15].
Material and methods
Reagents
Pep-1 with purity /95% was produced by custom
synthesis by GenScript Corporation (Piscataway,
New Jersey). Synthetic lipids 1-Palmitoyl-2-Oleoyl-
sn-Glycero-3-Phosphocholine (POPC), 1-Palmi-
toyl-2-Oleoyl-sn-Glycero-3-(Phospho-rac-(1-glyce-
rol)) (POPG), 1,2-Dipalmitoyl-sn-Glycero-3-phos-
phocholine (DPPC), 1,2-Diphytanoyl-sn-Glycero-
3-phosphocholine (DPhPC) and 1,2-Dipalmitoyl-
sn-Glycero-3-Phosphoethalonamine-N-(Lissamine
Rhodamine B Sulfonyl) (N-Rh-PE), were obtained
from Avanti polar lipids (Alabaster, Alabama).
Cholesterol (Chol) and Thioflavin T (ThT) were
from Sigma-Aldrich (St. Louis, Missouri). Alexa
Fluor633 C5-maleimide (Mr/1300), Alexa
Fluor546- Dextran (Mr/10000) Alexa Fluor488-
Dextran (Mr/3000) and 1,1?-dioctadecyl-3,3,3?,3-
tetramethylindocerbocyanine perchlorate (DiIC18)
were purchased from Molecular Probes (Eugene,
Oregon).
The samples were prepared in 10 mM HEPES
buffer with 150mM NaCl and pH 7.4, unless stated
otherwise.
Circular Dichroism (CD) measurements
CD spectra were recorded for 68.8 mM pep-1 in
aqueous solution or in the presence of lipid. 1 mM of
POPC or POPC:Chol (2:1 molar) large unilamellar
vesicles (LUVs), prepared by the extrusion method
[16], were used for these studies (peptide/lipid molar
ratio/0.069). Samples with negatively-charged li-
pids (e.g., POPG down to 20%) were not possible to
prepare due to aggregation of vesicles induced by
pep-1 at these peptide/lipid ratios (see [8]), which
are mandatory to perform spectra with good S/N
ratios. Samples were prepared in 10 mM phosphate
buffer with 75 mM NaF, pH 7.5. The CD measure-
ments were made on a Jasco J-810 Circular Dichro-
ism Spectropolarimeter equipped with a Julabo F25-
HE Temperature Unit Control in a quartz cell with
an optical path of 0.1 cm at 208C. Wavelengths from
260 to 185 nm were recorded with a 0.1 nm step and
a 20 nm/min speed. Spectra were collected and
averaged over 3 scans and corrected for background
contributions. Molar absorptivity was calculated
considering o/1.8/104 M1cm1 (data not
shown). Computer fittings using the Jasco software
package JWSSE-480 with the CD reference dataset
of Yang [17] were performed to estimate the con-
tributions of spectral components from different
secondary structures.
ATR-FTIR spectroscopy
Attenuated total reflection infrared (ATR-FTIR)
spectra were obtained on a Bruker Equinox 55
FTIR spectrophotometer (Ettlingen, Germany)
equipped with a MCT detector (broad band
2 S. T. Henriques et al.
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12000420 cm1, liquid N2 cooled, 24 h hold time)
at a resolution of 2 cm1. The spectrometer was
continuously purged with dry air (Whatman 7562,
Haverhill, MA, USA). The internal reflection ele-
ment was a 52/20/2 mm trapezoidal germanium
ATR plate (ACM, Villiers St Fre´de´ric, France) with
an aperture angle of 458 yielding 25 internal reflec-
tions. A total of 128 scans (8004000 cm1) were
averaged for each spectrum with a resolution of
2 cm1. The spectrophotometer was continuously
purged. Background of the internal reflection ele-
ment was collected and subtracted to the samples.
Peptide samples in the absence/presence of lipid
were prepared with 10 mM HEPES buffer pH 7.4
and spread on the Ge plate under a stream of N2 to
evaporate the solvent (see [18] for further informa-
tion).
Secondary structure of the pep-1, in absence and
in the presence of membranes with various lipidic
compositions: POPC, POPC:Chol (2:1 molar) and
DPPC, was evaluated (negatively-charged phospho-
lipids could not be used due to precipitation caused
by pep-1, as stated above). After liposome forma-
tion, pep-1 was added to the solution to obtain a
final peptide concentration of 20% (w/w) and mixed
in vortex; the lipidic concentration was maintained
at 2 mg/mL (/2.6 mM, depending on the exact
lipid molar mass) and the peptide concentration at
0.4 mg/mL (0.138 mM, peptide/lipid molar ratio/
0.053). A film with 8 mg peptide/40 mg lipid was
prepared by spreading the peptide/lipid solution on
the Ge plate. The kinetic of peptide deuteration was
evaluated; non-deutered and deutered samples were
compared.
The determination of protein secondary struc-
tures was performed using a curve-fitting procedure,
where the amide I band was decomposed into the
various component bands which can be assigned to
the different types of secondary structure. First the
band positions were determined by deconvolution
using a Lorentzian deconvolution function
(FWHH/30), a Gaussian apodization function
(FWHH/15) and a 2 cm1 resolution enhance-
ment. The amide I was fitted with bands placed at
the positions found and the integrated absorbance of
the component bands was calculated. The compo-
nents bands were assigned to secondary structures
comparing the results with data presented in differ-
ent references [1923].
Orientation of the secondary structure
ATR-FTIR Spectroscopy provides information on
the orientation of peptides inserted in lipid bilayers
[18,23]. Peptide spectra were recorded with parallel
and perpendicular polarized incident light at the
same conditions as non-polarized spectra (see
above). With polarized light it is possible to deter-
mine the dichroic spectra (see Supplementary Figure
S.2 in the Online version for results obtained with
pep-1) and the dichroic ratio (RATR) which provides
information about the orientation of the peptide
inserted in lipidic bilayers.
The integrated areas corresponding to the a-helix
components from the two polarized spectra were
determined and the ratio of the integrated areas is
the dichroic ratio of a-helix, RATRa : Dichroic ratios
were used to determine the tilt angle with the
membrane normal (see [13] for further informa-
tion). The angle between helix axis and the amide I
transition dipole moment is 33.38 [24]. Riso was used
to compute the film thickness and the values of the
electric field components at 1650cm1 as described
previously [18]. For these calculations refractive
indexes of 4.0 and 1.44 were used for the Ge plate
and the sample film, respectively.
Electrophysiological studies
PLMs were formed according to the Montal and
Mueller method [25]. Briefly, a thin teflon film
(25 mm) with a hole (130160 mm) was clamped
between two compartments (referred as cis and trans
chambers) filled with HEPES buffer (the level of
solution was kept below the hole) 5 ml of a lipid
solution (20 mg/ml in n-hexane) were spread in each
compartment and the solvent was left to evaporate
(10 min). Raising the level of the buffer solution
above the aperture, first in one side and then in the
other, induced the formation of the bilayer in the
teflon hole. The two chambers were connected
(through Ag/AgCl electrodes and a 1 M KCl agar
bridge) to a BLM-120 amplifier (biologic). The cis
chamber was connected to the active input of the
BLM-120 amplifier and trans chamber was held at
ground. The electrical potential was defined as cis
with respect to trans . The formation of bilayer was
followed by membrane capacitance, see [26]. Only
membranes with a resistance/100GV were used to
perform the measurements. Pep-1 was added to the
cis side of the chamber and the ion current was
recorded for increasing potential differences (alter-
nating from negative to positive potential). The
electric signal was low pass filtered at 100 Hz,
sampled at 44.1 kHz and stored on CD using a
DRA 200 analog to digital converted (biologic).
DPhPC was used to perform PLMs because it is
known to form stable bilayers [27], this lipid exhibits
no detectable phase transition over a large tempera-
ture range (/1208C to /1208C) [28] and the
presence of methyl groups along acyl chains results
in considerable disorder chain [29], so a fluid-like
Pep-1 translocates without pore formation 3
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phase is expected at room temperature. DPhPC was
preferred over POPC because POPC did not form
bilayers. Both lipids form fluid phase bilayers at
room temperature. The charge effect was tested by
the presence of 10% and 20% (mol/mol) of POPG
in the bilayers. Different peptide concentrations
were added at cis chamber. Asymmetrical mem-
branes were also tested with 20% POPG in the trans
side and pure DPhPC in the cis side. Titrations with
peptide were realized in the trans side or in the cis
side or alternating (one addition in the trans side and
other in the cis side). Controls without peptide were
carried on.
Leakage experiments with GUVs
Membrane leakage induced by pep-1 was evaluated
in GUVs using the method previously described by
Ambroggio et al. [15,30]. Briefly, for GUVs produc-
tion 4 ml of lipid stock solution (0.2 mg/ml) in
chloroform were spread on each Pt wire under
a stream of N2, residual organic solvent was removed
in a vacuum chamber overnight. Sucrose solution
with three dyes, (2 mM Alexa Fluor633 C5-
maleimide (Mr/1300), 2 mM Alexa Fluor546-
Dextran (Mr/10000) and 2 mM Alexa
Fluor488-Dextran (Mr/3000)) with an overall os-
molarity of 150 mOsM, was equilibrated at a
temperature above lipid phase transition and added
to the chamber (500 ml final volume) covering the Pt
electrodes. The Pt wires were connected to a
function generator and a low frequency AC field
(sinusoidal wave function with a frequency of 10 Hz
and amplitude of 1.5V) was applied for 120 min to
form GUVs. Vesicle solutions were carefully re-
moved from the chamber and placed into a sephadex
G-100 column equilibrated with a gluocose iso-
osmolar solution [15]. With this procedure the
fluorescent dyes located out of the vesicles are
removed and vesicles with homogeneous size (about
1015 mm) are obtained. GUVs solution suspended
in glucose (250 mL) were added to an eight well
plastic chamber (Lab-tek Brand Products) and left
to precipitate overnight. The density difference
between glucose and sucrose causes the precipitation
of the vesicles, which facilitates observation in the
inverted confocal fluorescence microscope. An iso-
osmolar solution of pep-1 was added to the chamber
and the fluorescence intensity of the different dyes
was followed for a period of time of up to 30 min;
different peptide concentrations were studied in the
presence of GUVs prepared with POPC or POPC:-
POPG (4:1 molar). The membrane integrity was
evaluated repeating these experiments with GUVs
labelled with a membrane dye (0.5% DiIC18/lipid
mol/mol) and with 2 mM Alexa Fluor633 C5-mal-
eimide internalized. An inverted scanning confocal
fluorescence microscope (Zeiss -LSM 510 META,
Carl Zeiss, Jena, Germany) was used to perform the
experiments. The excitation wavelengths were 543
nm (HeNe laser, 1 mW; for DiIC18 or Alexa
Fluor546- Dextran), 488 nm (Ar laser, 30 mW; for
Alexa Fluor488-Dextran) and 633 nm (HeNe laser, 5
mW; for Alexa Fluor633 C5-maleimide). The objec-
tive used for the experiments was a Zeiss C-
Apochromat 40/1.20 W corr (water immersion,
NA/1,2). The fluorescent images were simulta-
neously collected using the fluorescence micro-
scope’s META detection device (Polychromatic 32-
channel detector) by selecting the proper emission
wavelength range for the different fluorescent
probes. The time-dependence of the fluorescent
intensities of the different dyes during the course of
the experiment were quantitatively recorded and
treated by the standard Zeiss LSM 510 META
software package (with the inclusion of the multiple
time series software option).
Lipid quantification in GUVs solution was carried
out to enable the determination of the peptide/lipid
ratio. POPC GUVs doped with 5% N-Rh-PE were
prepared using the same procedure above described
and the Rh fluorescence emission intensity
(lexcitation/570 nm and lemission/590 nm) was
followed before and after the washing step in the
Sephadex G100 column. The calibration curve was
set with multilamellar vesicles dispersions in sucrose
or glucose with a well-known lipidic concentration.
Blanks were discounted. Considering the total lipid
added to the Pt wire, the final lipid concentration in
the chamber is /4 mM; after GUV formation the
average lipid concentration determined was 1.03
9/0.49 mM (8 samples) before washing step and
0.719/0.22 mM (4 samples) after vesicle washing.
Results and discussion
Pep-1 has a high affinity for zwiterionic membranes,
which is enhanced in the presence of negatively-
charged phospholipids [8]. The peptide has an
amphipathic nature, the hydrophobic domain, con-
taining five Trp residues, inserts in the membrane
with a shallow position [8,10], but not accessible to
the aqueous environment [8]. The hydrophilic
domain, with five basic residues, does not insert in
the hydrophobic core of the membrane [9]. This
highly charged domain is probably responsible for
the first contact of the peptide with the membrane
due to electrostatic attraction between the polar
phospholipids headgroup and the positive charges
of pep-1 [9]. The dehydration induced by the
hydrophilic domain at membrane surface and the
insertion of hydrophobic domain promote mem-
4 S. T. Henriques et al.
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brane destabilization. As a consequence of
membrane destabilization induced by pep-1, aggre-
gation and fusion events with LUVs were detected
[7]. These perturbations in the membrane occurred
without evidence for pore formation. [7,10]. Fusion
events without leakage were also observed for other
CPPs such as R7W, TATP59W and TATLysP59W
[31]. Moreover, membrane integrity in HeLa cells is
only disrupted in the presence of high peptide
concentration (concentration much higher than the
one required for the translocation to occur) [10].
At variance, Deshayes et al. proposed a barrel-
stave-like mechanism of pore formation [12]. Such a
hypothesis is based on the observation that pep-1
undergoes conformational changes after insertion in
the lipidic bilayer (hydrophobic domain change from
unordered to a-helix structure) and due to changes
in the membrane conductance in voltage-clamped
oocytes, when a transmembrane potential is applied.
Moreover, it is suggested that the helical axis of pep-
1 is inserted with a perpendicular orientation to the
membrane plane; this proposal was putative.
Secondary structure determination
In the present work a study of the peptide secondary
structure was carried out in the absence and
presence of lipidic membranes at physiological pH.
To evaluate the conformational state of pep-1, its
secondary structure was studied by both CD spec-
troscopy and ATR-FTIR spectroscopy in the pre-
sence and absence of lipidic bilayers. It is normally
accepted that CD spectroscopy is a powerful tech-
nique to identify the presence of random coil and a-
helix contributions [17,32,33] where IR is more
sensitive to b-sheets structures [34].
In CD measurements a good computer fitting
with concomitant quantification of different spectral
components contributions was obtained in the
spectra carried out on aqueous solution with 68.8
mM pep-1 (Figure 1A). Contributions of a-helix and
random coil were identified.
LUVs are an adequate model of biological mem-
branes with no significant curvature effects as the
ones present in SUVs (small unilamellar vesicles)
[35]. The secondary structure of 68.8 mM pep-1 in
the presence of 1mM POPC or POPC:Chol (2:1
molar) vesicles (Figure 1B and C) has a higher
contribution of a-helix than in aqueous environ-
ment.
ATR-FTIR spectroscopy enables to further ex-
tend the information on peptide secondary structure
because this technique is more robust than CD
spectroscopy to identify the presence of b-structures.
Amide I mode (/17001600 cm1) is the most
sensitive to the protein secondary structure [23].
The membrane phase effect was evaluated with
different lipids at room temperature, instead of
heating/cooling one lipidic system, to avoid arte-
facts/denaturation in the pep-1. At room tempera-
ture POPC forms fluid phase bilayers, POPC:Chol
(2:1 molar) forms liquid-ordered phases and DPPC
forms gel phase bilayers.
A broad band was obtained in the absence and
presence of the lipidic systems (Figure 2A), suggest-
ing that there are contributions of different con-
formations. Comparison of deconvoluted spectra
Figure 1. The 68.8 mM pep-1 Far-UV CD spectra obtained,
Mean Residue Elipticity (MRE) is presented, (A) in aqueous
solution, (B) in the presence of 1 mM POPC LUVs or (C) in the
presence of 1 mM POPC:Chol (2:1 molar). Solid lines represent
original spectra; dotted lines fitted spectra and dashed lines the
residual. The samples were prepared in 10 mM phosphate buffer
(pH 7.5) containing 75 mM NaF.
Pep-1 translocates without pore formation 5
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(Figure 2B) reveals that the same secondary struc-
tures but with different percentages are present in
the different conditions tested.
Spectra of deutered samples (1 h of deuteration;
see 1H/2H exchange kinetic in Supplementary ma-
terial Online, Figure S.1) were used to improve the
assignment of band components and for a better
quantification of secondary structure. In the non-
deutered form the random coil and a-helix confor-
mation absorb at the same wave number range. At
variance, the band of the deutered form of the
random coil is usually shifted to lower wave num-
bers. Therefore, the deutered form facilitates the
identification and quantification of the two classes of
structures. Moreover, the amide I in non-deutered
form can also have contribution of the water hydra-
tion [23] and of amino acid side chains [20], which
further hampers detailed data analysis.
The spectra of pep-1 or pep-1-lipid mixtures dried
on the Ge plate were compared after 1 h of
deuteration (Figure 2C). Deconvolution (Figure
2D) shows 3 peaks (1691, 1674 and 1622 cm1),
and a large shoulder between 16571640 cm1.
By comparison with deconvoluted spectra ob-
tained in non-deutered and deutered forms (Figure
2B,D) it is possible to say that there is a contribution
of intermolecular b-structure (1692 and 1625 cm1
in 1H, which are shifted to 1674 and 1622 cm1 in
2H) [21,23]. The existence of intermolecular b-
structure instead of intramolecular b-sheet is identi-
fied by the low frequency signal at 1625 cm1 in 1H,
and 1622 cm1 in 2H; in the case of intramolecular
b-sheet a longer wave number was expected for the
low frequency component (16361630 cm1 in-
stead of 1625 cm1) [23]. The existence of a
contribution at /1674 cm1 in 1H suggests the
existence of b-turns [23]. In 2H a peak with this
wavenumber has a contribution of b-turn [19] and
also with the high frequency component of inter-
molecular b-sheet. Absorbances between 1657
cm1 and 1640 cm1 in 2H are characteristic for
a-helix and random coil [23]. Results obtained with
Figure 2. ATR-FTIR amide I band of 8 mg of pep-1 in aqueous solution (solid line) or in the presence of 40 mg of lipid in multilayers with
different compositions: POPC (alternated dashes and dots), POPC:Chol (2:1 molar) (long dashes) and DPPC (short dashes). (A) Non-
deutered form, (B) Deconvoluted spectra of the non-deutered form. (C) Recorded after 1 h of deuteration. (D) Deconvoluted spectra of
deutered form. All the spectra were normalized. The samples were prepared in 10 mM HEPES with 150 mM NaCl (pH 7.4).
6 S. T. Henriques et al.
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CD spectroscopy confirm the existence of these two
contributions.
For the quantification of each contribution a five-
band fitting was preformed in deutered spectra, as
follows: (i) 17051685cm1, (ii) 16801669cm1,
(iii) 16601648cm1, (iv) 16481640cm1, (v)
16301620cm1. Band assignment and relative
weights are present in Table I.
In the presence of lipids, the contribution of b-
sheet (bands with maximum at 1674 cm1 and
1621 cm1) decreases, while a-helix (1657 cm1)
and random coil contributions (1640 cm1) in-
crease. The contribution at /1690 cm1 is weak for
all the conditions and may result from a small
fraction of peptide quantity in non-deutered form
in b-sheet conformation (see Figure 2 and Table I).
In ATR-FTIR measurements, an increase in
intermolecular b-sheet signal, with the peptide
quantity spread in the Ge plate, was verified (data
not shown). It was previously published that pep-1
has a tendency to aggregate in aqueous solution [8];
in order to verify that the b-structure signal is due to
intermolecular interactions resulting from peptide
aggregation with b-sheet conformation, a titration of
the ThT dye with a pep-1 stock solution was realized
(see Supplementary material online). An increase in
ThT fluorescence intensity emission (with excitation
at 450 nm) with peptide concentration (see Figure
S.3 in Supplementary material online) confirms that
pep-1 has a tendency to aggregate with b-sheet
conformation.
While analysing ATR-FTIR results one should
bear in mind that samples are semi-dehydrated.
When the sample is semi-dehydrated for multi-
bilayer deposition, the fraction of pep-1 not inserted
in the membranes precipitates in the aggregated
form and contributes in this form to the ATR-FTIR
spectrum. Comparison of spectra in Figure 2 shows
that the signal at 1621 cm1 (intermolecular b-
structure component) decreases in the order H2O/
DPPC/POPC:Chol/POPC. The percentage of
peptide precipitated decreases when the membrane
becomes more fluid (membrane fluidity follows the
order: DPPCB/POPC:CholB/POPC) which is re-
lated to the ability of the peptide to insert in the
membrane [8]. Therefore, the relative percentage for
the contribution of the different secondary struc-
tures is affected by the contribution of aggregates in
solution. To evaluate if there is alteration in the a-
helix content of the fraction of peptides inserted in
the lipidic matrix it is a better approach to compare
the contribution of a-helix components in relation to
random coil component. For instance in the absence
of lipid a-helix/random coil contribution/3.8%/
32.7%/0.12. When DPPC is present, 7.7%/
35.4%/0.22, and for POPC/14.6%/44.2%
/0.33 (see Table I). These results show that in
the presence of lipidic bilayers there is an increase in
a-helix contribution relative to random coil, and this
contribution is enhanced by membrane fluidity (see
Figure 2 and Table I).
CD and ATR-FTIR measurements were carried
out with different peptide and lipidic concentrations
but the peptide/lipid ratios were nearly the same
(0.069 and 0.054, respectively). With CD measure-
ments it was possible to identify the presence of
random coil and a-helix contributions; this facili-
tated the band assignment in amide I ATR-FTIR
spectra. A fraction of peptide, either in the absence
or in the presence of vesicles, is aggregated when the
peptide/lipid suspensions is spread over the Ge Plate
(identified by the presence of intermolecular b-
sheet). An a-helix conformation of the other frac-
tions is favoured when the pep-1 is inserted in the
membrane (see Figure 1, Figure 2 and Table I).
Considering the primary structure of pep-1, the
hydrophobic domain has a bigger tendency to
acquire an amphipathic a-helix conformation, in
agreement with NMR results proposed by others
[10,12], while the hydrophilic domain is expected to
be in the random coil conformation. The presence of
Pro residue in the spacer domain, between hydro-
philic and hydrophobic domains, is responsible
for the separation of a-helix and random coil
conformations, inducing the flexibility necessary
for the integrity of these two domains.
Table I. Pep-1 secondary structure evaluated by ATR-FTIR spectroscopy in the absence/presence of different lipidic multibilayers at 208C
and pH7.4*.
Frequencies (cm1) Assignment POPC POPC:Chol (2:1) DPPC Aqueous solution
1690 /¡/ b-Sheet 2.89/0.1 1.99/0.0 1.39/0.3 1.39/0.5
1674 Turn and /¡/ b-Sheet 31.29/1.1 28.89/1.7 34.59/2.6 39.59/2.1
1657 a-helix 14.69/0.6 11.29/0.4 7.79/1.5 3.89/1.1
1640 Random coil 44.29/0.1 47.29/2.3 35.49/1.2 32.79/1.4
1621 Intermolecular b-Sheet 7.29/0.4 10.99/0.1 21.19/2.1 22.79/0.8
*Samples were spread on Ge plate from solutions with 138 mM pep-1 and /2.6 mM lipid (8 mg of pep-1 and 40 mg lipid); spectra were
recorded after 1 h of deuteration. Five bands were used to fit amide I spectra as follows: (i) 17051685 cm1, (ii) 16801669 cm1, (iii)
16601648 cm1, (iv) 16481640 cm1, and (v) 16301620 cm1. The frequency (cm1) of Amide I components and the respective
percentage for each condition are presented in the form.
Pep-1 translocates without pore formation 7
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Orientation of the pep-1 when partitioned in lipidic
membranes
Polarized ATR-FTIR is a powerful technique to
obtain information about peptide orientation in a
lipid bilayer [18]. Calculation of the a-helix mean tilt
angle, with membrane normal, was performed. This
required the evaluation of RATRa (see Material and
methods section). Barrel-stave-like pore formation,
such as the one proposed for antimicrobial peptides
[36] and pep-1 [12], demand the a-helix domain of
peptide to span across lipid membrane with an
amphipathic helix and acquire an orientation parallel
to the membrane normal (08) [36]. In POPC
vesicles and POPC:Chol (2:1 molar) the mean tilt
angle of helix contribution with respect to the
normal to the membrane is 46.58 and 44.58,
respectively. These values are close to the average
value expected for a randomly oriented structure
(54.78) [37]. So, peptide populations with no pre-
ferred orientation cannot be discarded. A perpendi-
cular orientation relative to the bilayer surface for
peptide hydrophobic domain was not expected from
the previous quenching experiments [8]. These
findings are not consistent with a barrel-stave-like
organization.
In DPPC an angle closer to membrane normal
(208) was found for the a-helix domain. This result
supports the idea that peptide is constricted to gel
line defects in these rigid membranes [8].
Membrane disruption caused by pep-1
When planar bilayers, PLMs, are used it is possible
to have access to both sides of the membrane and the
ion flux can be determined by electrical measure-
ments. The electrical capacity of bilayers prepared
by the Montal and Mueller method matches that of
biological membranes [25].
DPhPC, which form stable and neutral bilayers at
room temperature, was used. Pep-1 was added to the
cis chamber and the ionic current was recorded for
increasing potential differences alternating from
negative to positive potential (from 0 to9/100mV).
Different peptide concentrations were added
(03 mM). For low peptide concentration
(0.5 mM) there was no effect; increasing peptide
concentration (/2 mM), ion current fluctuations
were detected in the presence of transmembrane
potential (Figure 3A). The current-voltage relation-
ship (Figure 3B) shows that these current fluctua-
tions are amplified with the transmembrane
potential; however, the shape of fluctuations is
completely disordered. When the transmembrane
potential was increased to values higher than9/100
mV, or the peptide concentration was increased (/3
mM), the membrane was destroyed.
In the presence of a transmembrane potential, an
increase in peptide concentration in the membrane
due to electrostatic attraction is expected. Therefore,
the membrane becomes more loosely packed, which
results in transient membrane permeability instabil-
ities in the presence of the electric field (Figure 3B).
In the presence of a barrel-stave pore a single-
channel conductance was expected, which is
characterized by reproducible multiple discrete con-
ducting states [36]. A barrel-stave model cannot
account for the results performed with DPhPC
PLMs because the conductance induced by the
pep-1 is continuously variable rather than discrete
[36] (Figure 3A).
The charge effect in the membrane was tested in
DPhPC bilayers with 10% or 20% of POPG and also
with asymmetrical membranes. These membranes
were less stable. By the addition of peptide to
bilayers an intermediary step with current fluctua-
tions did not occur. The membrane became leaky at
low pep-1 concentration (/1 mM) (data not
shown). This is probably due to high electrostatic
attraction of pep-1 to negatively-charged membranes
[8].
The hypothesis of pore formation whether barrel-
stave-like or not was further tested by fluores-
cence microscopy with GUVs loaded with three
fluorescent dyes differing in their molecular sizes
(Alexa Fluor633 C5-maleimide (Mr/1300), Alexa
Fluor488-Dextran (Mr/3000) and Alexa Fluor546
-Dextran (Mr/10000)). This experimental setup
enables direct observation of any change in the
membrane permeability during time course observa-
tions [15,30]. Moreover, in the case of pore forma-
tion it is also possible to have information on pore
size due to sequential escape of the dyes from the
GUVs. The membrane integrity was evaluated with
DiIC18 to probe the membrane bilayer structure
[30]; this dye was incorporated in GUVs loaded with
Alexa Fluor633 C5-maleimide (Mr/1300)
GUVs prepared with POPC or POPC:POPG (4:1
molar) with a final lipid concentration of /0.7 mM
were studied in the presence of different peptide
concentrations. POPC:POPG vesicles in the pre-
sence of peptide concentrations bellow /0.7 mM
did not undergo noticeable effect in the membrane
shape, permeability or integrity; none of the probes
escape from the GUVs, during the time window of
the experiment (/30 min). With higher peptide
concentration (/0.7 mM) GUVs were completely
destroyed with the simultaneous leakage of the three
dyes (Figure 4), which resulted in deformed lipid
aggregates (see also Movies 1 and 2 in the Supple-
mentary material Online).
Figure 5 confirms membrane destruction caused
by pep-1 in these conditions, where the leakage of
8 S. T. Henriques et al.
87
D
ow
nl
oa
de
d 
By
: [
M
on
as
h 
U
ni
ve
rs
ity
] A
t: 
06
:5
4 
24
 A
pr
il 
20
07
 
Alexa Fluor633 C5-maleimide (Mr/1300) and the
membrane disintegration (followed with DiIC18)
occurred concomitantly. These results prove that
the peptide does not induce pore formation. Instead,
it induces disintegration of the vesicles with a
detergent-like mechanism (see Movies 1 and 2 in
the Supplementary material Online). It is worth
stressing that the approximate lipid concentration in
GUVs solution is /0.7 mM which is approximately
the peptide concentration required for the mem-
brane disruption. With lower peptide concentrations
there was no effect on the membrane permeability.
Similar results were obtained with POPC vesicles,
but a higher peptide concentration was required for
vesicle destruction, about 24 mM. This is expected
because pep-1 has higher affinity for negatively-
charged vesicles [8].
The lag time between peptide addition and
vesicles destruction is dependent not only on peptide
affinity for membranes but also on the peptide
concentration and its diffusion in the chamber
(continuous stirring was not possible in these con-
ditions) [15].
Taken together, the results obtained in GUVs and
in PLMs suggest that pep-1 at low peptide/lipid (P/
L) ratios does not cause significant alterations in
membrane properties and does not induced serious
perturbations in permeability. For high bulk P/L
ratio the membrane is disrupted with a detergent-
like mechanism. The P/L ratio required to cause this
effect is dependent on the membrane composition,
which governs the local peptide concentration in the
membrane.
‘Carpet’-model disintegration vs. barrel-stave pore
formation
Aurein and Citropin, antibiotic peptides, disrupt
membranes in a similar way to pep-1 and a ‘carpet’
model mechanism was proposed [15]. In this model,
electrostatic interactions drive the peptide binding
onto the surface of the membrane and cover it in a
‘carpet’-like manner. Membrane permeation only
occurs above a certain critical local peptide concen-
tration, resulting in disintegration of the membrane.
Figure 3. Electrical measurements in the DPhPC planar bilayers prepared in buffer with 10 mM HEPES (pH 7.4) and 150 mM NaCl.
Pep-1 was added to the cis compartment. (A) Current fluctuations in the presence of 2 mM pep-1 at the membrane voltage was clamped at
/70 mV. (B) Current-voltage relationship in the absence (filled circle) or in the presence of 0.86 mM pep-1 (open circle) or 2.58 mM pep-1
(filled triangle). Current signals were averaged over 10 s.
Figure 4. Pep-1 (0.9 mM) interaction with POPC:POPG (4:1)
GUVs (0.7 mM) by confocal microscopy. Time course of the
normalized fluorescence intensity, of the three internalized
vesicles: Alexa Fluor546- Dextran (Mr/10000) (open triangle),
Alexa Fluor488-Dextran (Mr/3000) (filled circle) and Alexa
Fluor633 C5-maleimide (Mr/1300) (filled square). Fluorescence
intensity was determined in each micrograph using the standard
Zeiss LSM 510 META software package (with the inclusion of the
multiple time series software option) to quantify the average
fluorescence intensity over time. Background was corrected and
fluorescence intensities were normalized to zero time.
Pep-1 translocates without pore formation 9
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A previous step before the collapse of the membrane
packing may include the formation of transient holes
in the bilayer [38]. The formation of such holes
enables the passage of low molecular weight mole-
cules prior to complete lyses [38]. These small
transient holes explain the ion current fluctuations
detected in DPhPC PLMs and also the results
obtained by Deshayes et al. [12]. Nevertheless,
such holes do not make the membrane permeable
for molecules with a molecular weight ]/ 1300 Da
(See Figures 4 and 5 and also Movies 1 and 2 in the
Supplementary material online), so this mechanism
cannot explain the translocation of proteins as big as
b-Galactosidase (116 KDa), which, as verified
previously, can be translocated by pep-1 in HeLa
cells [6,9].
The adequacy of a ‘carpet’ model-like mechanism
to explain membrane disruption and absence of the
pore formation (barrel-stave or other) are further
supported by the fact that the hydrophobic domain
length in a-helix conformation mismatches the
membrane depth. Considering 1.5 A˚ per residue
Figure 5. Direct visualization of membrane integrity, of POPC:POPG (4:1 molar) GUVs (0.7 mM) in the presence of pep-1 (0.9 mM), by
confocal microscopy. (A) GUVs before and after peptide addition (3.7 and 6.5 min). Pictures show the merge fluorescence of the DiIC18
and Alexa Fluor633 C5-maleimide (Mr/1300) (red and blue, respectively in online version). Scale bar, 15 mm. (B) Time course of the
normalized fluorescence intensity of the two dyes during the experiment: DiIC18 (open triangle), and Alexa Fluor
633 C5-maleimide (Mr/
1300) (filled circle). Fluorescence intensity was determined as stated in Figure 4. Part A of this Figure is reproduced in colour in Molecular
Membrane Biology online.
10 S. T. Henriques et al.
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for an ideal a-helical structure [15], 19.5 A˚ length is
expected for the peptide domain inserted in the
membrane while 40 A˚ is the thickness for fluid lipid
bilayers [39]. In barrel-stave pore the peptide inter-
action with the target membrane is driven predomi-
nantly by hydrophobic interactions and the peptides
should bind to phospholipid membranes irrespective
of their charge [38], with a transmembrane domain
that spans across the membrane [36]. These events
are favoured in the absence of Trp residues in the
peptide [40]. Pep-1 however does not fulfil any of
such requirements for pore formation.
Membrane destruction is an extreme event that
only occurs at very high pep-1 concentration. There-
fore ‘carpet’-like mechanism may explain the cyto-
toxicity of pep-1, but does not explain its
translocating activity at lower concentrations
[5,6,10].
Conclusions
Pep-1 translocates and transports proteins across
membranes even with relatively low peptide concen-
trations [5,6,10]. With concentrations required for
peptide translocation pep-1 shows a high affinity for
membranes [8] and is able to induce membrane
destabilization [7] without evidence of pore forma-
tion [7,10]. Translocation occurs both in vitro [7]
and in vivo [6] by a mechanism mediated by the
transmembrane potential. Such a mechanism is
governed by electrostatic interaction between the
peptide and the membrane and the peptide ability to
destabilize membranes seems to play an important
role.
For high peptide concentration more pronounced
membrane damage occurs, which induces toxicity in
cells [5,10]. Membrane disintegration occurs for
high P/L ratios and is dependent on the peptide
affinity for membranes. A ‘carpet’-model mechan-
ism is suggested by all sets of data but only in
extreme conditions, far from typical physiological
conditions.
It should be stressed that in the presence of a
transmembrane potential, translocation occurs and
peptide accumulation in the membrane is not
favoured, i.e., the membrane saturation/disintegra-
tion point is only reached at very high peptide
concentration, which explains the low cytotoxicity
of pep-1.
In spite of the a-helix contribution increase when
pep-1 inserts in the membrane, there was no direct
evidence for a transmembrane pore. Pep-1 first
interaction with membrane is driven by electrostatic
interaction [9] followed by membrane carpeting,
which occurs with lateral rearrangement of the acidic
lipids [7]. Similar phenomena were observed with
other peptides and a ‘membrane-thinning’ effect was
proposed [41]. In this model, the peptide aggregates
on the surface and the reduced local surface tension
allow the peptide to intercalate the membrane.
Flexible sealing between peptide side-groups and
lipid head-groups minimize leakage during the CPP
passage through the membrane [1].
Supplementary material available online
(1) Pep-1 deuteration in the presence of lipidic
bilayers monitorized by ATR-FTIR; (2) Pep-1
dichroic spectrum obtained by ATR-FTIR spectro-
scopy; (3) Evaluation of existence of pep-1 b-sheet
aggregates by Thioflavin T fluorescence, and (4)
Movies showing the interaction of the pep-1 with
GUVs.
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Online supplementary material
(1) Pep-1 deuteration in the presence of lipidic
bilayers monitorized by ATR-FTIR
The 1H/2H exchange kinetics was studied to estab-
lish an appropriate duration for peptide deuteration
to evaluate secondary structure by ATR-FTIR
spectroscopy. The kinetics of pep-1 deuteration in
the presence of POPC bilayers is fast (Figure S.1).
There are no significant differences in amide I band
after 1 min of deuteration. A decrease in the area of
the amide II band (15901505 cm1) is also
noticed. The shape change in amide I and the area
decrease in amide II bands suggest that the pep-1 is
easily accessible to the solvent [1]. A fast kinetics of
pep-1 deuteration was observed for all the lipidic
systems tested (POPC, POPC:Chol (2:1) and
DPPC).
(2) Pep-1 dichroic spectrum obtained by ATR-
FTIR spectroscopy
The dichroic spectrum is the difference between the
spectra recorded with parallel and perpendicular
polarizations; the perpendicular spectrum was multi-
plied by the dichroic ratio of the lipid n (C/O)
determined at 1738cm1 (Riso) to take into account
the difference in the relative power of the evanescent
fields (see [2] for further information). The dichroic
spectrum provides information on the peptide or-
ientation relative to the normal of membrane plane
[2].
The dichroic spectrum, //-Riso/, for pep-1 in the
presence of different lipids shows a positive dichro-
ism signal, for amide I region, indicating that the
peptide has a preferential orientation in the lipid
membrane (see Figure S.2). This band, however, is
relatively broad (FWHH/50cm1) with a max-
imum at 1674cm-1 and a shoulder at 1650cm1.
(3) Evaluation of existence of pep-1 b-sheet
aggregates by Thioflavin T fluorescence
ThT dye was used to evaluate if pep-1 forms b-sheet
aggregates in aqueous solution. In the absence of b-
sheet aggregates the dye has an excitation and
emission maxima at 350 and 438nm, respectively.
In the presence of amyloid fibrils the ThT excitation
spectrum shifts with a new peak at 450nm and
emission at 482nm [3]. Titration of 15mM ThT with
a pep-1 stock solution (688 mM) was followed by
fluorescence intensity at lemission/490nm with
lexcitation/450nm.
(4) Movies showing the interaction of the pep-1
with GUVs
Movie 1. Leakage of the probes entrapped in GUVs.
0.9mM pep-1 was added to the vesicles composed by
POPC:POPG (4:1 molar) with a lipid concentration
/ 0.7mM. Fluorescence merge of the three dyes
(Alexa Fluor546- Dextran (Mr/10000) (red), Alexa
Fluor488-Dextran (Mr/3000) (green) and Alexa
Fluor633 C5-maleimide (Mr/1300) (blue)) is pre-
sented. The three dyes escape from the vesicles at
the same time. In the film the velocity was increased
40 times.
Figure S.2. ATR-FTIR spectra of pep-1 (20% w/w) partitioned in
POPC bilayers obtained using parallel or perpendicular polariza-
tion. The dichroic spectrum was obtained by the difference
between the spectra recorded with parallel and perpendicular
polarizations; the perpendicular spectrum was multiplied by Riso.
All the spectra are in the same scale, but dichroic spectrum
intensity has been multiplied by 2.
Figure S.1. 1H/2H exchange kinetic of pep-1 in the presence of
POPC bilayers (20% w/w). Spectra of 8 mg of pep-1 in the
presence of 40mg of POPC were recorded as a function of the
deuteration time (from 0 to 60 min of deuteration). All the spectra
were normalized.
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Movie 2. Leakage of DiIC18-labelled GUVs filled
with Alexa Fluor633 C5-maleimide (Mr/1300).
0.9mM pep-1 was added to the vesicles composed
by POPC:POPG (4:1 molar) with a lipid concentra-
tion / 0.7mM. Fluorescence merge of the DiIC18
(red) and Alexa Fluor633 (blue) is presented. Mem-
brane disruption and Maleimide escape occurred at
once, which demonstrates that membrane is dis-
rupted in these conditions. In the film the velocity
was increased 30 times.
Supplementary material references:
[1] Manciu L, Chang XB, Buyse F, Hou YX, Gustot A, Riordan
JR, Ruysschaert JM. 2003. Intermediate structural states
involved in MRP1-mediated drug transport. Role of glu-
tathione. J Biol Chem 278:33473356.
[2] Bechinger B, Ruysschaert JM, Goormaghtigh E. 1999.
Membrane helix orientation from linear dichroism of infra-
red attenuated total reflection spectra. Biophys J 76:552
563.
[3] LeVine H 3rd. 1993. Thioflavine T interaction with syn-
thetic Alzheimer’s disease beta-amyloid peptides: detection
of amyloid aggregation in solution. Protein Sci 2:
404410.
Figure S.3. Peptide concentration effect in the ThT (15mM)
fluorescence emission intensity, with excitation at 450nm and
emission at 490nm. Experiments were carried out in 10mM
HEPES buffer, pH 7.4, with 150mM NaCl.
14 S. T. Henriques et al.
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Pep-1 and mammalian cells 
 
 
4.1. Introduction  
 
 It is accepted that Tat peptide and penetratin are internalized by an endosomal-
dependent mechanism; however there is no consensus in the specific endocytic pathway 
used for the import of these peptides [62, 68, 70]. A description of these endocytic 
pathways, how can they be used, what is the physiological significance of these routes 
and how can be used for the uptake of extracellular material is presented next.  
 
4.1.1. Endocytic routes for cell entry 
Endocytosis is a hallmark of all eukaryotic cells and is responsible for the uptake 
of membrane proteins and lipids, extracellular ligands and soluble molecules from the 
cell surface [211]. It modulates the delivery of essential metabolites to cells (e.g. 
nutrients uptake) and also the responses to many protein hormones and growth factors. 
Proteins targeted for destruction are taken up by endosomes and delivered to lysosomes 
for digestion [212]. In addition, endocytosis is also involved in synaptic vesicle 
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recycling and regulation of cell-surface expression of signalling receptors, remodelling 
of the plasma membrane and the generation of cell polarity [211]. To meet these 
different functions endocytic pathways have different regulation processes, specificity 
for different cargoes and destination within cells [211]. Endocytosis can be divided into 
two broad categories: phagocytosis, responsible for the uptake of large particles, and 
pinocytosis for the uptake of fluid and solutes [213-215] (see Figure 4.1).  
 
Figure 4.1. Different endocytosis routes for cell entry. Endocytic pathways can be classified according to 
the size of the endocytic vesicle, the nature of the cargo and the mechanism of vesicle formation. Large 
particles can be engulfed by phagocytosis, while solutes are internalized by pinocytosis. Phagosomes are 
responsible for internalization and afterwards degradation in lysosomal compartment. In macropinocitosis, 
large uncoated vesicles are formed, while in clathrin- and caveolin- mediated uptake vesicles are coated 
and present a smaller and uniform size. Clathrin- and caveolin- independent pathways are uncoated but 
present a small size when compared with macropinosomes or phagosomes. These vesicles are here 
designated as clathrin and dynamin-independent carriers (CLIC) and are derived from the plasma 
membrane. Virtually all the pinocytosis routes reach early endosomes but may first traffic to intermediate 
compartments such as the caveosome or glycosyl phosphatidylinositol-anchored protein enriched early 
endosomal compartment (GEEC). The fate of cargos macromolecules internalized by these different 
endocytic pathways is dependent on the cargo nature and possible target signal. By default, 
macromolecules without signal sequence end in lysosomal compartment where enzymatic degradation 
takes place. Image adapted from reference [216]. 
 
Phagocytosis is conducted primarily by specialized cells like neutrophils, 
macrophages and dendritic cells, that function to clear pathogens such as bacteria or 
Micropinocytosis 
Pinocytosis
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yeast and other particles such as remnants of dead cells or fat particles [214] higher than 
> 0.5µm in diameter [213]. It is an active and highly regulated process that involves 
interaction with specific cell-surface receptors, that trigger the formation of phagocytic 
compartments and subsequent internalization of the particles [213]. There are multiple 
modes of phagocytosis, which are determined by the particle to be ingested and the 
receptor that recognizes that particle; however in all the phagosomes actin drives its 
formation [214]. 
 
Pinocytosis, also known as fluid-phase uptake, can be followed by the 
intracellular accumulation of tracer molecules (e.g. enzymes, proteins, or labelled 
compounds known to be internalized by a specific pinocytosis route) present in the 
medium. Endocytosis can be initiated with non-specific binding of solutes to the cell 
membrane or captured by specific high-affinity receptors. Such receptors are 
concentrated into specialized endocytic transport vesicles where the molecule and its 
receptor determine the pathway through which the solute enters into the cell [214]. 
Fluid-phase uptake can be divided into macropinocytosis and micropinocytosis [213].  
Macropinocytosis is related to phagocytosis but is less specific [215, 217]. They 
are alike in morphology but differ in the biochemical mechanisms employed in their 
regulation [213]. Typically, macropinocytosis is triggered by growth factor stimulation 
or downstream-activated signalling molecules [217] and refers to the formation of large 
irregular primary endocytic vesicles by the closure of lamellipodia at ruffling membrane 
domains [213, 217], which can be transiently induced in most cells [214]. 
Macropinosomes are uncoated dynamic structures and can reach several μm in diameter 
[217]. Macropinocytosis fulfils diverse functions such as endocytic removal of large 
membrane domains, alter the adhesive and communicative properties of the cell and it is 
involved in cell contraction and migration [217]. The formation of large 
macropinosomes is also driven by actin as occurs for phagosomes [214]. 
Micropinocytosis refers to endocytic processes and differs mechanistically from 
the previous ones. It involves more selective plasma-membrane domains [214] that 
originate small pinocytic vesicles that appear somewhat uniformly over the cell surface 
[218]. Micropinocytosis can be divided in three mechanistically distinct pathways of 
uptake: clathrin-mediated endocytosis; caveolin-mediated endocytosis and clathrin- and 
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caveolin- independent endocytosis, which probably encompasses more than one 
pathway [214].  
Clathrin-mediated endocytosis occurs in all mammalian cells and is responsible 
for the continuous uptake of essential nutrients. It is also involved in cell and serum 
homeostasis and is required for efficient recycling of synaptic vesicle membrane 
proteins after neurotransmission [214]. Clathrin-mediated endocytosis is involved in 
concentrating of transmembrane receptors together with their bound ligands into 
“coated pits” [214]. This receptor-mediated endocytosis starts with the invagination of a 
coated pit that is encapsulated by clathrin-induced excision from the plasma membrane 
to form a “coated vesicle”, which rapidly loses it clathrin coat and fuses with an 
endosome [212].  
Caveolae-mediated endocytosis is a dynamin-dependent endocytic route. 
Caveolae are 50-80nm flask-shaped, plasma-membrane invaginations enriched in 
caveolins, sphingolipids and cholesterol that are present in many cells [216]. Different 
signalling molecules and membrane transporters are concentrated in these caveolae 
domains pointing to a role in the regulation of specific signalling cascades [214]. 
Caveolar cargoes are diverse, including lipids, proteins, lipid-anchored proteins and 
pathogen [216]. A cargo molecule can be internalized by different mechanisms under 
different conditions, the molecular basis for the correlation between caveolae-localized 
receptors and triggered endocytosis remains to be elucidated [214, 216]. 
The mechanisms responsible for caveolae- and clathrin- independent 
endocytosis seem to be dependent on rafts, which can presumably be captured by, and 
internalized within any endocytic vesicles. The unique lipid composition of these 
domains, where specific glycolipids and membrane proteins are associated, may be 
responsible for their specific sort [214]. In contrast to clathrin-dependent endocytosis, in 
which a ligand-receptor binding is required, no such well defined finding for clathrin-
independent endocytosis has been identified. A possible mechanism is the association of 
cargo with plasma membrane domains. However association of the cargo with such 
domains does not assume subsequent internalization by endocytosis [216]. The potential 
mechanisms for the selection o cargo for endocytosis can be divide into lipid- and 
protein-based mechanisms and were reviewed in reference [216]. An example is cholera 
toxin B (CTxB) which seems to be internalized by a non-clathrin, non-caveolar 
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mechanism. CTxB is observed in parts of the membrane where its receptor, the 
monosialoganglioside GM1, is located [216] 
 
Overall, it seems that endocytosis is regulated by the cargo nature and its 
hypothetical receptor, thus cargo molecules internalized by endocytosis are not passive 
passengers [214]. A variety of destinations can be followed after entry into the 
endocytic route. The fate of internalized solutes is also dependent on the cargo 
molecules. Virtually all routes of pinocytosis merge at early endosomes (see Figure 3.1); 
cargo molecules are then organized to be delivered to different intracellular targets or to 
be recycled back to the plasma membrane (e.g. some endocytic receptors such as LDL 
receptors) [216]. Lysosome is the default destination of any material that does not 
possess a signal sequence with target information. In the lysosome, macromolecules 
degradation takes place due to hydrolytic enzymes within the compartment [219]. It is 
worth mentioning that when two cargo molecules are internalized by the same 
mechanism they may have different intracellular destinations [216]. A particular amino 
acid sequence for instance may target proteins to the endoplasmic reticulum or a protein 
modification may target proteins to lysosomes [219].  
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4.2. Pep-1 internalization into mammalian cells 
 
Uptake of pep-1 into mammalian cells is of first importance for peptide 
functionality and applications in vivo. The elucidation of the mechanism for cell entry is 
compulsory in order to fully take advantage of its properties. In this chapter two articles 
with studies carried on with pep-1 and HeLa cells are presented.  
In the article titled: Translocation of β-Galactosidase mediated by the cell-
penetrating peptide pep-1 into lipid vesicles and Human HeLa cells is driven by 
membrane electrostatic potential, the principles that govern the mechanisms of 
internalization of pep-1 associated with the protein β-Galactosidase are unravelled. 
In the short communication titled: Re-evaluating the role of strongly charged 
sequences in amphipathic cell-penetrating peptides. A fluorescence study using pep-1, 
the effect of an attached fluorescent dye and the importance of the hydrophilic domain 
to translocation efficiency are revealed. A comparison between labelled and non-
labelled peptide is presented.  
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4.2.1. Translocation of β-Galactosidase mediated by the cell-
penetrating peptide pep-1 into lipid vesicles and Human HeLa cells is 
driven by membrane electrostatic potential.  
 
4.2.1.1. Motivation and methodologies 
The functionality of pep-1 as CPP is related to its capacity to internalize 
macromolecules inside cells. Results presented in chapter 2 reveal its high affinity for 
lipidic membranes and ability to pass through model membranes by a mechanism 
mediated by electrostatic interactions and promoted by transmembrane potential [153, 
186]. Previous reports on CPP translocation suggest endocytosis as the main mechanism 
[59, 61]. In this chapter a comprehensive study on the pep-1 capacity to pass through 
cell membrane and to introduce a macromolecule inside mammalian cells is presented. 
The possibility of a physical mechanism mediated by transmembrane potential was 
tested against an alternative mechanism mediated by endocytosis using HeLa cells 
(Adherent human negroid cervix epitheloid carcinoma cells). The result and conclusions 
are presented in the published article titled: Translocation of β-Galactosidase mediated 
by the cell-penetrating peptide pep-1 into lipid vesicles and Human HeLa cells is driven 
by membrane electrostatic potential.  
 
Most of published studies on CPP translocation with cellular lines were carried 
out with fluorescently-labelled peptides and in the absence of a cargo. Such procedures 
can create artefacts and bias CPP activity; moreover the significance of these peptides 
as CPP is not achieved unless its capacity to internalize cargoes inside cells is proven. 
In addition, recent observations show that fixation conditions can mask the peptide 
internalization mechanism [55, 58]. In order to avoid such artefacts, a protein cargo was 
followed through the studies, instead of the peptide.  
β-Galactosidase (β-Gal) from E. Coli was chosen to study the capacity of pep-1 
to internalize a protein and to evaluate the translocation efficiency. This protein does not 
have a valid signal sequence inside human cells and consequently is unable to address a 
specific organelle inside the cell. This protein is a homotetramere (116kDa each subunit) 
with an enzymatic activity dependent on it quaternary structure. The usage of a protein 
with these characteristics is useful because its cellular location, upon internalization 
mediated by pep-1, can give valuable information about the possible entry route. 
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Moreover, accessing its enzymatic activity one can conclude on the 
stability/functionality of the protein upon interaction with pep-1 and after cellular 
uptake. A disruptive aggressive process leave the protein unable to work as a catalytic. 
One should also emphasise the protein size; if pep-1 is able to mediate the uptake of this 
large protein one can consider that proteins can be internalized by a mechanism where 
size restriction is not operative (not likely a pore, for instance).  
 
A photophysical characterization of the protein and of the complex pep-1/β-Gal 
was performed by means of Trp fluorescence (each subunit of β-Gal has 38 Trp residues) 
using the methodologies referred in chapter 2. β-Gal enzymatic activity was followed 
upon pep-1/β-Gal complex formation for different pep-1/β-Gal ratios. Internalization of 
β-Gal mediated by pep-1 into HeLa cells was accessed by immunofluorescence using 
epifluorescence microscopy and confocal microscopy. Enzymatic activity after cellular 
internalization was also studied.  
 
For immunofluorescence detection, cell fixation and permeabilization 
procedures were performed prior to primary antibody anti-β-Gal addition. Primary 
antibody can be recognized by a secondary antibody with a fluorescent marker (e.g. 
Fluorescein isothiocyanate (FITC) or tetramethylrhodamine (TRITC)) (Figure 4.2). 
 
 
 
Figure 4.2. β-Gal internalization mediated by pep-1 can be 
detected by indirect immunofluorescence method. In the 
primary reaction binding of antibody anti-β-Gal with the 
antigen occurs. Followed by the secondary reaction where 
FITC-conjugated secondary antibody binds to anti-β-Gal 
to obtain complexes of β-Gal-antibody-FITC-conjugated 
antibody. FITC fluorescence is observed by fluorescence 
microscopy after washing. Source: 
http://www.mbl.co.jp/e/diagnostics/product/method.html.  
 
 
The entry by a mechanism dependent on endocytosis was tested by co-
localization of β-Gal with different endocytic markers: Dextran-TRITC was used to 
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follow macropinocytosis; antibody anti-early endosome antigen 1 to localize early 
endosomes; antibody anti-caveolin-1 to target caveosomes in caveolae endocytosis and 
antibody anti-cathepsin D to localize lysosomes. The two fluorescent markers (one to 
identify β-Gal location and the other to mark the specific endosomal compartment) were 
imaged in the same cells and each fluorophore was excited and detected independently 
by confocal microscopy to avoid any signal crossover. Quantification of co-localization 
of β-Gal with each endosomal marker was performed by comparison of a z-series of 14 
images in 6-10 cells [220-222]. Briefly, using the open source Image J software 
(http://rsb.info.nih.gov/ij/), the pixels of interest were first identified by generating a 
mask for each channel (in this particular case, red and green signals) to eliminate 
background signal resulting from the non-specific binding signal. Shared pixels between 
the red and green masks were identified and quantified; the overlap was defined as the 
percentage of total pixel intensity for the shared pixels.   
 
β-galactosidase is an enzyme responsible by the hydrolysis of β-galactosides 
into monosaccharide’s, releasing β-(1-4) linked galactose from the non-reducing end of 
oligosaccharides. This enzyme’s substrate specificity can be used to evaluate it activity 
by the use of synthesizing compounds which when hydrolyzed by β-gal result in a 
measurable product. The most commonly used chromogenic subtract is o-nitrophenyl-β-
galactopyranoside (ONPG); when β-gal cleaves ONPG, o-nitrophenol is released, 
which has a yellow colour and its formation can be accessed by absorbance at 420nm 
[223]. Alternatively, a fluorescence based assay can be used because it is more sensitive 
than the colorimetric ones. An example is 4-methylumbelliferone-β-D-galacto-
pyranoside (MUG) which becomes fluorescent upon hydrolysis, producing 4-
methylumbelliferone (4-MU) along with galactose (Figure 4.3). 4-MU emits 
fluorescence at 440nm (excitation at 360nm), whereas the precursor molecule MUG 
does not. A basic pH is necessary for the development of the fluorescence signal (i.e. 
higher quantum yield) from 4-MU. Addition of NaOH stops the enzymatic reaction and 
enables the development of the fluorescent signal [224].  
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Figure 4.3. Reaction catalysed by β-galactosidase using a non-fluorescent substrate (4-MUG; 4-
methylumbelliferone-β-D-galacto-pyranoside) which can be converted into a fluorescent product (4-MU; 
4-methylumbelliferone) along with galactose. 
 
The enzymatic activity of β-Gal was followed by progression curves of MUG 
hydrolysis and the initial velocity of the enzymatic reaction. Considering that the 
substrate is at non-limiting concentrations, MUG conversion into 4-MU is limited to 
enzyme concentration and functionality. For further information on enzymatic 
parameters see reference [212]. 
 
Oligoarginine is able to translocate lipid membranes; a passive diffusion across 
the non-polar interior of plasma membrane seems unrealistic to describe the 
internalization of a peptidic sequence with such polarity. An association of 
oligoarginines with cell surface groups with complementary charge was proposed by 
Rothbard et al. to attenuate the polarity of the basic amino acids [81]. The previous 
chapter, shows that the presence of anionic phospholipids facilitates the association of 
pep-1 with the cell membrane but is not sufficient to promote the passage of this 
positively charged peptide through the lipidic membrane [153]. Translocation, in vitro 
was only achieved when negative transmembrane potential across the lipidic membrane 
exists [186].  
The transmembrane potential is related to the concentration gradient and 
permeabilities of K+, Na+ and Cl- ions [225]. Channels that enable the potassium flow in 
and out of the cell are much more abundant than channels that enable the passage of the 
other ions, therefore, the changes in membrane potential are intimately dependent on K+ 
permeability [225-227]. Intracellular K+ is mainly regulated by active inflow of K+ 
trough the Na+/K+ pump and passive influx and efflux of K+ depending on the 
concentration gradient through K+ leak channels in the cell membrane [225]. 
Depolarization of the resting membrane potential can be achieved by an increase in 
β-galactosidase
H2O
+
MUG 4-MU Galactose 
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extracellular K+ which induces a decrease of the electrochemical gradient of these ions 
across the cell membrane [228]. In practice this can be obtained by substitution of 
extracellular Na+ by K+ [110, 228, 229].  
The possible effect of electrochemical gradient on pep-1 translocation in 
cultured cells was tested by incubating cells with an isotonic buffer with K+ 
concentrations ranging between 5mM and 115mM. The intracellular concentration of 
potassium is about 140mM whereas the extracellular concentration is believed to be 
around 5mM [81]. With the partial of the sodium salt in PBS with equimolar amounts of 
the equivalent potassium salt, it was possible to obtain different degrees of membrane 
depolarization (the total ionic strength was kept constant ([K+] + [Na+] =150mM)). 
Therefore it was possible to evaluate the effect of membrane polarization.  
Membrane polarization can be related to a certain extent with the potassium 
Nernst potential, which is dependent on K+ concentration in extracellular medium (the 
intracellular concentration was considered to be constant and 140mM). Negative 
transmembrane potential was calculated by potassium Nernst potential, EK, by the use 
of the equation:  
⎟⎟⎠
⎞
⎜⎜⎝
⎛⎟⎠
⎞⎜⎝
⎛=
i
K K
K
F
RTE 0ln           (eq. 3.1) 
R is the gas constant, T is the absolute temperature, F is the Faraday constant and K0 and 
Ki are the extracellular and intracellular potassium concentrations respectively. With 
increasing extracellular K+ concentration a decrease in the negative potential is noticed. 
It should be stresses that the contributions of other ions is also important for the total 
membrane potential and make the membrane potential more positive than the potassium 
Nernst potential prediction at low extracellular concentration of K+. Nevertheless 
Potassium Nernst is a good approximation [81].  
 
The methodologies above referred were used to evaluate the internalization of 
pep-1/β-Gal inside cultured cells; the following manuscript presents the most relevant 
results achieved on the studies with pep-1 and mammalian cells. 
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Translocation of â-Galactosidase Mediated by the Cell-Penetrating Peptide Pep-1
into Lipid Vesicles and Human HeLa Cells Is Driven by Membrane Electrostatic
Potential†
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ABSTRACT: The cell-penetrating peptide (CPP) pep-1 is capable of introducing large proteins into different
cell lines, maintaining their biological activity. Two possible mechanisms have been proposed to explain
the entrance of other CPPs in cells, endosomal-dependent and independent types. In this work, we evaluated
the molecular mechanisms of pep-1-mediated cellular uptake of â-galactosidase (â-Gal) from Escherichia
coli in large unilamellar vesicles (LUV) and HeLa cells. Fluorescence spectroscopy was used to evaluate
the translocation process in model systems (LUV). Immunofluorescence microscopy was used to study
the translocation in HeLa cells. Enzymatic activity detection enabled us to monitor the internalization of
â-Gal into LUV and the functionality of the protein in the interior of HeLa cells. â-Gal translocated into
LUV in a transmembrane potential-dependent manner. Likewise, the extent of â-Gal incorporation was
extensively decreased in depolarized cells. Furthermore, â-Gal uptake efficiency and kinetics were
temperature-independent, and â-Gal did not colocalize with endosomes, lysosomes, or caveosomes.
Therefore, â-Gal translocation was not associated with the endosomal pathway. Although an excess of
pep-1 was mandatory for â-Gal translocation in vivo, transmembrane pores were not formed as concluded
from the trypan blue exclusion method. These results altogether indicated that protein uptake both in
vitro with LUV and in vivo with HeLa cells was mainly, if not solely, dependent on negative transmembrane
potential across the bilayer, which suggests a physical mechanism governed by electrostatic interactions
between pep-1 (positively charged) and membranes (negatively charged).
The introduction of hydrophilic molecules into mammalian
cells has become a key strategy for the investigation of
intracellular processes and drug therapy. CPPs1 are very
attractive for these purposes because of their ability to
mediate cellular uptake of proteins and nucleic acids, which
is otherwise impossible because of membrane selective
permeability (1-7). These peptides are small (9-33 amino
acid residues), and their only common feature is the presence
of basic amino acid residues (2).
The most widely used CPPs are derived from HIV-1 tat
(TAT) and Drosophila Antennapedia homoprotein (1, 4, 6).
Covalent linkage of CPP with cargo molecules leads to their
nontoxic import into cells, both rapidly and efficiently, while
maintaining functional activity inside the cell (2). The
process, however, is dependent on CPP, cargo, and cell type
(8). The translocation of these cationic peptides is not well
understood. A single general mechanism for all does not
seem reasonable, and there are examples of CPPs (e.g., TAT)
that are able to use both endosomal and nonendosomal
pathways (5, 9).
Pep-1 (Ac-KETWWETWWTEWSQPKKKRKV-cyste-
amine) is an artificial CPP that has the ability to establish
hydrophobic interactions with the cargo molecule, which may
render covalent links unnecessary and favor the native
structure (10). This sequence contains a Trp-rich hydrophobic
domain, KETWWETWWTEW, a hydrophilic sequence,
KKKRKV, that is the nuclear localization sequence of simian
virus 40 large T antigen, and a spacer, SQP, linking the two
previous ones (10). This peptide has been successfully used
to translocate different biomolecules into distinct cell lines,
for instance, proteins into protoplasts (11), antibodies into
† This work was funded by Grant POCTI/BCI/38631 from FCT,
Portugal, and Grant LSHG-CT-2004-503228 from the European
Commission. We thank FCT, Portugal, for Grant SFRH/BD/14337/
2003 under the program POCTI to S.T.H.
* To whom correspondence should be addressed. Telephone:
+351217500931. Fax: +351217500088. E-mail: castanho@fc.ul.pt.
‡ Faculdade de Cieˆncias da Universidade de Lisboa.
§ Instituto de Tecnologia Quı´mica e Biolo´gica.
1 Abbreviations: CPP, cell-penetrating peptide; NLS, nuclear local-
ization sequence; SV-40, simian virus 40; TAT, CPP derived from
HIV-1 tat; â-Gal, â-galactosidase; LUV, large unilamellar vesicles;
MUG, 4-methylumbelliferyl galactoside; 4-MU, 4-methylumbelliferone;
PMSF, phenylmethanesulfonyl fluoride; phosphine, tris(2-cyanoethyl)-
phosphine; POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine;
POPG, 1-palmitoyl-2-oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)];
DPPC, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine; DPPS, 1,2-di-
palmitoyl-sn-glycero-3-(phospho-L-serine); MEME, Minimum Essential
Medium Eagle; NEAA, nonessential amino acids; FBS, fetal bovine
serum; BSA, bovine serum albumin; PBS, phosphate-buffered saline
solution; TRITC, tetramethylrhodamine â-isothiocyanate; FITC, fluo-
rescein isothiocyanate; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide; TX-100, Triton X-100; DMSO, dimethyl sulfox-
ide; DAPI, 4′,6-diaminidino-2-phenylindole.
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porcine renal epithelial cells (LLC-PK1) (12), and peptides
into rat pheochromocytoma cells (PC-12) (13). The unspeci-
ficity of this peptide is a potential advantage for ubiquitous
applications.
It has been shown that pep-1 translocates across lipidic
vesicles only when a negative transmembrane potential exists
(14). However, it is not known if endocytosis is also involved
in pep-1 translocation in vivo as described for CPPs Tat 48-
60 and (Arg)9 (5, 9). Furthermore, it is necessary to determine
if the translocation of cargo proteins via pep-1 follows a
mechanism identical to that of the free peptide.
In this work, we used â-galactosidase (â-Gal) from
Escherichia coli as the cargo protein. â-Gal is a homo-
tetramere with an enzymatic activity (EC 3.2.1.23) that is
easy to assess and dependent on its quaternary structure (15).
Each subunit contains 1023 amino acid residues (116 kDa),
with 38 Trp residues that enable a characterization by
fluorescence spectroscopy. The formal global charge at pH
7.4 is approximately -38 (the estimated charged is based
on the pKa’s for the isolated amino acids and was determined
using the software available at www.scripps.edu/cdputnam/
protcalc.html).
In this work, we have studied formation of the pep-1-â-
Gal complex and its translocation across membranes. We
have found that â-Gal translocation into LUV and human
HeLa cells depends on the negative transmembrane potential.
Alternative pathways, such as classical and caveolin-mediated
endosomal pathways, or possible pore formation induced by
pep-1, did not account for translocation of â-Gal into the
HeLa cells.
EXPERIMENTAL PROCEDURES
Reagents. Pep-1 (Ac-KETWWETWWTEWSQPKKKRKV-
cysteamine) that was >95% pure was obtained from Gen-
Script Corp. (Piscataway, NJ). â-Gal from E. coli, 4-methyl-
umbelliferyl galactoside (MUG), porcine pancreatic lyo-
philized trypsin, phenylmethanesulfonyl fluoride (PMSF),
cholesterol (chol), Triton X-100 (TX-100), and dextran (Mr
) 10 000) were obtained from Sigma-Aldrich (St. Louis,
MO). Tris(2-cyanoethyl)phosphine (phosphine) and dextran
tetramethylrhodamine â-isothiocyanate (TRITC) conjugate
(Mr ) 10 000) were from Molecular Probes (Eugene, OR).
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC),
1-palmitoyl-2-oleoyl-sn-glycero-3-[phospho-rac-(1-glyc-
erol)] (POPG), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine
(DPPC), and 1,2-dipalmitoyl-sn-glycero-3-(phospho-L-serine)
(DPPS) were from Avanti Polar-Lipids (Alabaster, AL);
Minimum essential medium Eagles with Earle’s salts (MEME),
L-glutamine, nonessential amino acids (NEAA), fetal bovine
serum (FBS), streptomycin and penicillin, and trypsin-EDTA
solution (0.05% trypsin and 0.53 mM EDTAâ4Na) were
obtained from Gibco Invitrogen Corp. (Carlsbad, CA). 4′,6-
Diaminidino-2-phenylindole (DAPI) was from Sigma. The
primary antibodies used were as follows: mouse monoclonal
anti-â-Gal (AB1; 1/500 dilution) from Promega (Madison,
WI), rabbit polyclonal anti-â-Gal (AB2; 1/500) from 5Prime
(Boulder, CO), mouse monoclonal anti-EEA1 (1/100) from
BD Biosciences (Palo Alto, CA), mouse monoclonal anti-
cathepsin D (1/20) from Sigma-Aldrich (St. Louis, MO), and
rabbit polyclonal anti-caveolin-1 (1/50) from Santa Cruz
Biotechnology (Santa Cruz, CA). The secondary antibodies
were goat polyclonal anti-mouse IgG TRITC conjugate
(1/60) and goat polyclonal anti-rabbit IgG fluorescein
isothiocyanate (FITC) conjugate (1/100) obtained from
Sigma-Aldrich.
Photophysics of â-Gal in Aqueous Solution. The experi-
ments in aqueous solution and with LUV were performed
at room temperature with a UV-vis Jasco V-530 spectro-
photometer and a SLM Aminco 8100 spectrofluorometer
(equipped with a 450 W Xe lamp and double monochroma-
tors). The solutions were prepared in 10 mM HEPES buffer
(pH 7.4) containing 150 mM NaCl, at physiologic ionic
strength. Fluorescence intensities were corrected for the inner
filter effect with the equation Ic ) I  100.5A, where Ic is the
corrected intensity, I the measured intensity, and A the
absorbance at the excitation wavelength.
Protein photophysical characterization was carried out by
means of Trp fluorescence emission (ìexcitation ) 280 nm).
Fluorescence emission characterization and determination of
quantum yield (16) were performed. Variation of fluores-
cence emission intensity with concentration (0-269 nM) and
fluorescence quenching by acrylamide (aqueous soluble Trp
quencher) were carried out in the absence and presence of a
reducing agent, 1 mM phosphine. The quenching assay was
performed by titration of â-Gal with acrylamide (0-60 mM)
and followed by fluorescence emission with a ìexcitation of
290 nm (to minimize the relative quencher/fluorophore light
absorption ratio). The Stern-Volmer equation (I0/I ) 1 +
KSV[Q], where I and I0 are the fluorescence intensity in the
presence and absence of quencher, respectively, KSV is the
Stern-Volmer constant, and [Q] is the concentration of
quencher; for a revision, see ref 17) was applied to the data.
Data were corrected for simultaneous absorption of the
fluorophore and quencher (see eq 5 in ref 18).
Enzymatic Assay of â-Gal. Enzyme activity of â-Gal was
determined by hydrolysis of 4-methylumbelliferone
â-D-galactopyranoside (MUG), a nonfluorescent substrate,
to 4-methylumbelliferone (4-MU), a fluorescent product
(ìexcitation ) 360 nm, ìemission ) 440 nm) (19). Time progres-
sion curves were performed (0-60 min); briefly, enzyme
was added to 2.5 mM MUG (substrate at nonlimiting
concentrations), in 10 mM HEPES buffer (pH 7.4), contain-
ing 150 mM NaCl, to start the reaction. The reaction was
stopped by the addition of 0.2 M NaOH-containing buffer
(to a final substrate dilution of 1/40, pH 13.2). The assay
was followed by 4-MU fluorescence intensity. The concen-
tration was determined by A360 [360 ) 1.9  104 M-1 cm-1
(20)].
Formation of the Pep-1-â-Galactosidase Complex. The
titration of 72 nM protein with peptide was performed up to
a pep-1/â-Gal molar ratio of 100. Trp fluorescence emission
spectra were monitored to follow complex formation. The
maximum of the fluorescence emission spectrum of â-Gal
occurs at a wavelength significantly different from that of
pep-1 (329 nm vs 346 nm). The fluorescence emission
spectra of pep-1 in the absence of â-Gal and vice versa were
followed simultaneously, under the same conditions. Enzy-
matic activity of â-Gal and quenching of Trp fluorescence
by acrylamide at different pep-1/â-Gal ratios was followed
as mentioned above.
Interaction of â-Gal and the Pep-1-â-Gal Complex with
Large Unilamellar Vesicles. LUV were prepared, in 10 mM
HEPES buffer (pH 7.4) containing 150 mM NaCl, by the
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extrusion method (21). To evaluate the interaction of 72 nM
â-Gal (free or complexed with pep-1 at different concentra-
tions) with LUV, Trp fluorescence spectral shifts were
followed (ìexcitation ) 280 nm) by titration of samples with
lipidic suspensions (0-3.75 mM). POPC and POPC/POPG
(4/1) bilayers in vesicles are in liquid crystalline phases;
POPC/chol (2/1) bilayers in vesicles are in the liquid-ordered
phase, and DPPC and DPPC/DPPS (4/1) bilayers are in the
gel phase.
Uptake of the Pep-1-â-Gal Complex in LUV with Nega-
tiVe Transmembrane Potential. The pep-1-â-Gal complex
(molar ratio of 320) was incubated (30 min) with POPC/
POPG (4/1) (final lipid concentration of 0.5 mM) LUV in
the absence or presence of negative transmembrane potential
(see ref 14 for a description of production of LUV with a
negative transbilayer potential). Briefly, valinomycin was
added, at a 1/104 molar ratio (moles per mole of lipid), to
K+-loaded LUV dispersed in Na+ buffer. Afterward, a trypsin
solution (final concentration of 1.3 mM) was added, and the
mixture was allowed to digest the nonincorporated pep-1 and
â-Gal, incubated for 30 min at 37 °C. After that, incubation
with 4 mM PMSF (final concentration) was carried out for
15 min to inhibit trypsin. To induce LUV permeabilization
and leakage of the incorporated â-Gal, 0.2% (w/v) TX-100
was added. Released â-Gal was detected by means of its
enzymatic activity, namely, by MUG hydrolysis during 20
min at 37 °C followed by fluorescence spectroscopy, as
described above. Controls without pep-1 were performed,
and the slight contribution from nonincorporated â-Gal
resistant to trypsin hydrolysis was discounted.
Cell Culture and Cell Viability Assays. Adherent human
negroid cervix epitheloid carcinoma cells (HeLa) were grown
in MEME supplemented with 2 mM Glu, 2 mM NEAA, 10%
(v/v) FBS, and 1% (v/v) streptomycin and penicillin, in a
5% CO2 humidified atmosphere at 37 °C. Cells were split
in a 1/4 dilution every 3-4 days, after they reached
confluency, which was monitored using an inverted micro-
scope (Olympus CK30). Cell viability was determined by
the colorimetric assay with 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT). MTT is reduced by
mitochondrial dehydrogenases of viable cells (22). Briefly,
cells were grown in 96-well plates and washed with serum-
free medium; 10 íL of MTT (5 mg/mL) was added to each
well, and a 3 h incubation at 37 °C was performed. The
purple product was solubilized in dimethyl sulfoxide (DMSO),
and the absorbance at 540 nm was determined. Alternatively,
cell viability was determined by the trypan blue exclusion
assay. Briefly, after being detached, the cell suspension was
added to a trypan blue solution (1/10 dilution) and counted
in hemacytometer. Viable cells exclude trypan blue; non-
viable cells absorb the dye and appear blue.
Cellular Uptake of Proteins and Dextran Monitored by
Immunofluorescence Microscopy. For immunofluorescence
microscopy, cells were grown on 12 mm diameter glass
coverslips in 24-well plates to approximately 70% conflu-
ence. Prior to the uptake assays, the pep-1-â-Gal complex
was formed in serum-free medium (23) during 30 min at
room temperature following the instructions of the supplier
(ActiVe Motif; Rixensart) (24). Translocation efficiency was
evaluated with different pep-1/â-Gal ratios (4, 32, 100, 200,
320, 600, and 1000) at 10.8 nM â-Gal. Coverslips were
inverted and placed over a drop of a macromolecular
complex solution (25) and incubated for 60 min at 37 °C.
Cells were washed three times in PBS containing 0.5 mM
MgCl2, fixed in 4% (w/v) paraformaldehyde for 20 min,
permeabilized with 0.1% (w/v) TX-100 for 15 min, and then
incubated in a blocking solution that consisted of PBS
containing 1% bovine serum albumin (BSA) for 1 h (26).
After that, incubations with primary and secondary antibodies
in blocking solution, for 2 and 1 h, respectively, were
performed. Washings were carried out in PBS. Coverslips
were mounted in Airvol and observed in the Leica DMRB
fluorescence microscope and/or in the Bio-Rad MRC1024
confocal microscope. The nucleus was visualized with DAPI
that was added to the secondary antibody mixture at a
dilution of 1/1000. The kinetics of the â-Gal translocation
process was evaluated by incubation at a pep-1/â-Gal ratio
of 320 for 10, 20, 30, 40, 50, 60, and 120 min at 4 or 37 °C.
Enzymatic activity of internalized â-Gal by HeLa cells was
monitored by the use of MUG (see Enzymatic Assay of
â-Gal). After incubation of the complex for 60 min at 4 or
37 °C, trypsin was added to the cells to hydrolyze non-
incorporated peptide and protein. Cells were centrifuged at
500g for 5 min, washed twice in PBS, and resuspended in
0.1% (w/v) TX-100 for 15 min for permeabilization. Then
2 mM substrate was added to cells, and product progression
curves were followed for 120 min at 37 °C. NaOH was
added, and product formation was monitored as described
above. A control without pep-1 was carried out.
The uptake of the anti-mouse IgG-TRITC conjugate
mediated by pep-1 was monitored by immunofluorescence
microscopy under live conditions, without the paraformal-
dehyde fixation step, in a 60 min incubation at 4 or 37 °C,
at a 1/320 protein/pep-1 ratio.
Cells were also incubated with the endocytic tracer
dextran-TRITC at 2 mg/mL associated with pep-1, at 37
and 4 °C for 60 min, in the presence or absence of 20 mg/
mL nonlabeled dextran.
Confocal Microscopy and Colocalization Analysis. For
each picture, laser intensities and amplifier gains were
adjusted to prevent pixel saturation. This was done using
GLOW LUT in the Leica Confocal software. Each fluoro-
phore that was used was excited and detected separately to
avoid any signal crossover. Each picture consisted of a
z-series of 14 images of 1024  1024 pixel resolution with
a pinhole Airy unit. Colocalization analysis was per-
formed using open source Image J version 1.30 (http://
rsb.info.nih.gov/ij/). The procedure was applied for a popula-
tion of 6-10 cells. Quantification of colocalization of â-Gal
(AB1 or AB2) with endosomes (anti-EEA1), lysosomes (anti-
cathepsin D), and caveosomes (anti-caveolin-1) was based
on that previously described (27).
Effect of Transmembrane Potential on the Uptake of the
Pep-1/â-Gal Complex by HeLa Cells. To decrease the
transmembrane potential, cells were incubated, for 30 min
at 37 °C, with the pep-1-â-Gal complex preformed in PBS
buffer, containing different K+ concentrations, with Na+
replaced by K+, at increasing concentrations (28). Quanti-
fication of internalized â-Gal was carried out by using
enzymatic activity. Cell viability in the presence of different
K+ concentrations was determined by the trypan blue
exclusion method. Absolute fluorescence intensity data were
divided by the number of viable cells.
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RESULTS
Formation of the Pep-1-â-Gal Complex in Aqueous
Solution. To investigate the suitability of â-Gal for cellular
uptake studies mediated by pep-1, characterization of the
protein and the complex formed in aqueous solution has been
performed. Each subunit of â-Gal contains 38 Trp, 35 Phe,
and 25 Tyr residues. Fluorescence emission with a ìexcitation
of 280 nm is largely dominated by the Trp residues. Most
hydrophobic residues are not accessible to the aqueous
environment as concluded from the â-Gal crystallographic
structure. In aqueous solution, fluorescence emission has a
quantum yield (…) of 0.099 ( 0.005 (constant up to 269
nM) with a band maximum at 329 nm which was signifi-
cantly different from the maximum of free Trp. This blue-
shifted emission is in agreement with most of the Trp
residues being inaccessible to the aqueous environment. The
low accessibility of Trp residues to the aqueous environment
was confirmed by acrylamide quenching; KSV was signifi-
cantly lower from that obtained for free Trp (5.6 ( 0.3 and
18.9 ( 0.3 M-1, respectively). The initial velocity of MUG
hydrolysis, catalyzed by â-Gal, was 17.5 íM min-1, and
linearity was maintained for 30 min.
Since the cytoplasm is a reducing environment, we have
tested the effect of the reducing agent phosphine (1 mM) on
â-Gal conformation and activity. The quantum yield was
slightly decreased (… ) 0.067 ( 0.007), but the accessibility
of Trp to aqueous solution (KSV by acrylamide is 5.4 ( 0.2
M-1) was not altered. A concomitant slight decrease in the
initial velocity of enzymatic activity occurred (12.0 íM
min-1).
The initial velocity of the enzymatic reaction catalyzed
by â-Gal was maintained up to a peptide/protein molar
ratio of 16. In this range, the peptide strongly interacts
with the protein (see the Supporting Information for experi-
mental results and discussion). The initial velocity de-
creased to 78% (V0 ) 13.4 íM min-1) and 54% (V0 ) 9.4
íM min-1) of the starting value at pep-1/â-Gal ratios of 40
and 400, respectively. In a reducing environment, a more
pronounced decrease was observed: for the 400 complex,
V0 ) 5.8 íM min-1, which corresponded to a reduction of
52% of the enzymatic activity in the absence of pep-1 (12.0
íM min-1).
Transmembrane Potential Is Required for Translocation
of the Pep-1-â-Gal Complex into LUV. No spectral alter-
ations occurred when â-Gal was in the presence of neutral
or negatively charged LUV [POPC, POPC/POPG (4/1),
POPC/chol (2/1), DPPC, and DPPC/DPPS (4/1)] (Table 1).
A slight blue shift in emission spectra was detected for pep-
1-â-Gal complexes (molar ratios of 4, 16, 38, 60, and 400)
in POPC, POPC/POPG (4/1), and POPC/chol (2/1) lipidic
systems (Table 1).
We investigated the uptake of â-Gal mediated by pep-1
into LUV after the induction of an electrostatic gradient
across the membrane by valinomycin. Briefly, after a 30 min
incubation with the complex, hydrolysis of the pep-1-â-
Gal complex outside LUV was achieved with trypsin; then
the activity of â-Gal enclosed in the LUV lumen was
determined after release with TX-100. Product formation
concentration was enhanced by a factor of 5 in the presence
of the negative transmembrane potential (when compared
with the situation without a potential). The fraction of
translocated protein is low, which is expected considering
the total volume of the vesicles in the total bulk solution
(0.016%).
Therefore, these results indicate not only that pep-1
improves the affinity of the protein for the membrane but
also that the presence of a transmembrane potential induces
its translocation across a bilayer.
Pep-1 Does Not Induce Pore Formation in HeLa Cells. It
has been suggested that protein uptake mediated by pep-1
involves pore formation (29), but this is controversial in light
of biophysical studies with lipidic vesicles (14). To test this
hypothesis, we have determined the cell viability by the
trypan blue exclusion method. This method relies on the
inclusion of the dye trypan blue by dead cells once their
plasma membrane is permeable or damaged. If pep-1 would
induce pores on the plasma membrane of cells, a larger
amount of intracellular trypan blue would be observed.
However, this was not the case since viabilities were similar
for control cells (96.4 ( 0.6%) or cells incubated with pep-1
and the pep-1-â-Gal complex (95.5 ( 1.6 and 95.6 ( 0.1%,
respectively). These results indicated that pep-1 did not
induce permeability changes and hence pore formation in
the plasma membrane of HeLa cells.
To evaluate the possible toxic effect of pep-1 on the cells,
we have used an independent cell viability test, the MTT
assay. MTT is a very sensitive way of determining cytotox-
icity. In living cells, mitochondrial dehydrogenase enzymes
oxidize the yellow MTT and convert it into purple formazan
crystals (22). It was observed that the peptide induced a
reduction in cell viability of approximately 22%. Since
viability calculated by the trypan blue assay was not
decreased after addition of pep-1, these results suggested that
pep-1 might inhibit mitochondrial dehydrogenases.
Electrostatic Transmembrane Potential Is a Sine-Quanon
Requirement for Translocation of the Pep-1-â-Gal Complex
into HeLa cells. To monitor the uptake of the pep-1-â-Gal
complex by HeLa cells, increasing pep-1 concentrations and
Table 1: Partition of the Pep-1-â-Gal Complex into LUVa
lipid sample
aqueous
solution
(nm)
3.75 mM
lipid (nm)
shift
(nm)b
POPC â-Gal 329 329 0
pep-1-â-Gal (4/1) 330 325 5
pep-1-â-Gal (16/1) 331 327 4
pep-1-â-Gal (38/1) 336 332 4
pep-1-â-Gal (60/1) 337 332 5
pep-1-â-Gal (400/1) 343 336 7
pep-1 346 338 8
POPC/POPG â-Gal 329 329 0
(4/1) pep-1-â-Gal (4/1) 330 327 3
pep-1-â-Gal (16/1) 332 330 2
pep-1-â-Gal (38/1) 337 333 4
pep-1-â-Gal (60/1) 335 331 4
pep-1 346 338 8
POPC/chol â-Gal 329 329 0
(2/1) pep-1-â-Gal (4/1) 330 325 5
pep-1-â-Gal (16/1) 331 325 3
pep-1-â-Gal (38/1) 335 330 5
pep-1-â-Gal (60/1) 341 336 5
pep-1 346 337 9
a Maximum fluorescence emission of the pep-1-â-Gal complex, at
different ratios, in aqueous solution [10 mM HEPES buffer containing
150 mM NaCl (pH 7.4)] and in the presence of a 3.75 mM lipidic
suspension. b The shift is the difference between the two conditions.
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different incubation times have been tested. After a 60 min
incubation at a pep-1/â-Gal ratio of 320, a significant uptake
of â-Gal has been observed (Figure 1A). â-Gal was found
dispersed in aggregates within the cytosol. The presence of
protein inside the cell and not adsorbed on the cell surface
was confirmed by confocal microscopy. Apparently, the
translocation efficiency did not increase for complex ratios
between 320 and 1000. For lower ratios, between 4 and 200,
uptake of â-Gal did not occur. Therefore, the chosen pep-
1/â-Gal ratio for all the experiments was 320. At this ratio,
there was an excess of soluble pep-1 in solution (see Figure
S1 of the Supporting Information).
Transfection was relatively fast; after 10 min, it was
already possible to identify a small quantity of protein in
some cells. The level of transfection increased until ap-
proximately 40 min; after this time, it seemed to stabilize
(data not shown). Translocation occurred with a similar
efficiency at 4 °C (Figure 1A). To test if â-Gal was active
after translocation, MUG hydrolysis was monitored in cells
incubated at 37 and 4 °C with the complex. It was observed
that â-Gal was indeed active after translocation at both
temperatures (Figure 1B).
For a typical animal cell characterized by dominant
potassium permeability, increasing the external potassium
concentration necessarily reduces the transmembrane poten-
tial due to the decrease in the electrochemical gradient of
K+ across the cell membrane (28, 30). Negative transmem-
brane potential is dominated by potassium potential equi-
librium, which can be estimated by the potassium Nernst
potential (EK): EK ) (RT/F) ln(K0/Ki), where R is the gas
constant, T is the absolute temperature, F is Faraday’s
constant, and K0 and Ki are the extracellular and intracellular
potassium concentrations, respectively. So, increasing the
extracellular K+ concentration leads to less negative Nernst
potentials (Figure 2).
To test if the electrostatic membrane potential would be
required for translocation of the pep-1-â-Gal complex, HeLa
cells have been incubated with the complex at increasing
external K+ concentrations. The total ionic strength ([K+]
+ [Na+] ) 150 mM) was kept constant. The internalized
â-Gal concentration was estimated from enzymatic MUG
hydrolysis. This assay was performed for 30 min to guarantee
that the initial velocity of the reaction was maintained, and
that the concentration of â-Gal uptake was directly related
FIGURE 1: Translocation of â-Gal, mediated by pep-1, into HeLa cells. Panel A shows immunofluorescence microscopy detection of â-Gal.
The pep-1-â-Gal complex (molar ratio of 320) was incubated with HeLa cells, at 37 or 4 °C, for 60 min. Cells were fixed with 4%
paraformaldehyde and permeabilized with 0.1% (w/v) TX-100. â-Gal was detected with rabbit polyclonal anti-â-Gal and the secondary
anti-rabbit antibody coupled to FITC. DAPI was used to identify the nucleus. Internalized â-Gal is in the cytosol. The scale bar is 10 ím.
Panel B shows enzymatic activity of â-Gal internalized in a HeLa cell suspension. â-Gal uptake, after incubation with the pep-1-â-Gal
complex (molar ratio of 320) for 60 min at 4 (9) or 37 °C (0), was followed by the progression curve of enzymatic MUG hydrolysis, at
37 °C. The control without pep-1 was subtracted. The formation of 4-MU monitored by fluorescence intensity at 440 nm with excitation
at 360 nm indicates that â-Gal was efficiently translocated, at both temperatures, in an active form.
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with 4-MU production. A decrease in the absolute value of
the electrochemical K+ gradient (calculated considering Ki
) 140 mM) led to a severe drop in the level of â-Gal uptake
(Figure 2). When K0 ) 114.6 mM, uptake was almost
completely inhibited.
Although for low extracellular K+ concentrations the
contribution of other conductors makes the membrane
potential less negative than that predicted by K+ Nernst
potential (28), the dependence of â-Gal uptake on trans-
membrane K+ Nernst potential was clear.
The Pep-1-â-Gal Complex Is Not Internalized by HeLa
Cells Via the Endosomal Pathways. Other CPPs such as the
one derived from TAT and (Arg)9 (5) seem to translocate
proteins across cells by two different mechanisms: one is
fast and physical in nature and the other is mediated by
endocytosis. In the case of an endosomal-dependent pathway
of â-Gal uptake mediated by pep-1, colocalization with
endosomes or lysosomes at some extension would be
expected. To evaluate this possibility, colocalization of pep-
1-translocated â-Gal with EEA1 (early endosomal marker),
caveolin-1 (caveosomes marker), and cathepsin D (lysosomal
marker) was performed. Monitoring localization of the
protein, instead of a fluorescence-labeled pep-1, is a better
choice. It prevents problems associated with the apparent
uptake of cationic peptides bound to negatively charged
membranes, causing an artifactual localization in cells (5)
and the possible influence of the fluorescent label in the
uptake and intracellular localization of the peptide (31). The
percentages of colocalization with each of the organelles from
the endocytic pathway determined after immunofluorescence
confocal microscopy were very low (shown on the right in
Figure 3), after incubation for 60 or 120 min. Similar results
were obtained at 4 °C. These results indicate that the uptake
of â-Gal did not involve the endocytic pathway.
It has been suggested that fixation conditions could lead
to an artifactual uptake of cationic peptides associated with
the cell membrane at 4 °C (5, 9, 32). The uptake of a protein
FIGURE 2: Variation of uptake of â-Gal into a HeLa cell suspension,
mediated by pep-1, with potassium Nernst potential. The pep-1-
â-Gal complex (molar ratio of 320) was incubated with HeLa cells,
for 30 min at 37 °C, in the presence of increasing external K+
concentrations, and a constant ionic strength ([K+] + [Na+] ) 150
mM). The relative level of â-Gal uptake was determined from â-Gal
enzymatic hydrolysis of MUG for 20 min at 37 °C. The potassium
Nernst potential was determined considering an internal K+
concentration of 140 mM; the external K+ concentration ranged
from 5 to 114.6 mM, which corresponded to a range from -89 to
-5.4 mV, respectively (see the equation in the text). An increasing
external K+ concentration severely reduces the level of â-Gal
uptake.
FIGURE 3: Immunofluorescence microscopy localization of pep-1-translocated â-Gal, EEA1, caveolin-1, and cathepsin D from HeLa cells.
Cells were incubated with the pep-1-â-Gal complex (molar ratio of 320) for 60 min. Cells were fixed with 4% paraformaldehyde and
permeabilized with 0.1% (w/v) TX-100. â-Gal, detected with rabbit polyclonal or mouse monoclonal antibodies, was colocalized with early
endosomal EEA1, caviosomal caveolin-1, and lysosomal cathepsin D. Secondary antibodies were the anti-rabbit antibody coupled to FITC
and the anti-mouse antibody coupled to TRITC. Pictures of a z-series of 14 images from the confocal microscope were analyzed with
Image J version 1.3 to perform colocalization analysis. Six to 10 cells were observed. The scale bar is 10 ím.
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covalently marked with a fluorescent probe can be visualized
by fluorescence microscopy without the need to fixate or
permeabilize the cells. The uptake of anti-mouse TRITC at
4 and 37 °C was performed and visualized by immuno-
fluorescence microscopy without fixation (Figure 4). It was
possible to identify the presence of protein inside the cell at
FIGURE 4: Uptake into HeLa cells of anti-mouse antibody conjugated with TRITC, mediated by pep-1. Incubation of cells with a pep-1-
anti-mouse-TRITC complex was performed for 60 min at 4 or 37 °C. Cells were visualized under live conditions in a fluorescence microscope.
The scale bar is 10 ím.
FIGURE 5: Immunofluorescence microscopy localization of translocated â-Gal and the dextran-TRITC marker in HeLa cells (incubation
for 60 min at 37 or 4 °C). Panel A shows incubation with the pep-1-â-Gal complex (molar ratio of 320) where the endocytic dextran-
TRITC marker (2 mg/mL) was added to the complex at the time of cell incubation. Panel B shows incubation with the preformed pep-
1-â-Gal-dextran-TRITC complex. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% (w/v) TX-100. â-Gal was
detected with rabbit polyclonal anti-â-Gal and anti-rabbit antibodies coupled to FITC. Pictures of a z-series of 14 images from the confocal
microscope were analyzed with Image J version 1.3 and were used to perform colocalization analysis. Six to 10 cells were used. The scale
bar is 10 ím.
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both temperatures. This indicated that internalized protein
was not an artifact associated with fixation.
The Polysaccharide Dextran Is Translocated into HeLa
Cells by Pep-1. Uptake of the dextran-TRITC complex by
HeLa cells occurs by a classical endosomal pathway. At
37 °C, â-Gal did not colocalize with the dextran-TRITC
marker (1.0%) (Figure 5A), supporting the idea that â-Gal
would be translocated into the cells by a mechanism
independent of the endocytic pathway. However, at 4 °C,
there was an extensive colocalization between â-Gal and the
dextran-TRITC marker (51.3%) (Figure 5A). At 4 °C, the
classical endosomal pathway is inhibited, so the endocytic
dextran-TRITC marker did not enter the cells via this
pathway (see control in Figure 6, left image). The internal-
ization of the dextran-TRITC marker at 4 °C and its
colocalization with â-Gal suggested that the uptake of
translocation of the polysaccharide was mediated by pep-1.
However, if the dextran-TRITC marker was preincubated
together with pep-1 and â-Gal, a ternary complex seems to
be formed and â-Gal-dextran-TRITC colocalization oc-
curred, even at 37 °C (Figure 5B).
To confirm that pep-1 was translocating the dextran-
TRITC marker via the polysaccharide without inter-
ference of artifacts from the fluorophore moiety, the HeLa
cells were incubated with pep-1-dextran-TRITC complex,
at 4 °C, in the presence of nonlabeled dextran (Figure 6). It
was observed that the presence of nonlabeled dextran
dramatically reduced the amount of dextran-TRITC marker
translocated into the cells, showing competition between
nonlabeled dextran and the dextran-TRITC marker. This
confirmed that pep-1 mediated the transport of the polysac-
charide into HeLa cells without any artifactual interference
of TRITC.
DISCUSSION
â-Gal from E. coli was chosen for the study of the
interaction of pep-1 with a protein and evaluation of the
translocation efficiency inside human tumoral cells. Its
enzymatic activity is easy to access. Trp residues enable
fluorescence spectroscopy techniques to be used as analytical
tools. The absence of a signal sequence makes the protein
unable to address any specific organelle inside the cell;
therefore, this molecule is very useful in evaluating if the
pep-1-mediated translocation leads protein to a specific
organelle in human cells. HeLa cells are derived from a
human cervix epitheloid carcinoma; they are relatively large
(approximately 20 ím) and particularly suitable for organelle
visualization by immunofluorescence studies. Therefore, they
were chosen as the cellular model system.
â-Gal characterization in aqueous solution and in the
presence of LUV revealed that Trp residues are protected
from interaction with aqueous solution and no significant
interaction with membranes was observed. Enzymatic assays
revealed that â-Gal maintains its quaternary structure, which
is required for enzymatic activity (15) in aqueous solution,
under reducing and nonreducing conditions. These results
showed that the reducing environment did not modify the
â-Gal conformation, so maintenance of enzyme activity
inside the cell was expected.
Fluorescence quenching upon the titration of the protein
with pep-1 suggests the existence of an excess of pep-1 in
solution not interacting with the protein above peptide/protein
molar ratios of 60 (data and detailed discussion in the
Supporting Information). Enzymatic activity is still detected
in the pep-1-â-Gal complex (a molar ratio of up to 400),
which eliminates the severe perturbation of â-Gal structure
due to pep-1.
FIGURE 6: Uptake of the dextran-TRITC marker, mediated by pep-1, into HeLa cells. Comparison of dextran-TRITC (2 mg/mL) uptake,
mediated by pep-1, at 4 °C for 60 min when the dextran-TRITC-pep-1 complex was preformed in the presence or absence of dextran (20
mg/mL). Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% (w/v) TX-100. The dextran-TRITC marker at 4 °C
was detected only when pep-1 was present. In the presence of dextran (nonconjugated), the rate of uptake of the dextran-TRITC marker
is decreased, indicating a competition of pep-1 for nonconjugated dextran. The scale bar is 10 ím.
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The wavelength of maximal fluorescence emission inten-
sity of pep-1 in lipidic membranes systems is higher than
that observed for the complex (see Table 1). The blue shift
observed for pep-1-â-Gal complexes relative to that of pep-1
alone together with its dependence on the peptide/protein
molar ratio showed that pep-1 is mediating the partitioning
of â-Gal into lipidic membranes.
Pep-1 translocation in LUV was previously found to be
dependent on the transmembrane potential across bilayers
(14). In fact, in this work, the same was concluded for the
translocation of â-Gal mediated by pep-1 in LUV. These
results suggested a common translocation mechanism for free
and complexed pep-1. This property has been shown
previously for other free peptides (28, 33) but is here
presented for the first time for a CPP-cargo protein complex,
to the best of our knowledge.
â-Gal from E. coli was efficiently transported by pep-1
into HeLa cells, maintaining its enzymatic activity. The
translocation of protein is dependent on peptide concentra-
tion; at a pep-1/â-Gal molar ratio of up to 200, translocation
was not detected. With a pep-1/â-Gal ratio of 320, the
process is very efficient. At this ratio, there is free pep-1 in
solution (see Figure S1 of the Supporting Information), which
seems to play a role in the translocation process. An excess
of pep-1 is probably necessary for membrane destabilization
(14), facilitating the uptake of the protein. If the translocation
was mediated by pore formation, a very large pore (104
Å  140 Å, estimated from the â-Gal crystallographic
structure) would be necessary for a protein as large as â-Gal
(116 kDa) to pass across the bilayer. A pore with such a
diameter would probably induce leakage of the cellular
contents at some extension, compromising cellular viability.
Cell viability was maintained in the presence of pep-1 and
the complex, and pore formation was not detected. This is
in agreement with the study of interaction of pep-1 with LUV
(see ref 14), where pep-1 translocation occurred without pore
formation.
The high velocity of the translocation mechanism (10 min
was enough to detect protein inside the cell) and the
independence of temperature (see Figure 1A,B) suggested a
physical mechanism not dependent on complex cellular
biochemical processes. This hypothesis was confirmed by
the correlation found between cell depolarization and â-Gal
translocation. Destroying the potassium electrochemical
gradient drastically reduced the level of â-Gal uptake in HeLa
cells (see Figure 2). These results are in agreement with those
obtained with LUV. Therefore, in vivo the membrane charge
asymmetry (34, 35) and the combined effect of membrane
potentials (36) seemed to be the driving forces responsible
for the translocation process.
Inside the cell, the protein was found in the cytosol and
did not colocalize with endosomes, lysosomes, or caveo-
somes (see Figure 3). These results were consistent with a
translocation process independent of the classical endosomal
pathways or caveolin-mediated endosomal pathways. In the
case of endocytosis being a secondary mechanism for uptake,
at least a small colocalization with one of these organelles
would be expected. Monitoring localization of the protein,
instead of pep-1, prevents problems associated with the
apparent uptake of cationic peptides bound to negatively
charged membranes, causing an artifactual localization in
cells (5). Lebleu and co-workers found that TAT and
oligoarginine uptake was dependent on endocytosis (5), but
Norde´n and co-workers (9) have proven that for arginine-
rich peptides both nonendocytic and endocytic uptake
pathways were involved in their cellular internalization. This
nonendocytic mechanism was fast and biologically relevant
(9). An endocytic pathway was not detected for pep-1, but
a physical transmembrane crossing mechanism was.
A translocation mechanism independent of endocytosis
was further confirmed under nonfixation conditions with anti-
mouse TRITC where protein uptake at 4 °C has been
observed (see Figure 4).
The transport of the dextran-TRITC marker mediated by
pep-1 under conditions where the endocytosis was inhibited
was also demonstrated (see Figures 5 and 6). It has been
suggested by Morris et al. (10) that pep-1 interacts with
macromolecules via hydrophobic interactions. Given the
hydrophilic nature of the molecule, the capacity of pep-1 to
translocate dextran demonstrated that hydrophobic pockets
are not essential for complex formation and uptake. Complex
formation of pep-1 and dextran is probably due to polar
interactions and hydrogen bonding.
In conclusion, the interaction of pep-1 with â-Gal from
E. coli was extensively studied to gain insight into the
translocation mechanism at the molecular level. It has been
demonstrated that pep-1 can establish a variety of electro-
static and/or hydrophobic and/or hydrophilic interactions with
the cargo. The existence of a negative transmembrane
potential promotes uptake of â-Gal, mediated by pep-1, in
vitro and in vivo, and the absence of a transmembrane
potential inhibits it. The charge asymmetry (negative inside)
seems to be the driving force for translocation to occur. There
was no evidence found for the involvement of the endocytic
pathway in the uptake of cargo mediated by pep-1. Further-
more, pep-1 did not induce the formation of pores in the
membrane. These results together suggested that the peptide
and the cargo translocate only by a physical process.
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SUPPORTING INFORMATION 
 
As expected titration of β-Gal with pep-1 led to a progressive red-shift in the 
emission spectra (Figure S1A) until the pep-1 maximum emission wavelength (346 nm) 
was achieved. Fluorescence spectrum for each pep-1:β-Gal ratio has the contribution of 
β-Gal and pep-1 in free and complexed form. The occurrence of the fluorescence 
emission spectral peak at 346 nm for the 100 pep-1:β-Gal ratio suggests an excess of 
free pep-1 in this condition. The result of integrated fluorescence intensity of the 
complex at different pep-1:β-Gal ratios are presented in Figure S1B. Curve 1 represents 
the fluorescence intensity variation of the complex, where three regimes were detected: 
I) up to 14 molar ratio there was a slight decrease in intensity; II) from 14 to 60 ratio 
there was a small increase in intensity and III) from 60 up, the slope increased. This 
curve was compared with the summed fluorescence intensities from free peptide and 
free protein (curve 2 in Figure S1B). Fluorescence quenching occurs in the first regime; 
in the second regime the fluorescence quenching was less pronounced, and in the third 
regime quenching was barely noticeable. This last regime corresponds to peptide-
saturated protein. From peptide:protein molar ratios of 60 and up peptide added to 
solution will remain free (unbound to the protein). In reducing environment the results 
were similar but the second regime did not vanish in the pep-1:β-Gal ratio experimental 
range (<100). 
A hypothesis to explain the results at molecular level is that in the first regime 
electrostatic interaction between pep-1 and β-Gal take place for charge neutralization 
(β-Gal has -38 charge and pep-1 +3; a peptide/protein ratio of 13 is required for 
neutralization). These interactions are strong enough to induce a decrease in 
fluorescence intensity relative to the summed individual contributions pep-1 and β-Gal. 
In the second regime weaker interactions are occurring (quenching is diminished); 
considering the amphipathic-like nature of pep-1, hydrophobic interactions between 
pep-1 and β-Gal can be speculated. Pep-1 in free form appears to be dominant after a 60 
ratio. Inexistence of a third slope in reducing environment up to a ratio of 100 suggests 
an increase of peptide affinity to β-Gal. 
Pep-1 and mammalian cells  Chapter 4. 
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FIGURE S1: Pep-1/β-Gal complex formation by β-Gal titration with pep-1. Panel A shows some of the 
fluorescence emission spectra obtained at constant protein concentration (72 nM) with excitation at 280 
nm. There is a change in the integrated intensity besides spectral shifting. Panel B shows the dependence 
of the integrated emission intensity on Pep-1:β-Gal molar ratio (curve 1). When the complex integrated 
intensity is divided by the sum of the isolated contributions of free β-Gal and free pep-1 (curve 2), it is 
possible to identify three different regimes having different slopes. I) up to 14 molar ratio quenching of 
fluorescence exists (direct or indirect consequence of electrostatic interaction between pep-1 and protein); 
II) from 14 to 60 molar ratio quenching of protein by pep-1 still exists but is less pronounced 
(hydrophobic interactions between pep-1 and β-Gal are probably dominant in this regime); III) β-Gal 
fluorescence intensity has a slightly increase (suggesting that there are no more pep-1-protein 
interactions). 
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4.2.2. Re-evaluating the role of strongly charged sequences in 
amphipathic cell-penetrating peptides. A fluorescence study using pep-1.  
 
4.2.2.1. Motivation and methodologies 
In the previous paper [230] we have tracked the internalization of the cargo (β-
Gal) mediated by pep-1. The cargo was followed instead of the CPP to avoid possible 
artefacts associated with high affinity of peptides for membranes which may remain 
attached to cells and an apparent localization in the cell could result therefrom [55, 56]. 
The experimental work presented in the previous paper [230] was important to confirm 
the ability of pep-1 to introduce large proteins inside the cell and to gain information 
about the translocation mechanism. Besides the translocation mechanism, we decided to 
gain insight on the pep-1 route after internalization. A modified pep-1 with a fluorescent 
probe attached to the hydrophilic domain was used.  
CPPs internalization into cellular lines has been followed by means of several 
methodologies through the literature. Fluorescent labels are commonly used to 
investigate the mechanisms of cellular uptake and intracellular distribution of CPPs [15, 
27, 31, 32, 54, 58-61, 65-67, 70, 73, 75, 78, 79, 105, 168, 231-255]. Fluorescein is the 
most frequent probe attached to CPPs [15, 27, 31, 58, 60, 61, 65, 73, 75, 79, 231, 232, 
234, 235, 237, 238, 241, 243-245, 250], however Lucifer yellow [105], Rhodamine [32, 
54, 59, 66, 242], Texas red [67, 233], NBD [59, 78, 239] or Alexa fluor [63, 251] are 
other possibilities. Alternatively CPPs can be biotynilated and detected by avidin or 
streptavidine [63, 252] or detected by a specific antibody [256]. Microscopy [32, 61, 65-
67, 241, 242, 254, 257], flow cytometry [67, 237, 245, 257, 258] or spectrofluorimetry 
[59, 78] are techniques that can be employed for CPP internalization detection.  
 To follow the pep-1 uptake into cultured cells the probe carboxyfluorescein (CF) 
was used. CF was linked to the hydrophilic domain by an extra Lys residue and the C 
terminal was blocked with a Ser instead of Cysteamine to avoid steric constraints. The 
final hydrophobic domain sequence was: KKRKVK(CF)-S.  
Fluorescein, as other labels are relatively large and lipophilic, and may 
significantly modify physicochemical properties of CPPs [259]. A careful evaluation of 
the possible effect of this fluorescent label attached to pep-1 was carried on.  
The characterization of the interaction of pep-1-CF with model membranes was 
followed by Trp fluorescence, as previously explained (see chapter 2 and reference 
Pep-1 and mammalian cells  Chapter 4. 
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[153]), and by CF fluorescence. Partition and in-depth location of peptide in lipidic 
membranes was studied and compared with results obtained for unlabelled pep-1.  
Alterations on membrane polarization were evaluated by the use of lipophilic 
probes DiSBAC2(3). This dye belongs to the family of bis-barbituric acid oxonols, also 
referred to as DiBAC dyes, or as “bis-oxonol”, which have an excitation maximum 
close to 490nm [260]. When it moves from a polar environment to a non-polar 
environment, like lipidic membranes, its fluorescence quantum-yield is markedly 
increased. Upon membrane depolarization the uptake the dye by the membrane 
increases and the overall fluorescence intensity also increases. When the membrane is 
hyperpolarized, partition to the membrane decreases and also does fluorescence 
intensity [261]. DiSBAC2(3) has affinity for liposomes, in the presence of peptide one 
can evaluate if the membrane is becoming more or less polarized. 
 
The possibility of peptide translocation across mammalian cells was evaluated in 
the presence/absence of β-Gal by fluorescence microscopy using the same methodology 
previously referred (see section 4.2.1.3 and reference [230]), however it was verified 
that pep-1-CF fluorescence intensity was not strong enough to be followed by 
microscopy. To overcome this limitation a fluorescence plate reader was used instead, 
taking advantages on trypan blue (TB) quencher properties [262-265]. TB diffuses 
rapidly into non-viable cells [266], however is unable to enter into viable cells [267], 
consequently TB will quench non-specific background fluorescence and also the 
fraction of peptide adsorbed at cell surface and non-internalized pep-1CF [262]. With 
this approach it is possible to follow internalization at several incubation times in non-
fixation conditions; briefly, TB is added after cell incubation and CF fluorescence is 
followed in the plate reader.   
  
Methodologies and results obtained are explained in more details in the short 
communication: Re-evaluating the role of strongly charged sequences in amphipathic 
cell-penetrating peptides. A fluorescence study using pep-1. 
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Abstract Cell-penetrating peptides (CPPs) are able to translo-
cate across biological membranes and deliver bioactive proteins.
Cellular uptake and intracellular distribution of CPPs is com-
monly evaluated with ﬂuorescent labels, which can alter peptide
properties. The eﬀect of carboxyﬂuorescein label in the Lys-rich
domain of the amphipathic CPP pep-1, was evaluated and com-
pared with non-labelled pep-1 in vitro and in vivo. A reduced
membrane aﬃnity and an endosomal-dependent translocation
mechanism, at variance with non-labelled pep-1, were detected.
Therefore, the charged domain is not a mere enabler of peptide
adsorption but has a crucial role in the translocation pathway
of non-labelled pep-1.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: Cell-penetrating peptide; Drug delivery;
Translocation mechanism; Transmembrane potential
1. Introduction
The discovery of various basic peptides (9–33 amino acid
residues) with ability to translocate across cell membranes
has attracted much interest in biomedical research [1]. These
peptides, known as cell-penetrating peptides (CPPs), have been
successfully used to deliver biopharmaceutical macromolecules
in vivo. The use of such delivery systems is of great interest to
evade the poor cellular access and bioavailability of drugs [2].
The translocation mechanism used by this group of carriers
has been extensively studied in the last 10 years, but the results
are frequently contradictory and disperse. A single general
mechanism for all does not seem reasonable and more than
one mechanism for a unique peptide is a possibility [3,4]. To
evaluate the cellular uptake and intracellular distribution of
CPP, ﬂuorescent labels are commonly used. However, when
these labels are large and lipophilic they may alter physico-
chemical properties and the cellular distribution of the peptide
[5].
Pep-1 (Ac-KETWWETWWTEWSQPKKKRKV-cystea-
mine) is a synthetic peptide carrier forming physical assemblies
with a great variety of proteins and other macromolecules,
which have been successfully translocated in diﬀerent cell lines
[6–10]. It has been shown that pep-1 translocates across mem-
branes by a physical process mediated by transmembrane po-
tential, both in vitro and in vivo, in free form [11] or when
complexed with a protein, with no evidence for an alternative
mechanism [7]. Because the translocation is solely physically
mediated, the hydrophobicity and charge distribution of the
peptide and its interaction with membranes is of ﬁrst impor-
tance. The amphipathicity of the carrier is probably responsi-
ble by the strong interaction with the lipidic membranes [12].
Unlike other cationic CPPs (e.g., penetratin) [13] pep-1 has a
high aﬃnity for neutral vesicles and for membranes in gel-like
phase. The presence of cysteamine group in C terminal seems
to play a crucial role in the delivery eﬃciency of cargoes into
cells [12].
In the present paper, the study of a modiﬁed peptide with a
carboxyﬂuorescein probe (pep-1CF) is compared with pep-1.
In this peptide, the hydrophilic domain (KKKRKV-cyste-
amine) has been customized to accommodate the label. An ex-
tra Lys was introduced to link the probe and C terminal is
blocked with a Ser instead of cysteamine to avoid steric con-
straints (KKRKVK(CF)-S). The eﬀect of the alteration intro-
duced in this hydrophilic domain in the translocation
mechanism is presented, using both the Trp residues and CF
moiety as reporters of the so-called hydrophobic and hydro-
philic domains, respectively.
2. Materials and methods
Pep-1 and Pep-1CF with purity >95% were obtained from
GenScript Corporation, New Jersey. b-Galactosidase from Esche-
richia coli (b-Gal), 4-methylumbelliferyl-galactoside (MUG), Triton
X-100 (TX-100) and trypan blue (TB) were obtained from Sigma–
Aldrich, MO. 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol))
(POPG), were from Avanti Polar-Lipids, Alabama. 5-Doxyl-stearic
acid (5DS) and 16-doxyl-stearic acid (16DS) from Aldrich Chem
Co., WI. Minimum essential medium Eagles with Earles salts
(MEME) and supplements were obtained from Gibco Invitrogen
Corporation, CA.
Abbreviations: CPP, cell-penetrating peptide; CF, carboxyﬂuorescein;
b-Gal, b-galactosidase; MUG, 4-methylumbelliferyl-galactoside; TX-
100, Triton X-100; TB, trypan blue; POPC, 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine; POPG, 1-palmitoyl-2-oleoyl-sn-glycero-3-
(phospho-rac-(1-glycerol)); 5DS, 5-doxyl-stearic acid; 16DS, 16-doxyl-
stearic acid; MEME, minimum essential medium Eagles; LUVs, large
unilamellar vesicles; 4-MU, 4-methylumbelliferone
*Corresponding author. Fax: +351217500088.
E-mail address: castanho@fc.ul.pt (M.A.R.B. Castanho).
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2.1. Characterization of pep-1CF in aqueous solution
Pep-1CF solutions were prepared in HEPES buﬀer (10 mM HEPES,
pH 7.4 containing 10 mM (low ionic strength) or 150 mM NaCl (the
so-called physiologic ionic strength)). The assays were performed at
room temperature in a UV–Vis spectrophometer Jasco V-560 and in
a spectroﬂuorometer SLM Aminco 8100. Fluorescence intensity values
were corrected for inner ﬁlter eﬀect [14].
The absorption and ﬂuorescence emission characteristics of the
hydrophobic domain (by means of Trp ﬂuorescence; kexc = 280 nm,
kem = 350 nm) and of the hydrophilic domain (by CF group;
kexc = 490 nm, kem = 520 nm), were studied. Quantum yield-depen-
dence on peptide concentration (0–18 lM) and ionic strength (by
means of NaCl concentration variation) were also evaluated. Fluores-
cence quenching of Trp residues by acrylamide was carried out using
kexc = 290 nm to minimize the relative quencher/ﬂuorophore light
absorption ratio. Quenching data were corrected as described in [12].
2.2. Interaction of pep-1CF with model membranes
Large unilamellar vesicles (LUVs), with typical 100 nm diameter
were prepared by the extrusion method described elsewhere [15] and
used as model of biological membranes. Liquid-crystal phase vesicles
composed by POPC or POPC:POPG (4:1 molar) were used to model
the outer leaﬂet (neutral) and the inner leaﬂet (negatively charged) of
mammals biological membranes [16]. The extent and kinetics of parti-
tion and the in-depth location of pep-1CF were evaluated using the
same procedure as for pep-1 [12]. Both hydrophobic and hydrophilic
domains were studied.
The DiSBAC2(3) dye is a probe with a higher aﬃnity for depolarized
than polarized membranes and its apparent quantum yield being
dependent on the extent of interaction with membranes [17]. These
ﬂuorescence properties were used to evaluate alterations in transmem-
brane potential of model membranes upon addition of pep-1CF. Ves-
icles in the absence and presence of a negative transmembrane
potential were prepared as described in [11]; DiSBAC2(3) was added
to lipidic suspension to a ﬁnal concentration of 0.25 mM and ﬂuores-
cence emission intensity (kexc = 540 nm, kem = 558 nm) was followed
during titration of lipidic suspension with pep-1CF (576 lM stock
solution) or non-labelled pep-1 (688 lM stock solution).
2.3. Translocation studies of pep-1CF in HeLa cells
Adherent human negroid cervix epitheloid carcinoma cells (HeLa)
were grown in MEME supplemented with 2 mM L-Glu, 2 mM non-
essential aminoacids, 10% (v/v) fetal bovine serum and 1% (v/v)
streptomycin and penicillin, in a 5% CO2 humidiﬁed atmosphere
at 37 C. Cell viability was determined by the TB exclusion assay,
see [7].
The translocation of pep-1CF and it capacity to mediate the uptake
of b-Gal were followed in non-ﬁxation conditions. Cells with 90% con-
ﬂuence, seeded in 96-well plates, were incubated with 40 lL of 3.5 lM
pep-1CF, (in free or complexed form with b-Gal (peptide/protein ratio
of 320), prepared in free-serum medium), in sixplicates, during 0, 30,
60, 90, 120, 150, 180, 210 and 240 min at 4 or 37 C.
The quencher properties of TB and it inability to enter in viable cells
[18] were used to evaluate the pep-1CF translocation. This hydrophilic
molecule is able to quench non-internalized particles, including the
fraction adsorbed to the cell membrane, but is inaccessible to internal-
ized fraction [19], so removal of extracellular peptide is needless. The
pep-1CF ﬂuorescence was followed, before and after addition of TB
(1.9 lL of stock solution, 0.4% w/v), with excitation and emission ﬁl-
ters at 485/20 (centre/width) and 590/35 nm, respectively, in a FL500
microplate ﬂuorescence reader. To evaluate the eﬀect of protein in
the extension of peptide internalization, the same procedure was fol-
lowed with pep-1CF complexed.
Delivery eﬃciency of b-Gal mediated by pep-1CF was evaluated by
it enzymatic activity using a non-ﬂuorescent substrate (MUG) which is
converted in a ﬂuorescent product (4-methylumbelliferone, 4-MU), see
[7] for a detailed description. Brieﬂy, after incubation with pep-1CF/b-
Gal complex (see above), cells were washed three times with phosphate
buﬀer saline solution to eliminate non-incorporated protein and pep-
tide. Internalized b-Gal was accessed after cell permeabilization with
0.1% (w/v) TX-100. Substrate (0.1 mM MUG) was added to the cells
and incubated with the enzyme during 30 min at 37 C. NaOH was
added to stop the reaction (pH  12) and product formation (4-MU)
was monitored with excitation and emission ﬁlters at 360/40 and
460/40 nm, respectively. The same procedure was performed with
non-labelled peptide. Controls without pep-1 or pep-1CF were carried
out.
The eﬀect of peptide in the protein was determined by comparing it
enzymatic activity in free and complexed forms (with non-labelled pep-
1 or pep-1CF) in vitro (see [7]).
3. Results and discussion
3.1. Pep-1CF aggregates in aqueous solution
Similarly to non-labelled pep-1 [12], Trp residues in the
hydrophobic domain of pep-1CF, have a red-edge excitation
shift and an eﬃcient ﬂuorescence quenching by acrylamide
(51.8 ± 12 and 42.1 ± 9.1 M1 for low and physiologic ionic
strength, respectively) with a negative deviation from linearity.
These results indicate that the peptide aggregates in solution
(see [12]). Nevertheless, the quantum yield and steady-state
anisotropy of the CF group in hydrophilic domain is not
dependent on concentration, for both ionic strengths (10 and
150 mM), which suggests that internal organization of the pep-
tide is not aﬀected by these factors.
3.2. Partition and in-depth location of pep-1CF in model
membranes
Aﬃnity of hydrophobic and hydrophilic domains for lipidic
membranes was evaluated by titration of an aqueous suspen-
sion of the pep-1CF (5.76 lM) with lipidic vesicles; both Trp
and CF ﬂuorescence emission were monitored. Spectral altera-
tions on ﬂuorescence emission and anisotropy (r = 0.05) were
not detected, either for POPC or POPC:POPG (4:1) LUVs.
These results suggest that the hydrophilic domain does not
strongly interact with model membranes. When Trp residues
were followed, the addition of lipidic suspension led to both
blue-shifted emission spectra (Fig. 1A) and an increase in the
ﬂuorophore quantum yield (Fig. 1B). The partition coeﬃcients
(determined by ﬂuorescence emission intensity as in [12]) are
(4.2 ± 0.8) · l02 for POPC and (1.7 ± 0.2) · l03 for POPC:-
POPG (4:1) at physiologic ionic strength. These values are sig-
niﬁcantly smaller than the ones obtained for non-labelled pep-1
((3.4 ± 0.6) · l03 and (2.8 ± 0.4) · l04 [12]), which indicates a
decrease in membrane aﬃnity even for the hydrophobic do-
main. Concomitantly, partition rates decrease (t1/2 = 197 ms
in POPC and 147 ms in POPC:POPG (4:1) for pep-1CF in com-
parison with 120 and 34 ms, respectively, for unlabelled pep-1).
An extensive ﬂuorescence emission quenching of Trp resi-
dues by acrylamide, in the presence of lipidic membranes, is
indicative of signiﬁcant amounts of peptide non-inserted in
the membrane, at discrepancy with pep-1 in the same condi-
tions where no signiﬁcant acrylamide quenching was detected
[12].
In-depth location of the hydrophobic domain of pep-1CF
was carried out by means of ﬂuorescence quenching of Trp res-
idues with doxyl-derivatized stearic acids. The quenching is
more eﬃcient when the quencher is closer to the Trp residues.
Therefore, 5DS probes the bilayer interface while 16DS probes
its core [20]. Quenching by 5DS is more eﬃcient than by 16DS,
this is true for POPC (KSV,5DS = 16.1 ± 3.8 M
1, KSV,16DS =
5.2 ± 0.9 M1) and POPC:POPG (4:1) (KSV,5DS = 15.3 ±
3.5 M1, KSV,16DS = 4.9 ± 1.0 M
1). This is evidence for a
position of the hydrophobic region at the membrane interface
in both lipidic systems studied. The same conclusion was ob-
tained in the study of non-labelled pep-1 [12].
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Quenching of CF group by 5DS and 16DS was negligible,
supporting the hypothesis that the hydrophilic domain does
not insert in the membrane.
3.3. Translocation of pep-1 and pep-1CF in LUVs is dependent
on transmembrane potential
To evaluate pep-1CF translocation in model membranes, the
ﬂuorescence of DiSBAC2(3) was followed. The quantum yield
of the probe increases with depolarization of membranes.
Titration of POPC LUVs (in absence (1) or presence (2) of
transmembrane potential) with pep-1CF is presented in
Fig. 2. The variation of probe ﬂuorescence emission diﬀers
for the two situations (with/without potential). When trans-
membrane potential exists the addition of pep-1CF induces
an increase in ﬂuorescence intensity, so membrane is depolar-
ized. In the absence of a transmembrane potential a decrease
quantum yield was detected, which indicates a polarization
of membrane.
These results suggest that in the absence of transmembrane
potential the peptide accumulates in the outer leaﬂet of mem-
brane, without translocation. The positive global charge of
pep-1CF is responsible by membrane polarization.
In the presence of a transmembrane potential (negative
inside) pep-1CF is able to translocate across membrane, reduc-
ing the negative transmembrane potential, with an increase in
quantum yield of DiSBAC2(3).
Similar results were obtained with non-labelled pep-1 using
this (Fig. 2, curve (3)) and other methodologies [11], but the
eﬀect of a negative transmembrane potential is more pro-
nounced, which suggest that pep-1 has a more eﬃcient translo-
cation than pep-1CF. This is expected considering the lower
aﬃnity of pep-1CF for phospholipids membranes.
3.4. Translocation kinetic of pep-1CF and pep-1CF/b-Gal in
HeLa cells
Translocation of pep-1CF in HeLa cells was evaluated at 4
and 37 C (Fig. 3) by the use of TB quenching properties. Its
capacity to interact with the CF dye and to quench its ﬂuores-
cence emission was used to distinguish internalized from sur-
face-bound pep-1CF [18]. The quenching extent is decreased
when the peptide translocates across cell membranes and
become inaccessible to the quencher.
At 37 C, we observed ﬂuorescence recovery up to 240 min
incubation at variance with results at 4 C where the ﬂuores-
cence intensity remained unchanged during the same time
(Fig. 3A). This suggest that translocation of pep-1CF occurs
via endocytosis. Recently, it has been found that two N-termi-
nally CF-labelled CPPs are internalized by HeLa cells via raft-
mediated endocytosis [21].
Signiﬁcant diﬀerences in the kinetics of translocation, for
free (Fig. 3A) or complexed (Fig. 3B) forms, of Pep-1CF were
not detected.
The uptake of the b-Gal cargo itself, at 4 and 37 C, was
evaluated by following the enzymatic hydrolysis, of a non-ﬂuo-
rescent substrate (MUG) to a ﬂuorescent product (4-MU). The
hydrolysis step is carried out at 37 C after the translocation
incubation step. We observed that the translocated protein
was active and that the uptake of protein was much more eﬃ-
cient at 37 C than at 4 C (180 min after incubation the ﬂuo-
rescence emission intensity of 4-MU was found to be 14.5
times higher at 37 C relative to 4 C).
In order to investigate the eﬀect of CF-derivatization in pep-
tide translocation, we compared the eﬃciency of b-Gal inter-
nalization mediated by pep-1 vs. pep-1CF (Fig. 4). When the
Fig. 1. Partition of Pep-1CF-hydrophobic domain in POPC LUVs
(kcxc = 280 nm). (A) shifting of pep-1CF ﬂuorescence emission spectra
with lipidic concentration (0–3.75 mM). (B) Fluorescence intensity
emission maximum dependence on lipidic concentration.
Fig. 2. Variation of transmembrane potential in POPC LUVs by
titration with pep-1CF in absence (1) or presence of transmembrane
potential (2) or with non-labelled pep-1 in presence of transmembrane
potential (3). Monitored with DiSBAC2(3) ﬂuorescence emission
(kexc = 540 nm, kem = 558 nm) (inserts indicate addition of 5lL from
pep-1CF or pep-1 stock solution).
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b-Gal uptake was mediated by pep-1 there were no signiﬁcant
diﬀerences between 4 and 37 C [7]. However, eﬃciency was
diﬀerent for the labelled and unlabelled peptides (Fig. 4),
revealing that the hydrophilic domain of the peptide is of crit-
ical importance for translocation.
We analysed the enzyme activity, in vitro, in free and in
complexed forms. The determined v0 of b-Gal are:
19.18 ± 0.24 lM/min for free form; 11.60 ± 0.53 lM/min when
complexed with unlabelled-pep-1 and 19.61 ± 0.38 lM/min in
the complex with pep-1CF. The presence of pep-1 reduces
the activity of the enzyme (in agreement with [7]), but this does
not hold for pep-1CF. This suggests that the pep-1CF does not
interact as strongly with the protein, which is an additional
eﬀect induced by the presence of CF in the Lys-rich domain.
This supports the hypothesis that pep-1 interacts with the car-
go both by means of hydrophobic and electrostatic interac-
tions [7].
The mechanism of translocation of pep-1CF is diﬀerent from
the one identiﬁed previously for pep-1. A simple physical
mechanism mediated by electrostatic interaction between
pep-1 and membrane is supported by diﬀerent sets of experi-
mental data [7,11]. However, Pep-1CF follows a diﬀerent path-
way, dependent on temperature, i.e., endocytic.
It should be stressed that pep-1CF has translocation ability
via physical (non-endocytic) processes (Fig. 2), however, such
ability is clearly decreased compared to unlabelled pep-1
(Fig. 2), in agreement with its smaller partition into mem-
branes. At 4 C, the low cell membrane ﬂuidity also contrib-
utes to inhibit physical translocation of pep-1CF. It is only
at 37 C that the endocytic pathway becomes an alternative
to the physical process and translocation occurs. A small
contribution of the endocytic pathway for translocation of
unlabelled pep-1 at 37 cannot be discarded, although a phys-
ical process is clearly dominant [7,11].
A reduced protein-uptake mediated by pep-1CF is due, not
only, to a decrease in translocation eﬃciency but also to a
diminished interaction of the pep-1CF with b-Gal.
3.5. Conclusion
Translocation of pep-1 is mediated by a physical process
governed by electrostatic interactions [7,11]. Modiﬁcation of
the hydrophilic domain, with a CF group, extensively de-
creases the aﬃnity of pep-1 for phospholipid membranes and
for the cargo macromolecule, which aﬀects the translocation
of the peptide alone as well as its capacity as delivery agent.
It was recently proposed that labelling CPPs inﬂuence the ﬁnal
location inside the cell [5]. We now generalize this diﬀerence to
a decrease in the extension of internalization and to a change
in the main mechanism of translocation. A small chemical
modiﬁcation of these sequences may modify the translocation
eﬃciency and even its pathway. It is worth mention that oligo-
Arg peptides have translocation ability on their own [22] with
no need for ‘‘hydrophobic’’ sequences.
Acknowledgments: We thank FCT, Portugal for the grant SFRH/BD/
14337/2003 under the program POCTI to S.T. Henriques. This work
was funded by grants POCTI/BCI/38631 from FCT, Portugal, and
LSHG-CT-2004-503228 from the European Commission.
References
[1] Bogoyevitch, M.A., Kendrick, T.S., Dominic, C.H. and Barr,
R.K. (2002) Taking the cell by stealth or storm? Protein
transduction domain (PTDs) as versatile vectors for delivery.
DNA Cell Biol. 21, 879–894.
Fig. 3. Kinetics of Pep-1CF uptake in HeLa cells: (A) in free form or
(B) complexed with b-Gal at 37 C (white circles) or 4 C (black
circles). Internalization was followed by means of ﬂuorescence
emission (If) dequenching of CF. Peptide internalization into cells
leads to ﬂuorescence recovery due to inaccessibility to TB (quencher).
The relative ﬂuorescence intensity, If/I0 (I0 is the ﬂuorescence intensity
in the absence of TB) was normalized at t = 0.
Fig. 4. Delivery of b-Gal into HeLa cells at 37 C, followed by
enzymatic production of 4-UM, mediated by pep-1CF (white circles)
or by pep-1 (black circles).
S.T. Henriques et al. / FEBS Letters 579 (2005) 4498–4502 4501
127
[2] Wadia, J.S., Becker-Hapak, M. and Dowdy, S.F. (2002) Interac-
tions of cell-penetrating peptides with membranes in: Cell-
penetrating Peptides, Processes and Applications (Langel, U¨.,
Ed.), CRC Press Pharmacology & Toxicology Series, pp. 365–375,
CRC Press, NY.
[3] Richard, J.P., Melikov, K., Vives, E., Ramos, C., Verbeure, B.,
Gait, M.J., Chernomordik, L.V. and Lebleu, B. (2003) Cell-
penetrating peptides, a reevaluation of the mechanism of cellular
uptake. J. Biol. Chem. 278, 585–590.
[4] Thoren, P.E.G., Persson, D., Isakson, P., Gokso¨r, M., O¨nfelt, A.
and Norde´n, B. (2003) Uptake of analogs of penetratin, Tat(48–
60) and oligoarginine in live cells. Biochem. Biophys. Res.
Commun. 307, 100–107.
[5] Szeto, H.H., Schiller, P.W., Zhao, K. and Luo, G. (2005)
Fluorescent dyes alter intracellular targeting and function of
cell-penetrating tetrapeptides. FASEB J. 19, 118–120.
[6] Morris, M.C., Depollier, J., Mery, J., Heitz, F. and Divita, G.
(2001) A peptide carrier for the delivery of biologically active
proteins into mammalian cells. Nat. Biotechnol. 19, 1143–1147.
[7] Henriques, S.T., Costa, J. and Castanho, M.A.R.B. (2005)
Translocation of b-galactosidase mediated by the cell-penetrating
peptide pep-1 into lipid vesicles and human HeLa cells is driven by
membrane electrostatic potential. Biochemistry 44, 10189–10198.
[8] Wu, Y., Wood, M.D. and Katagiri, F. (2003) Direct delivery of
bacterial avirulance proteins intro resistant Arabidopsis protop-
lasts lead to hypersensitive cell death. Plant J. 33, 131–137.
[9] Ikari, A., Nakaro, M., Kawano, K. and Suketa, Y. (2002) Up-
regulation of sodium-dependent glucose transporter by interac-
tion with heat shock protein 70. J. Biol. Chem. 277, 33338–33343.
[10] Zhou, J. and Hsieh, J.-T. (2001) The inhibitory role of DOC-2/
DAB2 in growth factor receptor-mediated signal cascade. J. Biol.
Chem. 276, 27793–27798.
[11] Henriques, S.T. and Castanho, M.A.R.B. (2004) Consequences of
nonlytic membrane perturbation to the translocation of the cell
penetrating peptide pep-1 in lipidic vesicles. Biochemistry 43,
9716–9724.
[12] Henriques, S.T. and Castanho, M.A.R.B. (2005) Environmental
factors that enhance the action of the cell penetrating peptide pep-
1. A spectroscopic study using lipidic vesicles. Biochem. Biophys.
Acta 1669, 75–86.
[13] Christiaens, B., Symoens, S., Vanerheyden, S., Engelborghs, Y.,
Joliot, A., Prochiantz, A., Vandekerckhove, J., Rosseneu, M. and
Vanloo, B. (2002) Tryptophan ﬂuorescence study of the interac-
tion of penetratin peptides with model membranes. Eur. J.
Biochem. 269, 2918–2926.
[14] Caputo, G.A. and London, E. (2003) Using a novel dual
ﬂuorescence quenching assay for measurement of tryptophan
depth within lipid bilayers to determine hydrophobic a-helix
location within membranes. Biochemistry 42, 3265–3274.
[15] Mayer, L.D., Hope, M.J. and Cullis, P.R. (1986) Vesicles of
variable sizes produced by a rapid extrusion procedure. Biochim.
Biophys. Acta 858, 161–168.
[16] Gennis, R.B. (1989) Biomembranes, Molecular Structure and
Function, Springer-Verlag, NY.
[17] Haugland, R.P. (2002) Handbook of Fluorescent Probes and
Research Products, 9th edn, Molecular Probes, Eugene.
[18] Wan, C.P., Park, C.S. and Lau, B.H. (1993) A rapid and
simple microﬂuorometric phagocytosis assay. J. Immunol.
Meth. 4, 1–7.
[19] Hed, J., Hallden, G., Johansson, S.G. and Larsson, P. (1987) The
use of ﬂuorescence quenching in ﬂow cytoﬂuorometry to measure
the attachment and ingestion phases in phagocytosis in peripheral
blood without prior cell separation. J. Immunol. Meth. 101, 119–
125.
[20] Fernandes, M.X., Torres, J.G. and Castanho, M.A.R.B. (2002)
Joint determination by brownian dynamics and ﬂuorescence
quenching of the in-depth location proﬁle of biomolecules in
membranes. Anal. Biochem. 307, 1–12.
[21] Foerg, C., Ziegler, U., Fernandez-Carnedo, J., Giralt, E., Renn-
ert, R., Beck-Sickinger, A.G. and Merkle, H.P. (2005) Decoding
the entry of the two novel cell-penetrating peptides in HeLa cells:
lipid raft-mediated endocytosis and endosomal escape. Biochem-
istry 44, 72–81.
[22] Sarai, N. and Matile, S. (2003) Anion-mediated transfer of
polyarginine across liquid and bilayer membranes. J. Am. Chem.
Soc. 125, 14348–14356.
4502 S.T. Henriques et al. / FEBS Letters 579 (2005) 4498–4502
128
  
 
 
 
 
 
Chapter 5 
 
 
Conclusion 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Chapter 5.  Conclusion 
 
 
   131
 
 
Chapter 5.   
 
 
Conclusion 
 
 
5.1. The overall mechanism – the importance of the lipidic 
membrane and electrostatic interaction on pep-1 uptake. 
 
The results presented through the thesis, along with some other published work 
related to pep-1 properties and its ability to internalize will be interpreted and gathered 
with other information available in the literature. Pep-1 translocation across plasma 
membrane has also been the subject of a recent review [268], which is presented in 
Chapter 6.  
 
Interaction of peptides with lipidic membranes comprises three thermodynamic 
steps governed by electrostatic forces, hydrogen bond formation and hydrophobic 
interactions. The first step is initiated by the electrostatic attraction between peptide and 
membranes; the second step involves a transition of the peptide into the plane of 
binding, which depends on the hydrophobic/hydrophilic balance of the molecules 
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groups and forces involved; and the third step involves a conformation modification of 
the bound peptide, normally from a random coil conformation into a α-helix structure 
upon interaction with lipidic bilayer [183]. Insertion in the lipid matrix may follow. 
The interaction of pep-1 can be described by these three steps as follow: in the 
first step, mainly governed by electrostatic interaction between peptide and membrane, 
there is an increase of peptide concentration at membrane surface due to large 
electrostatic interactions between basic amino acid residues and the phosphate groups in 
lipid molecule [183]; in the second step, pep-1 in close proximity to the membrane 
removes the hydration shell at membrane surface and promotes membrane 
destabilization by hydrophobic domain insertion [186]; in the third step, hydrophobic 
domain upon interaction with membrane acquires an α-helical conformation, as verified 
by us [269] and also by others [185, 270]. Such secondary structure modification is 
understood with respect to a reduction on the free energy at membrane surface and is 
thus an important driving force for membrane binding [183]. 
The hydrophobic domain inserts in the membrane with a shallow position [153, 
269]. This location was also confirmed by others [270]. Upon peptide insertion, 
liposome aggregation and fusion were detected [186], which indicates that pep-1 is able 
to destabilize the lipidic membrane. It is worth mentioning that the absence of 
membrane leakage as detected by us [186, 269] and by others [270, 271] conflicts  with 
the pore formation hypothesis suggested by Deshayes et al. [185, 272]. The peptide 
orientation in the membrane further rule out such hypothesis [153, 269]. A pore 
formation implies that the peptide spans across lipidic membrane with a perpendicular 
orientation to the membrane plane [172, 175]. Such orientation is thermodynamically 
unfavourable for pep-1 due to peptide length and structure: the hydrophilic domain with 
a large charge density and random coil conformation does not insert in the bilayer and 
the hydrophobic domain length with an α-helical conformation (∼19.5Å) does not 
match the bilayer membrane thickness (∼40Å), which is further hampered by the 
presence of five Trp residues in this domain, which work as anchors at membrane 
interface [273, 274].  
A membrane disintegration for high peptide/lipid ratios, as observed by us [269], 
and also by others [270, 271] suggests that the hydrophilic part binds onto the surface of 
the membrane and cover it in a “carpet”-like manner, whereas the hydrophobic domain, 
in the interface region, induces membranes destabilization, which above a critical local 
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peptide concentration (dependent on the lipidic composition and peptide affinity for 
these bilayers) induces membrane disintegration. This is an extreme event and cannot 
explain the capacity of peptide to translocate. Together, our results demonstrate that the 
pep-1 has a high affinity for membranes and is able to destabilize the lipidic bilayer 
without leakage of the aqueous contents of the vesicles. Membrane disintegration 
occurs in extreme conditions (peptide/lipid ≥1), which also explain the pep-1 
cytotoxicity in cultured cells with peptide concentrations much above the concentrations 
used for transfection purposes [84, 270].  
The plasma membrane is characterized by a negative transmembrane potential, 
due to electrochemical gradient and also by membrane composition asymmetry (inner 
leaflet is enriched on negatively-charged phospholipids, while the outer leaflet is mainly 
composed by zwitterionic phospholipids). In vitro studies show pep-1 capacity to 
disturb membranes without forming pores and to translocate by a mechanism dependent 
on transmembrane potential; moreover it also shows that pep-1 has a higher affinity for 
membranes with negatively-charged phospholipids. In cultured cells it was possible to 
confirm the capacity of pep-1 to translocate by a mechanism dependent on membrane 
potential gradient and no evidences for an endosomal pathway, were detected [230] in 
agreement with a previous report by Morris et al. [84].  
The importance of the peptide affinity for the membrane on the translocation 
process was confirmed with pep-1CF, where both a loss in membrane affinity and a 
decrease in uptake were identified. This suggests that translocation efficiency and 
partition of pep-1 in lipidic membranes are strongly correlated. However, comparing 
results at 4ºC and 37ºC it was possible to identify a slight internalization of pep-1CF by 
an endocytosis-dependent uptake (at 4ºC internalization was inhibited). This small 
uptake by endocytosis seems to operate only when the membrane affinity is severely 
decreased or lost, suggesting that membrane partition and the capacity to perturb it, 
dictate the extent to which the peptide enters the cell by a physical mechanism in 
detriment of endocytosis. 
 
Briefly, it is possible to conclude that the high affinity of pep-1 for lipidic 
bilayers leads to a high local concentration in the membrane, disturbing the cell surface. 
This effect associated with the transmembrane potential (negative inside) facilitates pep-
1 passage through the plasma membrane [153, 186]. Electrostatic attractions, which are 
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long range and are dominate when compared with hydrophobic ones [183], reallocate 
the peptide from the outer layer to the inner layer (more negatively-charged than the 
outer layer). The reduced local surface tension allows the peptide to intercalate the 
membrane and a flexible sealing between peptide side-groups and lipid head-groups 
minimize leakage during the peptide passage through the membrane and no leakage 
occurs [186, 269]. Once in contact with cytoplasm, pep-1 decreases the affinity for the 
lipidic membrane due to disulfide bond cleavage in the reducing environment [153], and 
is transferred into cytoplasm where is then available for uptake by cellular 
compartments. When a cargo molecule is associated with the peptide, an excess of pep-
1 molecules in free form is required for an efficient translocation. This suggests that part 
of the pep-1 molecules take part on pep-1/cargo complex formation whereas the pep-1 
molecules in free form are responsible for interaction with plasma membrane [230]. The 
overall mechanism is outlined in the Figure 5.2: 
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Figure 5.2. Pep-1 translocation mechanism across biological membranes is initiated by pep-1 partition 
into lipidic membrane. The peptide-lipid interaction is first governed by electrostatic interaction between 
hydrophilic domain and lipid headgroups, and subsequently in close proximity to the membrane 
hydrophobic domain inserts in the membrane, acquires an α-helical conformation and perturbs membrane. 
In extreme conditions where peptide concentration is higher than lipid concentration, peptide becomes 
cytotoxic due to membrane disintegration by a “carpet” model-like mechanism. In physiological 
conditions due to negative transmembrane potential and membrane asymmetry pep-1 passes from the 
outer layer to the inner layer by a electrostatic-mediated process where the peptide intercalates the 
membrane during the peptide passage through the membrane and no leakage occurs. When pep-1 faces 
the cytoplasm, loses the affinity for lipidic membrane. Therefore the equilibrium is shifted to intracellular 
environment, which facilitates peptide and cargo uptake.   
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5.2. Towards a new phase regarding CPP mechanisms: the 
coexistence of translocation mechanisms 
 
The plasma membrane is a barrier to the passage of a number of therapeutic 
agents. The efficient delivery of macromolecules into living cells is a challenge. In spite 
of all the approaches that have been used in the last decade to overcome membrane 
impermeability, they all present serious drawbacks. The recent strategy that employs the 
use of cationic peptides as carriers to introduce macromolecules has attracted much 
attention during the past few years and is a new hope on drug delivery for therapeutic 
purposes [1]. The use of CPPs for a general application implies the knowledge of the 
mechanism used to pass through the membrane and this has been the main goal in CPP 
research. In the last 20 years the studies on CPPs mechanism can be divided into three 
phases. 
First it was observed that internalization of CPPs and their cargoes was not 
inhibited by incubation at low temperature, by depletion of cellular ATP or by inhibitors 
of endocytosis. Furthermore structure-activity studies and the use of D-isomers 
indicated that the internalization of CPPs was not dependent on receptor recognition. 
Based on these observations the internalization of CPPs was commonly accepted to be 
both endocytosis- and receptor-independent and a translocation mechanism involving 
direct interaction with membranes and lipids was proposed [15, 16, 27, 53]. This 
hypothesis was supported by the strong correlation between lipid-binding affinity and 
cell uptake [168] and also by the observation of translocation in model membrane 
systems [78, 79, 147]. 
More recently it was verified that the fixation procedures used for 
immunochemistry and cell visualization may lead to artifactual cell localization [55, 56]. 
These observations led to a re-evaluation of the internalization mechanism by Richard et 
al. [60] followed by Thorén et al. [58] in 2002 and 2003. The confirmation of the 
involvement of endosomal pathway for internalization of, penetratin, TAT and 
oligoarginine [58, 60] led to a drastic turn on the CPP research and subsequent reports 
have shown that many CPPs are internalized by endocytosis [59, 61-66, 275]. From that 
period until now it was generally assumed that all the CPPs were internalized by an 
endocytic pathway and this can be regarded as the second phase on the CPP research. 
However, a consensus in the specific route was never reached and contradictory results 
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have been published [60, 62, 68]. In a picture where endosomal pathway is the 
physiological route used by CPP uptake, the escape from endosomes for an efficient 
delivery of a functional cargo must involve membrane interaction and a physically 
driven mechanism. Moreover the direct observation of the uptake of some CPPs in 
model membranes [77-79, 147] reinforces this mechanism. CPPs are an heterogeneous 
family with peptides from different sources (see reference [34]) and the mechanism of 
their action cannot be only black or white. A thorough and open-minded evaluation of 
the mechanism should be done. 
Our results with pep-1 [153, 186, 230, 269, 276] together with recently 
published reports [242, 248, 251, 252, 258] suggest a third phase in the CPP research, 
where the main physiological mechanism used by CPPs is dependent on the peptide and 
experimental conditions. A greater contribution of physically-mediated process in 
detriment of endocytosis is dependent on the bulk peptide concentration, the cargo 
molecule, the peptide affinity for cell membrane and the quantity of cells, which 
modulate the peptide concentration in membrane vicinity. For a further comprehension 
of this statement I will compare the uptake mechanism of different CPPs: Penetratin, 
TAT and analogues, maurocalcine, S413-PV and pep-1. This has also been object of a 
recent review by us ([277] presented in Annex I). 
Penetratin does not show a strong affinity for zwitterionic membranes [74, 278, 
279] and does not induce significant membrane destabilization [234, 280]. Interaction 
with model membranes is only evident when negatively-charged phospholipids are 
present [74, 278]. A large consensus on internalization of penetration by endocytosis as 
the physiological uptake route is evident through the literature [58, 59, 65] with no 
evidences for an alternative pathway [58]. 
For TAT, oligoarginine and other TAT analogues a more pronounced affinity for 
the membrane, together with capacity to induce more severe membrane destabilization 
when compared with penentratin, was oberved [234, 280]. For these peptides a 
contribution of the endocytosis and energy-independent mechanism was reported [58, 
281, 282] while other authors claim that endocytosis is the only physiological 
mechanism for TAT internalization [60, 61, 65, 70]. This apparent contradiction was 
recently elucidated by Duchardt et al. [248]. In this report the uptake of penetratin, TAT 
and oligoarginine was compared and evaluated at different peptide concentrations. 
Penetratin uptake mechanism was found to be endocytosis-dependent even at high 
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concentrations (20 μM) while for TAT and oligoarginine the endocytosis is particularly 
operative at low concentrations (2μM). At higher concentrations (20 μM) these later 
peptides were insensitive to endosomal inhibitors and a rapid release into the cytoplasm 
by a membrane mediated mechanism was detected. It was proposed that a critical 
concentration of peptide associated with the plasma membrane is required to trigger this 
physically-driven mechanism [248]. Similar conclusions were obtained by Fretz et al. 
[251] where the uptake mechanism followed by oligoarginine was dependent on the 
existence of a threshold concentration which when exceeded promotes direct 
translocation across the plasma membrane [251]. Moreover, Nakase et al. identified that 
higher quantities of oligoarginine were obtained in the cytoplasm when cells were 
incubated at 4ºC than at 37ºC. They proposed that when endosomal pathways are 
inhibited, and an alternative pathway can operate, the peptide is more efficiently 
translocated into the cytosol. When incubation is held at 37ºC, oligoarginine release in 
the cytoplasm is difficult due to endosome entrapment [67]. At variance, for penetratin a 
physically-driven mechanism was not operative and a strong contribution of the 
endocytic mechanism was always evident [248]. 
Results obtained with the chimaeric peptide S413-PV (a combination of a 13 
aminoacid sequence derived from the dermaseptin S4 (S413 domain) with the NLS from 
SV-40 large T antigen and also with CPP properties [32]) also support the finding that 
the peptide affinity for cell membrane and the cell concentration close to the cell surface 
dictates the main uptake mechanism. The uptake efficiency of this peptide was not 
reduced in the presence of endocytic inhibitors [257]. However, at low peptide 
concentration a contribution of endocytosis was verified [242]. A transient membrane 
destabilization due to electrostatic interactions between the S413-PV peptide and 
negatively-charged components at cell surface is considered to be responsible for the 
translocation [257, 283]. Endosomal internalization with low peptide concentration 
suggests that higher peptide concentrations are mandatory to induce membrane 
destabilization.  
The hypothesis of the coexistence of endosomal and physically-mediated 
mechanisms was also proposed by Boisseau et al. [258] in a study with maurocalcine, a 
CPP isolated from the scorpion Scorpio maurus palmatus [236]. A contribution of both 
mechanisms was identified where the physically-driven mechanism results from a 
transmembrane potential [258]. In a recent study with maurocalcine analogues, where 
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peptides with different point mutations were compared, it was verified that the 
analogues with a stronger interaction with membrane lipids have a better penetration 
into cells [252]. Conversely, analogues with less cellular uptake presented a diminished 
ability to interact with negatively-charged lipids [252].  
In all the above referred peptides no interaction with zwiterionic membranes or 
significant destabilizations were verified through the studies and it was evident that the 
interaction with model membranes only occurs in the presence of anionic lipids or 
proteoglycans [66, 252, 278, 280, 283]. In contrast, pep-1 has a high affinity for lipidic 
membranes, even in the absence of negatively-charged phospholipids or proteoglycans 
[153] and induces a significant membrane destabilization [186, 269] which seems to 
favour internalization [230]. At physiological concentrations, endocytosis was not 
detected even at 37ºC [230, 276], and so it is possible to conclude that the physically-
driven uptake is the only mechanism with physiological relevance for the pep-1. The 
observation that the pep1-CF, with a lower affinity for lipidic membrane when 
compared with pep-1, is not internalized at 4ºC but has a slight internalization at 37ºC, 
indicating an endosomal internalization, supports the hypothesis that membrane-affinity 
and the local concentration of the peptide partitionated in the membrane dictates the 
preferred uptake mechanism. 
Overall, is possible to conclude that the strategy used by a specific CPP to 
internalize inside the cell is dependent on the bulk peptide concentration [242, 248, 251], 
on the cargo molecule attached [241, 282], on the cellular line and the number of cells 
[284]. Altogether these factors modulate the peptide affinity for lipidic membrane and 
the peptide concentration on the membrane. Penetratin and pep-1 can be regarded as 
two extremes in the CPPs family. In one hand the penetratin with a low affinity for 
lipidic membrane and low ability to disturb it [234, 280] is mainly (if not solely) 
internalized by endocytosis [58, 248]. Pep-1, in the other extreme, with a high affinity 
for lipidic membranes [153] and able to disturb the membrane stability [186, 269] 
translocates across biological membranes without evidence for endocytosis mechanism.  
 
There are two requisites for an efficient cargo delivery by a CPP: a specific 
location inside the cell and an escape from endosomes into the cytoplasm. This implies 
membrane interaction and permeation. pH gradient in/out the lisosomes (pH5 in 
endosomal lumen and pH7 in cytosol) was suggested as a possible driving force to 
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promote the release of CPPs into cytosol [65], as supported by Magzoub et al. studies 
[77] where translocation into model membranes driven by a pH gradient was shown for 
penetratin. Another possibility is a transmembrane potential-driven mechanism [78, 81]. 
Once inside the endosomes the transmembrane potential (luminal side is positive) drives 
translocation from the endosomal lumen to the cytoplasm environment. The ability to 
pass through a pure lipid membrane mediated by the transmembrane potential was 
verified for TAT [282], oligoarginine and penetratin [78].  
 
The energy-independent mechanism has physiological relevance if the uptake 
occurs in non-toxic conditions. The importance of electrostatic interactions between the 
peptide and the cell membrane is consensual trough the literature (see for instance [168, 
230, 234, 252, 255, 276, 283, 285]). The transmembrane potential between extracellular 
and intracellular medium (negative inside) was implicated in the uptake of different 
CPPs as oligoarginine [81], TAT [282], maurocalcine [258], and pep-1 [186, 230].  
 
The biological application of CPPs as carriers is a compromise between efficacy 
and non-toxicity. Like CPPs, AMPs are short and cationic sequences with a high 
affinity for membranes, and in extreme conditions CPPs show antimicrobial effects 
[253] and can also be toxic for mammalian cells [270] (see also the review paper [277] 
in Annex I).  
 
Our contribution in the CPP field was important to exclude the general 
acceptance of an endosomal pathway to explain the uptake of all the CPPs. Pep-1, being 
clearly related to a physical mechanism was significant to reach this third stage where 
the particular peptide and the experimental conditions dictate the mechanism. This 
project has also contributed with new methodologies to study the translocation across 
model membranes, which has been the topic of a review [286] presented in Annex I. 
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Annex I 
 
 
6.1. Translocation or membrane disintegration? Implication of 
peptide-membrane interactions in pep-1 activity. 
 
 
The review titled: Translocation or membrane disintegration? Implication of 
peptide-membrane interactions in pep-1 activity, presents the most significant results 
obtained on pep-1 translocation studies. Our results together with other published 
reports are reviewed. In this review the pep-1 ability for cell penetration and/or 
antimicrobial activity is highlighted. The threshold between these two properties relies 
in the peptide concentration; the composition of the membrane and the final 
peptide/lipid ratio. In mammalian cells and at pep-1 physiological conditions the pep-1 
works as a CPP. With some bacteria strains pep-1 may work as AMP. 
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Translocation or membrane disintegration? Implication of
peptide–membrane interactions in pep-1 activity‡
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Abstract: The Cell membrane is impermeable for most peptides, proteins, and oligonucleotides. Moreover, some cationic peptides,
the so-called cell-penetrating peptides (CPPs), are able to translocate across the membrane. This observation has attracted much
attention because these peptides can be covalently coupled to different macromolecules, which are efficiently delivered inside
the cell. The mechanism used by these peptides to pass across the membrane is a controversial matter of debate. It has been
suggested that endocytosis is the main mechanism of internalization and this was confirmed by several studies for different
peptides. Pep-1 is an exception worthy of attention for its ability to translocate cargo macromolecules without the need to be
covalently attached to them. A preferential internalization by an endocytosis-independent mechanism was demonstrated both
in vitro and in vivo. Pep-1 has a high affinity to lipidic membranes, it is able to insert and induce local destabilization in the lipidic
bilayer, although without pore formation. No cytotoxic effects were found for pep-1 concentrations where translocation is fully
operative. At much higher concentrations, membrane disintegration takes place by a detergent-like mechanism that resembles
anti-microbial peptide activity. In this review, the ability of pep-1 to transverse the membrane by an endocytosis-independent
mechanism, not mediated by pores as well as an ability to induce membrane disintegration at high peptide concentration, is
demonstrated. Copyright  2007 European Peptide Society and John Wiley & Sons, Ltd.
Keywords: cell-penetrating peptides; peptide-membrane interactions; translocation mechanism; drug delivery; anti-microbial
peptides
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INTRODUCTION
The hydrophobic nature of the cell membrane is respon-
sible for cellular integrity and is one of the limitations
for the introduction of hydrophilic macromolecules in
the cytoplasm. Microinjection, electroporation, lipo-
somes and viral vectors have been used as delivery
strategies to overcome membrane permeability. All
these methods have drawbacks such as toxicity, poor
specificity and being time consuming [1]. The observa-
tion that some cytoplasmic proteins are able to cross the
membrane when added to extracellular medium, (e.g.
HIV-1 transcriptional activator Tat protein [2] and the
Drosophila antennapedia transcription protein (pAntp)
[3]) originated an alternative strategy based on the basic
amino acid sequences within these proteins which are
translocating-enabling sequences. The observation that
these basic peptides allow cellular delivery of conju-
gated molecules such as peptides or proteins made
these molecules attractive and a new class of vectors,
known as cell-penetrating peptides (CPPs), emerged [4].
This family now includes all the peptides with the abil-
ity to translocate across membranes, whether natural
* Correspondence to: So´nia Troeira Henriques, Centro de Quı´mica e
Bioquı´mica, Faculdade de Cieˆncias da Universidade de Lisboa, Ed. C8,
Campo Grande, 1749-016 Lisboa, Portugal;
e-mail: sthenriques@fc.ul.pt
‡ This article is part of Special Issue of the Journal of the Peptide Science
entitled ‘‘2nd workshop on biophysics of membrance-active peptides’’.
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peptides, synthetic, or chimaeric peptides.So far, these
vectors have been used to translocate a wide range of
macromolecules into living cells such as proteins [5–7],
peptides [8,9], oligonucleotides [10,11], peptide nucleic
acids [12], and polysaccharides [13]. Nanoparticles [14]
and liposomes [15] have also been internalized in cells
by means of CPP.
The mechanism used by these peptides to translocate
across biologic membranes has been a subject of
debate and controversy in the literature (Ref. 16 and
references therein). The CPP derived from pAntp
(penetratin) and the one from Tat protein (TAT)
are the two most intensively studied CPPs. Both
peptides use endocytic pathways to reach the cytoplasm
[17–23]. Moreover, even in a scenario where the
endocytosis is the physiological means of CPP uptake,
the escape of the CPP/cargo from endosomes into the
cytoplasm is mandatory for a successful delivery of
the cargo molecule. An escape from endosomes due
to acidification was proposed for penetratin and TAT
and confirmed [24]. A translocation dependent on a
transmembrane potential was also identified in vitro for
TAT and penetratin [25].
PEP-1 A CHIMAERIC PEPTIDE
Pep-1 (acetyl-KETWWETWWTEWSQPKKKRKV-cystea-
mine) is a CPP with primary amphipathicity (i.e
Copyright  2007 European Peptide Society and John Wiley & Sons, Ltd.
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amphipathicity resulting from the aminoacid sequence
itself, not from the folding structure) composed by:
(i) a Trp-rich domain (KETWWETWWTEW), responsible
for hydrophobic interactions with both proteins and
cell membranes, (ii) a hydrophilic domain (KKKRKV)
derived from a nuclear localization signal (NLS) of
Simian Virus 40 (SV-40) large T-antigen, required to
improve solubility, and (iii) a spacer domain (SPQ),
which improves the flexibility and the integrity of the
other two domains [26]. A cysteamine group is present
in the C-terminal and an acetyl group caps the N-
terminus. In oxidizing conditions dimmers may form
due to a disulfide linking of cysteamine groups.
Pep-1 has been efficiently used to introduce several
large proteins inside different cellular lines such as
mammalian cells [26–29] or plant cells converted
into protoplasts [30]. The efficiency of translocation,
however, can vary depending on the cell type and the
cargo molecule.
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PEP-1 INTERACTION WITH MEMBRANES
Pep-1 is intrinsically fluorescent, which overcomes the
necessity to couple a fluorescent dye in fluorescence
spectroscopy studies. Trp fluorescence emission is
environmental-sensitive: when Trp residues are totally
exposed to aqueous environment its fluorescence emis-
sion has a spectral maximum at ∼350 nm; at variance,
in a more hydrophobic environment there is a blue
shift in fluorescence emission spectrum with a con-
comitant increase in quantum yield (Figure 1(A)). The
pep-1 extent of interaction with lipid membranes was
quantified by means of molar ratio partition coefficient,
KP (KP = [Pep − 1]Lipid/[Pep − 1]Aqueous). The increase in
the fluorescence intensity (I ) with lipid concentra-
tion was used to determine KP (I = (IW + KpγL[L]IL)/(1 +
KPγL[L]); where IW and IL are the fluorescence intensi-
ties in the absence of lipid and limit value for increasing
lipid concentrations, respectively, γL is the molar vol-
ume of lipid and [L] is the lipid concentration – for
more details see Ref. 31). Pep-1 has high affinity for
neutral membranes vesicles. The peptide insertion
kinetics is fast and the interaction is highly enhanced
in the presence of negatively-charged phospholipids
(Figure 1(B)) [32]. This suggests that the highly charged
hydrophilic domain, should be responsible for the first
contact with the membrane owing to the electrostatic
interactions between the polar headgroup of phospho-
lipids and the positive charges of pep-1. This was
further confirmed by the effect of ionic strength on
peptide–membrane interaction [33]. The hydrophobic
domain, containing five Trp residues, inserts in the
membrane with a shallow positioning [32]. Together, the
dehydration at membrane surface by the hydrophilic
domain and the insertion of the hydrophobic domain
promote membrane destabilization. Membrane destabi-
lization was confirmed by aggregation (Figure 2(A)) and
fusion (Figure 2(B)) of vesicles in the presence of pep-1
[33,34]. Moreover, segregation of anionic phospholipids
induced by the presence of pep-1 was also detected
[34]. However, pore formation was not detected [34–37].
At variance, other study [38] proposed a pore forma-
tion by a barrel-stave-like mechanism. This conclusion
was based on changes in the membrane conductance
in voltage-clamped oocytes, when a transmembrane
potential was applied [38].
In reducing conditions the peptide decreases its
affinity for the membrane [32]. Under these conditions
the disulfide link in between two peptide molecules
is reduced. Therefore, the loss in affinity can result
from an alteration in peptide conformation due to
the cleavage of the disulfide bond. The importance
of the cysteamine group was confirmed with peptide
molecules without this group (non-capped peptide [35]
or peptide with an amide group [35] or a fluorophore
[39]) at C-terminal). The modified peptides have a
decreased capacity to translocate into cells.
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Figure 1 Pep-1 interaction with phospholipid bilayers, reported by Trp fluorescence emission (excitation at 280 nm). Titration
of 6.88 µM pep-1 with large unilamellar vesicles (LUVs) of POPC, followed by normalized Trp fluorescence emission spectra (A) and
total Trp fluorescence emission (B). With lipid addition there is a blue shift in the emission spectra and an increase in fluorescence
intensity. The pep-1 affinity for lipidic membranes can be quantified by means of partition coefficient, KP, which was calculated
by fluorescence emission intensity and obtained by non-linear regression fit (data points omitted for the sake of clarity) – see text
and Refs. 31,32 for further information. Neutral bilayers (POPC) and negatively-charged membranes [POPC : POPG (4 : 1)] are
compared. A more extensive partition is obtained with negatively-charged vesicles (for further details see Ref. 32).
Figure 2 Vesicle aggregation and fusion induced by pep-1. (A) Aggregation of LUVs [25 µM POPC : POPG (4 : 1)] induced by
6.88 µM pep-1, followed by optical density and confirmed by fluorescence microscopy (inserts). (B) Fusion percentage in POPC and
POPC/POPG LUVs. All data were obtained in the presence of 6.88 µM pep-1 total concentration; however, effective concentration
in membranes vary (Ref. 34). Fusion extension and effective concentration in membranes are linearly correlated.
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Pep-1 interaction with membranes is associated with
a conformational alteration [35,36,38]. In aqueous
environment the peptide is mainly unstructured but
with a tendency to aggregate forming inter-molecular
β-sheet aggregates [36]. In the presence of lipidic
membranes, a structural alteration from random coil to
α-helix conformation, was detected. NMR studies show
that the part of the molecule that undergoes structural
alteration is the hydrophobic domain [35,38]. This
domain is known to easily insert in the membrane [32].
PEP-1 TRANSLOCATION ACROSS CELL
MEMBRANES
Pep-1 has been efficiently used in different cellular
lines, with several proteins and cargoes. Although,
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in vitro studies with model membranes revealed a high
affinity for lipidic bilayers and capacity to perturb the
membrane mainly in the presence of anionic phos-
pholipids [34], peptide translocation in vitro was only
detected in the presence of a negative transmembrane
potential (negative inside) [34]. In the absence of trans-
membrane potential, the peptide inserts only in the
outer layer [32]. An excess of negative charges inside
the liposome promotes the passage of the peptide from
the outer layer to the inner layer (Figure 3(A)) [34].
The pep-1 uptake by endocytosis was tested by
means of different methodologies. Delivery efficiency
of a cargo molecule attached to pep-1 was compared
at 4 and 37 °C [13,26] and no differences in deliv-
ery efficiency were observed (Figure 4). These results
were confirmed not only by imaging methods follow-
ing the protein by immunofluorescence [13,26] but
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Figure 3 Pep-1 passes through membranes by a mechanism dependent on negative transmembrane potential, , (inside).
(A) Pep-1 translocation in vitro followed by rhodamine (Rh) quenching [POPC : POPG (4 : 1) LUVs doped with 1% of Rh-labelled
phospholipid] induced by the pep-1. In the absence of a  pep-1 is able to quench Rh fluorophores in the outer layer. In the
presence of a negative  (created by the addition of valinomycin to liposomes loaded with K+ and dispersed in Na+) pep-1
translocates and a drop in Rh fluorescence is clear. With a positive  (liposomes loaded with Na+ and dispersed in K+) pep-1
does not translocate. Controls without pep-1 and where a  is not established in the presence of valinomycin (a – liposomes
loaded with Na+ and dispersed in Na+; b – liposomes loaded with K+ and dispersed in K+) (Ref. 34 for further details) are also
represented. (B) β-Gal delivery into HeLa cells, mediated by pep-1. Pep-1/β-Gal complex was incubated with HeLa cells, for 30 min
at 37 °C. Cell polarization was decreased by increasing external K+ concentrations, and maintaining the ionic strength constant
([K+] + [Na+] = 150 mM). The relative level of β-Gal uptake was determined by its enzymatic activity (Ref. 13). Depolarization of
cells severely reduces the level of β-Gal uptake.
Figure 4 β-Gal delivery into HeLa cells mediated by pep-1 or pep-1 CF, followed by β-Gal enzymatic activity. HeLa cells
were incubated during different intervals [16] with Pep-1/β –Gal complex or pep-1CF/β-Gal (molar ratio 320) at 37 or 4 °C. No
fixation procedures were used in this protocol. Pep-1 is able to internalize β-Gal in HeLa cells maintaining its enzymatic activity.
No differences were detected for incubations at 4 or 37 °C, which suggests an endocytosis-independent internalization. β-Gal
internalization is decreased when pep-1CF is used instead of pep-1 (Ref. 39 for further details).
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also by protein activity (measurement of β-Gal enzy-
matic activity) (Figure 4) [13,26,39]. Procedures used to
quantify the protein activity inside the cells exclude the
possibility of artefacts associated with fixation proce-
dures. Moreover co-localization of β-Gal internalized by
the pep-1 with different endocytotic markers (Dextran,
EEA1, Caveolin-1, and cathepsin D) followed by confo-
cal microscopy revealed that this protein is inside cells
and does not co-localize with any of these endocytic
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markers [13] (in the case of translocation by an endo-
cytic pathway a co-localization with at least one of
these endocytic markers would be expected when the
incubation of cells with the complex pep-1/protein is
performed at 37 °C).
At variance, Weller et al. proposed an endocytosis-
mediated entrance based on the internalization of
pep-1/Thioredoxin (TRX) in the presence/absence of
endocytic inhibitors. In these experiments 0.1% NaN3
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and 50 mM deoxy-D-glucose were added to the cells
to inhibit ATP production. When pep-1/TRX was
incubated with cells (still in the presence of NaN3 and
50 mM deoxy-D-glucose) the TRX uptake was reduced
[35]. As has been previously verified, pep-1 is able
to interact with dextran molecules with 10 kDa (i.e.
about 55 glucose monomers per dextran molecule) and
introduce these molecules inside cells [13]. A decrease
in the TRX uptake mediated by the pep-1 could thus
result from the interference of glucose (which was
present in a high concentration, 50 mM), decreasing
pep-1/TRX complex formation and/or pep-1 capacity
to deliver TRX inside cells.
Under in vitro conditions, pep-1 translocates through
a mechanism mediated by the transmembrane poten-
tial. This hypothesis was also tested in vivo. Cellular
depolarization inhibited β-Gal uptake mediated by pep-
1 (Figure 3(B)) [13]. Considering the overall results we
conclude that the endocytic pathway is not the main
internalization pathway used by this peptide to intro-
duce proteins inside cells.
A modified pep-1, in which a carboxyfluorescein (CF)
probe was added at the C-terminus, lost the ability to
internalize β-Gal (Figure 4) [39]. This was emcompassed
by a decrease in the affinity for lipidic bilayers [39]. The
loss in membrane affinity with a decrease in uptake
suggests that translocation efficiency and partition of
pep-1 in lipidic membranes are strongly correlated.
However, comparing incubations at 4 and 37 °C it
was possible to identify a slight internalization of pep-
1 CF by an endocytosis-dependent uptake (at 4 °C
internalization was inhibited) [39]. This small uptake by
endocytosis seems to operate only when the membrane
affinity is lost, suggesting that membrane affinity and
the capacity to destabilize it, dictate the extent to which
the peptide enters the cell by a physical mechanism (a
process faster than the endocytosis) to the detriment of
the endocytosis itself.
CAN PEP-1 WORK AS ANTI-MICROBIAL PEPTIDES?
Like CPPs, anti-microbial peptides (AMPs) are short
and cationic peptides with high affinity for membranes.
These peptides are characterized by an efficient killing
of several species of bacteria with the ability to preserve
host-cell integrity. The main target of these peptides
is the bacterial membrane, provoking membrane lysis,
membrane permeabilization or other forms of bilayers
disruption [40].
A pep-1 translocation by pore formation was recently
suggested [38] but this suggestion was not confirmed
by experiments where the capacity of pep-1 to induce
leakage was tested [34–37]. For high peptide/lipid
ratios, pronounced membrane damage takes place in
lipidic vesicles. Pore formation is not the course of the
damage. A detergent-like mechanism seems to operate
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[36]. This explains the toxicity when pep-1 is present at
high concentration [26,35].
Pep-1 anti-microbial activity was tested for different
bacterial strains. The minimal inhibitory concentration
(MIC) is dependent on the strain [37]. Although pep-1
is not as efficient as mellitin to kill bacteria, it is able to
efficiently kill bacillus subtilus at a low concentration,
and to kill other strains at higher concentrations.
The capacity to kill bacteria was truly improved and
comparable to the one observed for mellitin when Glu
residues were replaced by Lys. The capacity of Lys-
modified-pep-1 to kill bacteria is not related with the
capacity to induce leakage [37], this further implying
that pep-1 translocation and vector activity cannot be
explained by a pore formation mechanism.
Considering these results we can conclude that
pep-1 has the capacity to work as a CPP or as an
AMP. The threshold between these two properties relies
on the peptide concentration, the composition of the
membrane, and the final peptide/lipid ratio.
CONCLUSION
Pep-1 translocates and is able to work as a vector
to introduce proteins or other cargo molecules inside
cells. This peptide is able to strongly interact with
the lipid bilayer causing local pertubation, and is also
able to cross the membrane by a physical mediated
mechanism promoted by the transmembrane potential
and not involving pore formation. For many CPPs
endocytosis uptake may be the main mechanism
of uptake but sound evidence show that pep-1
translocates by a mechanism mediated by physical
peptide–membrane interactions when a favourable
transmembrane potential is present. This does not
exclude a possible internalization by an endocytic route
in all situations. Nevertheless, the time required for
the physical mechanism to be completed is lesser
than that for the endocytic uptake. Therefore, if both
mechanisms are operative the non-endocytic route is
dominant. Differences between pep-1 and other CPPs
can be related to the affinity for membrane lipids.
Peptides with higher affinity have a greater propensity to
be internalized by a non-endocytic mechanism. Lower
affinity for membranes can favour endocytic uptake.
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6.2. Cell-Penetrating Peptides and Antimicrobial Peptides: how 
different are they? 
 
The observation that some AMPs can translocate across the cell, without 
damaging cytoplamatic membrane, as well as kill pathogenic agents, has attracted much 
attention. Like CPPs, AMPs are short and cationic sequences with high affinity for 
membranes. Similarities between CPPs and AMPs prompted us to question if these two 
classes of peptides are really unrelated families. In the paper titled: Cell-Penetrating 
Peptides and Antimicrobial Peptides: how different are they?, a critical comparative 
consideration of the mechanisms underneath cellular uptake is reviewed. Various CPPs, 
presenting different membrane affinities and uptake mechanisms, are compared and 
related with antimicrobial activity of some peptides belonging to AMP family. A 
reflection and a new perspective about CPPs and AMPs are exposed.  
Annex I  Chapter 6.  
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Cell-penetrating peptides and antimicrobial peptides:
how different are they?
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Some cationic peptides, referred to as CPPs (cell-penetrating pep-
tides), have the ability to translocate across biological membranes
in a non-disruptive way and to overcome the impermeable nature
of the cell membrane. They have been successfully used for drug
delivery into mammalian cells; however, there is no consensus
about the mechanism of cellular uptake. Both endocytic and non-
endocytic pathways are supported by experimental evidence. The
observation that some AMPs (antimicrobial peptides) can enter
host cells without damaging their cytoplasmic membrane, as well
as kill pathogenic agents, has also attracted attention. The capacity
to translocate across the cell membrane has been reported for some
of these AMPs. Like CPPs, AMPs are short and cationic sequences
with a high affinity for membranes. Similarities between CPPs and
AMPs prompted us to question if these two classes of peptides
really belong to unrelated families. In this Review, a critical
comparison of the mechanisms that underlie cellular uptake is
undertaken. A reflection and a new perspective about CPPs and
AMPs are presented.
Key words: antimicrobial peptide, cell-penetrating peptide, drug
delivery, internalization, translocation mechanism.
INTRODUCTION
The hydrophobic nature of cellular membranes makes them im-
permeable for most peptides, proteins and oligonucleotides. Dif-
ferent strategies have been employed to penetrate the membrane
barrier and deliver hydrophilic molecules inside the cell for either
experimental or therapeutic purposes. So far, microinjection,
electroporation, liposomes and viral vectors have been used.
Most of these delivery strategies have serious drawbacks, such as
low efficiency, poor specificity, poor bioavailability and extensive
toxicity [1]. Moreover, they are time-consuming. The endocytic
route has been used as an alternative for the import of hydrophilic
macromolecules into living cells [2]. However, the proteins
engaging in this mechanism stay enclosed within endosomes,
and so fail to access the cytoplasm, thus missing their final target.
Peptides as vectors to introduce macromolecules into cells
An efficient strategy with which to penetrate the membrane barrier
was identified by the observation that some intracellular proteins,
when added to extracellular medium, were able to pass through the
membrane. Tat (HIV-1 transcriptional activator protein) [3] and
pAntp (Drosophila antennapedia transcription protein) [4] were
the first proteins to be identified with this characteristic. The abi-
lity to translocate is attributed to basic amino acid sequences
in these proteins, and the minimal peptide sequence necessary
for the translocation to occur within Tat [5] and pAntp [6] have
been elucidated. The observation that these basic peptides allow
cellular delivery of conjugated molecules such as peptides [7] or
proteins [8] made these molecules attractive, and a new class of
vectors, initially known as PTDs (protein transduction domains)
[9], but more recently re-baptized as CPPs (cell-penetrating
peptides) [10], emerged. This family now includes all the peptides
with the ability to translocate across membranes, regardless of
whether they are natural, synthetic or chimaeric peptides.
So far, these vectors have been used to translocate a wide range
of macromolecules into living cells, including proteins [8,9,11],
peptides [7,12], oligonucleotides [13,14], peptide nucleic acids
[15] and polysaccharides [16]. Nanoparticles [17] and liposomes
[18] have also been internalized by means of CPPs.
Can AMPs (antimicrobial peptides) also work as vectors?
Most organisms produce gene-encoded AMPs as innate defences
to prevent colonization and infection by several microbial
pathogens [19–22]. Despite their ubiquity, AMPs can have very
distinct sequences and modes of action [23,24]; nonetheless,
they usually share several characteristics, such as their short
length (a few tens of residues) and their cationicity, typically
of charge 4+ or 5+ [25]. Other features of these peptides include
their strong interaction with lipidic membranes, a usually broad
killing spectrum and their ability to preserve host-cell integrity
[23,24].
Clinically these peptides display antimicrobial activity at
micromolar concentrations or less, and target bacteria do not seem
to readily develop resistance. These properties make AMPs very
promising candidates for new generations of drugs to fight anti-
biotic-resistant strains of pathogens [23,26].
Although most AMPs seem to act mainly at the membrane level
[24,25], their translocation into the cytoplasm is not uncommon
[27,28]; because of this property, membrane-crossing AMPs have
also been used as templates for CPP development [29]. Thus
AMPs can have clinical applications both as antibiotics and as
precursors of drug transporters.
HOW DO CPPs TRANSLOCATE ACROSS THE CELL MEMBRANE?
There is no consensus regarding the mechanism of translocation of
CPPs; the information available in the literature is controversial.
First it was suggested that these peptides translocate by a
Abbreviations used: AMP, antimicrobial peptide; CF, carboxyfluorescein; CPP, cell-penetrating peptide; NLS, nuclear localization signal; pAntp,
Drosophila antennapedia transcription protein; SV40, simian virus 40; Tat, HIV-1 transcriptional activator protein.
1 To whom correspondence should be addressed (email castanho@fc.ul.pt).
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Table 1 Source, amino acid sequences and possible internalization mechanism for some examples of peptides that work as CPPs or as AMPs
Name (sequence) Source [reference] [internalization mechanism(s), reference(s)]
Penetratin (RQIKIWFQNRRMKWKK) pAntp homeodomain (amino acids 43–58) [6]
(mainly endocytosis [39], endosomal escape mediated by pH gradient or
transmembrane potential [36,53])
Tat (GRKKRRQRRRPPQ) HIV-1 transcriptional activator Tat protein (amino acids 48–60) [5]
(mainly endocytosis [40], endosomal escape mediated by pH gradient or
transmembrane potential [37])
Pep-1 (Ac-KETWWETWWTEWSQPKKKRKV-cysteamine) Amphipathic chimaeric peptide with a tryptophan-rich domain and an NLS [57]
(physical mechanism mediated by peptide–membrane interaction promoted by
pore formation [60] or by transmembrane potential without pores [35])
S413-PV (ALWKTLLKKVLKAPKKKRKV-cysteamine) Chimaeric peptide with AMP dermaseptin S4 and an NLS [61]
(mainly physical mechanism promoted by a transient membrane destabilization [62])
Magainin 2 (GIGKFLHSAKKFGKAFVGEIMNS) AMP from the skin of the South-African clawed frog Xenopus laevis [101]
(translocation mediated by toroidal pore formation; peptide molecules translocate
stochastically as the pore disintegrates [28])
Buforin 2 (TRSSRAGLQFPVGRVHRLLRK) AMP from the stomach of the Korean common toad Bufo bufo gargarizans [102]
(peptide molecules translocate stochastically after the formation and disintegration
of a non-permeabilizing pore-like structure [84])
Apidaecins (RP - - - - - PRPPHPR (conserved AMP from the lymph fluid of several insects [103]
sequence among class members) (receptor-dependent membrane docking and translocation into target cell [104])
mechanism independent of receptors [30] and independent of
the endosomal pathway [5,6]. A physically driven mechanism
was suggested, because the cellular uptake at 4 ◦C and 37 ◦C was
similar [5,6,30,31].
More recent observations led to controversial results, sug-
gesting that the cell localization observed for CPPs is an artefact
and results from cell fixation for immunochemistry and cell visu-
alization [32]. The high peptide affinity for membranes may allow
CPPs to remain attached to cells during washing. During the cell
fixation process, CPPs are released, and the apparent localization
inside the cell results therefrom. However, direct observation
of translocation in model membrane systems for some CPPs
[33–35] supports the existence of physically driven mechanisms
governed by spontaneous peptide–membrane interactions. The
translocation mechanism issue is thus complex and may differ for
different classes of CPPs (Table 1).
CPPs derived from natural proteins
The CPP derived from pAntp has 16 amino acids and is the
sequence necessary and sufficient for translocation to occur [6]
(Table 1) and is commonly called ‘penetratin’. The Tat fragment
corresponding to residues 48–60 [5] (Table 1), and a shorter
fragment (residues 47–57) [18,36,37], have frequently been used
in CPP research.
An endosomal pathway for internalization was initially ex-
cluded by comparison of the uptake at 4 ◦C and 37 ◦C under fixa-
tion conditions [5,6,30]. After re-evaluation for the interference of
artefacts during fixation, an internalization mediated by endo-
cytosis was concluded for both penetratin [38,39] and Tat peptide
[37,40–43]. The basic amino acids are essential for translocation
to occur, and membrane binding seems to be the first step
prior to endocytic uptake. Heparan sulfate proteoglycans at the
cell membrane were proposed to act as receptor for penetratin
[42,44–46] and Tat peptide [42,47].
Although it is accepted that these CPPs can enter the cells
by endocytosis, there is no consensus in the specific endocytic
pathway used for the import of these arginine-rich peptides. A raft-
dependent pathway involving macropinocytosis [48] or caveolae
[41,49,50], or a clathrin-dependent endocytosis [47,51,52], were
proposed. The dissimilarities among these results can arise from
the use of different cell lines, methodologies, labelled peptides,
protein-conjugated peptides and different conditions, which can
inhibit some pathways while favouring others.
Even in a picture where the endosomal pathway emerges as the
physiological uptake of CPPs, the escape from endosomes into
the cytoplasm through a physically driven mechanism persists.
An escape from endosomes due to acidification was proposed for
penetratin and Tat peptide [36,37]. This hypothesis is supported
by the results obtained by Gra¨slund and co-workers [53] with
penetratin encapsulated in large unilamellar vesicles. The escape
of penetratin occurred only in the presence of a pH gradient. The
role of intracellular pH in the internalization of CPPs was also
investigated using neutralization agents [38].
A dependence of translocation on a negative transmembrane
potential was identified in vitro for both penetratin and Tat peptide
[34] and in vivo for Tat peptide [54]. Terrone et al. [34] suggested
that a fraction of the peptide can transverse through the membrane
by a transmembrane potential-driven mechanism, whereas the
other fraction is internalized by an endosomal pathway. Once in-
side the endosomes, the transmembrane potential (luminal side
positive) drives translocation from the endosomal lumen to the
cytoplasm. By contrast, Drin et al. [38] did not find any internal-
ization of penetratin in liposomes, even in the presence of a trans-
membrane potential. Recently Ba´ra´ny-Wallje et al. [55], following
electrophysiological measurements in planar bilayers, failed to
detect translocation, even in the presence of applied voltages.
Chimaeric peptides
The usefulness of peptides as vehicles to introduce macromole-
cules into cells led to the development of many chimaeric peptides.
Pep-1 (acetyl-KETWWETWWTEWSQPKKKRKV-cysteamine)
is a CPP with primary amphipathicity (i.e amphipathicity resulting
from the amino acid sequence itself, not from the folding structure
[56]) that comprises a tryptophan-rich so-called ‘hydrophobic’
domain, a hydrophilic domain derived from an NLS (nuclear local-
ization signal) of SV40 (simian virus 40) large T-antigen, and a
c© 2006 Biochemical Society
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spacer between them [57]. A cysteamine group is present at the
C-terminus [57] (Table 1).
Pep-1 has been used to introduce large proteins inside cell lines
[57–59]. An endosomal pathway was rejected because (1) there
was no difference in translocation efficiency at 37 ◦C and 4 ◦C [57]
and (2) no co-localization of a delivered protein (β-galactosidase
from Escherichia coli) with different cellular organelles (early
endosomes, caveosomes and lysosomes) was detected [59]. By
contrast, Weller et al. [58] proposed an endosome-mediated mech-
anism based on the internalization of Pep-1–protein complexes in
the presence or absence of endocytic inhibitors.
Deshayes et al. [60] proposed a transient transmembrane-pore-
like structure promoted by α-helix conformation of the hydro-
phobic domain when it interacts with membranes. This conclusion
was not corroborated by other groups, because no membrane leak-
age was detected [35,58]. An alternative mechanism, mediated
by electrostatic peptide–lipid interactions, was proposed after
observation that Pep-1 translocation both in vitro [35] or in vivo
[59] only occurs in the presence of a transmembrane potential.
When Pep-1 was modified at the C-terminus [lack of cysteamine
group and grafting of a CF (carboxyfluorescein) group], the mem-
brane affinity and the translocation efficiency was truly impaired,
but a small uptake seems to occur by an endocytic mechanism
[16].
The chimaeric peptide S413-PV, which results from the combi-
nation of a 13-amino-acid sequence derived from the dermaseptin
S4 (S413 domain) with the NLS from SV40 large T-antigen (see
Table 1), was proposed as a potential vehicle to introduce macro-
molecules into cells [61]. The uptake of this peptide under non-
fixation conditions was not decreased in the presence of endocytic
inhibitors [62]. An endocytic uptake was only evident at low
peptide concentration [63]. The binding of the S413-PV peptide to
the cell membrane is promoted by electrostatic interactions with
negatively charged components at the cell surface, and a confor-
mation change in the S413 domain upon insertion into the bilayers
was detected [62]. The translocation of S413-PV across the cell
membrane is considered to be a consequence of a transient mem-
brane destabilization produced by peptide–membrane interactions
[62]. Endosomal internalization at low peptide concentration
suggests that higher peptide concentrations are necessary to
induce membrane destabilization.
Translocation mechanism or mechanisms?
Considering the abovementioned examples, it is clear that the
mechanism by which CPPs translocate across cell membrane and
deliver their cargoes in the cytosol is far from being totally under-
stood. Although some CPPs are able to translocate by an endocytic
pathway, the escape from endosomes demands a physically driven
mechanism.
The affinity of each CPP for lipid bilayers may be the key factor
for their main mechanism of uptake. Penetratin, for instance, does
not show a strong affinity for zwitterionic membranes [46,64,65]
and does not induce significant membrane destabilization [66].
Interaction with model membranes only occurs in negatively
charged lipid bilayers [46,65]. In studies of the interaction of this
peptide with eukaryotic cells, negatively charged proteoglycans
presented at the cell surface were regarded as essential for trans-
location to occur [42,44,45]. Cellular uptake of penetratin occurs
via endocytosis, but requires the expression of proteoglycans [42],
which demonstrates the importance of electrostatic interactions in
increasing the affinity of the peptide for cell membranes [45].
By contrast, Pep-1 has a high affinity for lipidic membranes,
even in the absence of negatively charged phospholipids or pro-
teoglycans [67], and it induces significant membrane destabi-
lization [35], which seems to favour internalization. Moreover,
the introduction of a CF dye into the hydrophilic domain of
Pep-1 and/or deletion of a cysteamine group decreased the
peptide’s affinity and, consequently, its uptake [16,58], and a
slight internalization by endosomal pathway occurs [16]. This
suggests that the membrane affinity and the capacity to destabilize
it dictate the extent to which a peptide enters the cell by a physical
mechanism (a fast process during which the endosomal pathway
may be considered stationary) to the detriment of the endosomal
pathway.
The hypothesis of the co-existence of endosomal and physically
mediated mechanisms was also proposed by Boisseau et al. [68]
in a study with maurocalcine, a CPP isolated from the Israeli gold
scorpion (Scorpio maurus palmatus). A contribution of both me-
chanisms was identified where the physically driven mechanism
results from a transmembrane potential. Moreover, Nakase et al.
[69] showed that greater amounts of oligo-arginine were found
in the cytoplasm when cells were incubated at 4 ◦C than at 37 ◦C.
They proposed that, when endosomal pathways are inhibited and
an alternative pathway can operate, the peptide is more efficiently
translocated to the cytosol. When incubation is at 37 ◦C, oligo-
arginine release in the cytoplasm is difficult, owing to endosome
entrapment.
Translocation by a physical mechanism demands not only the
existence of a high membrane affinity, but also a promoting force:
pH gradients [53] and transmembrane potentials [34] are two poss-
ible driving forces. The existence of such driving forces is well
understood in the cell context, where in/out media are char-
acterized by the preservation of gradients.
HOW DO AMPs GET INSIDE CELLS?
The mechanisms by which AMPs gain access to a cell’s interior
can be classified as pore-dependent and pore-independent, the
former being the most usual. In fact, there are relatively few AMPs
that do not exert their main function via cell lysis, membrane
permeabilization or other forms of bilayer disruption. Few AMPs
attack internal targets, and, of those, only a small number can do
so without membrane perturbation [70].
AMPs that induce membrane permeabilization
After the initial peptide–membrane interaction, mechanisms
diverge; besides lysis, usually by a mechanism known as the
‘carpet’ model [71,72], two other models have been proposed for
AMP pore formation: the barrel-stave pore and the toroidal pore
(for further detailed information, see references [73,74]).
Independently of the pore type, diffusion of free peptide through
the pore may not be the principal process of translocation; instead,
it has been proposed that it is the peptide molecules that are in-
volved in pore formation that stochastically translocate as the pore
disintegrates [28]. Several factors support this statement, the most
relevant being the fact that, for AMPs, the local concentration
of membrane-bound peptide molecules is usually several orders of
magnitude higher than in the aqueous phase (e.g. [75,76]); as
such, there will be many more peptide molecules available for
pore formation than for pore crossing. In addition, pore diameters
are relatively narrow and usually not longer than the length of the
peptides (alamethicin barrel stave pores have a diameter of 2–3 nm
[77] and those of toroidal mellitin have a diameter of 3–4 nm [74]),
preventing or hindering a free diffusion of the peptide; lastly, pore
lifetimes are in the microsecond-to-millisecond range (between
40 µs for magainin and 200 ms for dermaseptins [28,78]), which
is long compared with a single-molecule translocation time, but
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probably not long enough to quickly equilibrate inner and outer
peptide concentrations.
Given this hypothesis, pore formation can be regarded not only
as a membrane perturbation process, but also as an important
intermediate step towards cellular invasion by AMPs. This is
in agreement with recent findings that indicate that a synergic
effect of activity at both membrane and cytoplasm levels may be
required to fully explain the mechanisms of some pore-forming
AMPs [79–81].
Non-lytic AMPs
For AMPs that preferentially attack internal cellular targets,
similar translocation mechanisms have been reported: for buforin
2, which translocates efficiently, but with little membrane activity
[70,82,83], the structure and orientation in the bilayer have been
observed to be very similar to those of magainin 2 (Table 1)
[83,84]. From these results a model was proposed whereby buforin
2 molecules would form a toroidal pore, just as magainin 2 does,
but less stable; this would result in shorter pore lifetimes – with a
concomitant decrease in permeabilization – at the same time that
the translocation rate would increase because pore disintegration,
which is the actual translocation step, would become more
frequent [83,84]. This model is supported by results that show
that the presence of bilayer components that prevent the formation
of toroidal pores (such as dioleyl phosphatidylethanolamine [28])
inhibit buforin 2 translocation, whereas anionic phospholipids,
which decrease the charge repulsions between the cationic peptide
molecules, stabilize the pore to a point that significant leakage
and flip-flop is observed [84]. Buforin 2 translocation has also
been shown to withstand cargo addition, as demonstrated by the
attachment of green fluorescent protein [29,85], which makes this
peptide a promising candidate for its development into a CPP.
Other mechanisms of translocation
Apidaecins, which are another class of non-lytic AMPs that are
able to kill bacteria with undetectable membrane permeabili-
zation, act by binding to a cytoplasmic target (Table 1) [86]. In this
case, translocation has been proposed to occur by specific inter-
action with a putative membrane permease or transporter in the
target bacterial cell; this was suggested by the fact that the all-D
enantiomers of the peptides lose the ability to cross the membrane
[86]. This characteristic confers a high selectivity on these pep-
tides, which can even be modulated [87], but, on the other hand,
the need for a membrane transporter makes apidaecins unap-
pealing as templates for CPP design.
Despite their apparent simplicity, many AMPs have been shown
to possess activity-specific regions: through sequence manipula-
tion it has been possible to regulate translocating behaviour, target
specificity or antimicrobial efficiency [87–89]. By means of these
alterations, it has become possible to broaden the spectrum of CPP
template candidates beyond non-cytotoxic translocating AMPs.
This has been taken advantage of, for example, in the derivatives
of the membrane-active Bac7 peptide [29,88,90], which, unlike
their precursor, are not membrane-disruptive, but have retained
translocation capabilities.
CPPs AND AMPs OR JUST MEMBRANE-ACTIVE PEPTIDES?
Membrane translocation is a corollary for membrane permeabili-
zation. Although treated differently by people interested in CPPs
and AMPs, the ability to reach the inner leaflet of lipid bil-
ayers is of crucial importance to both. Potentially, all CPPs are
AMPs and all AMPs are CPPs. At high enough concentration, pep-
tides reported as CPP perturb membranes and become membrane
permeabilizers (see reference [91], in which antimicrobial activity
of different CPPs is evaluated), whereas AMPs may reach cyto-
plasmatic targets before membrane permeabilization. This is
not surprising, because both CPPs and AMPs are very similar
molecules: short cationic peptides. It should be stressed that both
classes cannot be differentiated on account of their structure
because there is a wide diversity of conformations within each
class of peptides [25,92]. The attention devoted to both CPPs
and AMPs is very application-oriented, which dictates why
these very similar classes of molecules are considered in such
a separate fashion. CPPs are mainly studied by people focusing
on gene therapy and drug delivery. AMPs are mainly regarded as
tools to fight bacterial infections. However, from the molecular
mechanistic point of view, the separation of these peptides into
two groups is really rather academic.
Cellular membranes of target cells where the activity of these
two peptides are evaluated are quite different. CPPs are generally
evaluated against mammalian cells, whereas the target of AMPs
is the bacterial cell. The major differences rely on anionic-lipidic
and cholesterol contents. The bacterial membrane has a higher
percentage of negatively charged lipids and does not contain
sterols [24]. Different effects reported with CPPs and AMPs
can arise from the differences in membrane composition, factors
which modulate peptide affinity and membrane destabilization.
Considering the overlap between the mode of action of CPPs
and AMPs, it does not seem reasonable to obstinately seek an
exclusive answer to the question whether CPPs enter cells through
endocytic or physical processes. As indicated above in the present
Review, depending on circumstances, the same peptide may
potentially use both [16,63,68]. Moreover, endocytic entrapment
has to be followed by physical membrane translocation if the
peptide is to reach the cytoplasm. The physical pathway can be
mechanistically described by the interaction equilibrium between
the peptides in the medium and the outer leaflet of membranes,
perturbation of bilayers, translocation among leaflets and a
second equilibrium of the peptides between the inner leaflet of
the membrane and the reducing conditions of the cell interior
[67,93–95] (Figure 1). A more effective or faster formation of a
membrane-disturbing structure, mediated by the AMP magainin,
was identified when a transmembrane potential was present [96].
Certain chimaera peptides, such as Pep-1, may even be con-
sidered a ‘blend’ between AMPs and CPPs. Although reported
as a CPP, Pep-1 is a strongly amphipathic cationic peptide,
rich in basic amino acids and tryptophan, having a proline residue
in its sequence. These are classical characteristics attributed to
AMPs. The ability to cysteine-bridge monomers, which greatly
improves translocation efficiency, further increases the similar-
ities to AMPs. Not surprisingly, Pep-1 uses mainly physical routes
to translocate membranes [35,57,59]. However, this route is not
always operative [16], and endocytic pathways are alternatives.
The results obtained with Pep-1 confirm the co-existence of
endocytic and physically mediated pathways. Such co-existence
was previously proposed by other authors [97] using other CPPs,
but this proposal was largely overlooked. The kinetic factor
is important, as progress through physically driven pathways is
rapid compared with that through endocytic pathways: when
both physical and endocytic pathways are operative, the physical
pathway is dominant, owing to faster kinetics [67,93].
These peptides are able to destabilize the membrane (fusion and
vesicle aggregation were detected) without evidence for pore
formation or flip-flop [35,66]. A ‘membrane-thinning’ effect was
proposed for the AMP magainin 2 [98], in which the peptide
aggregates on the surface of the membrane and the decreased local
surface tension allows the peptide to intercalate the membrane.
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Figure 1 CPP translocation by a physically driven process can be regarded
as a composite of three sequential steps
(A) The peptide (dark-grey cylinder) inserts in the bilayer outer interface (light-grey head-groups
with fatty acid tails) and causes local membrane perturbation. (B) Owing to a membrane gradient
(e.g. transmembrane potential, pH gradient) or concentration effects, the peptide overcomes
the hydrophobic core of the bilayer by an unknown mechanism. (C) The peptide is released
from the inner leaflet of the membrane (blue head-groups with fatty acid tails) to the cytoplasm.
In a model artificial system (e.g. a vesicle) the system would tend to an equilibrium that can
be accounted for by three different partition constants, one for each of the elementary steps
(A, B and C).
Flexible sealing between peptide side groups and lipid head-
groups minimize leakage during the peptide passage through the
membrane [29].
A pore-formation mechanism was proposed for MPG (a 27-
residue amphipathic peptide) and Pep-1 [60,99], which is also
a common mechanism used by antimicrobial peptides. In the
case of a transmembrane pore, a large pore would be necessary
to allow the passage of attached macromolecules, a situation
that compromises cell viability and all the significance of these
peptides as vehicles. In some cases pore formation can explain
the translocation of the peptides per se; however, these pores are
not large enough to explain the translocation of proteins [28].
The history of CPP research can be summarized from two dif-
ferent periods, with a sudden change of paradigm in 2001 [32],
later confirmed in 2003 [100]. First, the physical paradigm domi-
nated. CPPs were considered to cross bilayers by a physical
process. Since 2001–2003 there has been a tendency to think the
opposite. Reality may not be so black-and-white, and this rather
simplistic view of physically driven versus endocytic mechanisms
seems inadequate. The CPP research community should go back
to basics and redefine CPPs on the basis of their cargo trans-
location ability rather than their stand-alone peptide properties.
Most of the CPP research focuses on the peptides’ membrane-
translocation ability in the absence of cargoes. It is thus crucial to
develop new methodologies to detect and quantify translocation
of peptide-mediated cargo translocation in vesicles and cells.
As to the peptides themselves, and their interaction with lipid
bilayers, it may be that the frontiers between fusogenic peptides,
AMPs and CPPs become so undefined that, in the near future,
only the unified broad-scope title of ‘membrane-active peptides’
will make sense.
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6.3. How to address CPP and AMP translocation? Methods to 
detect and quantify peptide internalization in vitro and in vivo? 
 
 
To guarantee that a specific peptide works as a CPP, its ability to cross the 
membrane is of first importance. Despite the fact that most AMPs exert their activity at 
the membrane level, translocation of some of them has been shown. The experimental 
methods to evaluate and quantify peptide translocation are of first importance in CPP 
and AMP field. Several methods for the assessment of membrane translocation have 
been reported in the last decades; however the information is scarse and spread over the 
literature. In the paper titled: How to address CPP and AMP translocation? Methods to 
detect and quantify peptide internalization in vitro and in vivo? we review the different 
methodologies described in the literature. Advantages and disadvantages associated to 
each methodology are presented in order to help others to find the most appropriate 
method for their studies.  
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Abstract
Membrane translocation is a crucial issue when addressing the activity of both cell-penetrating and antimicrobial peptides.
Translocation is responsible for the therapeutic potential of cell-penetrating peptides as drug carriers and can dictate the
killing mechanisms, selectivity and efficiency of antimicrobial peptides. It is essential to evaluate if the internalization of cell-
penetrating peptides is mediated by endocytosis and if it is able to internalize attached cargoes. The mode of action of an
antimicrobial peptide cannot be fully understood if it is not known whether the peptide acts exclusively at the membrane
level or also at the cytoplasm. Therefore, experimental methods to evaluate and quantify translocation processes are of first
importance. In this work, over 20 methods described in the literature for the assessment of peptide translocation in vivo and
in vitro , with and without attached macromolecular cargoes, are discussed and their applicability, advantages and
disadvantages reviewed. In addition, a classification of these methods is proposed, based on common approaches to detect
translocation.
Keywords: Cell-penetrating peptides, antimicrobial peptides, membrane translocation, peptide uptake, evaluation of peptide
internalization
Introduction
The introduction of hydrophilic molecules into
mammalian cells has become a key strategy for the
investigation of intracellular processes and drug
therapy. Several methods have been devised to
achieve this goal, but they all have limitations [1].
Some peptides are able to translocate across cell
membranes with low toxicity [25] and to mediate
cellular uptake of proteins [3] and other macromo-
lecules [6,7]. These peptides are known as cell-
penetrating peptides (CPPs) but the CPP designa-
tion is now generalized for all the peptides with the
ability to translocate across membranes even when
cargo uptake properties are unknown. They include
natural, newly synthesized and chimeric peptides
[8]. Beside the ability to translocate through cell
membrane, these peptides are normally character-
ized as short, cationic, water-soluble peptides with
high efficiency and low cytotoxicity [9]. The me-
chanism used by CPPs to pass the membrane is not
well understood and is a controversial topic in the
literature. At the beginning the internalization me-
chanism of CPPs was generalized and considered to
be endocytosis-independent [2,5]. Nowadays there
is experimental evidence for both endocytic and
non-endocytic routes (for further information see
[9,10]). Considering the information available in the
literature a unique mechanism for all the peptides
does not seem reasonable and more than one
mechanism can operate for a single peptide [10].
Ribosomal antimicrobial peptides, or AMPs, are
efficient antibiotics against a variety of microbial
pathogens [1114]. These peptides are usually short
and cationic [15] such as CPPs, but they are also
characterized by a strong interaction with cellular
membranes, and by the ability to selectively attack
pathogens without disturbing host cell integrity
[16,17]. AMPs are potential candidates of a new
antibiotic generation against multiresistant bacterial
strains [16].
Despite the fact that most AMPs exert their
principal activity at the membrane level [15,17],
translocation processes have been shown to occur for
many of them [18,19]. Considering this, AMPs are
natural templates for designing cell-penetrating
Correspondence: Miguel A. R. B. Castanho, Centro de Quı´mica e Bioquı´mica, Faculdade de Cieˆncias da Universidade de Lisboa, Ed. C8,
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molecules, which can be developed into carriers
[9,20]. AMPs and their derivatives are thus very
promising molecules to use both as antibiotics and as
drug transporters.
To guarantee that a specific peptide works as a
CPP, its ability to cross the membrane and the
capacity to transport attached cargoes is of first
importance. Regarding AMPs, internalization is not
a prerequisite and the biological efficiency of AMPs
can be evaluated without translocation assessment.
However the characterization of such membrane
processes is of great value both in the development
of new antibiotics and in the design of templates for
CPPs [10].
In this paper we will review methods that are
available to evaluate peptide uptake into cells or
vesicular model membranes.
Methods used to evaluate peptide uptake
Assessment of peptide translocation without attached
cargo or labelled with a fluorescent probe
In vivo methods. The CPPs internalization mechan-
ism is a matter of vibrant discussion in the literature.
To evaluate if CPPs are internalized by endocytosis
the dependence of translocation on temperature, or
in the presence of specific endocytic inhibitors must
be assessed in vivo. The intrinsic fluorescence of Trp
or Tyr residues cannot be used to investigate peptide
internalization in vivo, due to the relatively large
cellular background fluorescence in the near-UV.
Therefore, CPPs are normally derivatized with
fluorophores such as Rhodamine B (Rh) [2124],
Fluorescein [5,2532] and Nitrobenzoxadiazole
(NBD) [24,33]. Alternatively, the properties of
macromolecular cargoes can be used. In most of
the methods described in this section, peptide
fluorescence is the experimentally measured signal.
However the need to derivatize a peptide can be a
limitation not only due to experimental and costly
requirements but also because the presence of a dye
may alter its properties [34].
Available methods for the in vivo detection of
peptide internalization can be divided into three
categories: quantification of cytosolic concentration,
direct visualization of internalization and peptide
activity analysis.
Quantification of cytoplasmic concentration. Quantifi-
cation of cytoplasmic concentration is usually car-
ried out by means of direct measurement of
fluorescence emission of peptides. In these methods,
elimination of the non-internalized and cell-
adsorbed peptide fractions is required to avoid an
overestimation of peptide internalization; conse-
quently, extensive washing procedures, including
trypsinization and centrifugation, are required
[21,22,29,30,35,36]. Quenching of peptide fluores-
cence is an alternative to annihilate non-internalized
peptide signal [24,33,37].
A cell lysate should be prepared and the fluores-
cence intensity of labelled-CPP in supernatant
measured [29,32]. The washing procedures can be
responsible for a signal reduction, due to sample loss
and fluorescence bleaching. An additional limitation
is the necessity to distinguish the peptide fluores-
cence from the cell background fluorescence; to
assure a good signal/noise ratio the fluorophore
should be chosen carefully to avoid overlap with
intrinsic cellular fluorescence emissions and to
circumvent a fast fading of fluorescence. For in-
stance, Trp fluorescence of peptide can hardly be
used due to the intrinsic fluorescence of cellular
proteins. The fluorescence of cellular NAD(P)H
(/460 nm) and FAD (/530 nm) is an additional
concern. A high amount of cellular sample should be
used to provide a good emission signal and controls
without fluorophore in the same conditions (e.g.,
cell number and washing procedures) must also be
used; a calibration curve should be prepared to allow
quantification of internalization. In this case, abso-
lute quantification of the internal peptide concentra-
tion may also require information on the total
cellular volume.
Oehlke et al. developed a method to discriminate
membrane surface-bound, membrane-inserted and
internalized peptide fractions [38]. To obtain quan-
titative information on the peptide fraction asso-
ciated with plasma membrane and the peptide
fraction actually internalized, the exposed peptide
was treated with diazotized 2-nitroaniline. This
procedure modifies the peptide fraction bounded
to the surface, without damaging the cell [39].
Bound and internalized fractions were detected by
HPLC analysis of cell lysates and quantified by
spectrofluorimetry (5(6)-carboxyfluorescein-N-hy-
droxysuccinilmide esterlabelled peptide detected
with excitation at 445 nm and emission at 520 nm).
The fraction of surface bound peptide is strongly
modified by the diazo reagent which renders the
peptide completely undetectable in HPLC chroma-
togram (there is a strong retention of highly hydro-
phobic modified products on the stationary phase of
the HPLC column). The fraction of peptide inserted
into plasma membrane is slightly protected from
the attack of the diazo reagent, so this fraction is
only partially modified. The fraction of peptide
inaccessible to the diazo reagent is the internalized
fraction [38].
Flow cytometry analysis by fluorescence activated
Cell Sorter (FACS) is a tool to quantify cellular
174 S. T. Henriques et al.
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association of a fluorophore-labelled peptide. A large
number of cells are analysed and dead cells are
identified by propidium iodide staining [21,22,30,
32,33,35,40]. The cell subpopulation displaying
significant fluorescence emission is identified and
quantified, and the CPP uptake is measured as the
cell-associated fluorescence intensity. An absolute
quantification of the internalized amount of peptide
requires either a comparison with a standard [41] or
the use of additional methods, such as the ones
described above. The need to wash/quench the
membrane-bound peptide fraction, also applies for
flow cytometry analysis.
A kinetic evaluation of the translocation process
has been obtained by testing the inaccessibility of
externally added trypan blue to fluorescein-labelled
peptides [42]; the rationale behind this approach is
shared by many methods described for in vitro
translocation studies (see below).
Matrix-assisted laser desorption ionization-time-
of-flight mass spectroscopy (MALDI-TOF MS) has
been used to evaluate the exit of internalized
peptides from cells into the culture medium
[32,43], to detect peptide internalization and to
investigate intracellular degradation [32,36,4345].
This method allows the direct detection of the
peptide and uptake quantification [44]. The sample
(extracellular or intracellular supernatant) has to be
concentrated to improve the signal. Elmquist and
Langel proposed a procedure where samples are zip-
tipped, analysed by MALDI-TOF MS and com-
pared with synthetic peptides for a quantitative
analysis [32,43]. Instead of synthetic peptides the
quantification of the internalized CPP can be
achieved with an internal standard with the same
sequence but labelled with deuterium. Peptides are
biotinylated and, after cell lysis, they are captured by
streptavidin-coated magnetic beads. Finally, beads
are washed and analyzed by MALDI-TOF MS and
the absolute amount of internalized peptide is
determined. This procedure is also adequate to
know if the peptide has been degraded during
sample preparation or inside the cell [44]. Inherent
disadvantages in this method are the necessity for
specialized and expensive procedures, and equip-
ment to obtain peptide quantification. Moreover, it
is rather time-consuming.
Direct visualization of internalization. In early studies,
CPP internalization into cells was studied by fluo-
rescence microscopy or in fixed cells where the
fluorescence emission of a peptide-derivatized probe
was directly visualized [5,26,33,46]. Internalization
of some AMPs has also been identified by a
fluorescent label and visualized under the confocal
microscope. For instance, biotin-labelled polyphe-
musin I [47] and FITC-labelled buforin II [48] were
detected in the cytoplasm of E. coli without dama-
ging the membrane; FITC-labelled magainin 2 was
detected on the E. coli cell wall [48]. Internalization
in mammalian cells was also observed with biotin-
labelled LL-37 and localization in the perinuclear
region was detected [49]. Alternatively, the presence
of peptides in cells can be detected by immuno-
fluorescence; for example, the localization of LL-37
was visualized with a specific antibody [49].
Fixation procedures can bias the location of
peptides in cells as the illusionary presence of
peptides inside cells can arise from the high affinity
of cationic peptides to cell surface [50]. Therefore,
peptide internalization in cells has to be compared in
fixed and non-fixed conditions [27,30]. Cell treat-
ment with trypsin to digest the peptide at cell surface
[27,30,32], or quenching of peptide fluorescence has
to be performed to remove the interference of the
membrane-bound fraction. In these conditions it is
possible to distinguish a deep localization inside the
cell from membrane adsorption [24]. With confocal
microscopy different cellular plans can be used to
confirm, or refute, peptide internalization.
Peptide activity analysis. In this class of methodolo-
gies, the effect of the peptides in the cytosol or in the
membrane is evaluated. AMP translocation in vivo
has been inferred from observations of intracellular
damage (e.g., [51]) or morphological alterations of
bacteria [5254].
In other reports, the peptide interaction with
membranes was evaluated by electrophysiological
transmembrane current measurements in oocytes
[55,56]. With this setup it is possible to have access
to both sides of lipidic membranes and it is not
necessary to derivatize the peptide with a fluoro-
phore. However, this detection can be ambiguous
because transbilayer current can arise from the
activation of endogenous channels in oocyte mem-
branes. In order to rule out this possibility these
experiments should be repeated on artificial lipid
membranes [57]. In addition, only qualitative
information about translocation can be obtained
unless a quantitative relationship between trans-
membrane current and internalization is assumed.
Lastly, the occurrence of membrane destabilizations
induced by peptides is not a proof of their ability to
translocate across the membrane and reach the
cytoplasm.
In vitro methods. Various biophysical approaches
have been used to study peptide-lipid interaction in
model bilayers. When CPPs are internalized by a
physically-driven translocation mechanism, peptide-
lipid interactions are truly important. Application of
CPP and AMP translocation 175
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in vitro methods to evaluate the internalization of
CPP is, however, scarce; on the other hand, AMP
translocation has been essentially studied using
model membranes. Nevertheless, in vitro studies
face some difficulties and limitations. Large unila-
mellar vesicles (LUV), or small unilamellar vesicles
(SUV), are the most used membrane models for the
in vitro study of peptide-bilayer interactions. But,
detection of peptide entry into the vesicular lumen is
not easy. Theoretically, in a simple setup, it is
possible to encapsulate an aqueous phase entity
that could report peptide proximity or interaction
(a quencher, or a fluorescence resonance energy
transfer (FRET) acceptor for Trp fluorescence for
example) and use it to probe the translocation event.
However, the feasibility of this task can be hampered
by several factors (see worked examples in part 1 of
the Supplementary material in the online version).
Several methods have been proposed to overcome
these limitations, for instance peptide-lipid FRET
(e.g., between Trp-labelled peptide and Dansyl-
PE-labelled lipidic vesicles) and/or permanent
alteration of the peptide either in or out of the
vesicles (e.g., peptide digestion by trypsin) [18,19].
A classification of methods can be devised regarding
the peptide location with respect to the bilayer:
(i) detection of entrapped peptide lack of accessi-
bility from the outer phase, (ii) detection of inward
peptide positioning within the membrane, (iii) direct
detection of peptide in the inner phase, and
(iv) detection of encapsulated peptide escape. Be-
cause of the many possible combinations of techni-
ques and experimental setups some reported
methods do not fall within the given categories,
therefore, a fifth group of ‘unclassified methods’ is
also presented. This classification differs from the
one used for the in vivo methods mostly because for
in vitro a wider range of approaches to the assess-
ment of translocation have been described.
A schematic representation of in vitro methods
from all the classes, with focus on the fluorescence
methodologies, is depicted in Figure 1.
Detection of entrapped peptide lack of accessibility from
the outer phase. A semi-quantitative determination of
translocation can be performed by detection of
peptide inaccessibility to a non-translocating entity
[19,24,5860] after incubation with the model
membranes (see Figure 1, panel A). For example,
translocation of AMP magainin 2 was identified by
the observation that the percentage of inaccessible
peptide increases with peptide-lipid incubation
time [19]. To perform this experiment trypsin was
used to digest peptide after interaction with accep-
tor-labelled lipid vesicles. It was shown that proteo-
lysis-dependent FRET reduction decreases with
incubation time before trypsin addition. It was thus
concluded that the peptide becomes inaccessible to
trypsin with time. This is consistent with peptide
translocation.
This concept can be used with different external
components, for instance non-labelled vesicles to
desorb the peptide from the labelled vesicles [19,60].
An inverted setup has also been reported where the
peptide (in this case, labelled with NBD or bimane
fluorophores) was incubated with the non-labelled
vesicles and desorption was induced by addition of
acceptor-labelled anionic vesicles [59] (a FRET
increase, rather than a decrease, was detected in
this case). The use of NBD-labelled peptides and
addition of dithionite ion as the non-translocating
entity is another possibility; in this case, the NBD
fluorescence intensity was measured without the
need to label the vesicles [24,59]; dithionite acts in
a way similar to digestion by trypsin in that the NBD
reduction/quenching is permanent. In all these
approaches, an estimation of the translocation
kinetics can be obtained by adding the non-translo-
cating component at different incubation times
[24,59].
It should be noted that in all these methods a
time-dependent measurement is required to deter-
mine the degree of peptide inaccessibility (as ex-
plained in detail in section 2 in the Supplementary
material online).
These methods have a number of disadvantages:
first, they are unable to discriminate membrane-
bound and internalized peptide; second, in the case
of lysis, which can occur for AMPs, peptide popula-
tions in inner and outer layers could be accounted as
accessible, resulting in a low extent of apparent
translocation; finally, not all of these methods are
compatible with all peptides: for instance some
AMPs are resistant to trypsin proteolysis (e.g.,
Polymixin B and Gramicidin S) [18]. In addition,
when using trypsin, extents of translocation may be
overestimated if the peptide fragments also interact
with the membrane.
Detection of inward peptide positioning within the
membrane. In this category, the passage of the
peptide to the inner leaflet of the bilayer is mon-
itored. In all the reports where this method is used
[19,61,62], internalization is evaluated by the use of
vesicles with asymmetric labelling. The fluorophore
in membranes is a FRET acceptor for Trp-contain-
ing peptides (see Figure 1, panel B).
Wimley and White developed a methylcoumarin
derivatized lysophospholipid (LysoMC). This lipid
is easily incorporated into bilayers (into both bilayers
or only into the outer one) and is able to act as an
efficient Trp-fluorescence acceptor/quencher [63].
176 S. T. Henriques et al.
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This probe was initially used to characterize the in-
depth membrane distribution of Trp-containing
peptides [63], but more recently, Norden and co-
workers have developed a method in which LysoMC
is used to specifically test translocation; in addition,
they described a procedure where is possible to use
LysoMC to selectively label the inner layers [61,62].
Experimentally, translocation information is ob-
tained by comparison of emission spectra of inner
leaflet LysoMC-labelled vesicles in the presence and
absence of the peptide. The Trp residues are donors
for FRET. An increase in FRET efficiency in the
presence of the peptide means internalization; how-
ever, because some outer-to-inner bilayer FRET
may occur, it becomes necessary to compare the
obtained results with controls where translocating
(tryptophan octyl esther [63]) or non-translocating
(Ac-18A-NH2: Ac-DWLKAFYDKVAEKLKEAF-
NH2 [63]) Trp-containing molecules are used
[61,62].
Matsuzaki and co-workers had already described a
similar method to assess peptide translocation in
which vesicles are labelled only on the outer leaflet,
with the tryptophan FRET acceptor DNS-PE [19].
With this method it is possible to follow the FRET
change during time with a single sample and an end-
point approach for each incubation time is not
required. Experimentally, after peptide addition,
there is an initial increase in FRET efficiency (this
corresponds to a peptide partitioning to the outer
Figure 1. In vitro methods for translocation assessment, using FRET and quenching methodologies. Peptide molecules are represented by
empty rectangles and additional non-translocating compounds by circles; peptide molecules that have interacted with those compounds are
dashed; phospholipids labelled with an acceptor for the peptide’s fluorescence are indicated by light grey headgroups. (A) Measurement of
the inaccessibility of the peptide to a non-translocating entity with the ability to digest, sequester or permanently quench it; the interaction
between the two prevents the peptide from acting as a FRET donor to the labelled phospholipids; small FRET reductions will indicate that
the peptide was protected from that interaction; this indicates that the peptide is buried in the membrane or is located in lumen.
(B) Detection of inward peptide movement; after the initial adsorption interaction of the peptide with asymmetrically acceptor-labelled
vesicles (despite the representation, both inner-leaflet and outer-leaflet labelling can be used), translocation or membrane penetration
processes causes the mean distance between peptide and labelled phospholipids to increase (assuming an outer-leaflet labelling) and a
concomitant reduction of FRET. If the peptide has quenching capabilities, a quenchable probe can be used to symmetrically label the
vesicles; translocation can then be identified by full probe quenching, which is only possible if the peptide reaches the inner bilayer surface.
(C) Detection of peptide in the inner phase; in the case of translocation, digestion by encapsulated trypsin (solid circles) reduces the overall
amount of peptide available for membrane interaction and, consequently, FRET between peptide and labelled-membrane; trypsin
inhibition (dashed circles) is required in the outer phase, prior to peptide addition. (D) Detection of encapsulated peptide escape; in the
event of translocation, the peptide fluorescence decreases as it becomes accessible to an externally added, non-translocating quencher; the
quencher can, alternatively, be co-encapsulated with the peptide, and the quenching reduction monitored instead. The figure is reproduced
in colour in Molecular Membrane Biology online.
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leaflet); with time, a decrease in FRET efficiency is
observed (which corresponds to translocation where
peptide is no longer close to the FRET acceptor in
the outer leaflet). With this method, a kinetic
analysis of the translocation event can be carried
out. Quantitative information may be obtained if
additional methods are used to quantitatively relate
FRET intensity to luminal peptide concentration.
With these methodologies, peptides do not need
to be derivatized and small peptide and lipid con-
centrations can be used (0.7mM and 100mM respec-
tively [61]). With these methods, in-depth location
of peptide can be erroneously measured as translo-
cation; inaddition, they cannot be used with peptides
that induce lipid flip flop (FRET acceptor bilayer
asymmetry is lost). So far this methodology has been
applied only to Trp-containing peptides, although
the use of others donor/acceptor pairs is also
possible.
Direct detection of peptide in the inner aqueous phase.
Methods based on this principle are able to detect
the presence of peptides in the inner luminal
aqueous phase. With this approach actual transloca-
tion, rather than just membrane internalization, is
measured (see Figure 1, panel C).
Three different approaches fit in this class of
methods. In the first, described by Matsuzaki and
co-workers [19], encapsulated trypsin and a peptide-
lipid FRET system (Trp-containing peptide and
Dansyl chromophore incorporated in vesicles) is
used: trypsin is added at the hydration stage of the
preparation of symmetrically labelled vesicles; after
extrusion, non-encapsulated trypsin is inhibited by a
trypsin inhibitor. Upon addition of the peptide to
this system, an increase in acceptor fluorescence
through FRET is expected as the peptide enters the
bilayer; if the peptide is not internalized afterwards,
the fluorescence intensity is expected to remain
constant after the initial increase. However, if the
peptide translocates into the vesicle lumen, it be-
comes accessible to the uninhibited trypsin and is
digested; assuming that the resulting fragments
do not interact with the membrane, this degradation
of the peptide will lead to a decrease of the amount
of peptide in the bilayer and consequent reduction of
FRET. A quantitative analysis of the extent of
translocation can be easily carried out considering
that 100% translocation implies the digestion of all
the peptide molecules and absence of FRET; the
fluorescence intensity of the system should be the
same as in the absence of the peptide. Conversely,
0% translocation will correspond to the maximum
fluorescence intensity right after the peptide addition
[18,19]. This method cannot be applied to proteo-
lysis-resistent peptide and/or without Trp residues
(e.g., Polymixin B and Gramicidin S) [18]. At high
translocation efficiency, membrane perturbation
caused by peptide fragment accumulation inside
vesicles can cause difficulties in internalization
quantification. In addition, there is the possibility
of digested fragments re-entering the membrane,
which can lead to a translocation underestimation.
A second method that detects the presence of the
peptide in the inner aqueous phase was recently
developed by Ba´ra´ny-Wallje et al. In this method the
experiment is performed with planar lipid mem-
branes (PLMs) and the distribution of fluorescently-
labelled peptides, between the two compartments
and partitioned in PLM, is followed by confocal
fluorescence spectroscopy [64]. This powerful
method allows the direct scanning of fluorescence
intensity and quantification of peptide in each
compartment. Another advantage is the possibility
to easily generate asymmetric aqueous phase condi-
tions: a transmembrane potential can be set without
the need for ionophores [64]. Besides the need to
label the studied peptides (and care must be taken to
choose a photostable label), this method has the
disadvantage of requiring an uncommon setup with
a custom PLM trough.
Another possible method to evaluate peptide
translocation with model membranes is to follow
peptide interaction with giant vesicles (GVs). With
this method direct visualization of peptide interac-
tion with membranes is possible by confocal micro-
scopy. The translocation of peptide across these
vesicles can be confirmed by the presence of the
fluorophore inside the vesicles [64,65]; in this case,
just as with the methodology described for fluores-
cence imaging of in vivo internalization, the use of
confocal analysis is crucial to distinguish whether the
peptide is inside the vesicle or only adsorbed at the
membrane surface. As with the PLM method
described above, the peptide has to be derivatized
with a fluorophore, which should be carefully chosen
to avoid photobleaching.
With GVs it is possible not only to directly
visualize the peptide inside the vesicles but also to
evaluate its effect on membrane properties: mem-
brane integrity can be followed with a labelled lipid
such as N-Rh-PE (the fluorochrome has to be
different from the one used to label the peptide),
and the possibility of pore formation can be eval-
uated in GVs loaded with two similar dyes attached
to other molecules of very different sizes (for
instance Alexa488-Dextran (MW 10000) and
Alexa546-maleimide (MW/1300)). This experi-
mental setup enables direct observation of changes
in the membrane permeability during the course of
observations and in the case of pore formation to
178 S. T. Henriques et al.
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have information on pore size due to sequential
escape of the dyes from the GVs [66,67].
Detection of encapsulated peptide escape. Using a
fluorescence quenching assay, Magzoub et al. had
developed methodologies in which the escape of a
CPP from liposomes is determined in the presence
and absence of a pH gradient [68] (see Figure 1,
Panel D). To track the peptide escape two assays
based on encapsulation were carried out: (i) vesicles
were prepared with the peptide inside and the Trp
quencher acrylamide was added to the outer phase
(the escape of peptide from liposomes was followed
by fluorescence quenching of peptide Trp residues
caused by acrylamide); (ii) fluorescein-labelled pep-
tides were encapsulated with a quencher (iodide)
and, in the case of translocation, a de-quenching of
the fluorescein label was observed. The fluorescence
intensity corresponding to 100% peptide escape was
determined by vesicle lyses with Triton X-100 and
the fraction of peptide escape was calculated at
different incubation times [68].
Both these approaches allow the quantification of
translocation as well as the determination of mem-
brane crossing kinetics. Under certain situations,
however, both methods can lead to misleading
conclusions: in method (i) acrylamide is excluded
from membranes, so only the fraction of peptide that
reaches the outer aqueous environment is accounted
for (if the peptide remains essentially partitioned in
the outer leaflet after crossing the membrane, a
lower translocation extent is measured); in method
(ii) if the peptide does not translocate but has a deep
location in the bilayer, it becomes inaccessible to the
encapsulated quencher and is counted as having
crossed the membrane.
In these methods if the peptide translocates very
efficiently a significant amount of peptide can escape
from the liposome during the gel filtration step (used
to remove non-encapsulated peptide); therefore,
these methods are only applicable to peptides that
require special conditions to translocate (such as pH
or potential membrane gradients), so that mem-
brane crossing can be triggered only after the
separation procedure.
Another peptide escape assay was described by
Ba´ra´ny-Wallje et al. in which vesicles uniformly
preloaded with peptide both in the lumen and outer
medium are dialysed so that any peptide outside of
the liposomes is washed away [64]. If any peptide
absorption/fluorescence remains after the dialysis,
it can be concluded that translocation from the
lumen/inner leaflet to the outer side did not occur;
conversely, the occurrence of translocation can
be inferred from the absence of any peptide signal.
Due to the very simple setup and instrumentation
requirements, this seems a good option to begin a
translocation study with; however, there are a
number of disadvantages that are addressed in
section 3 of the Supplementary material online.
Other methods. A methodology based on a particular
peptide property was developed in reference [69].
For this purpose, the specific fluorescence quench-
ing of Rh by the CPP pep-1 was taken advantage of.
Vesicles labelled symmetrically with N-Rh-PE were
used to evaluate fluorescence emission quenching of
Rh by pep-1 in the presence and absence of a
transmembrane potential. After the peptide is added
to LUVs, Rh fluorescence in the outer layer is
quenched. If translocation occurs, it can be identi-
fied by a further reduction in Rh fluorescence due to
contact of the peptide with Rh in the inner leaflet.
The effect can be improved by using labelled multi-
lamellas vesicles (MLVs): the fraction of Rh-PE
available for peptide access is smaller than if LUVs
are used, therefore a much larger relative increase in
quenching is expected if the peptide translocates and
accesses all the phospholipids [69]. Alternatively,
soluble Rh can be encapsulated in vesicles and its
fluorescence followed after peptide addition [69].
This method allows measurements to be taken
during a time course, enabling the kinetic evaluation
of the translocation process. Its main disadvantage is
that it is only applicable to peptides that are able to
quench a given fluorophore.
Another method using MLVs has been reported
[60,70]: dithionite ion was externally added to
NBD-PE-doped MLVs, resulting in quenching of
the fluorophores in the outermost leaflet; upon the
addition of a pore-forming peptide the dithionite ion
will have access to the first intramembranar space of
the MLVs, resulting in an increase in quenching; full
NBD quenching, however, will only be attained if
the peptide can translocate and form pores in the
inner bilayers because only then will all the fluor-
ophore become accessible to the dithionite ion.
This method does not require any peptide label-
ling or intrinsic fluorescence but, on the other hand,
this can only be applied to peptides that perturb the
membrane to an extent where dithionite can cross it
(by a pore or otherwise). Kinetic information can be
extracted but it is necessary to take into considera-
tion the multiple membrane crossing steps.
Assessment of peptide translocation with attached cargo
The translocation process of CPPs may vary if the
peptide is in free form or attached to a cargo.
Differences in peptide kinetics and cell localiza-
tion can occur [7173]. In the above described
methodologies the only attached ‘cargoes’ were
CPP and AMP translocation 179
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fluorophores. The nature and size of the cargoes and
the nature of attachment to the peptide (whether
covalent [3,74] or weaker [7,75]) can also be a
determinant for the translocation mechanism. Given
these differences, development of consistent meth-
ods to evaluate the capacity to translocate/deliver
proteins across artificial/natural membranes would
be fruitful to systematically confirm (or refute)
vector properties of CPPs. Practically all methods
described above for in vivo or in vitro testing can, in
principle, be extended to assess the translocation of
CPP-cargo complexes, although no reports on such
usage were found; however, some properties of the
macromolecule attached to the peptide are addi-
tional advantages to detect and quantify transloca-
tion, opening the possibility for more sensitive
methodologies. Three methods that have been
reported for the in vivo studies and one for the in
vitro studies of the internalization of CPP-cargo
complexes are discussed here; while these can easily
fit into the above classification, they are presented
separately to underscore their importance in con-
firming the vector properties of a CPP.
Morris et al. had observed the efficiency of pep-1
to deliver GFP [75] and a similar approach demon-
strated the ability of the AMP buforin 2 to translo-
cate across bilayers with a macromolecular cargo
[76]. Recombinant proteins with CPP and GFP
domains have also been produced [7779]. Instead
of GFP, Wadia et al. labelled TAT-Cre recombinase
by coupling it to Alexa 488 or Alexa 546 fluoro-
phores [80]. GFP or Cre recombinase translocation
is followed by its intrinsic fluorescence; this is in all
aspects identical to what was previously described
for the in vivo direct visualization of internalization.
Another possibility to measure Cre recombinase
translocation mediated by TAT is by recombination
reporter assay, where the expression of enhanced
GFP (EGFP) is dependent on TAT-Cre transduc-
tion into cells, followed by nuclear import. The
signal of EGFP is followed and measured as a
consequence of TAT-Cre import [80].
Detection of b-Gal delivery into cells was also
reported. Translocation was assessed by monitoring
the X-Gal staining enzymatic activity of b-Gal
[75]. The detection of the enzymatic activity of the
cargo not only allows a sensitive detection of the
Figure 2. To evaluate the translocation of b-Gal/pep-1 (hexagons/rectangles) complexes across model membranes the following steps were
reported [81]: (1) valinomycin was added to K-loaded vesicles in Na-buffer to create a negative transmembrane potential; the complex
was added to the solution and translocated across bilayer; (2) trypsin (circles) was added to digest non-incorporated complex and free pep-1
or b-Gal (dashed hexagons/rectangles); (3) after digestion, trypsin was inhibited (dashed circles) with phenylmethylsulfonyl fluoride and
TX-100 was then added to facilitate the release of internalized b-Gal and allow its quantification (digestion debris were excluded from the
last two panels, and inhibited trypsin from the last, to avoid image crowding); (4) b-Gal activity was assayed by MUG (black triangles)
hydrolysis to a fluorescent product, 4-MU (lighter triangles). The figure is reproduced in colour in Molecular Membrane Biology online.
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internalized CPP-cargo complex, but also tests
whether CPP-mediated translocation can occur
without cargo damage/denaturation. A quantifica-
tion of b-Gal internalization was developed by
means of its enzymatic activity on the substrate 4-
methylumbelliferone b-D-galactopyranoside (MUG),
a non fluorescent substrate that is converted to 4-
methylumbelliferone (4-MU), which is a fluorescent
product. 4-MU production enables quantification of
protein internalization from its activity [37,81].
Another possibility to evaluate protein delivery
efficiency is by immunofluorescence, using a pri-
mary antibody raised against the carried protein and
a fluorescently labelled secondary antibody, as was
preformed with b-Gal [81]. This method is inde-
pendent of particular cargo properties; therefore, it
is suited to study the transport of cargoes that do not
have intrinsic fluorescence or detectable enzymatic
activity. With these methodologies it is possible to
obtain cell transfection efficiency, but not the
quantification of peptide/protein internalization.
Protein uptake was also evaluated in vitro with
pep-1/b-Gal, by taking advantage of the b-Gal
enzymatic activity and 4-MU fluorescent properties
(see Figure 2). Briefly, after peptide/protein incuba-
tion with LUVs, trypsin was added externally to
digest the non-incorporated peptide and b-Gal;
afterwards, phenylmethanesulfonyl fluoride (PMSF)
was added to inhibit trypsin. To induce LUV
permeabilization and leakage of the incorporated
b-Gal, Triton X-100 was added, and enzymatic
activity of b-Gal was determined by MUG hydrolysis
[81]. Intrinsic cargo fluorescence and/or enzymatic
activity are specific properties that can be used
for application of a similar methodology to other
peptides/proteins complexes.
The classification and the general advantages and
disadvantages of the application of each reviewed
method are summarized in Table I.
For all the methods presented here, it is possible
to conclude about the ability of peptides to translo-
cate. When further information is sought, quantita-
tive analysis should always be carefully carried out;
for this, several different complementing methodol-
ogies should be conjugated, regarding not only the
actual evaluation of translocation but also to quan-
tify the peptide distribution between the membrane
and aqueous environments and to characterize the
membrane topology upon peptide interaction (oc-
currence of membrane thinning, pore formation,
lysis, etc.).
Concluding remarks
Because most methods for the assessment of mem-
brane translocation have only been reported during
the last decade, it is understandable that this field is
regarded as being underdeveloped, methodology-
wise [18]. In addition, the description of new
methods has not always been given the due emphasis
by their authors, which further contributed to the
lack of visibility of these procedures. Yet, over 20
methods that address the assessment of membrane
translocation have been found. The authors of this
work hope that the gathering of this knowledge will
help others find and use the most appropriate
methods for their studies. On the other hand, this
compilation should by no means be regarded as an
ultimate source for information on translocation
assessment methodologies in a way that the devel-
opment of new methods, or the improvement of
already described ones, is discouraged. Rather, by
exposing the strengths and weaknesses of several
methodologies, it is hoped that the development of
newer and better methods is encouraged and facili-
tated.
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Supplementary Material
Problems associated with the detection of entry
of peptide into vesicles
At usual lipid concentrations, used to perform in vitro
studies, the volume occupied by the vesicles is very
small when compared to the bulk aqueous phase: for
100 nm diameter LUVs, produced at a total lipid
concentration of 1 mM, and assuming a mean
membrane surface area of 0.7 nm2 per phospholipid
[1], the ratio of luminal volume over the total volume
will be about r/0.003 v/v. Another problem arises
from the fact that these peptides usually have large
molar ratio partition constants towards lipidic mem-
branes (about 103 to 104, e.g., [2,3]). This means
that only a small concentration of peptide will be in
the aqueous phase unless relatively low lipid con-
centrations are used. Given the above-mentioned
obstacles, it is clear that methods based on the
detection of the concentration of internalized peptide
will have to deal with very low signal intensities that
will likely lie below instrumental detection limit.
Comments on time-dependent measurements
It should be noted that in all the methods presented
in the section Measurement of peptide inaccessibility
from the outer phase a time-dependent measurement
is required to determine the degree of peptide
inaccessibility: because the amount of free peptide
in the outer phase will decrease  as it is digested,
sequestered or permanently quenched  the inter-
nalized peptide will equilibrate back to the outer
phase. Consequently, two stages are expected: in the
first, signal magnitude increases (here ‘signal’, in a
very broad sense, can be FRET reduction, FRET
increase or fluorescence reduction, depending on the
particular method used), detecting the adsorbed/
non-internalized peptide fraction; then a second
stage ensues with a usually slower signal increase
[4,5], which corresponds to the detection of the
internalized peptide molecules that are returning to
the outer phase. At equilibrium, the signal magni-
tude should be approximately the same whether
translocation has occurred or not. The percentage of
accessible peptide is usually obtained by comparing
the end of the first stage with a control where
peptide, membrane and the non-translocating entity
are added simultaneously [4, 5]. From this, it can be
seen that, in a hypothetical situation where the
translocation kinetics were of the same magnitude
of the desorption kinetics, this method would be very
difficult to apply as both stages would have the same
approximate slopes and the end of the first stage
would be hard to detect. On the other hand,
information about translocation kinetics could, in
principle, be obtained from the rate at which the
peptide molecules return to the outer phase, in the
second stage.
Advantages and disadvantages associated with
the dialysis method
Due to the very simple setup and instrumentation
requirements for this experiment (see the section
Detection of encapsulated peptide escape) this seems a
good option to begin a translocation study with,
because membrane crossing may be ruled out
immediately avoiding the need to use more complex
and costly methodologies. However, in order for this
method to provide a measurable absorbance/fluores-
cence peptide signal in the absence of translocation
it is required that the amount of internalized peptide
be relatively large, to compensate for the effect of the
small encapsulation volume. This is only possible to
attain if the peptide partitions strongly towards the
bilayer and the lipid concentration is high enough:
under these conditions, upon vesicle preparation,
the peptide molecules can be expected to be equally
distributed by the inner and outer leaflets and very
few to be left in the aqueous phase; in the absence of
translocation, roughly one half of the peptide signal
will remain, correspondent to the peptide molecules
partitioned in the inner leaflet. Should the peptide
partition weakly to the membrane or there be a small
lipid concentration, the inner leaflet peptide fraction
could be undetected in the absence of translocation,
which would generate a false positive. This limita-
tion has to be accounted for by quantifying the
extent of membrane interaction. Other disadvan-
tages include the lengthy dialysis process and the
lack of any kind of translocation characterization,
which makes this method more suited to rule out,
rather than ascertain, peptide translocation.
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7.1. Neurotoxicity of PrP(106-126) revisited. A biophysical study 
with model membranes. 
 
During this PhD project other peptide was studied, PrP(106-126), a prion protein 
fragment considered to be responsible for toxicity in prion disease. The exact 
mechanism behind PrP(106-126) toxicity is largely unknown. In similarity with pep-1, 
PrP(106-126) has an amphiphatic structure. In this work the possibility of PrP(106-126) 
to translocate across the membrane by a related mechanism was studied. Once inside the 
cell, PrP(106-126) could become toxic. This was the hypothesis tested. Fluorescence 
and UV-vis spectroscopies, CD spectroscopy and surface Plasmon resonance were used 
to carry on these studies.  
Fluorescence and UV-Vis methodologies were used at the Molecular Biophysics 
laboratory in FCUL, while CD spectroscopy and surface plasmon resonance were 
carried out at Monash University in Victoria, Australia.  
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Part of the obtained results are presented in a first version of the manuscript, 
titled: Neurotoxicity of PrP(106-126) revisited. A biophysical study with model 
membranes. This will be shortly submitted. 
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ABSTRACT 
 
Transmissible spongiform encephalopathies are neurodegenerative diseases with 
characteristic accumulation of an abnormal isoform of the prion protein, PrPSc. Its 
fragment 106-126 was reported to maintain most of the pathological features of PrPSc 
and a role in neurodegeneration has been proposed based on the modulation of 
membrane properties and channel formation. Nevertheless, this issue is quite 
controversial in the literature. In the case channels are formed the peptide-membrane 
interactions should be the key feature to explain the toxicity of PrPSc. In the present 
work we examined the interaction of PrP(106-126) with model membranes by surface 
plasmon resonance and fluorescence methodologies. A comprehensive study where 
different conditions, such as: membrane charge, viscosity, lipid composition, presence 
of ganglioside, pH and ionic strength, were tested, modulated, and compared. PrP(106-
126) has a very low affinity for lipidic membranes at physiological conditions. Only in 
extreme conditions, where strong electrostatic interactions are operative, insertion in 
lipid bilayer and leakage were detected. These results support the hypothesis of the 
requirement PrPC to mediate PrP(106-126) toxic effects in neuronal cells. 
 
Keywords: Prion Disease, Fluorescence methodologies, Model membranes, Surface 
Plasmon resonance, Pore formation. 
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INTRODUCTION 
 
Prion diseases, also known as transmissible spongiform encephalopathies (TSE), are 
human and animal diseases, characterized by progressive neuronal loss often 
accompanied by a spongiform brain alteration and the deposition of amyloid fibrils. 
These diseases appear in sporadic, familial and infectiously acquired forms and are 
invariably fatal without evoking in the host any inflammatory or immune response [1]. 
The interest in prion diseases has grown from the emergence of bovine spongiform 
encephalopathy and the possible infection of human beings [2].  
This pathology is initiated by a post-translational modification of a glycoprotein called 
prion protein (PrP) abundantly expressed in the central nervous system (CNS) of 
mammalian species. A pathological scrapie form, PrPSc, interacts with the physiological 
form, PrPC, which is converted into another scrapie form molecule (PrPSc + PrPC → 2 
PrPC). This conversion occurs by a mechanism not well understood and is likely to take 
place at cell surface, more specifically in rafts domains, where the PrPC is preferentially 
located due to its glycosylphosphatidylinositol (GPI)-anchor (see [3, 4] and references 
therein). 
These two PrP isoforms possess different physico-chemical properties: PrPC has an α-
helical structure susceptible to enzymatic digestion, while PrPSc has a large amount of 
β-structure contribution and is resistant to proteolysis. With this conformation, highly 
insoluble aggregates are formed within the brain and seem to be responsible for the 
neurological damages that occur in this disease [5].  
PrPSc aggregates are not the only cause of pathology and the time course of its 
accumulation is not coincident with the time course of neurodegeneration [6]. The 
observation of PrPSc accumulation in intracellular compartments and the identification 
of some other forms of PrP (transmembrane forms [6] and a cytosolic form [7]) suggest 
that the endosomal pathway can also be involved in disease propagation where all these 
forms can be involved and take part on the propagation of the disease (see [6] and 
references therein).  
Among all the synthetic peptides that have been tested, the fragment spanning human 
PrP region 106-126 (KTNMKHMAGAAAAGAVVGGLG) was identified as the most 
highly amyloidogenic region, with the capacity to readily form fibrils [8, 9], with 
neurotoxic activity [10] and partially resistant to proteolysis [11]. Regarding these 
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observations it was postulated that the PrP(106-126) may be a major contributor to the 
physico-chemical and pathogenic properties of PrPSc [12] with a role in amyloid 
formation and in the nerve cell degeneration occurring in prion-related 
encephalopathies, therefore it was proposed as a model peptide of PrP infectious form 
[11]. PrP(106-126) sequence is present in all abnormal PrP isoforms accumulated in the 
patients brain [12] suggesting that this region may possess the ability to trigger or 
enable a fundamental pathogenic mechanism common to different forms of Prion 
disease [13].   
The amphiphatic primary structure of PrP(106-126), characterized by two domains, one 
hydrophilic (KTNMKHM) and other hydrophobic (AGAAAAGAVVGGLG), suggests 
an ability to interact with cell membrane [14]. Previous studies of the interaction of PrP 
(106-126) with model membranes show that the pH and ionic strength are of first 
importance both on secondary structure and interaction with membranes [8, 15]. An 
increased affinity for membranes at acidic pH together with a concomitant increase in β-
sheet content support the hypothesis of endosomal pathway involment in PrPSc 
formation/propagation through the neuronal cells and a possible effect of PrP(106-126) 
fragment in the Prion disease toxicity. Not only the formation of fibril aggregates but 
also membrane pore induced by PrP(106-126) may be a possible explanation for PrP 
toxicity, as shown by electrophysiological studies [16, 17]. However, pore formation 
[18] and neurotoxicity [19] were not confirmed by other groups. Moreover Fioriti et al, 
had not found evidences for PrP(106-126) infection or ability for conversion of PrPC to 
PrPSc or to any other toxic PrP species [13]. Furthermore, it was suggested that PrP(106-
126) is not toxic by itself, it becomes toxic only in the presence of PrPC form [13, 20]. It 
was proposed that it toxicity results from an alteration of physiological functions of 
PrPC instead of an effect induced by the PrP(106-126) fragment per si [13]. 
Therefore, the existence of a physiological role for this peptide remains unclear in the 
literature. If a toxic effect in fact exists, peptide-membrane interactions are the key 
feature to explain it effects. This prompt us to perform a study of the interaction of 
PrP(106-126) with model membranes. These experiments were carried out by Surface 
Plasmon Resonance (SPR) with supported lipid bilayers and by fluorescence 
spectroscopy methodologies with large unilamellar vesicles (LUVs). Peptide affinity to 
membranes, kinetics of peptide interaction, effects on membrane stability, and the 
possibility of pore formation were addressed. Different conditions such as: membrane 
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charge, viscosity, lipid composition, pH, and ionic strength were studied. The 
interaction with membranes appears to be relevant only at low ionic strength and high 
anionic-phospholipids contents, which are non-physiological conditions, and no 
evidence for pore formation was detected. This supports the hypothesis that PrP(106-
126) toxicity can be explained by a loss/modification of biological PrPC function within 
neuronal cells in opposition to this peptide being toxic by itself.  
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MATERIALS AND METHODS 
 
Materials 
PrP(106-126) with purity higher than 95% was obtained from Genscript corporation 
(piscataway, New Jersey); 2-(4-(2-Hydroxyethul)-1-piperazinyl)ethanesulfonic acid 
(HEPES), sodium chloride, L-Tryptophan, acrylamide, ethanol and chloroform 
spectroscopic were obtained from Merk (Darmstadt, Germany); 1-Palmitoyl-2-Oleoyl-
sn-Glycero-3-Phosphocholine (POPC), 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-(Phospho-
rac-(1-glycerol)) (POPG), 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-(Phospho-rac-(1-serine)) 
(POPS), 1,2-Dipalmitoyl-sn-Glycero-3-phosphocholine (DPPC) and 1-Palmitoyl-2-
Oleoyl-sn-Glycero-3-(phospho-L-serine) (POPS), 1,2dipalmitoyl-sn-glycero-3-
phosphoethanolamine-N(7-nitro-2-1,3-benzoxadiazol-4-yl) (N-NBD-PE), and 
monoganglioside GM1 were obtained from Avanti Polar-Lipids (Alabaster, Alabama); 
congo red (CR), Thioflavin T (ThT), (3-[3-Cholamidpropy)-dimethyl-ammonio]-1-
propanesulfonate (CHAPS) and Cholesterol (chol) were obtained from sigma (St. Louis, 
Missouri); tris-(2-cyanoethyl)phosphine (phosphine), 1-anilinonaphthalene-8-sulfonic 
acid (ANS) and 4-(2-[6-(dioctylamino)-2-naphthalenyl]ethenyl)-1-(3-sulfopropyl)-
pyridinium (Di-8-ANEPPS) were obtained from molecular probes (Eugene, Oregon).  
 
Working conditions and apparatus  
PrP(106-126) was dissolved in sterile water with 2mg/mL (1.05mM). Throughout this 
study, pH effect was evaluated comparing cytoplasmatic physiological conditions (10 
mM HEPES, pH7.4 containing 150mM NaCl) with pH5 to mimic endosomal medium 
(20mM Sodium Acetate, pH 5 containing 150 mM NaCl). The effect of low ionic 
strength was evaluated at pH5 (20mM Sodium Acetate, 10mM NaCl). Assays were 
performed at room temperature (25ºC). UV-vis spectrophotometer Jasco V-560 was 
used for UV-vis measurements. Steady-state fluorescence measurements were carried 
out in a Spex ® FluoroLog-3 (Horiba Jobin Yvon) with double excitation and emission 
monochromators and a 450W xenon lamp. SPR measurements were performed in a 
Biacore T100 (GE Healthcare) with a series S sensor chip L1. Circular Dichroism (CD) 
measurements were done on a Jasco J-810 spectropolarimeter equipped with a 
temperature unit control.  
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Intermolecular β-structures determined by Thioflavin T and Congo Red 
The presence of β-structures was analysed by fluorescence emission of ThT [21] and 
CR absorbance [22, 23]. Titration of 15µM ThT with PrP(106-126) was followed by 
fluorescence spectra with λexcitation=450nm.  
CR absorption was followed by titration of 5μM CR with PrP(106-126) stock solution 
for final peptide concentrations in the range 0-50μM.  
 
Peptide aggregation followed by ANS fluorescence 
The effect of peptide concentration on PrP(106-126) aggregation was followed by 
means of ANS fluorescence emission [24-26] with excitation at 369nm; 12.8μM ANS 
(A369~0.1) was used through the experiments.  
 
Lipid vesicles preparation for peptide-membrane studies 
Large unilamellar vesicles (LUVs) are good model membranes due to their large radii 
of curvature and because they are equilibrium structures [27]. With these model 
membranes different properties can be modulated (e.g. lipid charge, membrane 
viscosity, the presence of a sterol, the effect of pH and ionic strength). Using different 
lipidic mixtures is possible to explore selected membrane properties on peptide 
insertion. LUVs were prepared by extrusion method as previously stated [28]. Briefly, 
lipid solutions in chloroform were dried under a stream of N2 and residual organic 
solvent was removed in vacuum chamber overnight. The lipidic film was hydrated with 
buffer and subject to eight freeze-thaw cycles to produce multilamellar vesicles 
(MLVs). MLVs were extruded through polycarbonate filters (400nm and 100nm pore 
size filter two and eight times, respectively), to obtain LUVs. For SPR measurements 
vesicles were prepared by the same procedure but extruded with a 50nm pore size in 
order to obtain smaller vesicles, more unstable and easier to fuse at chip surface. 
 
Peptide affinity for lipidic membranes followed by SPR 
Interaction of PrP(106-126) with lipidic bilayers was studied by SPR. Liposomes 
composed by different lipidic mixtures (POPC, POPC/POPG (20% POPG molar), 
POPC/Chol (33% Chol molar) and POPC/GM1 (10% GM1 molar)) were prepared as 
stated above. For lipid deposition on chip surface, LUVs (1mM lipid concentration) 
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were injected across the L1 chip for 40min at a flow rate of 2μL/min; with this 
procedure an equilibrium level was reached. The signal obtained varied with lipidic 
composition, but was reproduced for each composition though the assays.  
A short injection of 10mM NaOH (36s at a flow rate of 50μL/min) was used to remove 
loosely bound LUVs with a final stabilization period of 300s, which resulted in a stable 
baseline. The response units of lipid membranes immobilized on the chip were in the 
range 5000-11000, depending on the liposome lipidic composition.   
Peptide solutions with different concentrations (0-50μM) were injected over the lipid 
surface for 180s at 20μL/min, and dissociation was followed for 600s. The sensor chip 
surface was washed with injection of 20mM CHAPS (60s, 5μL/min), 10mM NaOH in 
20% MeOH (36s, 50μL/min) and 10mM NaOH (36s, 50μL/min), with a final 
stabilization period of 600s. All solutions were freshly prepared and filtered through 
0.22μm pores. The operating temperature was 25ºC. The procedure was followed 
maintaining the conditions to ensure that the experimental conditions are comparable 
between experiments as far as possible.  
The affinity of peptide for the lipid bilayer membrane was determined from analysis and 
curve fitting of a series of response curves collected with different peptide 
concentrations. When appropriate, association and dissociation rate constants were 
globally fitted using BIAevaluation version 3.0. 
 
Secondary structure by CD spectroscopy 
CD measurements were performed to have insights on PrP(106-126) secondary 
structure. CD spectra in absence and presence of LUVs composed by POPC/POPG 
(20% POPG molar percentage) (2mM final lipid concentration) were carried out with 
100μM PrP(106-126) in a quartz cell with an optical path of 0.1cm at 25ºC. For this 
particular experiment, samples were prepared in buffer containing NaF instead of NaCl. 
Wavelengths from 260 to 190nm were recorded with a 0.1nm step and 20nm/min speed. 
Spectra were collected and averaged over 5 scans and corrected for background 
contribution.  
A peptide lipid/ratio of 1:20 was used. Lower peptide lipid ratios are normally advised 
(e.g. 1:100) however in this particular case it was not possible (10mM of lipid would be 
necessary which would greatly contribute for dispersion). In the case of alteration of 
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secondary structure upon interaction with lipid, an effect on CD spectrum should be 
evident.  
 
Membrane effects induced by the presence of PrP(106-126) 
Pore formation was tested for different lipid compositions with 100µM final lipid 
concentration and was evaluated with a methodology based on NBD fluorescence 
quenching by Co2+ ions (see ref [29] and references therein). To follow permeability to 
Co2+ ions, vesicles doped with 1% of N-NBD-PE were prepared with or without 20mM 
Co2+ inside and outside (positive control). For positive control, lipid was hydrated with 
buffer containing 20mM Co2+; therefore, quencher is accessible to NBD in the outer and 
in the inner layer. This control was compared with samples where Co2+ was added after 
vesicle preparation; in this case Co2+ is accessible only to outer layer. In the case of pore 
formation, after peptide addition, Co2+ will become accessible to the NBD fluorophores 
in the inner layer. Addition of different PrP(106-126) concentrations was carried out (0-
50µM). Controls with the different peptide concentrations were performed. PrP(106-
126) was left to incubate for 30 min and Co2+ was added to the samples. NBD 
fluorescence emission spectrum was followed with λexcitation = 460 nm before and after 
PrP(106-126) addition. Data were corrected for the inner filter effect [30]. Control 
samples with Co2+ outside and inside vesicles were carried out at the same conditions. 
For this particular assay MLVs were used instead of LUVs. Usage of MLVs enables a 
gradual effect in case of translocation after pore formation and therefore a more reliable 
reading of the spectroscopic signal. Several lipid mixtures were used: POPC/POPG (0, 
5, 10, 20 and 50% molar POPG); POPC/Chol (33% molar chol) and POPC/POPG/Chol 
(47, 20 and 33 molar respectively).  
 
Dipolar potential in the presence of PrP(106-126) and the pH gradient effect 
Membrane dipolar potential is dependent on the orientation of dipoles in the 
membrane/water interface. Variations of the membrane dipole potential can be used to 
report membrane binding and insertion of molecules by recording fluorescence 
excitation spectra of di-8-ANEPPS-labelled vesicles which are particularly sensitive to 
dipolar potential variations [31]. 25μM PrP(106-126) was added to LUVs with 200μM 
lipid and 4μM of dye (di-8-ANEPPS is not fluorescent in aqueous medium). To detect 
spectral variations in di-8-ANEPPS excitation the spectrum (λemission=570nm) in the 
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absence of the peptide was subtracted from the spectrum in the presence of 25μM 
PrP(106126) (both spectra were normalized to total integrated area). This differential 
spectrum enables detection of peptide-induced changes on the membrane dipolar 
potential [31, 32]. Fresh solutions and aging peptides (48h, 37ºC) were used in these 
experiments. Several lipid compositions were used: POPC/POPG (0, 20, 30, 40, 50 and 
100% molar POPG) to evaluate the charge effect; POPC/POPS (20% molar POPS) to 
test any particular effect with serine; POPC/Chol (0, 18 and 33% molar Chol) to 
evaluate the effects of the presence of cholesterol; POPC/GM1 (0, 5, 10, 20 and 50% 
molar GM1) and a mixture of POPC/POPG/Chol/GM1 (37, 20, 33, 10% molar, 
respectively) was also used to test if the mixture would improve the interaction with 
membranes. Liposomes with a pH gradient (pH=5.0 inside and pH=7.4 outside 
liposomes) were prepared in order to mimetize the environment at the 
liposome/cytoplasm interface. POPC/POPG (50% molar percentage) vesicles were 
tested. Controls with pH=7.4/pH=5 (in/out); pH=7.4 (in/out) and pH=5 (in/out) were 
performed.  
 
RESULTS 
 
It has been suggested that PrP(106-126) has a role in PrPSc- PrPC association and also in 
prion disease propagation and amplification [6], which is dictated by its physico-
chemical properties. Several activities have been attributed to this peptide but so far its 
contribution in Prion disease is not clarified (see references [6, 13] and references 
therein). In this study it is our main goal to elucidate the membrane role on the activity 
of this PrP fragment.  
The endosomal pathway may be implicated on PrPSc synthesis and propagation [3, 33-
35]. PrPSc synthesis is likely to occur during PrP recycling through the endosomal 
pathway. Exogenous prions could initiate infection by entry through the endosomal 
pathway to induce the conversion of PrPC molecules from cell surface to PrPSc [35]. 
Moreover toxic forms of PrP have been identified in endosomal pathway and have been 
suggested to play a role in neurotoxicity which cannot be explained solely by fibril 
formation [6]. In this regard, PrP(106-126) interaction with membranes was studied not 
only at pH7.4, but also at pH5 to evaluate pH effect on peptide-membrane interaction 
and possible differences in cytoplasm/endosomal environment.  
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PrP(106-126) aggregates in aqueous solution and forms amyloid fibrils  
Previous studies had shown that PrP(106-126) tends to aggregate and to form β-
structures as the scrapie PrP isoform [9, 10]. In order to verify if the same occurs in 
conditions of the present study, the formation of β-structures aggregates was tested by 
the fluorescence of ThT and also by the absorbance of CR. These two dyes are widely 
used to detect the formation of amyloid structures [25].  
In the absence of β-sheet aggregates, the ThT dye has an excitation and fluorescence 
emission maxima at 350 and 438nm, respectively. In the presence of amyloid fibrils the 
ThT spectra shift to 450nm and 482nm, respectively [21]. During titration of ThT with 
PrP(106-126) a slight increase in the fluorescence intensity at 482nm, characteristic of 
ThT interacting with β-sheet structures was observed (data not shown). This effect is 
not strong, but some β-sheet-rich proteins are unable to induce the characteristic ThT 
fluorescence [36]. CR absorbance was used to further study if this peptide has a 
significant β-sheet conformation. In the case of amyloid fibrils formation a red-shift in 
CR absorbance spectrum at physiological pH is expected [22, 23]. At pH 7.4, 150mM 
NaCl the CR maximum appears at 489nm. When CR was titrated with PrP(106-126) a 
red shift in absorbance spectra was observed (Figure1A), due to an increase of the 
component at 535nm (see differential spectra inset in Figure1A). At pH 5, 150mM 
NaCl, the CR absorbance spectrum peaks at 502nm which is blue shifted in the presence 
of PrP(106-126) (Figure1B). An increase at 496nm is detected in differential spectra 
(see inset in Figure1B). The direct comparison of the effects on CR absorbance at pH5 
and pH7.4 is not straightforward because CR absorbance properties change with pH 
[15]. However it is possible to conclude that at pH7.4 and pH5 PrP(106-126) is able to 
interact with CR and this strongly suggests β-sheet conformation.  
 
As a final test, the possibility of peptide aggregation was also followed by ANS 
fluorescence. This dye is sensitive to the polarity of its micro-environment and is 
frequently used to identify the presence of hydrophobic “pockets” in proteins and 
peptides [24-26]. In the presence of hydrophobic “pockets”, ANS fluorescence emission 
intensity increases and concomitantly blue-shifts.  
Titration of ANS with PrP(106-126) causes an increase in the fluorescence intensity and 
a significant blue shift (59nm) on the maxima of ANS emission (Figure 2), which is 
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indicative of the presence of aggregates in solution. This was detected at pH7.4 and pH5 
both for low and physiologic ionic strength. 
 
A        B 
 
Figure 1. Identification of β-structures in the PrP(106-126) by Congo Red absorbance. Absorbance 
spectra of 5μM CR in the presence of PrP(106-126) 0-50μM (A) at pH7.4, 150 mM NaCl or (B) at pH5, 
150mM NaCl. Absorbance was normalized to highlight the red shift at pH7.4 and the blue shift at pH5.0 
upon peptide addition. Inset: initial CR absorbance spectrum was subtracted to all the spectra obtained 
after peptide addition at pH 7.4 or pH5. At pH 7.4 is possible to identify an increase in the CR absorbance 
at 535nm with peptide concentration and at pH5 there is an increase at 496nm. This indicates that 
PrP(106-126) is interacting with CR, suggesting β-structures. This effect is stronger at pH7.4 than at pH5.  
 
 
Figure 2. Aggregation of PrP(106-126) evaluated 
by ANS fluorescence properties. A) The effect of 
peptide concentration in 12.5 μM ANS 
fluorescence emission spectrum (λexcitation=369nm, 
pH7.4, 150mM NaCl). Spectra were normalized to 
highlight ANS blue shift upon interaction with 
PrP. Inset: Dependence of integrated fluorescence 
intensity of ANS with peptide concentration. A 
significant blue shift and a concomitant increase in 
ANS fluorescence intensity indicates that this 
peptide is in an aggregated form.  
 
PrP(106-126) interaction with membranes – kinetic and affinity  
The interaction and affinity of PrP(106-126) to lipidic bilayers was studied by SPR with 
lipid membranes onto a sensor chip L1 (which contains a carboxymethylated dextran 
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matrix with lipophilic alkyl chains giving the surface amphiphilic properties). SPR has 
proven to be a valuable experimental approach to study the interaction of peptides with 
lipidic bilayers, which allows the real-time monitoring of peptide binding to and 
dissociation from the lipidic bilayers, and has the advantage of overcoming the need to 
use labelled peptides [37]. Liposomes are immobilized on the surface of the sensor chip 
and the peptide is passed across membrane. SPR detects changes in the optical 
properties of the sensor surface caused by the association/dissociation of the peptide 
to/from the lipid immobilized onto the sensor surface. The sensor surface response is 
proportional to the adsorbed mass on the sensor surface [37].  
In this study we have examined the association/dissociation of PrP(106-126) to/from 
lipidic membranes with different lipid compositions to get more insights on the 
parameters that govern peptide affinities and membrane preferences. 
 
A       B 
 
Figure 3. Lipidic composition and buffer effects on peptide affinity for lipidic membranes. (A) pH and 
ionic strength effect on PrP(106-126) (25μM) interaction with POPC membranes immobilized on the 
surface of L1 chip. HEPES buffer pH7.4, 150mM NaCl, Acetate buffer pH5, 150mM NaCl and Acetate 
buffer pH5, 10mM NaCl were used. The peptide does not have a detectable affinity for physiological 
membranes. At acidic pH a slightly increase in the peptide fraction bound occurs, which is enhanced at 
low ionic strength. (B) 25μM PrP(106-126) affinity for lipidic membranes immobilized on the surface of 
L1 chip at pH5, 10mM NaCl is represented for different lipidic composition: POPC, POPC/POPG (20% 
molar POPG), POPC/Chol (33% molar Chol) and POPC/GM1 (10% molar GM1). PrP(106-126) has 
higher affinity for membranes when anionic phospholipids are present. The Peptide does not bind 
significantly to POPC/Chol and POPC/GM1 lipidic membranes.  
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After bulk shift correction and evaluation of possible mass transport effect (see 
supporting information for this subject) it was possible to compare different sets of 
sensorgrams obtained in different conditions. The effect of pH and ionic strength on 
PrP(106-126) interaction with POPC is represented in Figure 3A. It is possible to 
conclude that in physiological conditions (pH7.4, 150mM NaCl) the peptide does not 
have a significant affinity for POPC membranes (see Figure 3A and Figure S.1.A in 
supporting information). A weak peptide interaction was detected for POPC at pH5, 
150mM NaCl (see Figure 3A and Figure S.1.B in supporting information). With acidic 
pH and low ionic strength (pH5, 10mMNaCl) an increase of RU signal intensity is 
observed (see Figure 3A and Figure S.1.C in supporting information). By comparison of 
POPC membranes with the ones containing POPG a charge effect is evident; an 
increase of peptide bound occurs in the presence of anionic phospolipid (Figure 3B). 
Interaction with POPC/Chol (33% molar chol) and POPC/GM1 (10% molar GM1) is 
not significant whatever the conditions tested (Figure 3B).  
 
A kinetic analysis was performed only with sensorgrams obtained with concentrations 
up to 25μM with POPC and POPC/POPG (20% molar POPG) surfaces in pH5 10mM 
NaCl (see Figure 4). These were the conditions where peptide/membrane interactions 
are more notorious. Using the simplest 1:1 Langmuir binding model resulted in a poor 
fit of the sensorgrams. The two-step binding model, which assumes a change in the 
structure of the peptide after initial binding to the membrane, leads to a significant 
improvement in fit quality. In this model the first step is the initial peptide interaction 
with membranes and is described by ka1 and kd1. Peptide binding is followed by 
reorientation and/or insertion of the peptide into the hydrophobic core (step two, 
described by ka2 and kd2) (for further details see references [37, 38] and references 
therein). Association rates (ka1, ka2), dissociation rates (kd1, kd2) and affinity constant 
obtained are present in Table 1. The most significant outcome of this kinetics analysis is 
the higher affinity constant for this peptide on the POPC/POPG membranes.  
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TABLE 1 Association (ka1 and ka2), dissociation (kd1 and kd2) and affinity constant (K) of PrP(106-126) 
binding to POPC and POPC/POPG (20% POPG molar percentage) lipidic bilayers in Acetate buffer, pH5 
containing 10mM NaCla 
 
Lipid type 
ka1 
(×102 1/Ms) 
kd1 
(×10-2 1/s) 
ka2 
(×10-3 1/s) 
kd2 
(×10-3 1/s) 
K 
(×104 1/s) χ
2 
POPC 5.05 1.35 5.30 1.56 1.26 5.14 
POPC/POPG 2.14 5.69 1.37 1.17 4.39 13.9 
 
a Binding constants were obtained after fitting the SPR data from Figure 5 to a two-step binding model 
with BIAevaluation version 3.0. Experimental conditions are described in the legend of Figure 4. 
 
 
A       B 
 
Figure 4. Global analysis of SPR data PrP(106-126) in the presence of POPC and POPC/POPG (20% 
molar POPG) membranes immobilized onto a L1 chip surface. Peptide samples (5, 10, 15, 20 and 25μM) 
prepared in acetate buffer, pH5, 10mM NaCl were injected at 20μL/min flow rate. Sensorgrams were 
corrected for bulk shift effect (grey lines) and a two-step binding model was fitted to data with 
BIAevaluation version 3.0 (black lines). All the parameters were fitted globally. K is the global affinity 
constant. Other kinetic constants are presented in table 1. 
 
CD spectroscopy for PrP(106-126) – secondary structure   
Regarding the previous results with ThT and CR dyes and previous publications [8] on 
PrP(106-126) secondary structure there are evidences for the contribution of β-sheet 
secondary structure in solution. In order to study the implications of the secondary 
structure of the peptide upon interaction with membranes, CD spectroscopy was used. 
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There are three major secondary structures identifiable by CD: a random coil structure 
which is characterized by the well defined poli(Pro)II (PPII) CD spectral form with a 
strong negative band around 195nm; a α-helix conformation with minima bands at 208 
and 222nm and a positive band at 192nm; and β-sheet with a positive band below 
200nm but with a single negative band at ∼ 220nm [39]. The CD signal for β-sheet 
conformation is weaker than the other two. β-rich proteins, depending on the 
interference of random coil signal can have a CD spectra that resemble those of model 
β-sheets or a CD spectra mainly dominated by random coil conformation domains, 
depending on the total random coil contribution. [39, 40]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. CD spectra of 100μM 
PrP(106-126) in the absence and in 
the presence of POPC/POPG (20% 
molar POPG) LUVs ([Lipid]=2mM). 
Three conditions were tested: 10mM 
HEPES buffer, pH7.4, 150mM NaCl; 
20mM Acetate buffer, pH5, 150mM 
NaCl and 20mM acetate buffer, pH5, 
10mM NaCl. 
 
Annex II  Chapter 7.  
 
 
 196
Figure 5 show no α-helix signal. At pH5, PrP(106-126) CD spectra have a strong 
negative band around 198nm which suggests that at acidic pH the peptide has a high 
contribution of random coil structure. This characteristic band is in agreement with 
previous results obtained in similar conditions [15], where the hydrophobic core 
(AGAAAAGAVVGGLG) seems to be important in the magnitude of this negative band 
(Ala was identified as the aminoacid with more propensity to have this random-like 
structure spectrum [41]).  
Upon interaction with membranes, the effect of the positive β band convoluted with the 
198nm random coil signal causes an apparent shift to lower energies and a concomitant 
decrease in intensity (see references [41-43]). This effect can only be ascertained to an 
increase in β content because the strong α-helix component at 222nm is absent. At 
physiological condition alteration in the band position was not detected in the presence 
of liposomes. Alteration in PrP(106-126) convoluted spectra after lipid addition, at pH 5 
and not at pH 7.4 is in agreement with SPR results. 
 
PrP(106-126) does not form ionic channel in physiological conditions 
One possible explanation for PrP(106-126) toxicity is channel formation across cell 
membranes. To test pore formation we took advantage of Co2+ properties as quencher of 
NBD fluorophores (for further details see material and methods section). SPR results 
showed that PrP(106-126) prefers vesicles with negatively-charged phospholipids. 
PrP(106-126) was not able to make vesicles permeable to Co2+ ions, regardless of the 
POPG percentages (0, 5, 10, 20 and 50% molar) at physiological conditions. At acidic 
pH it was only possible to have a noteworthy effect with low ionic strength (10mM 
NaCl) and high POPG percentage (50% molar – Figure 6). These are extreme 
conditions, and Co2+ permeability can only be achieved if electrostatic interactions force 
PrP(106-126) to interact with negatively charged vesicles. To rule out the possibility of 
a specific effect of phospholipid headgroup, experiments with POPS instead of POPG 
were also performed and no difference was noticed in the capacity to induce channel 
formation. 
The presence of cholesterol, and GM1 was also tested by the use of liposomes 
composed by POPC/Chol (33% molar chol) and POPC/GM1 (10% molar GM1). No 
leakage was observed in these liposomes neither in POPC/POPG/Chol (47:20:33 molar) 
in any of the buffers tested.  
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A       B 
 
Figure 6. Cross-bilayer channel formation induced by PrP(106-126) in 100 μM POPC/POPG (50% molar 
POPG) vesicles followed by NBD quenching by Co2+. The ratio of NBD fluorescence emission (λexcitation 
= 460nm) in the absence of quencher (I0) and in presence of 20mM Co2+ (I), for the vesicles with Co2+ 
accessible to both layers (white columns) and for the vesicles where Co2+ is only accessible to the outer 
layer (black columns), is presented for different peptide concentrations. These experiments where carried 
at pH5 containing A) 150mM NaCl or B) 10mM NaCl. Comparing the results (black columns) with the 
positive control (white columns) is possible to conclude that at 150mM NaCl PrP(106126) does not form 
pores even at high peptide/lipid ratio (1:2, for 50μM PrP(106-126)). At 10mM NaCl leakage increases is 
evident with peptide concentration. 
 
The effect of PrP(106-126) on membrane potential and the pH gradient 
Peptide insertion in lipidic bilayers is likely to perturb membrane dipolar potential 
which can be monitored by means of spectral shift in the excitation spectra of Di-8-
ANEPPS [32]. This dye is located in lipid headgroup region, where is sensitive to the 
local electric field [31]. In order to screen PrP(106-126) interaction with membranes, 
25μM PrP(106-126) fresh solution or aged solution was added to liposomes with 
different lipid compositions: POPC/POPG (0, 20, 30, 40, 50 and 100% molar POPG); 
POPC/POPS (20% molar POPS); POPC/Chol (0, 18 and 33% molar Chol); POPC/GM1 
(0, 5, 10, 20 and 50% molar GM1) and a mixture of POPC/POPG/Chol/GM1 
(37:20:33:10 molar). A noticeable shift in Di-8-ANEPPS was only observed with pH5 
10mM NaCl in lipidic vesicles composed by POPC/POPG (50% molar POPG) (Figure 
7). 
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Figure 7. PrP(106-126) effect in the dipolar potential of POPC/POPG (50% molar POPG) vesicles 
followed by fluorescence difference spectra of Di-8-ANEPPS-labelled vesicles. Excitation spectrum 
obtained in the absence of peptide was subtracted to the spectrum obtained in the presence of 25μM 
PrP(106-126); both spectra were normalized to the integrated areas to reflect only the spectral shift. The 
difference spectrum obtained in acetate buffer, pH5 10mM NaCl has a more pronounced shift than the 
other four difference spectra obtained with 150mM NaCl: pH 7.4, pH5 or with a pH gradient pH7.4/pH5 
(in/out) and pH5/pH7.4 (in/out). PrP(106-126) effect on dipolar potential is independent on pH or pH 
gradient but depends on ionic strength.  
 
A pH gradient can promote translocation across membrane of some peptides [44]. In the 
present work we have tested if pH gradient across endosomes/cytoplasm can promote 
PrP(106-126) interaction with membranes and induce membrane translocation. With a 
constant ionic strength (150mM NaCl), a pH gradient across membranes was created in 
POPC/POPG (50% molar POPG). Liposomes with pH5/pH7.4 (in/out) were compared 
with pH7.4/pH5 (in/out), pH7.4 (in/out) and pH5 (in/out) 150mM NaCl. No significant 
differences were detected between the samples with pH gradient and the controls (see 
Figure 7).  
 
DISCUSSION 
 
In the present work our main goal is to understand if PrP(106-126) interacts with 
biological membranes and if this possible interaction can or cannot explain toxic effect 
due to PrP(106-126). The study was carried on in model membranes and different 
membrane properties were modulated and three different buffers were tested: pH7.4 
containing 150mM NaCl to evaluate PrP(106-126) features at physiological conditions; 
pH5 containing 150mM NaCl to have insights in the possible interaction with 
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endosomes where some toxic PrP species were identified and possible PrPSc 
propagation has been suggested. A third condition, pH5 with low ionic strength (10 mM 
NaCl) was also studied for a better evaluation of charge effect and possible electrostatic 
interactions driving events.  
 
PrP(106-126) aggregation and secondary structure dependence on pH 
The existence of aggregates for PrP(106-126) was confirmed (Figure 2). CD spectra 
show a random coil organization without contribution of α-helix (Figure 5). 
Peptides/protein with different secondary structures (α-helix, α + β contributions) are 
able to interact with CR, while unfolded proteins are unable to interact with CR [45]. 
Due to lack of α-helix, binding of PrP(106-126) to CR (Figure 1) is explained by the 
presence of β-sheet structures. The relative contribution of random coil and β-sheet 
conformation in PrP(106-126) is dependent on pH and ionic strength (Figure 5). A 
higher β-sheet contribution is present at pH7.4 than at pH5.  
 
PrP(106-126) does not interact strongly with lipid membranes at physiological 
conditions 
PrP(106-126) interaction with membrane could be involved in cytotoxicity mechanisms 
by perturbation of membrane functions [46]. Interaction of PrP(106-126) with lipid 
membranes was evaluated by SPR and using fluorescence methodologies related to the 
variation of dipolar potential at the membrane. In an attempt to screen different lipidic 
systems in order to evaluate the effect of a specific phospholipid or other membrane 
components, model membranes of POPC were compared with membranes with more 
complex lipidic compositions such as POPC/POPG (20% molar POPG), POPC/Chol 
(33% molar Chol) or POPC/GM1(10% molar GM1). 
Phospholipids with a phosphatidylcholine (PC) headgroup are the major component in 
animal cell membranes [47]. This lipid forms bilayers in fluid phase at room 
temperature and can be used to represent the bulk phase in cell membrane. Negatively-
charged phospholipids are mainly present in the inner leaflet of plasma membrane [47] 
and have been implicated in amyloid fibril stimulation in vivo whatever the acidic 
headgroup [46]. This was been tested by means of membranes composed by 
POPC/POPG.   
Annex II  Chapter 7.  
 
 
 200
Rafts are specialized plasma membrane domains enriched in cholesterol and have been 
implicated in conversion of PrPC to PrPSc, where both isoform are localized. A chol 
depletion induces a decrease in PrPC-PrPSc conversion in prion infected cellular lines 
[48, 49]. The possible interaction of PrP(106-126) with these domains within plasma 
membrane was tested with vesicles composed by POPC/Chol.  
GM1 is a ganglioside abundantly expressed in neurons and concentrated in caveolae and 
lipid rafts regions and has been identified to bind specifically to Aβ peptide leading to 
the induction of β-structure [50-52] and also to induce membrane disruption [53]. The 
similarities between Aβ peptide amyloid formation in Alzheimer disease and Prion 
disease prompt us to study the effect of GM1 in PrP(106-126) membrane affinity with 
vesicles composed by POPC/GM1.  
At physiological conditions no interaction of PrP(106-126) with any of these lipidic 
membranes was detected. A lack of affinity for membranes at physiological buffer 
conditions was confirmed by membrane dipolar potential studies and leakage 
measurements. Moreover POPC/POPS was also tested, to exclude a possible specific 
interaction with PS and also a mixture of POPC/POPG/GM1/Chol. In none of these 
conditions PrP(106-126) insertion or membrane leakage was identified.  
 
PrP(106-126) only interacts with membranes at conditions where strong 
electrostatic interactions are operative 
At pH5, His residue in PrP(106-126) sequence is ionized and the formal net charge of 
peptide increases from +2 to +3 [6]. With pH5, 150mM NaCl a slight increase in 
membrane affinity was detected by SPR for POPC membranes. This affinity was greatly 
increased in the presence of POPG (negatively-charged phospholipid) and with low 
ionic strength. In such conditions, electrostatic interactions are enhanced due to 
electrostatic interactions between the positively charged peptide and negatively charged 
membrane. Even though, the RU obtained by SPR are lower than values verified for 
other peptides known to interact with membranes (values between 1000-10000 were 
obtained for peptides with similar length with the same sensor chip, [54, 55] compared 
to 100-250 for PrP(106-126) – Figure 4B). Nevertheless no insertion or pore formation 
was detected. 
It was suggested that amyloid formation is stimulated in the presence of hydrophobic 
environment at acidic pH [56]. PrP(106-126) at acidic pH and low ionic strength has a 
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lower propensity for β-sheet conformation, although an increase in β-structures was 
verified in the presence of lipidic vesicles (see Figure 6). SPR shows that a two state 
model kinetics of PrP(106-126) interaction with membranes at pH5 10mM NaCl are 
adequate to describe the data. Based on the results obtained, the two states may be 
identified: 1st) peptide interaction with membrane interface (governed by electrostatic 
interactions between peptide and membrane) and 2nd) the peptide undergoes a secondary 
structure modification at the bilayer surface; no insertion was detected.   
PrP(106-126) does not bind specifically with ganglioside GM1. GM1 has tendency to 
form microdomains in PC membranes [57, 58]. These domains are probably hindering 
the interaction of PrP(106-126) with POPC due to sugar headgroups stearic constraints, 
which explains the lower affinity for POPC/GM1 than to POPC at acidic pH (see Figure 
3B).  
The presence of Chol also reduces the affinity of PrP(106-126) to POPC membranes. A 
decrease in peptide affinity can arise from an increase in membrane viscosity due to 
Chol presence [59].  
Membrane insertion and channel formation was only detected with model membranes 
composed by POPC/POPG (50% molar POPG) at pH5 containing 10mM NaCl. In these 
conditions the membrane is strongly negatively charged and the low ionic strength is 
not enough to prevent a strong electrostatic attraction to the positively charged peptide. 
Regarding the possible importance of endosomes in PrP propagation we decided to 
mimic the pH gradient in cytoplasm/endosome environment. The pH gradient: pH7.4/5 
(in/out) or pH 5/7.4 (in/out) could eventually be a driving force for peptide insertion in 
the membrane, as observed for other peptides [44]. However for PrP(106-126) the pH 
gradient does not lead insertion (see Figure 7).  
 
Altogether peptide membrane studies show that PrP does not have affinity for lipidic 
membranes at conditions similar to the cytoplasmatic environment. At conditions 
similar to endosomal environment PrP(106-126) has weak interaction with membrane 
and in these conditions insertion or pore formation were not detected. Only in extreme 
conditions insertion and leakage were detected.   
The lack of affinity for lipid membrane can be understood based on thermodynamics of 
lipid-peptide interactions [60] and the interfacial hydrophobicity scale published by 
White and Wimley [61]. The interaction of a peptide with the lipid membrane can be 
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divided into three thermodynamic steps governed by electrostatic forces, hydrogen bond 
formation and hydrophobic interactions. The first step is initiated by the electrostatic 
attraction between peptide and membranes; the second step involves a transition of the 
peptide into the plane of binding, which depends on the hydrophobic/hydrophilic 
balance of the molecules groups and forces involved; and the third step involves a 
conformation modification of the bound peptide [60]. Electrostatic attraction is 
responsible for increasing the peptide concentration in membrane vicinity, however, 
even in conditions were PrP(160-126) charge can be prominent and a concentration of 
peptide occurs, the interfacial partitioning, mainly governed by hydrophobic effect, is 
not favourable considering the free energy for interfacial transfer of the overall PrP(106-
126) sequence (see Figure 8). An increase in partition at low ionic strength results from 
the increase in peptide concentration close to membrane environment.       
 
 
 
Figure 8. Theoretical analysis of PrP(106-126) 
partition into interfacial membrane region 
based free energy change ΔGwif from water 
transfer to lipid membrane interface (see 
reference [61]). Residues with Values ΔGwif <0 
have tendency to the membrane water-
interface. 
 
 
Contextualization of present results and biological relevance of PrP(106-126) 
Prion disease is initiated by conversion of physiological PrPC, a protein abundantly 
expressed in mammalian brain, into a pathological isoform PrPSc, which accumulates 
within the brain as highly toxic insoluble aggregates [1]. The neurodegeneration rate 
verified in Prion disease cannot be explained solely by PrPSc formation and deposition 
[6]; some other PrP toxic species have been identified inside the cells, which seem to 
have an important role in disease propagation and transmission after infection by PrPSc 
[6]. A neurotoxic PrP fragment, PrP(106-126) with physico-chemical properties similar 
to PrPSc and present in all abnormal toxic species within the patient brain, has been used 
as a model of PrPSc and to study the possible mechanism in disease propagation and 
transmission [8-13]. 
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PrP(106-126) toxicity remains controversial in literature. A mechanism by a non-
selective pore formation responsible for ionic gradient destabilization was proposed to 
explain PrP(106-126) neurotoxicity [16]. However channel formation was not 
reproduced in some reports [18] and neurotoxicity of this peptide was verified only in 
the presence of PrPC [62, 63].  
The present work shows that PrP(106-126), in conditions that mimic cytoplasmic 
environment, lacks propensity to interact with lipidic membranes and to form pores, 
whatever the lipid composition tested. Such observation indicates that toxic effects of 
PrP(106-126) cannot be explained by cell membrane leakage. Alternatively, it can be 
hypothesized that the PrP(106126) toxic effects occur inside the cell. Such suggestion 
implies PrP(106-126) cellular internalization, which is a phenomenon that has been 
verified for some peptides belonging to the cell-penetrating peptides (CPPs) family (for 
further information see reference [64]). The uptake of CPP can follow two routes: one is 
physically-mediated and the other is dependent on endosomal pathway. Both routes 
require peptide-membrane interactions as the first step [65] . With the lack of affinity of 
PrP(106-126) for lipid membranes both routes for cell entry are discarded, unless 
PrP(106-126) cellular internalization occurs via a mechanism mediated by the presence 
of a physiological PrP (e.g. mediated by caveolae or rafts where PrP is localized in cell 
surface). The N-terminal domain of PrP with a non-cleaved signal sequence has CPP 
properties and can be responsible by internalization of sizeable cargo into cells [66]. 
Implication in PrP trafficking as well as in prion infectivity has been suggested [66]. A 
possible internalization of PrP(106-126) in cells mediated by this N-terminal domain of 
PrP could explain possible toxic effects inside cells after internalization.  
In the present work we have tested if at endosomal environment PrP(106-126) has 
affinity for the membrane. An increased propensity to interact with lipid bilayer (see 
Figure 3A) and to form β-sheet structures in membrane vicinity (see Figure 5) was 
shown, however this does not represent a significant membrane insertion (see Figure 7) 
or an improved tendency to form transmembrane pore. This is in agreement with 
previous finding that the fibrilogenic properties alone are not sufficient for neurotoxicity 
as verified by other PrP fragments able to assemble into filaments but with lack of toxic 
effects [10]. Moreover, even with a pH gradient across membrane, similar to 
endosomal/cytoplasmic interface, insertion in membrane was not identified. Therefore, 
in the case PrP(106-126) fragment endosomal internalization, the toxic effect cannot be 
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explained by acidic pH. Altogether is possible to rule out the pore formation/or any 
direct effect on membrane properties to explain PrP(106-126) toxicity.  
Our results corroborate with previous reports where pore formation was not detected 
[18] reinforcing the hypothesis that PrPC is necessary to mediate PrP(106-126) toxicity 
[13]. One possible explanation is the formation of heterodimers of PrPC with PrP(106-
126) that stimulate PrPSc conversion into a pathological channel formation and manifest 
neurotoxicity or induce formation of abnormal PrP species upon interaction with PrPC. 
Formation of abnormal PrP species induced by PrP(106-126) was not confirmed [13]. 
Instead, it was suggested that this peptide may kill neurons by modification/inhibition of 
a physiological function of PrPC. In this hypothesis PrP(106-126) toxicity is related to a 
loss of PrP function instead of a gain of toxic properties in the presence of PrP(106-126) 
[13]. 
Physiological function of PrP is still in debate in literature. A SOD activity has been 
attributed to PrPC [67, 68] and recent reports suggest that PrP(106-126) inhibits SOD 
activity of PrPC [69]. Other hypothesis is that PrPC is important on β-secretase activity, 
which is responsible for Aβ peptide formation as in Alzheimer disease [70]. PrPC has 
been implicated in signal pathway, namely a possible blockage of a signal mediated by 
PrPC was also proposed to explain PrP(106-126) toxic effects [13]. 
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SUPPORTING INFORMATION 
 
Bulk shift correction 
Equivalent buffer composition in the sample and in running buffer is required, although 
exact matching was difficult to achieve due to varying peptide concentrations in the 
samples. Peptide samples were prepared by diluting stock solution in the running buffer. 
Because stock solution was in H2O sterile, the final concentration of buffer varies with 
peptide concentration, which results in different refractive indexes and thus vertical 
jumps in the responses upon peptide addition are observed in sensorgram curves (see 
Figure S.1). In order to compare the data analysis for the different peptide 
concentrations in different buffers studied, a bulk shift correction was applied to all sets 
of sensorgrams as suggested by good practice guidelines [71]. Examples of this effect 
and the correction of sensorgrams obtained with POPC are shown in Figure S.1.  
 
 
 
 
 
 
 
 
 
 
 
Figure S.1. Bulk refractive index effect on sensorgrams obtained in the study of PrP(106-126) interaction 
with POPC membranes immobilized on the surface of L1 chip. Sensorgrams obtained for PrP(106-126) 
interaction with lipidic membranes are affected by bulk refractive index, the response observed during 
injection sample in Biacore results from a combination of peptide binding to the sensor and differences 
between refractive index between samples and running buffer. To correct this effect, refractive indexes 
were calculated by the signal difference between the end of injection and a report point clear of bulk 
effects (in this case 2s after injection end). Refractive indexes were subtracted from the association curve. 
Sensograms obtained with different PrP(10-126) samples (0-50μM) injections onto POPC lipidic 
membrane at three different conditions are represented: A) HEPES buffer, pH7.4 with 150mM NaCl; B) 
Acetate buffer, pH5 with 150mMNaCl and C) Acetate buffer, pH5 with 10mMNaCl. At pH7.4 with 
150mM NaCl there is not a concentration effect, the signal is low and comparable with buffer signal. 
Peptide binding in this buffer is neglected.   
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A) pH7.4, 150mM NaCl 
 
 
 
 
 
 
 
 
 
 
 
  
B) pH5 150mM NaCl 
 
 
 
C) pH510mMNaCl 
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Evaluation of mass transport effect on SPR sensorgrams  
The kinetic in a sensorgram is a result of peptide molecules diffusion from the bulk 
solution to the surface and the peptide-membrane binding rate. The ideal situation is 
when the transport is faster than the binding and kinetic is not affected by molecule 
diffusion [72]. When the peptide/membrane binding rate is faster than peptide diffusion 
to the surface, or when the rate of these two processes are of similar magnitude kinetic 
an accurate binding rate constant is not possible to calculate unless this diffusion effect 
is accounted for. This effect is commonly designated by mass transport effect and its 
magnitude is dependent on the peptide flow rate [71]. In order to evaluate if kinetics is 
or not affected by this effect, sensograms obtained at different flow rates should be 
compared. In this particular case, peptide injections at 5μL/min and 20μL/min flow 
rates were compared. Peptide-membrane binding rate is highest at the beginning of the 
injection, while mass transport rate is constant through the injection since the peptide 
concentration is constant in solution. The relative contribution of mass transport rate on 
biochemical interaction varies during peptide injection. Diffusion effects have a higher 
contribution to the overall kinetics immediately after injection start. Comparing the 
initial rates for the sensograms obtained at 5μL/min vs. 20μL/min (Figure S.2) it was 
possible to conclude that the flow rate does not affect the kinetic. Binding rate for this 
system is not affected by mass transport effect; even though, the faster flow rate was 
chosen to carry on the experiments in order to avoid unspecific interactions or other 
effects.  
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Figure S.2. Evaluation of mass transport effect on PrP(106-126) interaction with POPC/POPG(4:1) 
membranes immobilized on the surface of L1 chip, pH 5 with 10mM NaCl. Two peptide injection flow 
rates, 5μL/min and 20μL/min, were compared to test if kinetic binding is affected by mass transport. 
Initial peptide binding rate was calculated in sensorgrams (corrected for bulk refractive index effect) by 
the initial slope of the sensogram using a report point placed shortly after the injection start (2s). By 
calculation of initial binding rates obtained within a peptide range concentration of 0-50μM it was 
possible to verify that initial binding is dependent on peptide concentration but independent on flow rate. 
No mass transport effects were detected for PrP(106-126). 
 
REFERENCES 
 
1 BIACORE (2001) Biacore concentration analysis handbook. Version AA. Biacore AB, Upsala 
 
2 Goldstein, B., Coombs, D., He, X., Pineda, A. R. and Wofsy, C. (1999) The influence of 
transport on the kinetics of binding to surface receptors: application to cells and BIAcore. J Mol 
Recognit 12, 293-299 
 
 
 
 214
 
    
 
 
 
 
 
 
 
Chapter 8 
 
 
 Bibliography 
 
  
 
 
 
 
Chapter 8.  Bibliography 
 
 
  217
 
 
Chapter 8.   
 
 
Bibliography 
 
 
1 Wadia, J. S., Becker-Hapak, M. and Dowdy, S. F. (2002) Protein Transport. In Cell-
penetrating peptides, processes and applications (Langel, Ü., ed.), pp. 365-375, CRC 
Press, New York 
 
2 Gao, X., Kim, K. S. and Liu, D. (2007) Nonviral gene delivery: what we know and what 
is next. Aaps J 9, E92-104 
 
3 Burton, E. A., Fink, D. J. and Glorioso, J. C. (2002) Gene delivery using herpes simplex 
virus vectors. DNA Cell Biol 21, 915-936 
 
4 Lai, C. M., Lai, Y. K. and Rakoczy, P. E. (2002) Adenovirus and adeno-associated virus 
vectors. DNA Cell Biol 21, 895-913 
 
5 Quinonez, R. and Sutton, R. E. (2002) Lentiviral vectors for gene delivery into cells. 
DNA Cell Biol 21, 937-951 
 
Bibliography  Chapter 8. 
 
 
 218
6 Smyth Templeton, N. (2002) Liposomal delivery of nucleic acids in vivo. DNA Cell 
Biol 21, 857-867 
 
7 Celis, J. E. (1984) Microinjection of somatic cells with micropipettes: comparison with 
other transfer techniques. Biochem J 223, 281-291 
 
8 Stephens, D. J. and Pepperkok, R. (2001) The many ways to cross the plasma 
membrane. Proc Natl Acad Sci U S A 98, 4295-4298 
 
9 Neumann, E., Schaefer-Ridder, M., Wang, Y. and Hofschneider, P. H. (1982) Gene 
transfer into mouse lyoma cells by electroporation in high electric fields. Embo J 1, 
841-845 
 
10 Henshaw, J. W. and Yuan, F. (2007) Field distribution and DNA transport in solid 
tumors during electric field-mediated gene delivery. J Pharm Sci 
 
11 Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, 
J. P., Ringold, G. M. and Danielsen, M. (1987) Lipofection: a highly efficient, lipid-
mediated DNA-transfection procedure. Proc Natl Acad Sci U S A 84, 7413-7417 
 
12 Hashida, M., Kawakami, S. and Yamashita, F. (2005) Lipid carrier systems for targeted 
drug and gene delivery. Chem Pharm Bull (Tokyo) 53, 871-880 
 
13 Frankel, A. D. and Pabo, C. O. (1988) Cellular uptake of the tat protein from human 
immunodeficiency virus. Cell 55, 1189-1193 
 
14 Joliot, A., Pernelle, C., Deagostini-Bazin, H. and Prochiantz, A. (1991) Antennapedia 
homeobox peptide regulates neural morphogenesis. Proc Natl Acad Sci U S A 88, 1864-
1868 
 
15 Vives, E., Brodin, P. and Lebleu, B. (1997) A truncated HIV-1 Tat protein basic domain 
rapidly translocates through the plasma membrane and accumulates in the cell nucleus. 
J Biol Chem 272, 16010-16017 
 
Chapter 8.  Bibliography 
 
 
  219
16 Derossi, D., Joliot, A. H., Chassaing, G. and Prochiantz, A. (1994) The third helix of 
the Antennapedia homeodomain translocates through biological membranes. J Biol 
Chem 269, 10444-10450 
 
17 Theodore, L., Derossi, D., Chassaing, G., Llirbat, B., Kubes, M., Jordan, P., Chneiweiss, 
H., Godement, P. and Prochiantz, A. (1995) Intraneuronal delivery of protein kinase C 
pseudosubstrate leads to growth cone collapse. J Neurosci 15, 7158-7167 
 
18 Fawell, S., Seery, J., Daikh, Y., Moore, C., Chen, L. L., Pepinsky, B. and Barsoum, J. 
(1994) Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci U 
S A 91, 664-668 
 
19 Ezhevsky, S. A., Nagahara, H., Vocero-Akbani, A. M., Gius, D. R., Wei, M. C. and 
Dowdy, S. F. (1997) Hypo-phosphorylation of the retinoblastoma protein (pRb) by 
cyclin D:Cdk4/6 complexes results in active pRb. Proc Natl Acad Sci U S A 94, 10699-
10704 
 
20 Lindgren, M., Hallbrink, M., Prochiantz, A. and Langel, U. (2000) Cell-penetrating 
peptides. Trends Pharmacol Sci 21, 99-103 
 
21 Prochiantz, A. (2000) Messenger proteins: homeoproteins, TAT and others. Curr Opin 
Cell Biol 12, 400-406 
 
22 Schwarze, S. R. and Dowdy, S. F. (2000) In vivo protein transduction: intracellular 
delivery of biologically active proteins, compounds and DNA. Trends Pharmacol Sci 21, 
45-48 
 
23 Schwarze, S. R., Ho, A., Vocero-Akbani, A. and Dowdy, S. F. (1999) In vivo protein 
transduction: delivery of a biologically active protein into the mouse. Science 285, 
1569-1572 
 
24 Elmquist, A., Lindgren, M., Bartfai, T. and Langel, U. (2001) VE-cadherin-derived cell-
penetrating peptide, pVEC, with carrier functions. Exp Cell Res 269, 237-244 
 
25 Elliott, G. and O'Hare, P. (1997) Intercellular trafficking and protein delivery by a 
herpesvirus structural protein. Cell 88, 223-233 
Bibliography  Chapter 8. 
 
 
 220
 
26 Hallbrink, M., Floren, A., Elmquist, A., Pooga, M., Bartfai, T. and Langel, U. (2001) 
Cargo delivery kinetics of cell-penetrating peptides. Biochim Biophys Acta 1515, 101-
109 
 
27 Futaki, S., Suzuki, T., Ohashi, W., Yagami, T., Tanaka, S., Ueda, K. and Sugiura, Y. 
(2001) Arginine-rich peptides. An abundant source of membrane-permeable peptides 
having potential as carriers for intracellular protein delivery. J Biol Chem 276, 5836-
5840 
 
28 Langel, U., Pooga, M., Kairane, C., Zilmer, M. and Bartfai, T. (1996) A galanin-
mastoparan chimeric peptide activates the Na+,K(+)-ATPase and reverses its inhibition 
by ouabain. Regul Pept 62, 47-52 
 
29 Morris, M. C., Vidal, P., Chaloin, L., Heitz, F. and Divita, G. (1997) A new peptide 
vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids 
Res 25, 2730-2736 
 
30 Scheller, A., Oehlke, J., Wiesner, B., Dathe, M., Krause, E., Beyermann, M., Melzig, M. 
and Bienert, M. (1999) Structural requirements for cellular uptake of alpha-helical 
amphipathic peptides. J Pept Sci 5, 185-194 
 
31 Mitchell, D. J., Kim, D. T., Steinman, L., Fathman, C. G. and Rothbard, J. B. (2000) 
Polyarginine enters cells more efficiently than other polycationic homopolymers. J Pept 
Res 56, 318-325 
 
32 Hariton-Gazal, E., Feder, R., Mor, A., Graessmann, A., Brack-Werner, R., Jans, D., 
Gilon, C. and Loyter, A. (2002) Targeting of nonkaryophilic cell-permeable peptides 
into the nuclei of intact cells by covalently attached nuclear localization signals. 
Biochemistry 41, 9208-9214 
 
33 Chaloin, L., Vidal, P., Lory, P., Mery, J., Lautredou, N., Divita, G. and Heitz, F. (1998) 
Design of carrier peptide-oligonucleotide conjugates with rapid membrane translocation 
and nuclear localization properties. Biochem Biophys Res Commun 243, 601-608 
 
Chapter 8.  Bibliography 
 
 
  221
34 Magzoub, M. and Graslund, A. (2004) Cell-penetrating peptides: from inception to 
application. Q Rev Biophys 37, 147-195 
 
35 Harada, H., Hiraoka, M. and Kizaka-Kondoh, S. (2002) Antitumor effect of TAT-
oxygen-dependent degradation-caspase-3 fusion protein specifically stabilized and 
activated in hypoxic tumor cells. Cancer Res 62, 2013-2018 
 
36 Klekotka, P. A., Santoro, S. A., Ho, A., Dowdy, S. F. and Zutter, M. M. (2001) 
Mammary epithelial cell-cycle progression via the alpha(2)beta(1) integrin: unique and 
synergistic roles of the alpha(2) cytoplasmic domain. Am J Pathol 159, 983-992 
 
37 Rojas, M., Donahue, J. P., Tan, Z. and Lin, Y. Z. (1998) Genetic engineering of proteins 
with cell membrane permeability. Nat Biotechnol 16, 370-375 
 
38 Borsello, T., Clarke, P. G., Hirt, L., Vercelli, A., Repici, M., Schorderet, D. F., 
Bogousslavsky, J. and Bonny, C. (2003) A peptide inhibitor of c-Jun N-terminal kinase 
protects against excitotoxicity and cerebral ischemia. Nat Med 9, 1180-1186 
 
39 Giorello, L., Clerico, L., Pescarolo, M. P., Vikhanskaya, F., Salmona, M., Colella, G., 
Bruno, S., Mancuso, T., Bagnasco, L., Russo, P. and Parodi, S. (1998) Inhibition of 
cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-type peptide 
fused to an internalization sequence. Cancer Res 58, 3654-3659 
 
40 Rojas, M., Yao, S., Donahue, J. P. and Lin, Y. Z. (1997) An alternative to 
phosphotyrosine-containing motifs for binding to an SH2 domain. Biochem Biophys 
Res Commun 234, 675-680 
 
41 Cutrona, G., Carpaneto, E. M., Ulivi, M., Roncella, S., Landt, O., Ferrarini, M. and 
Boffa, L. C. (2000) Effects in live cells of a c-myc anti-gene PNA linked to a nuclear 
localization signal. Nat Biotechnol 18, 300-303 
 
42 Moulton, H. M., Hase, M. C., Smith, K. M. and Iversen, P. L. (2003) HIV Tat peptide 
enhances cellular delivery of antisense morpholino oligomers. Antisense Nucleic Acid 
Drug Dev 13, 31-43 
 
Bibliography  Chapter 8. 
 
 
 222
43 Allinquant, B., Hantraye, P., Mailleux, P., Moya, K., Bouillot, C. and Prochiantz, A. 
(1995) Downregulation of amyloid precursor protein inhibits neurite outgrowth in vitro. 
J Cell Biol 128, 919-927 
 
44 Pooga, M., Soomets, U., Hallbrink, M., Valkna, A., Saar, K., Rezaei, K., Kahl, U., Hao, 
J. X., Xu, X. J., Wiesenfeld-Hallin, Z., Hokfelt, T., Bartfai, T. and Langel, U. (1998) 
Cell penetrating PNA constructs regulate galanin receptor levels and modify pain 
transmission in vivo. Nat Biotechnol 16, 857-861 
 
45 Simeoni, F., Morris, M. C., Heitz, F. and Divita, G. (2003) Insight into the mechanism 
of the peptide-based gene delivery system MPG: implications for delivery of siRNA 
into mammalian cells. Nucleic Acids Res 31, 2717-2724 
 
46 Simeoni, F., Morris, M. C., Heitz, F. and Divita, G. (2005) Peptide-based strategy for 
siRNA delivery into mammalian cells. Methods Mol Biol 309, 251-260 
 
47 Ignatovich, I. A., Dizhe, E. B., Pavlotskaya, A. V., Akifiev, B. N., Burov, S. V., Orlov, 
S. V. and Perevozchikov, A. P. (2003) Complexes of plasmid DNA with basic domain 
47-57 of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-
mediated pathways. J Biol Chem 278, 42625-42636 
 
48 Rudolph, C., Plank, C., Lausier, J., Schillinger, U., Muller, R. H. and Rosenecker, J. 
(2003) Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of 
transferring plasmid DNA into cells. J Biol Chem 278, 11411-11418 
 
49 Lewin, M., Carlesso, N., Tung, C. H., Tang, X. W., Cory, D., Scadden, D. T. and 
Weissleder, R. (2000) Tat peptide-derivatized magnetic nanoparticles allow in vivo 
tracking and recovery of progenitor cells. Nat Biotechnol 18, 410-414 
 
50 Torchilin, V. P., Rammohan, R., Weissig, V. and Levchenko, T. S. (2001) TAT peptide 
on the surface of liposomes affords their efficient intracellular delivery even at low 
temperature and in the presence of metabolic inhibitors. Proc Natl Acad Sci U S A 98, 
8786-8791 
 
Chapter 8.  Bibliography 
 
 
  223
51 Bucci, M., Gratton, J. P., Rudic, R. D., Acevedo, L., Roviezzo, F., Cirino, G. and Sessa, 
W. C. (2000) In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide 
synthesis and reduces inflammation. Nat Med 6, 1362-1367 
 
52 Rousselle, C., Clair, P., Lefauconnier, J. M., Kaczorek, M., Scherrmann, J. M. and 
Temsamani, J. (2000) New advances in the transport of doxorubicin through the blood-
brain barrier by a peptide vector-mediated strategy. Mol Pharmacol 57, 679-686 
 
53 Derossi, D., Calvet, S., Trembleau, A., Brunissen, A., Chassaing, G. and Prochiantz, A. 
(1996) Cell internalization of the third helix of the Antennapedia homeodomain is 
receptor-independent. J Biol Chem 271, 18188-18193 
 
54 Suzuki, T., Futaki, S., Niwa, M., Tanaka, S., Ueda, K. and Sugiura, Y. (2002) Possible 
existence of common internalization mechanisms among arginine-rich peptides. J Biol 
Chem 277, 2437-2443 
 
55 Lundberg, M. and Johansson, M. (2001) Is VP22 nuclear homing an artifact? Nat 
Biotechnol 19, 713-714 
 
56 Lundberg, M. and Johansson, M. (2002) Positively charged DNA-binding proteins 
cause apparent cell membrane translocation. Biochem Biophys Res Commun 291, 367-
371 
 
57 Melan, M. A. and Sluder, G. (1992) Redistribution and differential extraction of soluble 
proteins in permeabilized cultured cells. Implications for immunofluorescence 
microscopy. J Cell Sci 101 ( Pt 4), 731-743 
 
58 Thoren, P. E., Persson, D., Isakson, P., Goksor, M., Onfelt, A. and Norden, B. (2003) 
Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells. Biochem 
Biophys Res Commun 307, 100-107 
 
59 Drin, G., Cottin, S., Blanc, E., Rees, A. R. and Temsamani, J. (2003) Studies on the 
internalization mechanism of cationic cell-penetrating peptides. J Biol Chem 278, 
31192-31201 
 
Bibliography  Chapter 8. 
 
 
 224
60 Richard, J. P., Melikov, K., Vives, E., Ramos, C., Verbeure, B., Gait, M. J., 
Chernomordik, L. V. and Lebleu, B. (2003) Cell-penetrating peptides. A reevaluation of 
the mechanism of cellular uptake. J Biol Chem 278, 585-590 
 
61 Potocky, T. B., Menon, A. K. and Gellman, S. H. (2003) Cytoplasmic and nuclear 
delivery of a TAT-derived peptide and a beta-peptide after endocytic uptake into HeLa 
cells. J Biol Chem 278, 50188-50194 
 
62 Fittipaldi, A., Ferrari, A., Zoppe, M., Arcangeli, C., Pellegrini, V., Beltram, F. and 
Giacca, M. (2003) Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat 
fusion proteins. J Biol Chem 278, 34141-34149 
 
63 Console, S., Marty, C., Garcia-Echeverria, C., Schwendener, R. and Ballmer-Hofer, K. 
(2003) Antennapedia and HIV transactivator of transcription (TAT) "protein 
transduction domains" promote endocytosis of high molecular weight cargo upon 
binding to cell surface glycosaminoglycans. J Biol Chem 278, 35109-35114 
 
64 Lundberg, M., Wikstrom, S. and Johansson, M. (2003) Cell surface adherence and 
endocytosis of protein transduction domains. Mol Ther 8, 143-150 
 
65 Fischer, R., Kohler, K., Fotin-Mleczek, M. and Brock, R. (2004) A stepwise dissection 
of the intracellular fate of cationic cell-penetrating peptides. J Biol Chem 279, 12625-
12635 
 
66 Fuchs, S. M. and Raines, R. T. (2004) Pathway for polyarginine entry into mammalian 
cells. Biochemistry 43, 2438-2444 
 
67 Nakase, I., Niwa, M., Takeuchi, T., Sonomura, K., Kawabata, N., Koike, Y., Takehashi, 
M., Tanaka, S., Ueda, K., Simpson, J. C., Jones, A. T., Sugiura, Y. and Futaki, S. (2004) 
Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin 
rearrangement. Mol Ther 10, 1011-1022 
 
68 Wadia, J. S., Stan, R. V. and Dowdy, S. F. (2004) Transducible TAT-HA fusogenic 
peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat 
Med 10, 310-315 
 
Chapter 8.  Bibliography 
 
 
  225
69 Vendeville, A., Rayne, F., Bonhoure, A., Bettache, N., Montcourrier, P. and Beaumelle, 
B. (2004) HIV-1 Tat enters T cells using coated pits before translocating from acidified 
endosomes and eliciting biological responses. Mol Biol Cell 15, 2347-2360 
 
70 Richard, J. P., Melikov, K., Brooks, H., Prevot, P., Lebleu, B. and Chernomordik, L. V. 
(2005) Cellular uptake of unconjugated TAT peptide involves clathrin-dependent 
endocytosis and heparan sulfate receptors. J Biol Chem 280, 15300-15306 
 
71 Renigunta, A., Krasteva, G., Konig, P., Rose, F., Klepetko, W., Grimminger, F., Seeger, 
W. and Hanze, J. (2006) DNA transfer into human lung cells is improved with Tat-
RGD peptide by Caveoli-mediated endocytosis. Bioconjug Chem 17, 327-334 
 
72 Vives, E., Granier, C., Prevot, P. and Lebleu, B. (1997) Structure-activity relationship 
study of the plasma membrane translocating potential of a short peptide from HIV-1 Tat 
protein. Lett Pept Sci 4, 429-436 
 
73 Wender, P. A., Mitchell, D. J., Pattabiraman, K., Pelkey, E. T., Steinman, L. and 
Rothbard, J. B. (2000) The design, synthesis, and evaluation of molecules that enable or 
enhance cellular uptake: peptoid molecular transporters. Proc Natl Acad Sci U S A 97, 
13003-13008 
 
74 Ghibaudi, E., Boscolo, B., Inserra, G., Laurenti, E., Traversa, S., Barbero, L. and Ferrari, 
R. P. (2005) The interaction of the cell-penetrating peptide penetratin with heparin, 
heparansulfates and phospholipid vesicles investigated by ESR spectroscopy. J Pept Sci 
11, 401-409 
 
75 Letoha, T., Gaal, S., Somlai, C., Venkei, Z., Glavinas, H., Kusz, E., Duda, E., Czajlik, 
A., Petak, F. and Penke, B. (2005) Investigation of penetratin peptides. Part 2. In vitro 
uptake of penetratin and two of its derivatives. J Pept Sci 11, 805-811 
 
76 Letoha, T., Kusz, E., Papai, G., Szabolcs, A., Kaszaki, J., Varga, I., Takacs, T., Penke, 
B. and Duda, E. (2006) In vitro and in vivo NF-{kappa}B inhibitory effects of the cell-
penetrating penetratin Mol Pharmacol 69, 2027-2036 
 
Bibliography  Chapter 8. 
 
 
 226
77 Magzoub, M., Pramanik, A. and Graslund, A. (2005) Modeling the endosomal escape 
of cell-penetrating peptides: transmembrane pH gradient driven translocation across 
phospholipid bilayers. Biochemistry 44, 14890-14897 
 
78 Terrone, D., Sang, S. L., Roudaia, L. and Silvius, J. R. (2003) Penetratin and related 
cell-penetrating cationic peptides can translocate across lipid bilayers in the presence of 
a transbilayer potential. Biochemistry 42, 13787-13799 
 
79 Thoren, P. E., Persson, D., Karlsson, M. and Norden, B. (2000) The antennapedia 
peptide penetratin translocates across lipid bilayers - the first direct observation. FEBS 
Lett 482, 265-268 
 
80 Mann, D. A. and Frankel, A. D. (1991) Endocytosis and targeting of exogenous HIV-1 
Tat protein. Embo J 10, 1733-1739 
 
81 Rothbard, J. B., Jessop, T. C., Lewis, R. S., Murray, B. A. and Wender, P. A. (2004) 
Role of membrane potential and hydrogen bonding in the mechanism of translocation of 
guanidinium-rich peptides into cells. J Am Chem Soc 126, 9506-9507 
 
82 Abes, S., Turner, J. J., Ivanova, G. D., Owen, D., Williams, D., Arzumanov, A., Clair, 
P., Gait, M. J. and Lebleu, B. (2007) Efficient splicing correction by PNA conjugation 
to an R6-Penetratin delivery peptide. Nucleic Acids Res 35, 4495-4502 
 
83 Bogoyevitch, M. A., Kendrick, T. S., Ng, D. C. and Barr, R. K. (2002) Taking the cell 
by stealth or storm? Protein transduction domains (PTDs) as versatile vectors for 
delivery. DNA Cell Biol 21, 879-894 
 
84 Morris, M. C., Depollier, J., Mery, J., Heitz, F. and Divita, G. (2001) A peptide carrier 
for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol 19, 
1173-1176 
 
85 Peluso, J. J., Pappalardo, A. and Fernandez, G. (2001) Basic fibroblast growth factor 
maintains calcium homeostasis and granulosa cell viability by stimulating calcium 
efflux via a PKC delta-dependent pathway. Endocrinology 142, 4203-4211 
 
Chapter 8.  Bibliography 
 
 
  227
86 Zhou, J. and Hsieh, J. T. (2001) The inhibitory role of DOC-2/DAB2 in growth factor 
receptor-mediated signal cascade. DOC-2/DAB2-mediated inhibition of ERK 
phosphorylation via binding to Grb2. J Biol Chem 276, 27793-27798 
 
87 Zhang, Q., Nottke, A. and Goodman, R. H. (2005) Homeodomain-interacting protein 
kinase-2 mediates CtBP phosphorylation and degradation in UV-triggered apoptosis. 
Proc Natl Acad Sci U S A 102, 2802-2807 
 
88 Jurney, W. M., Gallo, G., Letourneau, P. C. and McLoon, S. C. (2002) Rac1-mediated 
endocytosis during ephrin-A2- and semaphorin 3A-induced growth cone collapse. J 
Neurosci 22, 6019-6028 
 
89 Bandichhor, R., Petrescu, A. D., Vespa, A., Kier, A. B., Schroeder, F. and Burgess, K. 
(2006) Synthesis of a new water-soluble rhodamine derivative and application to 
protein labeling and intracellular imaging. Bioconjug Chem 17, 1219-1225 
 
90 Jiang, J., Borisenko, G. G., Osipov, A., Martin, I., Chen, R., Shvedova, A. A., Sorokin, 
A., Tyurina, Y. Y., Potapovich, A., Tyurin, V. A., Graham, S. H. and Kagan, V. E. 
(2004) Arachidonic acid-induced carbon-centered radicals and phospholipid 
peroxidation in cyclo-oxygenase-2-transfected PC12 cells. J Neurochem 90, 1036-1049 
 
91 Sebbagh, M., Hamelin, J., Bertoglio, J., Solary, E. and Breard, J. (2005) Direct cleavage 
of ROCK II by granzyme B induces target cell membrane blebbing in a caspase-
independent manner. J Exp Med 201, 465-471 
 
92 Wu, Y., Wood, M. D., Tao, Y. and Katagiri, F. (2003) Direct delivery of bacterial 
avirulence proteins into resistant Arabidopsis protoplasts leads to hypersensitive cell 
death. Plant J 33, 131-137 
 
93 Jain, A., Brady-Kalnay, S. M. and Bellamkonda, R. V. (2004) Modulation of Rho 
GTPase activity alleviates chondroitin sulfate proteoglycan-dependent inhibition of 
neurite extension. J Neurosci Res 77, 299-307 
 
94 Buster, D., McNally, K. and McNally, F. J. (2002) Katanin inhibition prevents the 
redistribution of gamma-tubulin at mitosis. J Cell Sci 115, 1083-1092 
 
Bibliography  Chapter 8. 
 
 
 228
95 Coulpier, M., Anders, J. and Ibanez, C. F. (2002) Coordinated activation of 
autophosphorylation sites in the RET receptor tyrosine kinase: importance of tyrosine 
1062 for GDNF mediated neuronal differentiation and survival. J Biol Chem 277, 1991-
1999 
 
96 Gallo, G., Yee, H. F., Jr. and Letourneau, P. C. (2002) Actin turnover is required to 
prevent axon retraction driven by endogenous actomyosin contractility. J Cell Biol 158, 
1219-1228 
 
97 Ikari, A., Nakano, M., Kawano, K. and Suketa, Y. (2002) Up-regulation of sodium-
dependent glucose transporter by interaction with heat shock protein 70. J Biol Chem 
277, 33338-33343 
 
98 Remacle, A. G., Rozanov, D. V., Baciu, P. C., Chekanov, A. V., Golubkov, V. S. and 
Strongin, A. Y. (2005) The transmembrane domain is essential for the microtubular 
trafficking of membrane type-1 matrix metalloproteinase (MT1-MMP). J Cell Sci 118, 
4975-4984 
 
99 Tisdale, E. J. (2002) Glyceraldehyde-3-phosphate dehydrogenase is phosphorylated by 
protein kinase Ciota /lambda and plays a role in microtubule dynamics in the early 
secretory pathway. J Biol Chem 277, 3334-3341 
 
100 Aoshiba, K., Yokohori, N. and Nagai, A. (2003) Alveolar wall apoptosis causes lung 
destruction and emphysematous changes. Am J Respir Cell Mol Biol 28, 555-562 
 
101 Maron, M. B., Folkesson, H. G., Stader, S. M. and Walro, J. M. (2005) PKA delivery to 
the distal lung air spaces increases alveolar liquid clearance after isoproterenol-induced 
alveolar epithelial PKA desensitization. Am J Physiol Lung Cell Mol Physiol 289, 
L349-354 
 
102 Fernandez-Carneado, J., Kogan, M. J., Pujals, S. and Giralt, E. (2004) Amphipathic 
peptides and drug delivery. Biopolymers 76, 196-203 
 
103 Yeaman, M. R. and Yount, N. Y. (2003) Mechanisms of antimicrobial peptide action 
and resistance. Pharmacol Rev 55, 27-55 
 
Chapter 8.  Bibliography 
 
 
  229
104 Oehlke, J., Krause, E., Wiesner, B., Beyermann, M. and Bienert, M. (1996) 
Nonendocytic, amphipathicity dependent cellular uptake of helical model peptides. 
Protein Peptide Lett 3, 393-398 
 
105 Chaloin, L., Vidal, P., Heitz, A., Van Mau, N., Mery, J., Divita, G. and Heitz, F. (1997) 
Conformations of primary amphipathic carrier peptides in membrane mimicking 
environments. Biochemistry 36, 11179-11187 
 
106 Edidin, M. (2003) Lipids on the frontier: a century of cell-membrane bilayers. Nat Rev 
Mol Cell Biol 4, 414-418 
 
107 Gennis, R. B. (1989) Biomembranes molecular structure and function Spreinger-Verlag, 
New york 
 
108 Tanford, C. (1978) The hydrophobic effect and the organization of living matter. 
Science 200, 1012-1018 
 
109 Kranenburg, M. and Smit, B. (2005) Phase behavior of model lipid bilayers. J Phys 
Chem B 109, 6553-6563 
 
110 Sankaram, M. B. and Thompson, T. E. (1990) Modulation of phospholipid acyl chain 
order by cholesterol. A solid-state 2H nuclear magnetic resonance study. Biochemistry 
29, 10676-10684 
 
111 Singer, S. J. and Nicolson, G. L. (1972) The fluid mosaic model of the structure of cell 
membranes. Science 175, 720-731 
 
112 Simons, K. and Ikonen, E. (1997) Functional rafts in cell membranes. Nature 387, 569-
572 
 
113 de Almeida, R. F., Fedorov, A. and Prieto, M. (2003) 
Sphingomyelin/phosphatidylcholine/cholesterol phase diagram: boundaries and 
composition of lipid rafts. Biophys J 85, 2406-2416 
 
Bibliography  Chapter 8. 
 
 
 230
114 Chiantia, S., Kahya, N. and Schwille, P. (2007) Raft domain reorganization driven by 
short- and long-chain ceramide: a combined AFM and FCS study. Langmuir 23, 7659-
7665 
 
115 Op den Kamp, J. A. (1979) Lipid asymmetry in membranes. Annu Rev Biochem 48, 
47-71 
 
116 Depierre, J. W. and Dallner, G. (1975) Structural aspects of the membrane of the 
endoplasmic reticulum. Biochim Biophys Acta 415, 411-472 
 
117 Pomorski, T., Hrafnsdottir, S., Devaux, P. F. and van Meer, G. (2001) Lipid distribution 
and transport across cellular membranes. Semin Cell Dev Biol 12, 139-148 
 
118 Bretscher, M. S. (1972) Phosphatidyl-ethanolamine: differential labelling in intact cells 
and cell ghosts of human erythrocytes by a membrane-impermeable reagent. J Mol Biol 
71, 523-528 
 
119 Crain, R. C. and Zilversmit, D. B. (1980) Two nonspecific phospholipid exchange 
proteins from beef liver. 2. Use in studying the asymmetry and transbilayer movement 
of phosphatidylcholine, phosphatidylethanolamine, and sphingomyelin in intact rat 
erythrocytes. Biochemistry 19, 1440-1447 
 
120 Verkleij, A. J., Zwaal, R. F., Roelofsen, B., Comfurius, P., Kastelijn, D. and van 
Deenen, L. L. (1973) The asymmetric distribution of phospholipids in the human red 
cell membrane. A combined study using phospholipases and freeze-etch electron 
microscopy. Biochim Biophys Acta 323, 178-193 
 
121 Daleke, D. L. (2003) Regulation of transbilayer plasma membrane phospholipid 
asymmetry. J Lipid Res 44, 233-242 
 
122 Hill, W. G. and Zeidel, M. L. (2000) Reconstituting the barrier properties of a water-
tight epithelial membrane by design of leaflet-specific liposomes. J Biol Chem 275, 
30176-30185 
 
123 Zachowski, A. (1993) Phospholipids in animal eukaryotic membranes: transverse 
asymmetry and movement. Biochem J 294 ( Pt 1), 1-14 
Chapter 8.  Bibliography 
 
 
  231
 
124 O'Shea, P. (2003) Intermolecular interactions with/within cell membranes and the 
trinity of membrane potentials: kinetics and imaging. Biochem Soc Trans 31, 990-996 
 
125 Izumida, Y., Seiyama, A. and Maeda, N. (1991) Erythrocyte aggregation: bridging by 
macromolecules and electrostatic repulsion by sialic acid. Biochim Biophys Acta 1067, 
221-226 
 
126 McLaughlin, S. (1989) The electrostatic properties of membranes. Annu Rev Biophys 
Biophys Chem 18, 113-136 
 
127 Cladera, J. and O'Shea, P. (1998) Intramembrane molecular dipoles affect the 
membrane insertion and folding of a model amphiphilic peptide. Biophys J 74, 2434-
2442 
 
128 Shapovalov, V. L., Kotova, E. A., Rokitskaya, T. I. and Antonenko, Y. N. (1999) Effect 
of gramicidin A on the dipole potential of phospholipid membranes. Biophys J 77, 299-
305 
 
129 Skerjanc, I. S., Shore, G. C. and Silvius, J. R. (1987) The interaction of a synthetic 
mitochondrial signal peptide with lipid membranes is independent of transbilayer 
potential. Embo J 6, 3117-3123 
 
130 Wall, J., Ayoub, F. and O'Shea, P. (1995) Interactions of macromolecules with the 
mammalian cell surface. J Cell Sci 108 ( Pt 7), 2673-2682 
 
131 Wall, J., Golding, C. A., Van Veen, M. and O'Shea, P. (1995) The use of 
fluoresceinphosphatidylethanolamine (FPE) as a real-time probe for peptide-membrane 
interactions. Mol Membr Biol 12, 183-192 
 
132 Veiga, A. S. and Castanho, M. A. (2006) The membranes' role in the HIV-1 
neutralizing monoclonal antibody 2F5 mode of action needs re-evaluation. Antiviral 
Res 71, 69-72 
 
133 Bangham, A. D., Standish, M. M. and Watkins, J. C. (1965) Diffusion of univalent ions 
across the lamellae of swollen phospholipids. J Mol Biol 13, 238-252 
Bibliography  Chapter 8. 
 
 
 232
 
134 Mayer, L. D., Hope, M. J. and Cullis, P. R. (1986) Vesicles of variable sizes produced 
by a rapid extrusion procedure. Biochim Biophys Acta 858, 161-168 
 
135 Huang, C. (1969) Studies on phosphatidylcholine vesicles. Formation and physical 
characteristics. Biochemistry 8, 344-352 
 
136 Ladokhin, A. S., Jayasinghe, S. and White, S. H. (2000) How to measure and analyze 
tryptophan fluorescence in membranes properly, and why bother? Anal Biochem 285, 
235-245 
 
137 Wieprecht, T., Beyermann, M. and Seelig, J. (2002) Thermodynamics of the coil-alpha-
helix transition of amphipathic peptides in a membrane environment: the role of vesicle 
curvature. Biophys Chem 96, 191-201 
 
138 Lakowicz, J. R. (1999) Principles of fluorescence spectroscopy. Kluwer Academis, 
New York 
 
139 Santos, N. C. and Castanho, M. (2002) Fluorescence spectroscopy methodologies on 
the study of proteins and peptides. On the 150th anniversary of protein fluorescence. 
Trends Applied Spectroscopy 4, 113-125 
 
140 Santos, N. C., Prieto, M. and Castanho, M. A. (2003) Quantifying molecular partition 
into model systems of biomembranes: an emphasis on optical spectroscopic methods. 
Biochim Biophys Acta 1612, 123-135 
 
141 Fernandes, M. X., Garcia de la Torre, J. and Castanho, M. A. (2002) Joint determination 
by Brownian dynamics and fluorescence quenching of the in-depth location profile of 
biomolecules in membranes. Anal Biochem 307, 1-12 
 
142 Caputo, G. A. and London, E. (2003) Using a novel dual fluorescence quenching assay 
for measurement of tryptophan depth within lipid bilayers to determine hydrophobic 
alpha-helix locations within membranes. Biochemistry 42, 3265-3274 
 
Chapter 8.  Bibliography 
 
 
  233
143 Buser, C. A., Sigal, C. T., Resh, M. D. and McLaughlin, S. (1994) Membrane binding 
of myristylated peptides corresponding to the NH2 terminus of Src. Biochemistry 33, 
13093-13101 
 
144 Murray, D., Hermida-Matsumoto, L., Buser, C. A., Tsang, J., Sigal, C. T., Ben-Tal, N., 
Honig, B., Resh, M. D. and McLaughlin, S. (1998) Electrostatics and the membrane 
association of Src: theory and experiment. Biochemistry 37, 2145-2159 
 
145 Parasassi, T., Di Stefano, M., Loiero, M., Ravagnan, G. and Gratton, E. (1994) 
Influence of cholesterol on phospholipid bilayers phase domains as detected by Laurdan 
fluorescence. Biophys J 66, 120-132 
 
146 Reyes Mateo, C., Ulises Acuna, A. and Brochon, J. C. (1995) Liquid-crystalline phases 
of cholesterol/lipid bilayers as revealed by the fluorescence of trans-parinaric acid. 
Biophys J 68, 978-987 
 
147 Persson, D., Thoren, P. E. and Norden, B. (2001) Penetratin-induced aggregation and 
subsequent dissociation of negatively charged phospholipid vesicles. FEBS Lett 505, 
307-312 
 
148 Khlebtsov, B. N., Burygin, G. L., Matora, L. Y., Shchyogolev, S. Y. and Khlebtsov, N. 
G. (2004) A method for studying insoluble immune complexes. Biochim Biophys Acta 
1670, 199-207 
 
149 Basanez, G. (2002) Membrane fusion: the process and its energy suppliers. Cell Mol 
Life Sci 59, 1478-1490 
 
150 Nir, S. and Nieva, J. L. (2000) Interactions of peptides with liposomes: pore formation 
and fusion. Prog Lipid Res 39, 181-206 
 
151 Pecheur, E. I., Martin, I., Ruysschaert, J. M., Bienvenue, A. and Hoekstra, D. (1998) 
Membrane fusion induced by 11-mer anionic and cationic peptides: a structure-function 
study. Biochemistry 37, 2361-2371 
 
Bibliography  Chapter 8. 
 
 
 234
152 Huebsch, N. D. and Mooney, D. J. (2007) Fluorescent resonance energy transfer: A tool 
for probing molecular cell-biomaterial interactions in three dimensions. Biomaterials 28, 
2424-2437 
 
153 Henriques, S. T. and Castanho, M. A. (2005) Environmental factors that enhance the 
action of the cell penetrating peptide pep-1 A spectroscopic study using lipidic vesicles. 
Biochim Biophys Acta 1669, 75-86 
 
154 Dupont, E., Joliot, A. and Prochiantz, A. (2002) Penetratins. In Cell-Penetrating 
Peptides. Processes and Applications. (Langel, U., ed.), pp. 23-51, CRC press, New 
York 
 
155 Matsuzaki, K., Yoneyama, S. and Miyajima, K. (1997) Pore formation and translocation 
of melittin. Biophys J 73, 831-838 
 
156 Papo, N. and Shai, Y. (2003) Exploring peptide membrane interaction using surface 
plasmon resonance: differentiation between pore formation versus membrane disruption 
by lytic peptides. Biochemistry 42, 458-466 
 
157 Matsuzaki, K., Murase, O., Fujii, N. and Miyajima, K. (1995) Translocation of a 
channel-forming antimicrobial peptide, magainin 2, across lipid bilayers by forming a 
pore. Biochemistry 34, 6521-6526 
 
158 Kobayashi, S., Chikushi, A., Tougu, S., Imura, Y., Nishida, M., Yano, Y. and 
Matsuzaki, K. (2004) Membrane translocation mechanism of the antimicrobial peptide 
buforin 2. Biochemistry 43, 15610-15616 
 
159 Chattopadhyay, A. and London, E. (1988) Spectroscopic and ionization properties of N-
(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-labeled lipids in model membranes. Biochim 
Biophys Acta 938, 24-34 
 
160 Fattal, E., Nir, S., Parente, R. A. and Szoka, F. C. (1994) Pore-Forming Peptides Induce 
Rapid Phospholipid Flip-Flop in Membranes. Biochemistry 33, 6721-6731 
 
161 Kol, M. A., de Kroon, A. I. P. M., Rijkers, D. T. S., Killian, J. A. and de Kruijff, B. 
(2001) Membrane-spanning peptides induce phospholipid flop: A model for 
Chapter 8.  Bibliography 
 
 
  235
phospholipid translocation across the inner membrane of E-coli. Biochemistry 40, 
10500-10506 
 
162 Matsuzaki, K., Murase, O., Fujii, N. and Miyajima, K. (1996) An antimicrobial peptide, 
magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and 
peptide translocation. Biochemistry 35, 11361-11368 
 
163 John, K., Schreiber, S., Kubelt, J., Herrmann, A. and Muller, P. (2002) Transbilayer 
movement of phospholipids at the main phase transition of lipid membranes: 
implications for rapid flip-flop in biological membranes. Biophys J 83, 3315-3323 
 
164 Marx, U., Lassmann, G., Holzhutter, H. G., Wustner, D., Muller, P., Hohlig, A., Kubelt, 
J. and Herrmann, A. (2000) Rapid flip-flop of phospholipids in endoplasmic reticulum 
membranes studied by a stopped-flow approach. Biophys J 78, 2628-2640 
 
165 Maier, O., Oberle, V. and Hoekstra, D. (2002) Fluorescent lipid probes: some properties 
and applications (a review). Chemistry and Physics of Lipids 116, 3-18 
166 Abdalah, R., Wei, L., Francis, K. and Yu, S. P. (2006) Valinomycin-induced apoptosis 
in Chinese hamster ovary cells. Neurosci Lett 405, 68-73 
 
167 Rose, L. and Jenkins, A. T. (2007) The effect of the ionophore valinomycin on 
biomimetic solid supported lipid DPPTE/EPC membranes. Bioelectrochemistry 70, 
387-393 
 
168 Drin, G., Mazel, M., Clair, P., Mathieu, D., Kaczorek, M. and Temsamani, J. (2001) 
Physico-chemical requirements for cellular uptake of pAntp peptide. Role of lipid-
binding affinity. Eur J Biochem 268, 1304-1314 
 
169 Herbig, M. E., Weller, K., Krauss, U., Beck-Sickinger, A. G., Merkle, H. P. and Zerbe, 
O. (2005) Membrane surface-associated helices promote lipid interactions and cellular 
uptake of human calcitonin-derived cell penetrating peptides. Biophys J 89, 4056-4066 
 
170 Deshayes, S., Gerbal-Chaloin, S., Morris, M. C., Aldrian-Herrada, G., Charnet, P., 
Divita, G. and Heitz, F. (2004) On the mechanism of non-endosomial peptide-mediated 
cellular delivery of nucleic acids. Biochim Biophys Acta 1667, 141-147 
 
Bibliography  Chapter 8. 
 
 
 236
171 Zasloff, M. (2002) Antimicrobial peptides of multicellular organisms. Nature 415, 389-
395 
 
172 Shai, Y. (1999) Mechanism of the binding, insertion and destabilization of phospholipid 
bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-
lytic peptides. Biochim Biophys Acta 1462, 55-70 
 
173 Ludtke, S., He, K. and Huang, H. (1995) Membrane thinning caused by magainin 2. 
Biochemistry 34, 16764-16769 
 
174 Chen, F. Y., Lee, M. T. and Huang, H. W. (2002) Sigmoidal concentration dependence 
of antimicrobial peptide activities: a case study on alamethicin. Biophys J 82, 908-914 
 
175 Toke, O. (2005) Antimicrobial peptides: new candidates in the fight against bacterial 
infections. Biopolymers 80, 717-735 
 
176 Baumann, G. and Mueller, P. (1974) A molecular model of membrane excitability. J 
Supramol Struct 2, 538-557 
 
177 Ojcius, D. M. and Young, J. D. (1991) Cytolytic pore-forming proteins and peptides: is 
there a common structural motif? Trends Biochem Sci 16, 225-229 
 
178 Shai, Y. (1995) Molecular recognition between membrane-spanning polypeptides. 
Trends Biochem Sci 20, 460-464 
 
179 Zemel, A., Ben-Shaul, A. and May, S. (2005) Perturbation of a lipid membrane by 
amphipathic peptides and its role in pore formation. Eur Biophys J 34, 230-242 
 
180 Yang, L., Harroun, T. A., Weiss, T. M., Ding, L. and Huang, H. W. (2001) Barrel-stave 
model or toroidal model? A case study on melittin pores. Biophys J 81, 1475-1485 
 
181 Pouny, Y., Rapaport, D., Mor, A., Nicolas, P. and Shai, Y. (1992) Interaction of 
antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid 
membranes. Biochemistry 31, 12416-12423 
 
Chapter 8.  Bibliography 
 
 
  237
182 Shai, Y. (2002) Mode of action of membrane active antimicrobial peptides. 
Biopolymers 66, 236-248 
 
183 Seelig, J. (2004) Thermodynamics of lipid-peptide interactions. Biochim Biophys Acta 
1666, 40-50 
 
184 Blondelle, S. E., Lohner, K. and Aguilar, M. (1999) Lipid-induced conformation and 
lipid-binding properties of cytolytic and antimicrobial peptides: determination and 
biological specificity. Biochim Biophys Acta 1462, 89-108 
 
185 Deshayes, S., Heitz, A., Morris, M. C., Charnet, P., Divita, G. and Heitz, F. (2004) 
Insight into the mechanism of internalization of the cell-penetrating carrier peptide Pep-
1 through conformational analysis. Biochemistry 43, 1449-1457 
 
186 Henriques, S. T. and Castanho, M. A. (2004) Consequences of nonlytic membrane 
perturbation to the translocation of the cell penetrating peptide pep-1 in lipidic vesicles. 
Biochemistry 43, 9716-9724 
 
187 Kelly, S. M. and Price, N. C. (2000) The use of circular dichroism in the investigation 
of protein structure and function. Curr Protein Pept Sci 1, 349-384 
188 Greenfield, N. J. (1996) Methods to estimate the conformation of proteins and 
polypeptides from circular dichroism data. Anal Biochem 235, 1-10 
 
189 Sreerama, N. and Woody, R. W. (2003) Structural composition of betaI- and betaII-
proteins. Protein Sci 12, 384-388 
 
190 van Mierio, C. P. M., de Jongh, H. H. J. and Visser, A. J. W. G. (2000) Circular 
dichroism of proteins in solution and at interfaces. Applied spectroscopy reviews 35, 
277-313 
 
191 Kelly, S. M., Jess, T. J. and Price, N. C. (2005) How to study proteins by circular 
dichroism. Biochim Biophys Acta 1751, 119-139 
 
192 Miles, A. J. and Wallace, B. A. (2006) Synchrotron radiation circular dichroism 
spectroscopy of proteins and applications in structural and functional genomics. Chem 
Soc Rev 35, 39-51 
Bibliography  Chapter 8. 
 
 
 238
 
193 Goormaghtigh, E., Raussens, V. and Ruysschaert, J. M. (1999) Attenuated total 
reflection infrared spectroscopy of proteins and lipids in biological membranes. 
Biochim Biophys Acta 1422, 105-185 
 
194 Vigano, C., Manciu, L., Buyse, F., Goormaghtigh, E. and Ruysschaert, J. M. (2000) 
Attenuated total reflection IR spectroscopy as a tool to investigate the structure, 
orientation and tertiary structure changes in peptides and membrane proteins. 
Biopolymers 55, 373-380 
 
195 Tatulian, S. A. (2003) Attenuated total reflection Fourier transform infrared 
spectroscopy: a method of choice for studying membrane proteins and lipids. 
Biochemistry 42, 11898-11907 
 
196 Goormaghtigh, E., Cabiaux, E. and Ruysschaert, J. M. (1994) Determination of soluble 
and membrane protein structure by Fourier transform infrared soectroscopy. I. 
Assignments and model compounds. In Subcellular Biochemistry. Volume 23: 
Physicochemical methods in the study of Biomembranes (Herwig, J. and Ralston, G. B., 
eds.), pp. 329-362, Plenum Press, New York 
 
197 Arrondo, J. L. and Goni, F. M. (1999) Structure and dynamics of membrane proteins as 
studied by infrared spectroscopy. Prog Biophys Mol Biol 72, 367-405 
 
198 Barth, A. and Zscherp, C. (2002) What vibrations tell us about proteins. Q Rev Biophys 
35, 369-430 
 
199 Torrecillas, A., Martinez-Senac, M. M., Goormaghtigh, E., de Godos, A., Corbalan-
Garcia, S. and Gomez-Fernandez, J. C. (2005) Modulation of the membrane orientation 
and secondary structure of the C-terminal domains of Bak and Bcl-2 by lipids. 
Biochemistry 44, 10796-10809 
 
200 Oberg, K. A., Ruysschaert, J. M. and Goormaghtigh, E. (2004) The optimization of 
protein secondary structure determination with infrared and circular dichroism spectra. 
Eur J Biochem 271, 2937-2948 
 
Chapter 8.  Bibliography 
 
 
  239
201 Bechinger, B., Ruysschaert, J. M. and Goormaghtigh, E. (1999) Membrane helix 
orientation from linear dichroism of infrared attenuated total reflection spectra. Biophys 
J 76, 552-563 
 
202 Montal, M. and Mueller, P. (1972) Formation of bimolecular membranes from lipid 
monolayers and a study of their electrical properties. Proc Natl Acad Sci U S A 69, 
3561-3566 
 
203 Bivas, I. and Danelon, C. (2004) Fields and forces acting on a planar membrane with a 
conducting channel. Phys Rev E Stat Nonlin Soft Matter Phys 69, 041901 
 
204 Fuks, B. and Homble, F. (1994) Permeability and electrical properties of planar lipid 
membranes from thylakoid lipids. Biophys J 66, 1404-1414 
 
205 Micelli, S., Gallucci, E., Meleleo, D., Stipani, V. and Picciarelli, V. (2002) 
Mitochondrial porin incorporation into black lipid membranes: ionic and gating 
contribution to the total current. Bioelectrochemistry 57, 97-106 
 
206 Fidorra, M., Duelund, L., Leidy, C., Simonsen, A. C. and Bagatolli, L. A. (2006) 
Absence of fluid-ordered/fluid-disordered phase coexistence in ceramide/POPC 
mixtures containing cholesterol. Biophys J 90, 4437-4451 
 
207 Angelova, M. I. and Dimitrov, D. S. (1986) Liposome electroformation. Faraday 
Discuss. Chem. Soc. 81, 303-311 
 
208 Ambroggio, E. E., Separovic, F., Bowie, J. H., Fidelio, G. D. and Bagatolli, L. A. (2005) 
Direct visualization of membrane leakage induced by the antibiotic peptides: maculatin, 
citropin, and aurein. Biophys J 89, 1874-1881 
 
209 Ambroggio, E. E., Kim, D. H., Separovic, F., Barrow, C. J., Barnham, K. J., Bagatolli, 
L. A. and Fidelio, G. D. (2005) Surface behavior and lipid interaction of Alzheimer 
beta-amyloid peptide 1-42: a membrane-disrupting peptide. Biophys J 88, 2706-2713 
 
210 Bagatolli, L. A. and Gratton, E. (1999) Two-photon fluorescence microscopy 
observation of shape changes at the phase transition in phospholipid giant unilamellar 
vesicles. Biophys J 77, 2090-2101 
Bibliography  Chapter 8. 
 
 
 240
 
211 Nichols, B. J. and Lippincott-Schwartz, J. (2001) Endocytosis without clathrin coats. 
Trends Cell Biol 11, 406-412 
 
212 Stryer, L. (1996) Biochemistry. W. H. Freeman and company, New York 
 
213 Cardelli, J. (2001) Phagocytosis and macropinocytosis in Dictyostelium: 
phosphoinositide-based processes, biochemically distinct. Traffic 2, 311-320 
 
214 Conner, S. D. and Schmid, S. L. (2003) Regulated portals of entry into the cell. Nature 
422, 37-44 
 
215 Soldati, T. and Schliwa, M. (2006) Powering membrane traffic in endocytosis and 
recycling. Nat Rev Mol Cell Biol 7, 897-908 
 
216 Mayor, S. and Pagano, R. E. (2007) Pathways of clathrin-independent endocytosis. Nat 
Rev Mol Cell Biol 8, 603-612 
 
217 Meier, O. and Greber, U. F. (2003) Adenovirus endocytosis. J Gene Med 5, 451-462 
 
218 Swanson, J. A. and Watts, C. (1995) Macropinocytosis. Trends Cell Biol 5, 424-428 
 
219 Lewin, B. (2000) Genes VII. Oxford University Press, Oxford 
 
220 Hammond, A. T. and Glick, B. S. (2000) Dynamics of transitional endoplasmic 
reticulum sites in vertebrate cells. Mol Biol Cell 11, 3013-3030 
 
221 Sousa, V. L., Brito, C. and Costa, J. (2004) Deletion of the cytoplasmic domain of 
human alpha3/4 fucosyltransferase III causes the shift of the enzyme to early Golgi 
compartments. Biochim Biophys Acta 1675, 95-104 
 
222 Zhao, X., Lasell, T. K. and Melancon, P. (2002) Localization of large ADP-ribosylation 
factor-guanine nucleotide exchange factors to different Golgi compartments: evidence 
for distinct functions in protein traffic. Mol Biol Cell 13, 119-133 
 
Chapter 8.  Bibliography 
 
 
  241
223 Griffith, K. L. and Wolf, R. E., Jr. (2002) Measuring beta-galactosidase activity in 
bacteria: cell growth, permeabilization, and enzyme assays in 96-well arrays. Biochem 
Biophys Res Commun 290, 397-402 
 
224 McGuire, J. B., James, T. J., Imber, C. J., St Peter, S. D., Friend, P. J. and Taylor, R. P. 
(2002) Optimisation of an enzymatic method for beta-galactosidase. Clin Chim Acta 
326, 123-129 
 
225 Remani, P., Ostapenko, V. V., Akagi, K., Bhattathiri, V. N., Nair, M. K. and Tanaka, Y. 
(1999) Relation of transmembrane potential to cell survival following hyperthermia in 
HeLa cells. Cancer Lett 144, 117-123 
 
226 Li, Y., Um, S. Y. and McDonald, T. V. (2006) Voltage-gated potassium channels: 
regulation by accessory subunits. Neuroscientist 12, 199-210 
 
227 Iliev, I. G. and Marino, A. A. (1993) Potassium channels in epithelial cells. Cell Mol 
Biol Res 39, 601-611 
 
228 Chifflet, S., Hernandez, J. A., Grasso, S. and Cirillo, A. (2003) Nonspecific 
depolarization of the plasma membrane potential induces cytoskeletal modifications of 
bovine corneal endothelial cells in culture. Exp Cell Res 282, 1-13 
 
229 Sheline, C. T., Takata, T., Ying, H., Canzoniero, L. M., Yang, A., Yu, S. P. and Choi, D. 
W. (2004) Potassium attenuates zinc-induced death of cultured cortical astrocytes. Glia 
46, 18-27 
 
230 Henriques, S. T., Costa, J. and Castanho, M. A. (2005) Translocation of beta-
galactosidase mediated by the cell-penetrating peptide pep-1 into lipid vesicles and 
human HeLa cells is driven by membrane electrostatic potential. Biochemistry 44, 
10189-10198 
 
231 Scheller, A., Wiesner, B., Melzig, M., Bienert, M. and Oehlke, J. (2000) Evidence for 
an amphipathicity independent cellular uptake of amphipathic cell-penetrating peptides. 
Eur J Biochem 267, 6043-6050 
 
Bibliography  Chapter 8. 
 
 
 242
232 Kramer, S. D. and Wunderli-Allenspach, H. (2003) No entry for TAT(44-57) into 
liposomes and intact MDCK cells: novel approach to study membrane permeation of 
cell-penetrating peptides. Biochim Biophys Acta 1609, 161-169 
 
233 Takeshima, K., Chikushi, A., Lee, K. K., Yonehara, S. and Matsuzaki, K. (2003) 
Translocation of analogues of the antimicrobial peptides magainin and buforin across 
human cell membranes. J Biol Chem 278, 1310-1315 
 
234 Thoren, P. E., Persson, D., Esbjorner, E. K., Goksor, M., Lincoln, P. and Norden, B. 
(2004) Membrane binding and translocation of cell-penetrating peptides. Biochemistry 
43, 3471-3489 
 
235 Barany-Wallje, E., Keller, S., Serowy, S., Geibel, S., Pohl, P., Bienert, M. and Dathe, M. 
(2005) A critical reassessment of penetratin translocation across lipid membranes. 
Biophys J 89, 2513-2521 
 
236 Esteve, E., Mabrouk, K., Dupuis, A., Smida-Rezgui, S., Altafaj, X., Grunwald, D., 
Platel, J. C., Andreotti, N., Marty, I., Sabatier, J. M., Ronjat, M. and De Waard, M. 
(2005) Transduction of the scorpion toxin maurocalcine into cells. Evidence that the 
toxin crosses the plasma membrane. J Biol Chem 280, 12833-12839 
 
237 Farrera-Sinfreu, J., Giralt, E., Castel, S., Albericio, F. and Royo, M. (2005) Cell-
penetrating cis-gamma-amino-l-proline-derived peptides. J Am Chem Soc 127, 9459-
9468 
 
238 Holm, T., Netzereab, S., Hansen, M., Langel, U. and Hallbrink, M. (2005) Uptake of 
cell-penetrating peptides in yeasts. FEBS Lett 579, 5217-5222 
 
239 Jones, S. W., Christison, R., Bundell, K., Voyce, C. J., Brockbank, S. M., Newham, P. 
and Lindsay, M. A. (2005) Characterisation of cell-penetrating peptide-mediated 
peptide delivery. Br J Pharmacol 145, 1093-1102 
 
240 Mae, M., Myrberg, H., Jiang, Y., Paves, H., Valkna, A. and Langel, U. (2005) 
Internalisation of cell-penetrating peptides into tobacco protoplasts. Biochim Biophys 
Acta 1669, 101-107 
 
Chapter 8.  Bibliography 
 
 
  243
241 Maiolo, J. R., Ferrer, M. and Ottinger, E. A. (2005) Effects of cargo molecules on the 
cellular uptake of arginine-rich cell-penetrating peptides. Biochim Biophys Acta 1712, 
161-172 
 
242 Mano, M., Teodosio, C., Paiva, A., Simoes, S. and Pedroso de Lima, M. C. (2005) On 
the mechanisms of the internalization of S4(13)-PV cell-penetrating peptide. Biochem J 
390, 603-612 
 
243 Parenteau, J., Klinck, R., Good, L., Langel, U., Wellinger, R. J. and Elela, S. A. (2005) 
Free uptake of cell-penetrating peptides by fission yeast. FEBS Lett 579, 4873-4878 
 
244 Rennert, R., Wespe, C., Beck-Sickinger, A. G. and Neundorf, I. (2006) Developing 
novel hCT derived cell-penetrating peptides with improved metabolic stability. Biochim 
Biophys Acta 1758, 347-354 
 
245 Veach, R. A., Liu, D., Yao, S., Chen, Y., Liu, X. Y., Downs, S. and Hawiger, J. (2004) 
Receptor/transporter-independent targeting of functional peptides across the plasma 
membrane. J Biol Chem 279, 11425-11431 
 
246 Bjorklund, J., Biverstahl, H., Graslund, A., Maler, L. and Brzezinski, P. (2006) Real-
time transmembrane translocation of penetratin driven by light-generated proton 
pumping. Biophys J 91, L29-31 
 
247 Bodor, N., Toth-Sarudy, E., Holm, T., Pallagi, I., Vass, E., Buchwald, P. and Langel, U. 
(2007) Novel, cell-penetrating molecular transporters with flexible backbones and 
permanently charged side-chains. J Pharm Pharmacol 59, 1065-1076 
 
248 Duchardt, F., Fotin-Mleczek, M., Schwarz, H., Fischer, R. and Brock, R. (2007) A 
comprehensive model for the cellular uptake of cationic cell-penetrating peptides. 
Traffic 8, 848-866 
 
249 D'Ursi, A. M., Giusti, L., Albrizio, S., Porchia, F., Esposito, C., Caliendo, G., Gargini, 
C., Novellino, E., Lucacchini, A., Rovero, P. and Mazzoni, M. R. (2006) A membrane-
permeable peptide containing the last 21 residues of the G alpha(s) carboxyl terminus 
inhibits G(s)-coupled receptor signaling in intact cells: correlations between peptide 
structure and biological activity. Mol Pharmacol 69, 727-736 
Bibliography  Chapter 8. 
 
 
 244
 
250 Fernandez-Carneado, J., Kogan, M. J., Van Mau, N., Pujals, S., Lopez-Iglesias, C., 
Heitz, F. and Giralt, E. (2005) Fatty acyl moieties: improving Pro-rich peptide uptake 
inside HeLa cells. J Pept Res 65, 580-590 
 
251 Fretz, M. M., Penning, N. A., Al-Taei, S., Futaki, S., Takeuchi, T., Nakase, I., Storm, G. 
and Jones, A. T. (2007) Temperature-, concentration- and cholesterol-dependent 
translocation of L- and D-octa-arginine across the plasma and nuclear membrane of 
CD34+ leukaemia cells. Biochem J 403, 335-342 
 
252 Mabrouk, K., Ram, N., Boisseau, S., Strappazzon, F., Rehaim, A., Sadoul, R., Darbon, 
H., Ronjat, M. and De Waard, M. (2007) Critical amino acid residues of maurocalcine 
involved in pharmacology, lipid interaction and cell penetration. Biochim Biophys Acta 
1768, 2528-2540 
 
253 Palm, C., Netzereab, S. and Hallbrink, M. (2006) Quantitatively determined uptake of 
cell-penetrating peptides in non-mammalian cells with an evaluation of degradation and 
antimicrobial effects. Peptides 27, 1710-1716 
 
254 Rhee, M. and Davis, P. (2006) Mechanism of uptake of C105Y, a novel cell-penetrating 
peptide. J Biol Chem 281, 1233-1240 
 
255 Wu, R. P., Youngblood, D. S., Hassinger, J. N., Lovejoy, C. E., Nelson, M. H., Iversen, 
P. L. and Moulton, H. M. (2007) Cell-penetrating peptides as transporters for 
morpholino oligomers: effects of amino acid composition on intracellular delivery and 
cytotoxicity. Nucleic Acids Res 35, 5182-5191 
 
256 Marinova, Z., Vukojevic, V., Surcheva, S., Yakovleva, T., Cebers, G., Pasikova, N., 
Usynin, I., Hugonin, L., Fang, W., Hallberg, M., Hirschberg, D., Bergman, T., Langel, 
U., Hauser, K. F., Pramanik, A., Aldrich, J. V., Graslund, A., Terenius, L. and Bakalkin, 
G. (2005) Translocation of dynorphin neuropeptides across the plasma membrane. A 
putative mechanism of signal transmission. J Biol Chem 280, 26360-26370 
 
257 Mano, M., Henriques, A., Paiva, A., Prieto, M., Gavilanes, F., Simoes, S. and Pedroso 
de Lima, M. C. (2006) Cellular uptake of S4(13)-PV peptide occurs upon 
Chapter 8.  Bibliography 
 
 
  245
conformational changes induced by peptide-membrane interactions. Biochim Biophys 
Acta 1758, 336-346 
 
258 Boisseau, S., Mabrouk, K., Ram, N., Garmy, N., Collin, V., Tadmouri, A., Mikati, M., 
Sabatier, J. M., Ronjat, M., Fantini, J. and De Waard, M. (2006) Cell penetration 
properties of maurocalcine, a natural venom peptide active on the intracellular 
ryanodine receptor. Biochim Biophys Acta 1758, 308-319 
 
259 Szeto, H. H., Schiller, P. W., Zhao, K. and Luo, G. (2005) Fluorescent dyes alter 
intracellular targeting and function of cell-penetrating tetrapeptides. Faseb J 19, 118-
120 
 
260 Haugland, R. P. (2002) Handbook of fliorescent probes and research products. 
Molecular Probes, Inc., Eugene 
 
261 Rink, T. J., Montecucco, C., Hesketh, T. R. and Tsien, R. Y. (1980) Lymphocyte 
membrane potential assessed with fluorescent probes. Biochim Biophys Acta 595, 15-
30 
 
262 Wan, C. P., Park, C. S. and Lau, B. H. (1993) A rapid and simple microfluorometric 
phagocytosis assay. J Immunol Methods 162, 1-7 
 
263 Schwartz, J. W., Blakely, R. D. and DeFelice, L. J. (2003) Binding and transport in 
norepinephrine transporters. Real-time, spatially resolved analysis in single cells using a 
fluorescent substrate. J Biol Chem 278, 9768-9777 
 
264 Wang, Z., Leisner, T. M. and Parise, L. V. (2003) Platelet alpha2beta1 integrin 
activation: contribution of ligand internalization and the alpha2-cytoplasmic domain. 
Blood 102, 1307-1315 
 
265 Rejman, J., Oberle, V., Zuhorn, I. S. and Hoekstra, D. (2004) Size-dependent 
internalization of particles via the pathways of clathrin- and caveolae-mediated 
endocytosis. Biochem J 377, 159-169 
 
266 Mosiman, V. L., Patterson, B. K., Canterero, L. and Goolsby, C. L. (1997) Reducing 
cellular autofluorescence in flow cytometry: an in situ method. Cytometry 30, 151-156 
Bibliography  Chapter 8. 
 
 
 246
 
267 Zuhorn, I. S., Kalicharan, R. and Hoekstra, D. (2002) Lipoplex-mediated transfection of 
mammalian cells occurs through the cholesterol-dependent clathrin-mediated pathway 
of endocytosis. J Biol Chem 277, 18021-18028 
 
268 Henriques, S. T. and Castanho, M. A. (2007) Translocation or membrane disintegration? 
Implication of peptide-membrane interactions in pep-1 activity. J Pept Sci In press 
 
269 Henriques, S. T., Quintas, A., Bagatolli, L. A., Homble, F. and Castanho, M. A. (2007) 
Energy-independent translocation of cell-penetrating peptides occurs without formation 
of pores. A biophysical study with pep-1. Mol Membr Biol 24, 282-293 
 
270 Weller, K., Lauber, S., Lerch, M., Renaud, A., Merkle, H. P. and Zerbe, O. (2005) 
Biophysical and biological studies of end-group-modified derivatives of Pep-1. 
Biochemistry 44, 15799-15811 
 
271 Zhu, W. L., Lan, H., Park, I. S., Kim, J. I., Jin, H. Z., Hahm, K. S. and Shin, S. Y. (2006) 
Design and mechanism of action of a novel bacteria-selective antimicrobial peptide 
from the cell-penetrating peptide Pep-1. Biochem Biophys Res Commun 349, 769-774 
 
272 Deshayes, S., Plenat, T., Charnet, P., Divita, G., Molle, G. and Heitz, F. (2006) 
Formation of transmembrane ionic channels of primary amphipathic cell-penetrating 
peptides. Consequences on the mechanism of cell penetration. Biochim Biophys Acta 
1758, 1846-1851 
 
273 Killian, J. A. and von Heijne, G. (2000) How proteins adapt to a membrane-water 
interface. Trends Biochem Sci 25, 429-434 
 
274 Yau, W. M., Wimley, W. C., Gawrisch, K. and White, S. H. (1998) The preference of 
tryptophan for membrane interfaces. Biochemistry 37, 14713-14718 
 
275 Vives, E., Richard, J. P., Rispal, C. and Lebleu, B. (2003) TAT peptide internalization: 
seeking the mechanism of entry. Curr Protein Pept Sci 4, 125-132 
 
Chapter 8.  Bibliography 
 
 
  247
276 Henriques, S. T., Costa, J. and Castanho, M. A. (2005) Re-evaluating the role of 
strongly charged sequences in amphipathic cell-penetrating peptides: a fluorescence 
study using Pep-1. FEBS Lett 579, 4498-4502 
 
277 Henriques, S. T., Melo, M. N. and Castanho, M. A. (2006) Cell-penetrating peptides 
and antimicrobial peptides: how different are they? Biochem J 399, 1-7 
 
278 Christiaens, B., Symoens, S., Verheyden, S., Engelborghs, Y., Joliot, A., Prochiantz, A., 
Vandekerckhove, J., Rosseneu, M. and Vanloo, B. (2002) Tryptophan fluorescence 
study of the interaction of penetratin peptides with model membranes. Eur J Biochem 
269, 2918-2926 
 
279 Magzoub, M., Kilk, K., Eriksson, L. E., Langel, U. and Graslund, A. (2001) Interaction 
and structure induction of cell-penetrating peptides in the presence of phospholipid 
vesicles. Biochim Biophys Acta 1512, 77-89 
 
280 Thoren, P. E., Persson, D., Lincoln, P. and Norden, B. (2005) Membrane destabilizing 
properties of cell-penetrating peptides. Biophys Chem 114, 169-179 
 
281 Ziegler, A., Nervi, P., Durrenberger, M. and Seelig, J. (2005) The cationic cell-
penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly 
transported into living fibroblasts: optical, biophysical, and metabolic evidence. 
Biochemistry 44, 138-148 
 
282 Tunnemann, G., Martin, R. M., Haupt, S., Patsch, C., Edenhofer, F. and Cardoso, M. C. 
(2006) Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins 
and peptides in living cells. Faseb J 20, 1775-1784 
 
283 Mano, M., Henriques, A., Paiva, A., Prieto, M., Gavilanes, F., Simoes, S. and de Lima, 
M. C. (2007) Interaction of S413-PV cell penetrating peptide with model membranes: 
relevance to peptide translocation across biological membranes. J Pept Sci 13, 301-313 
 
284 Hallbrink, M., Oehlke, J., Papsdorf, G. and Bienert, M. (2004) Uptake of cell-
penetrating peptides is dependent on peptide-to-cell ratio rather than on peptide 
concentration. Biochim Biophys Acta 1667, 222-228 
 
Bibliography  Chapter 8. 
 
 
 248
285 Binder, H. and Lindblom, G. (2003) Charge-dependent translocation of the Trojan 
peptide penetratin across lipid membranes. Biophys J 85, 982-995 
 
286 Henriques, S. T., Melo, M. N. and Castanho, M. A. (2007) How to address CPP and 
AMP translocation? Methods to detect and quantify peptide internalization in vitro and 
in vivo (Review). Mol Membr Biol 24, 173-184 
 
 
 
